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high throughput sequencing (HTS) data. These include RNA-seq, ChIP-seq and scRNA-
seq data that have been generated in the laboratory as well as data that were publicly
available. The results are organized around two main topics:
The identication of conserved transcriptomic signatures for all ma-
jor pancreatic cell types. This work has already been associated to a rst
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results using the emerging scRNA-seq data.
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the pax6b gene. This reveals the pax6-dependent gene regulatory network
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1.1 Overview of Digestive System
Digestive system regroups all organs playing role in the processus of digestion (Figure
1) . Gastrointestinal (GI) tract is the main performer and its intervention starts directly
after food intake. Its functions are as varied as the mechanical food integrity disruption,
the progression of food bolus, the extraction and the absorption of nutrients or the
elimination of remaining solid wastes in the form of feces. Mobility of food bolus inside
the gut is performed through a large smooth muscle tissue maintaining constant tonus
in semi-tense state. It can be locally adapted to allow food to progress (peristalsis) or
to be stored in some specic portions [1]. Each region of the GI tract produces specic
secretions containing enzymes which will contribute to digest food. They are joined
in this function by accessory organs of digestion localized along the gut. Accessory
organs include both the tongue and the salivary glands, the pancreas, the liver and the
gallbladder. The rst two are involved in tasting and they respond by secreting mucous, to
facilitate swallowing, and digestive enzymes for breaking food. The pancreatic juice and
the bile, produced by liver and gallbladder, react with the chyme and create environment
which facilitates food degradation by the pancreatic digestive enzymes and the other GI
enzymes.
The global process of digestion needs to be strongly regulated and controlled in order to
work optimally. This is why the digestive system shelters an intrinsic nervous system
together with a specic part of the endocrine system. Enteroendocrine cells (EECs)
scattered in the GI tract represent the largest endocrine organ in the body in terms of
number of cells. Pancreatic endocrine cells (PECs) form another endocrine tissue inside
the digestive system which plays key role in glucose homeostasis by controlling the
balance between insulin/glucagon release. PECs are grouped in clusters, called the islets
(Islets of Langerhans), which are scattered in pancreatic tissue. This dispersion of both
EECs and PECs inside digestive organs suggests an interaction between exocrine and
13
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Figure 1: General overview of the gastrointestinal tract. Upper GI tract extends from
oral cavity to the duodenum. Lower GI tract extends from the end of the duodenum to the
anus. The tongue, the salivary glands, the pancreas, the liver and the gallbladder constitute
the accessory organs of digestion (https://en.wikipedia.org/wiki/Gastrointestinal_tract).
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endocrine cells. Endocrine cells act as sensors and initiate optimally the local response.
They also inform the rest of the body about what is happening in specic regions during
bolus progress. Finally, endocrine cells are closely associated with the enteric nervous
system (ENS) and the central nervous system (CNS) for controlling global GI processes.
1.2 Gastrointestinal tract
1.2.1 Anatomical description and functional organization
GI tract, or digestive tract, consists of all organs crossed by food intake during the
digestive process. In humans, it starts with the mouth and it runs successively through
pharynx, oesophagus, stomach, all parts of the intestine (duodenum, jejunum, ileum,
cecum, colon, rectum) and ends with the anus. GI tract can be divided in two spatial
regions separated by suspensory muscle of duodenum: upper and lower gastrointestinal
tracts.
1.2.2 Upper Gastrointestinal tract
Upper GI consists of all organs until the duodenum included [2] and it represents portions
where all secretions are continually added to food in order to break it down into small
nutrients before they can be absorbed. Salivary glands produce the rst secretions to
contribute to the rst bolus. They are represented by the major salivatory glands which
include parotid, submandibular and sublingual salivatory glands and by many minor
salivatory glands distributed in buccal cavity [3] (Figure 2). There are two dierent
types of secretions: serous and mucous. Serous secretions contains mainly two digestive
enzymes, amylase and lipase, which initiate digestion of starch and lipids respectively
[3, 4]. Mucous secretions contain mucin which acts as lubricant to facilitate mechanical
processes like mastication, swallowing and the bolus progress through oesophagus. The
junction between the oesophagus and the stomach, called the cardia, is kept shut by
muscles of the oesophagus and by the diaphragm. These muscles will relax during
swallowing to let food enters stomach [5].
The stomach consists of dierent parts: the fundus is the upper-part, the body (or corpus)
and the antrum represent the main region, and the pylorus is the nal portion connected
15
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Figure 2: The salivary glands. Major salivatory glands include parotid, submandibular
and sublingual salivatory glands. Multiple ducts lead their secretion in the buccal cavity.
Figure 3: The anatomy of the stomach. Food bolus enters the stomach cavity from
the oesophagus and reach the duodenum through the pyloric sphincter. Dierent regions
are observed: the fundus, the body, the antrum and the pylorus
16
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to the duodenum through pyloric canal and sphincter [5]. Stomach serves as a storage
point where gastric secretions create an acid environment which will bathe bolus to
progressively transform it into the chyme [6, 7]. Gastric smooth muscles perform regular
contractions to mix and to trigger gastric emptying. Pepsinogen is the proenzyme secreted
in the stomach and the acidication of the gastric content is mandatory for its conversion
to pepsin. Pepsin initiates protein degradation in order to reduce the size of nutrients [7].
Once it is suciently digested, chyme can run through the pyloric sphincter to reach
the duodenum (Figure 3). Duodenum forms the smallest part of intestine but plays a
key role for the absorption in the following intestine sections. Descending part of the
duodenum receives terminations of Wirsung duct (pancreatic juice) and bile duct (bile
from liver and gallbladder). Pancreatic juice has a high concentration of bicarbonates
to balance acidity of chyme inherited from stomach and contains pancreatic digestive
enzymes required for the rest of digestion [8]. Bile has hydrophillic and hydrophobic
properties which plays role in the emulsication of lipids. This leads to the essential
formation of fatty acid micelles to allow their absorption in intestine.
1.2.3 Lower Gastrointestinal tract
Lower GI consists of the rest of small intestine (jejunum and ileum) and the large intestine
(colon) [2]. Its main roles are the absorption of all nutrients together with the disposal
of solid waste in the form of feces. In both jejunum and ileum, mucosal layer increases
the surface in order to absorb maximum of nutrients. It is achieved by formation of
dierent macro and micro-anatomical structures. Circular folds are large projections
of the mucosal layer into the lumen which slows down the progress of chyme. Both
villi and crypts (crypt of Lieberkühn) form an intermediate structural organization of
the intestinal epithelium, closely associated with its stratication (Figure 4). Indeed,
the proliferative stem cells, found at the bottom of crypts, dierentiate progressively
into new enterocytes and secretory cells as they migrate along villi to balance the loss
of senescent cells at the apex [9]. Intestinal epithelium cells have the highest turnover
rate in adult mammals body and almost complete renewal of enterocytes occurs every 2
to 6 days [10] (Figure 5). Microvilli form micro-structures in comb shape adopted by
enterocytes at their apex which highly increase the cell surface in contact with lumen
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in order to maximize the absorption. Both jejunum and ileum are anatomically closed
but they present slightly functional dierences. The jejunum is where the majority of
nutrients are absorbed while the ileum is responsible for absorption of vitamin B12, bile
acids along with the remaining nutrients [11].
Figure 4: The anatomical organization of the intestin. The macro and micro-
anatomical structures adopted by the mucosal layer increase greatly the surface of
absorption in the intestin.
Colon does not possess the absorptive structural properties of the small intestine as
everything that reaches the colon is intended to be evacuated. The colon reabsorbs
remaining water molecules and causes waste desiccation to constitute feces which will
be evacuated through the anus sphincter [13, 14]. In the same time, microbiota starts
fermentation of products inside the colon to extract the remaining nutrients and it
produces additional waste important for feces formation [15]. Strong smooth muscles
contract sequentially (by waves) to assure peristalsis and the solid waste mashing in
order to facilitate formation of feces. Mobility in the colon is slower than in the small
intestine but waves allow progress of feces until rectum [14].
1.2.4 Nervous control of Gastrointestinal tract
Digestive tract needs to be well controlled to work optimally. It diers from all peripheral
organs by sheltering an extensive intrinsic nervous system, the enteric nervous system
(ENS). The ENS originates from the neural crest with enteric neural crest-derived cells
colonizing the entire GI tract. The ENS develops to constitute a network of neurons
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Figure 5: The intestinal epithelium present a high turnover rate (~ 2-6 days)
(adapted from Leushacke et al, 2014 [12]). Progenitor cells are located at the bottom
of the crypts and progressively migrate to the apex during maturation.
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and glia that pattern concentrically within the wall of the bowel [16]. It has multiple
roles: coordinating mobility across all GI tract, regulating gastric acid secretion and uid
movement, changing local blood ow and modifying nutrient handling [16–18]. Control
can be local with specic enteric reexes from ENS or central with the intervention
of central nervous system (Figure 6). The importance of integration of signals between
ENS and CNS diers along GI tract and the ENS organisation diers from conventional
descriptions of the autonomic nervous system. Indeed, eerent pathways from CNS
normally adopt two neurons in series structure [19] while the intestinofugal neurons from
ENS are neurons with cell bodies in GI wall and axons projecting directly to sympathetic
ganglia, pancreas, gallbladder and trachea but also to CNS [17] (Figure 6). In both
small and large intestine, ENS uses full reex mechanisms to direct movements in correct
direction and to control uid movements between the lumen and tissues [20]. Furthermore,
ENS is in strong relationship with both immune and endocrine systems which leads to
essential synergic roles in maintining mucosal barrier integrity and modulating nutrient
absorption.
1.2.5 Enteric endocrine system
The imposing surface area of the GI tract consists mostly of absorptive enterocytes.
Enteric endocrine system is represented by the large range of subsets of endocrine
cells called Enteroendocrine cells (EECs). They represent about 1% of GI epithelial cell
population and they are scattered along the tract together with other secretory cells [21].
All EECs collectively constitute the largest endocrine organ in the human body, in terms
of number of cells and especially in terms of the variety of hormones secreted. They
express more than 30 dierent hormone genes in all GI subsets combined [22]. They sense
the luminal content and release corresponding hormones to act on the digestive processes
locally or through direct connections with the nervous system to initiate appropriate
responses in the global GI tract [19, 23]. The EECs originate from the same progenitors
as other epithelial cells (Figure 7) and are also involved in the constant turnover from GI
epithelium [21].
Depending on their localization, EECs hormone expression and morphology can dier to
adapt to local GI functions. They are divided into two categories: “open” and “closed”
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Figure 6: Overview of the innervation of the gastrointestinal tract (from Furness




Figure 7: Schematic overview of dierentiation of intestinal epithelial cells in
mammals (from Posovszky et al, 2017). Early in the dierentiation, secretory or
absorptive fate are separated. Neurog3 expression initiates the enteroendocrine fate.
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types. Open-type EECs present bottle neck shape and apical prolongation in order to
reach lumen of the gut as they sport microvilli to directly sense luminal content. Closed-
type EECs localize near the basal membrane and don’t reach lumen which means that
their activation is indirect [23, 24]. For example, Gastrin secretion is exclusive of open-
type G-cells from stomach body and piloric region in response to luminal detection of
aminoacids and calcium. Gastrin acts on close-type enterochroman-like cells (ECL) of
gastric corpus which respond by producing histamine to activate secretion of acid gastric
by parietal cells [25].
More than 15 dierent subtypes of EECs have been identied along GI tract [26, 27]
(Figure 8). EECs are usually classied into subtypes according to the main hormone they
secrete. This classication has been discussed and it has to be modied as extensive
coexpression of hormones has been recently reported [28, 29]. Furthermore, all subtypes
are not distributed equally in GI tract as the location and environment drive the regulatory
mechanisms associated and required.
Figure 8: Enteroendocrine Cell Products and Functions (from Shroyer et Ko-
coshis, 2011)
1.3 Pancreas
1.3.1 Anatomical description and functional organization
Pancreas is one of the accessory organs of digestion along with tongue, salivary glands,
liver and gallbladder. Located behind the stomach, it divides in 3 anatomical regions:
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head of pancreas inserted inside the C-shape of duodenum; body representing the middle
portion; tail of pancreas which extends to spleen region. It forms a glandular organ
with amphicrine functions. Most of the pancreatic tissue is dedicated to pancreatic juice
production[30]. The large network of ducts collects and drives juice into the duodenum
lumen through duodenal papilla. Together they form the exocrine pancreas. On the
other hand, endocrine pancreas represents a very small portion of the pancreatic tissue.
However it produces and releases important hormones and performs fundamental role
in blood glucose homeostasis.
1.3.2 Exocrine pancreas
Exocrine tissue represents around 95% of the whole pancreatic tissue and is in charge of
pancreatic digestive contribution. It consists of two mains functional structures: acini and
ductal tree. The exocrine fundamental unit is composed of one acinus and an intercalated
duct. Acinar cells are organized in a lobule around an open chamber into which they
release their secretions. Intercalated ducts converge from acini and merge progressively
to form successively intralobular and interlobular ducts. It results into a principal duct
(Wirsung) which meets the common bile duct to form the ampulla of Vater before
owing into the duodenum through major duodenal papilla. A secondary duct (Santorini)
is sometimes observed. It has been observed that it can connect directly to the duodenum
through minor duodenal papilla or drains into the principal duct. Sphincter of Oddi is
the smooth muscular muscle forming a valve to control the ow of digestive juice from
ampulla of Vater and it also avoids any reux of duodenum content into the ductal tree
[31].
Acinar cells are specialized for production and export of a large amount of proteins. They
adopt a polarized morphology favorable to this function. The basal side of the cell contains
large and developed endoplasmic reticulum which actively produces enzymes and pro-
enzymes (zymogens) which are encapsulated inside vesicles and transported to the Golgi
apparatus. Immature secretory granules leave the Golgi complex and the maturation
occurs as they move closer to the apical side of the cell. Mature zymogen granules,
marked by condensation of proteins, are more electron-dense and their size has decreased
to two third [33]. Finally, exocytosis of secretory granules content is under the control
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Figure 9: Morphology of pancreatic acini and ductal tree (from Medical physiol-
ogy - 3rd edition[32]). Acinar cells are organized around an open chamber to form a
lobule. Acini secretions are collected by the ductal tree which brings them to the duo-
denum. Both cell types present a polarized morphology in relation with their function.
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of neurohumoral stimulation on the basal side of the cells [34, 35]. Cholecystokinin
and gastrin produced by EECs have been associated with the hormonal stimulation of
exocytosis. This induces the fusion of granules with the apical cell membrane followed
by the release of digestive enzymes in acinus lumen. Pancreatic digestive enzymes
include trypsin, chymotrypsin, pancreatic lipase, amylase but also ribonuclease,
deoxyribonuclease, gelatinase and elastase [36]. Trypsin and chymotrypsin are proteases
synthesized in their inactive form, trypsinogen and chymotrypsinogen respectively,
in order to avoid protease activity inside acinar cells. Trypsinogen will be activated into
trypsin by enterokinase expressed at the surface of the intestinal epithelium. Trypsin
activates successively the conversion of chymotrypsinogen into chymotrypsin together
with additional trypsinogen molecules.
Centroacinar cells ensure the junction between acini and the ductal tree and are followed
by ductal cells which adopt more classical cuboïdal morphology [31]. Pancreatic duct cells
produce an ion-rich uid, increasing the pancreatic juice volume, which hydrates and
alkalinizes protein-rich secretions of acini through secretion of water and and bicarbonate
(NaHCO3) [37–39]. The EECs inside duodenum produce a hormone, secretin, which
stimulates the production of bicarbonate by the ductal cells [40]. When owing in the
duodenum, pancreatic juice neutralizes gastric-inherited acidity of the chyme in order
to allow pancreatic enzymes to work optimally for the digestion of nutrients. Finally,
pancreatic ductal cells also secrete glycoproteins in order to protect the ductal tree from
enzymatic activity.
1.3.3 Endocrine pancreas
The endocrine tissue represents 1-2% of the whole pancreatic tissue [41]. All pancreatic
endocrine cells (PECs) are regrouped inside encapsulated small structures, called islets
of Langerhans, which are scattered between exocrine tissue with a higher density
detected in the tail of pancreas in human. Endocrine cells represent the great majority
of islet cells and numerous other cell types are represented: endothelial cells, other
stromal cells, immune cells, and neural elements [42, 43]. Vascularization of islets is
strongly developed according to the role performed by endocrine cells in sensing blood
content. PECs release the hormones directly into the blood, regulating distant target
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organs. While they represent only 1-2% of pancreatic mass, islets receive 10 to 15% of
blood ow dedicated to whole pancreas [43]. This is achieved through the formation of a
glomerular-like structure of fenestrated capillaries which allows close relationship with
endocrine cells.
We distinguish ve major PECs depending of the main hormone they produce: beta
cell (β) producing insulin, alpha cell (α) and glucagon, delta cell (δ) and somatostatin,
gamma (γ or PP) cell producing pancreatic polypeptide and nally the ghrelin-expressing
epsilon cell (ε) [44] (Figure 10).
In human, alpha (~40%) and beta (~50%) cells represent around 90% of PECs. A large
interspecies comparison of the islet structure has demonstrated that the proportion of
alpha and beta cells varies between species (Figure 11) [45]. Moreover, variations have
also been observed in the organization of the dierent endocrine cells within islets.
Insulin and glucagon are the two key regulators of the glucose homeostasis and they will
be discussed in the next section. Somatostatin (sst) is a widely eective hormone in human
body which acts as general inhibitory hormone in several organs. In the digestive tract, it
has global inhibitory eect on several processes: Sst is an inhibitor of the gastrin release
and thus the gastric acid secretion; it inhibits both bile and pancreatic secretions; it has
been described that sst inhibits the intestinal nutrient absorption but also the intestinal
mobility; nally it acts as an inhibitor of both insulin and glucagon secretions [46–49].
Pancreatic polypeptide (PP) acts as a postprandial important feedback hormone and it
has been associated with the control of appetite, weight and both endocrine and exocrine
pancreatic secretions [50–52]. Finally, ghrelin is known to be the hunger hormone but
recent ndings highlighted ghrelin roles in glucose homeostasis, energy homeostasis,
cardiac functions, muscle atrophy and bone metabolism. The presence of ghrelin hormone
and its receptor are also detected in many tumors where they might be associated to the
tumor growth and progression [53].
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Figure 10: The organization of the endocrine tissue. Islets are clusters of endocrine
cells and they are dissiminated inside the pancreatic exocrine tissue. Islets are vastly
vascularized as endocrine cells act as sensor of blood content.
1.4 Glucose homeostasis
Glycemia is the glucose concentration in blood circulation. Glucose homeostasis consists
of all mechanisms activated dynamically to maintain this concentration in physiologi-
cal range (80-100 mg/dl) [54]. As multiple events aect glycemia, this means that the
regulation is constant and highly dynamic. The balance between insulin and glucagon
secretion is the crucial driving mechanism for blood glucose homeostasis. Insulin is
the hypoglycemic hormone secreted by pancreatic β cells in response to an increased
glycemia. β cells present glucose sensing ability through expression of the glucose trans-
porter SLC2A2, glucokinase and through the glycolytic and oxidative metabolism of
this sugar [55, 56]. ATP-sensitive K+ (KATP) channels play central role by linking the
insulin secretion to the increase of blood glucose (glucose-dependent insulin secretion).
At physiological glucose concentrations, KATP channels are open and K+ eux creates a
negative potential on the cell membrane which keeps the voltage-gated Ca2+ channels
closed. A higher level of glycemia increases the glucose uptake by beta cells. It stimulates
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Figure 11: Multi-species comparison of the islet structure and composition (from
Steiner et al, 2010). The proportion of each endocrine cell type is subject to changes
between the dierent species. Alpha cells (red), Beta cells (green) and Delta cells (blue).
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the metabolism of beta cells resulting in changes in the cytosolic content, such as an
increase of ATP cytoplasmic concentration, and leading to the closure of KATP channels
[57]. The resulting depolarization of the membrane induces the opening of Ca2+ channels
and leads to a Ca2+ inux into the cell. The rise of Ca2+ cytoplasmic concentration
triggers exocytosis of secretory granules containing insulin [56, 58]. Recent evidence has
shown that a high glucose level in beta cells also induces the internalization of KATP
channels, and this could play an even greater eect on the excitability of beta cells than
the ATP-dependent closure of KATP channels [59]. Conversely, glucagon is an hyper-
glycemic hormone. Alpha cells present similar mechanisms of release at the dierence
they react to a decreased glycemia [60].
Glucose is the fundamental energy unit for cell activities and the cell glucose uptake
occurs through two mechanisms, called insulin-mediated glucose uptake (IMGU) and
non-insulin-mediated glucose uptake (NIMGU) [61]. Insulin aects preferentially skeletal
muscle, liver, adipose tissue and nervous system by stimulating the recruitment of glu-
cose transporters from cytoplasmic region to the plama membrane of cells [62, 63]. The
glucose excess is captured by these tissues and is successively metabolized for glucose
storage: glycogenesis (glycogen synthesis) in myocytes and hepatocytes; lipogenesis in
adipocytes and hepatocytes. Conversely, glucagon is expressed during physical activities
or between two meals, events characterized by decreasing glycemia. Glucagon triggers
glycogenolysis in liver which is the catabolism of glycogen molecules into glucose units.
The release of these units into blood circulation compensate the decrease in the glucose
concentration (Figure 12).
Furthermore, Insulin and glucagon act directly on opposite cell types to inhibit the antag-
onist secretion. This balance is also controlled by other hormones or signals from body
which implies that any disturbance can have major repercussions.
Finally, several dierent studies have identied a group of genes whose expression is
systematically reduced in pancreatic islet cells [64–68]. The expression of these “disal-
lowed” genes in pancreatic islet cells alters some of their important functional properties,
such as the normal regulation of insulin secretion in beta cells. The importance of the
repression of these genes in pancreatic islet cells is emphasized by the observation that a
disregulation of their expression is often observed in type 2 diabetes [69]. Moreover, the
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emergence of RNA-Seq datasets from puried islet cells has allowed to study the specic
repression of these disallowed genes in each individual islet cell types [70]. As a result,
the most strongly disallowed genes are similar in the dierent islet cell types. However,
several genes are only repressed in beta cells or alpha cells and could be associated with
more specic functional properties of these cells.
Figure 12: Glucose homeostasis. Imbalance in glycemia will trigger the response of the
corresponding cell type to bring back normal blood sugar. Insulin increases absorption of
glucose by the liver and the rest of the body tissues to decrease the glycemia. Conversely,




Diabetes is the term describing heterogeneous metabolic diseases where patient presents
hyperglycemia over prolonged period. Diabetes is often reduced to Diabetes Mellitus
(DM) in which the glucose homeostasis integrity is altered. However, it exists a second
form, called Diabetes insipidus, which originates from neurogenic or nephrogenic
defects of the vasopressin (ADH) signalling and resulting in excessive water loss by kidney
[71]. DM is divided in dierent categories based on the origin of the hyperglycemia.
Type 1 diabetes (T1D) covers all cases where insulin secretion is altered or missing.
It originates from an auto-immune disease which depends on genetic predispositions
or/and environmental conditions. Beta cells destruction is observed in T1D patients and
lead to a complete beta cell mass loss. Type 2 diabetes (T2D) is generally associated
with tissue insulin resistance disrupting IMGU. Evidence has shown that most of T2D
originate from two major pathophysiologic abnormalities [72]. (1) The gradual increase
of the peripheral resistance to insulin which can be due to defective insulin signaling
pathway or high lipidemia. In early stages of the developping disease, beta cells increase
insulin production to overcome the insulin-resistance and some patients will never
develop symptoms, even if no adaptation of diet or physical activities occurs. When
beta cells overload becomes unsustainable, beta cells destruction is observed together
with development of symptomes. (2) The beta cell failure plays a key role and can be
observed in the early stages of T2D development, already leading to a reduced expression
of insulin while a signicant peripheral resistance is yet to be observed [73]. It has been
associated with a reduced glucose sensitivity of the beta cells. Their functional activity
could continuously decline in parallel with the developement and the progression of the
disease. Genetic component is observed while an obesity associated with a fatty-rich
diet and a lack of sportive activities are two strong risk factors for developping T2D.
T1D and T2D accounts for ~10% and ~90%, respectively, of diagnosed diabetes [74, 75].
Beside those two, other forms of diabetes can be observed: Gestational Diabetes (GD)
can be developed during pregnancy; Maturity Onset Diabetes of the Young (MODY)




2 The Zebrash model
The use of animal models in biological and medical research is a common approach.
Rodents, such as mouse (Mus musculus) and rat (Rattus norvegicus), are widely used as
classical vertebrate models. Many strains have been actively selected and developed due
to their ability to mimic human traits, often associated to particular diseases. During the
last 3 decades, the use of the zebrash model (Danio rerio) has emerged quickly following
major breakthroughs in genetic engineering methods [76]. Zebrash is a small-bodied
tropical, freshwater sh species from South Asia with several key features such as the
ease of care and housing, year-round prolic breeding and its large ospring which
make it an interesting aordable model for laboratories. Beside the practical benets,
its biological features contributed widely to its recent success in many elds of biology.
External embryonic development, quick organogenesis, associated with the transparency
of the embryo and surrounding chorion make it an excellent model to study development,
notably using uorescent transgenic lines (Figure 13). As previously mentioned, progress
in molecular biology, high-throughput sequencing and imaging techniques increased
the eciency ot tools used on zebrash and prompt many scientists to work on that
animal model. Indeed, the relative ease of genetic manipulation in zebrash has led to
a wave of gene function studies by genetic screening of mutants at large scale. This
infatuation for zebrash was the so called “Big Screen” initiative undertaken by Christiane
Nusslein-Volhard in 90s [76, 77]. This eort has been followed by the sequencing of the
zebrash genome between 2001 and 2013 which highlighted about 26000 protein-coding
genes in zebrash [78]. In recent years, forward genetics has been progressively replaced
by targeted mutagenesis notably due to the emergence of new methods such as TALEN




Figure 13: Zebrash external development (from Meyers et al, 2018). During rst
stages of its developement, the zebrash embryo is translucent. It allows to observe and
study the development.
2.1 Comparative genomics of zebrash
Zebrash and human divergence time estimation is 450 mya (million years ago) when
bony vertebrates (Osteichthyes) divided into ray-nned shes (Actinopterygii) and lobe-
nned shes (Sarcopterygii). Zebrash belongs to Cyprinidae family inside Teleostei
infraclass, the largest of ray-nned shes. The teleosts (~ 310 mya [81]) experienced an
additional whole-genome duplication (WGD) to the two rounds of WGD experienced by
all vertebrates, with exception of the superclass Agnatha [82]. Comparative genomics
among the teleosts suggests that this teleost genome duplication (TGD) occured at the
base of the teleost radiation [83]. However, it is believed that whole genome chromo-
somal rearrangement occurred in the long lineage of teleosts leading to zebrash. This
hypothesis is supported by the fact that the zebrash genome only retained 20 to 30%
of the duplicated genes pairs from TGD. Moreover, zebrash genome presents a similar
amount of chromosomes as human (25 and 23 pairs respectively), rather than twice as
many, as would be expected from the TGF.
The identication of conserved syntenies between zebrash and human genomes was held
back by genome rearrangement and chromosomal restructuring between both species
[84]. The recent sequencing of the genome of spotted gar (Lepisosteus oculatus) [85], a
ray-nned sh diverging from teleosts prior to the TGD, revealed higher conservation
between human and gar compared to conservations between zebrash and human or
zebrash and gar. This observation supports the hypothesis that the TGD accelerated
the loss of ancestral syntenies in teleosts through chromosome rearrangement. WGD is




Conserved non-genic elements (CNEs) are invaluable resources in comparative genomics
as they represent non-coding regions selectively conserved. They have been associated
with transcription factor binding sites and other cis-acting regulatory elements and they
are potential important sites of evolutionary divergence. The gar genome also bridged
the teleosts to the tetrapods (including human) by highlighting novel syntenic regions,
including CNEs, between teleosts and human that do not directly align between them
[85]. The identication of CNEs by pairwise comparison of largely evolutionarily distant
species is challenging whereas comparing multiple genomes is more robust at capturing
orthologous sequences.
Finally, zebrash is evolutionarily distant from any other available sh genomes leading
to its current phylogenetic isolation [87] (Figure 14-A). The distance between zebrash
genome and the closest sequenced teleost is even higher than the distance between
human and chicken genomes (Figure 14-B). By identicating and sequencing a sh at
a comparable molecular distance to that between human and mouse, additional CNEs
currently not annotated in zebrash genome are expected to be revealed in the future.
Figure 14: The evolutionary distance between zebrash and human (adapted
from Hiller et al, 2013 [87]). (A) Phylogenic tree with branch lengths. Zebrash
is currently classied as a phylogenetic isolated species. (B) Evolutionary distances
(neutral substitutions per site) of sequenced species compared to zebrash and human




2.2 Zebrash and Gastroinstestinal tract
The zebrash owns a simplied version of the mammals GI tract highlighted by the
lack of a proper stomach. Intestine lls majority of the abdominal cavity and is divided
in three regions: the anterior, the mid and the posterior intestinal segments (Figure
15). The anterior intestinal segment, often called “the intestinal bulb”, presents wider
caliber than any other portions of the intestine and thus may function as a reservoir [88].
Similarly to mammals, GI functions are spatially distributed along the tract. Anterior
and mid intestinal segments are responsible on protein and lipid absorption, respectively,
while ion transport and water absorption occur in posterior segment [88, 89]. Zebrash
intestinal epithelium contains the same cell types as found in mammals, except that it
does not contain Paneth cells. Also, while the anatomy and architecture of the zebrash
gut are very similar to the mammalian gut, there are some dierences such as the absence
of the crypts of Lerberkuhn [88].
Figure 15: The anatomy of the zebrash GI tract (adapted fromWhite et al, 2013
[90]). The three intestinal segments are represented along with the pancreas. The red




2.3 Zebrash and Pancreas
The pancreas of zebrash presents anatomical and functional organization similar to
the mammalian pancreas. It is composed of pancreatic endocrine islets distributed
inside exocrine tissue, composed by acini and ducts. However, the pancreas does not
assemble in a concrete and compact individual organ but instead it forms a relatively
diuse tissue structure closely associated to the intestine (Figure 15). Exocrine tissue
organization is strongly similar to mammalian structure as ductal tree consists of extra and
intrapancreatic ducts connecting and collecting the secretions from acini [91]. However,
the endocrine tissue is slightly dierent. Indeed, zebrash endocrine pancreas consists
of a big principal islet located in the pancreatic head as well as smaller secondary islets
scattered in the tail segment [92]. Histologically, islets contain same cell subtypes with
the exception of PP cells which not exist in zebrash.
Pancreas functions are comparable to those found in mammals as evidenced by the
presence of active regulation of blood glucose through the balance between glucagon




Next generation sequencing (NGS) or high-throughput sequencing (HTS) refers to all tech-
nologies that perform massively parallel sequencing, producing millions of sequences
concurrently [94]. It has revolutionized genomic research by allowing the sequenc-
ing of genomes within a single day and by breaking “the $1000 genome” challenge
[95]. Last 10 to 15 years, NGS technologies have contributed to decrease drastically
the sequencing costs. They have driven the quick emergence of a multitude of ap-
plications with the most recent advances allowing researchers to work at the resolu-
tion of a single cell (Figure 16 and see https://www.illumina.com/content/dam/illumina-
marketing/documents/applications/ngs-library-prep/ForAllYouSeqMethods.pdf). In this
section, some popular applications will be presented as they were used in this work.
Figure 16: Genome sequencing costs (https://en.wikipedia.org/wiki/$1,000_genome). In
the past two decades, the evolution of technologies has decreased greatly the sequencing
cost per genome.
RNA Sequencing (RNA-Seq)
RNA-Seq is one of the most popular derived technology from NGS/HTS. The most com-
mon usage is to study the cell transcriptome by quantifying RNA presence in biological
samples. RNA can be isolated from heterogenous tissues or from a specic cell type using
cell sorting. RNA is puried to remove any DNA content. Quality of isolated RNA is
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then monitored as it will inuence the following steps. Depending on the interest, the
selection or depletion of specic type of RNA can be performed: messenger RNA selection,
ribosomal RNA depletion, RNA capture or size selection for micro-RNA. Selected RNA is
then reverse transcribed into more stable cDNA. Fragmentation of cDNA is performed
and is followed by the size selection of fragments with convenient size for the chosen
sequencing technology. Library preparation is the nal step before the sequencing as
specic adaptators will be added on both sides of fragments to allow the sequencing
process.
Chromatin Immuno-precipitation Sequencing (ChIP-Seq)
This method combines chromatin immunoprecipation and HTS. It is mainly used to study
the interaction of a protein with specic DNA regions. Using freshly dissected biological
materials, the crosslinking of protein-DNA complexes is performed using formaldehyde
solution. Complexes are then sheared into DNA fragments (~ 200-500 bp) by sonication or
nuclease digestion. Immunoprecipitation is performed using specic antibodies targeting
complexes formed by the protein of interest. Crosslinking is reversed by heating and
DNA molecules are puried and libraries are prepared for sequencing.
Single Cell Sequencing
Most recent optimizations of NGS capabilities allow now to dene signal at the level
of a single cell. RNA Sequencing at the level of a single cell (scRNA-Seq) has been the
rst application but protocols for ATAC-Seq or Whole-genome-amplication have also
been adapted to single cell resolution. scRNA-Seq allows highlighting and describing the
transcriptome of each existing cell type inside heterogenous tissue samples. It presents
the advantage to avoid the cell sorting step which has been the major concern to study
transcriptome of heterogeneous cell populations. However, the technique is less sensitive
than bulk RNA-Seq with the current estimation that around 15% to 20% of RNA content is
captured for a single cell. Finally, working with thousands of unique cell transcriptomes
in parallel has considerably increased the needed computational power and bioinformatic
software applied to single cell technology have developed quickly in recent years.
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4 Data analysis of transcriptomic experiments
4.1 The importance of the experimental design
The success of all RNA sequencing technologies is due to the improved sensibility and the
better ability at detecting transcripts than the previous methods, such as microarrays. It
is mainly due to a higher sensitivity and it detects more dynamically the gene expression
[96]. This sensitivity means that a special attention is required for the planication of the
global experiment: identifying the correct control condition, dening the required amount
of replicates, avoiding any confounding factors and listing all important parameters to
control during the experiment. It is important that the investigators clearly dene the
appropriate experimental design for their research. In a well-designed experiment, the
investigators should be aware of the characteristics and the weaknesses of their dataset
to correctly adjust their conclusions and ndings.
However, the increased sensitivity also means that all the small and uncontrolled changes
during the experiment could aect the outcomes of the analysis. The interpretation of
ndings depends on the ability to minimize all the external sources of variability. The
variability unrelated to the experimental design of the study is commonly called “batch
eect”. Koch and collaborators reviewed the most common sources of batch eect and
they proposed strategies to minimize them [96]. However, it is not always possible to
remove all sources of batch eect during the experiment. Using an appropriate software,
it is possible to control their impact during the in-silico analysis. This can only be
performed if the sources of variability have been clearly identied.
4.2 Aligning the data to a reference
Nowadays, most of the NGS facilities send the data to the researchers under FastQ format
[97]. It contains the sequence of all the fragments “read” by the HTS platform for a given
dataset, with the quality scores. When available, the reference genome is used to align
all these sequences on their source location, and they are mapped to the set of known
genes to obtain a raw count table. Specic pipelines allow the direct identication of
transcripts and to predict alternative splicing.
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The raw count table is the major output from this step. One could also use SAM/BAM les
[98] to directly visualize the alignment using a genome browser, such as IGV [99–101].
4.3 Normalization, sample variability, and outliers
The “downstream analysis” usually refers to all the analysis performed after getting
the raw count table. Based on the experimental design of the experiment, a variety of
dierent analysis can be performed. However, some key steps are mandatory to optimally
extract the information from a dataset.
The normalization of the dierent samples within a dataset is particularly important.
The simplest approach for the inter-sample normalization is to scale all gene expression
levels based on the dierence of library sizes between samples [102]. Depending on
the purpose, one could use dierent advanced methods to normalize the raw counts
between samples [102]. Some factors such as the gene length or the global distribution of
gene expression are then considered in non-linear normalization strategies. One could
mention the “Reads Per Kilobase per Millions mapped reads” (RPKM) approach which is
a quite popular method to normalize raw counts for sequencing depth and gene length.
This is an ecient intra-sample normalization procedure. However, this method has
been characterized to introduce a bias in the per-gene variances, in particular for lowly
expressed genes, when performing a dierential expression analysis [103].
The next important step is to assess the variability inside the dataset. Dierent methods
can be used to assess this variability. The most used approaches are the Principal Com-
ponent Analysis (PCA) and the dierent measures of correlation such as the Pearson’s
coecient or the Spearman’s rank correlation coecient [104, 105]. PCA is a method
from multivariate statistics for the dimensional reduction of data without the loss of
information. It reduces all the variables of a dataset, usually all the genes, to a limited
number of dimensions called Principal Components (PCs) still reecting the complete
variability inside the dataset. The PCs are ranked based on the variation they explain.
PC1 explains the most variation within the dataset, PC2 the second most, and so forth.
Both the PC1 and the PC2 usually cover together the majority of the total variation.
The two-dimensional visualization of PCs is generally called PCA plot (Figure 17). The
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measure of correlation between samples is another approach commonly used and it relies
on the calculation of the distance between samples. This distance is represented by a
correlation coecient depending on the correlation method used. The higher is the
coecient between two samples, the most similar they are.
Figure 17: PCA plot. This is an example of the two-dimensional visualization of principal
component analysis on the Iris Data Set. The contribution of original variables to each
PCs can be observed.
Both approaches are tools to visualize the clustering between the conditions and the
replicates to directly identify the potential outliers. The variability between the dierent
conditions, the intergroup variability, is expected to be higher than the variability between
samples inside a condition, the intragroup variability. In a well-design experiment, the
intragroup variability is correlated to the residual batch eect. It may originate from both
technical and biological variabilities. Moreover, the dierent experimental conditions
may present a dierent intragroup variability as they can be dierently aected by the
external sources of variability. At the end of this process, one should be aware of the
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variability inside a dataset and any clearly identied outliers must be removed to secure
the downstream analysis.
4.4 Dierential expression analysis
Once the quality control, normalization, and ltering steps are performed, the inves-
tigators may focus their analysis on the principal purpose of RNA-Seq analysis: the
identication of a set of dierentially expressed (DE) genes for the dierent conditions.
Several tools have been developed in the last decade, presenting their own methods.
Basically, they are quite similar and the choice of one or another may rely on the experi-
mental design of the experiment. For example, the methods provided by the R packages
DESeq2 and edgeR are very popular. Both rely on the strong assumption that most of the
genes are not dierentially expressed, and that for those dierentially expressed there
is an approximately balanced proportion of over- and under-expression [102, 106–108].
However, in most of these methods, the dierential expression analysis is performed
following a pairwise comparison between two conditions. When comparing multiple
conditions (n > 2), one may choose an alternative approach using an analysis of variance
(ANOVA) method.
The output of the dierential expression analysis is a table. For each gene, it contains
the log2 fold change between the two conditions (e.g. pairwise), the P value of the test,
and the adjusted P value for multiple testing. The volcano plot is a good tool to visualize
the table by plotting p-values against log2 fold change. However, the MA plot is an
alternative vastly used to visualize DE genes (Figure 18). It consists in plotting log2 fold
change against the mean of expression level over the two conditions (e.g. normalized
counts, logarithmically transformed of not).
4.5 Other downstream analysis
From a list of DE genes, several additional downstream analyses may be performed
depending on the interest of the investigators. One could be interested in clustering the
genes following their pattern of expression. Hierarchical and k-means clustering methods
are among the most frequently used. The purpose of these analyses is to identify dierent
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Figure 18: MA plot. This is an example of MA plot for the visualization of a dierential
expression analysis. For all genes, the log of the fold change between the two evaluated
conditions is plotted in relation to the expression level. Red dots are the genes with a
signicant dierential expression. Genes up-regulated in the treated condition are above
the red line, genes down-regulated are below this line.
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modules of genes with a similar expression pattern across the samples and conditions.
Functional enrichment analysis represents the dierent methods for imputing a bio-
logical meaning to a set of DE genes. The approach relies on testing a list of genes
against databases of biological information. Multiple “command-line” or online software
(PANTHER [109], GOrilla [110, 111], GSEA [112, 113] or Enrichr [114, 115]) allow to
use a variety of scientic databases such as Gene Ontology (GO), WikiPathways, KEGG
or Reactome. Most of these methods perform a hypergeometric test to evaluate the
signicance of the enrichment.
4.6 Working with single-cell data
Working at the level of a single cell transcriptome brings an additional challenge. Prior
to the downstream analysis, it already implies few changes to produce the gene count
matrix. One of the most signicant change is that you must attribute all reads to the all
individual cells. This is achieved through the combination of cell barcodes and Unique
Molecular Identier (UMI). The approach is quite similar between the dierent single-cell
technologies, with some specic methodological dierences. UMIs are used to reduce the
eect of the PCR amplication during the RNA-Seq library preparation. It results that
the duplicated reads of a same fragment will only count once.
Concerning the downstream analysis, a supplemental challenging step is to remove
barcodes corresponding to “doublet cells”. Doublet cells, or doublets, are barcodes for
which two cells have been taken together. Practically, it occurs when two cells were put
in the same droplet or the same well on a plate, depending on the single-cell technology.
The detection of doublets is not an easy task in silico. The library size of doublet is
expected to be higher, but it does not represent a reliable criterion to remove barcodes.
Recently, several advanced methods have been developed to improve the detection of
doublets. One of these methods allows adding dierent tags to all the cells and they
are analysed separately to dene droplets/well containing singlets or doublets [116].
Another approach relies on the combination of several individuals inside a multiplexed
SC experiment and it can associate each cell to the correct genotype using natural genetic
variation [117]. Moreover, eorts are also made to computationally detect them [118].
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It relies on the identication of a transcriptionally aberrant signature (e.g. mixing two
distinct cell type signatures).
The methods for most of the downstream analyses of single-cell data are similar to those
for bulk data. However, the normalization step is particularly aected by the “single-cell”
approach. Firstly, the number of genes detected by cell is quite low (it varies with the
technology used) and the variable eciency of the RNA capture (~10-30%) between all
cells leads to a “sparse” gene count matrix with many zero-count values. None of the
current pipelines present an ideal method for this step as it relies on the evolution of the
SC technology in the future. For example, the Seurat R package from Satija Lab started by
employing a global-scaling normalization method called “LogNormalize” that normalizes
the gene expression values for each cell by the total expression, multiplies this by a scale
factor, and log-transforms the result [119, 120]. Their eort in improving this step leads
to a new model called “SCTransform” which relies on the use of a regularized negative
binomial regression for normalization and variance stabilization [121].
Finally, the visualization of a SC dataset also implies some computational adaptation.
An initial linear dimensional reduction of the data is performed through PCA and the
identication of dierent clusters of cells is obtained through dierent clustering algo-
rithms using the PCA space. In recent years, several non-linear dimensional reduction
techniques, such as UMAP (Uniform Manifold Approximation and Projection) and t-SNE
(t-distributed Stochastic Neighbor Embedding), have been adapted for the visualisation
of single-cell data [122, 123]. These algorithms learn the underlying manifold of the data
to place similar cells together in a low-dimensional space. For an optimal visualization,




Figure 19: UMAP and t-SNE (from Becht et al, 2019). These non-linear dimensional
reduction methods are used to distribute cells into a two-dimensional embedding. Cells
are placed according to their similarity. (a) Colored according to broad cell lineages. (b)
Colored according to the tissue of origin.
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State of the art
1 Transcriptome of adult pancreatic cells
Transcriptomic proling of cell types is an important tool in modern molecular biology.
During nearly 20 years from the early 90s to 2010, microarray analysis and quantitative
RT-PCR were used to estimate expression level of chosen gene subsets. Then, NGS
technology strongly contributed to the quick development of transcriptomic analysis in
the last decade by allowing one to work more precisely and accurately at the genome-wide
level. RNA-Seq protocols have constantly evolved to be more sensitive for dierent types
of research. However, the bulk RNA-Seq approach had his limit of application when the
ability to isolate cell populations prior to RNA extraction was inecient. When studying
animal models, the use of transgenic lines expressing uorescent proteins in specic cell
types has allowed good cell population isolation using FACS. Using human tissue, this
approach was not possible and specic cells of interest were dicult to retrieve eciently.
Fortunately, the recent emergence of scRNA-Seq allowed overcoming this barrier and
many transcriptomic studies performed on dierent human tissues have been undertaken
recently using this technique.
Pancreas-associated transcriptomic studies have followed the same chronology. Human
pancreatic cell transcriptomes have rst been studied by microarrays and then bulk
RNA-seq using whole pancreatic islets [124] or were focused on beta cells [125, 126].
“Beta cell regeneration” has been one of the driving factors for pancreatic transcriptomic
interest. Identication of beta cell specic transcription factors was an important step for
programming pluripotent stem cells into beta cells. Beta cell interest implied that the other
pancreatic cell types have been somewhat neglected until the emergence of microarray
analyses for most of pancreatic cells [128], soon followed by RNA-Seq experiments [129–
133]. For human tissues, the use of cell-surface markers for the isolation of specic cell
types still presented limitations as it was a source of variability in the sample purity.
It is nally with scRNA-Seq that multiple studies using human tissues provided the
transcriptomes for most of the major pancreatic cell types [134–138]. However, dierent
technologies were developed leading to dierent impacts on outcomes.
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Limitations of human experimentation led pancreas studies to be transposed to animal
models. Mouse represents the most common mammalian model and pancreatic researches
make no exception. Pancreatic development or pancreatic diseases such as diabetes or
pancreatic cancer have been widely studied in the murine model. Concerning transcrip-
tomic studies, both bulk RNA-Seq and scRNA-Seq experiments have been performed on
pancreatic tissues [131, 134, 140, 141]. Zebrash is another model commonly used to
study pancreatic development or diseases. As previously mentioned, genome engineering
features of zebrash led to establishment of multiple transgenic lines in recent years.
The specic expression of uorescent proteins in pancreatic cells in dierent transgenic
models, associated with the transparency of the zebrash embryo and to its external
development, has been a powerful approach to characterize the dynamics of pancreatic
development in zebrash [142–145] . Moreover, relatively facilitated mutagenesis led to
the generation of many functional analyses of genes and to the modeling of pancreatic
diseases. Several transcriptomic studies have been published in recent years using RNA-
Seq or scRNA-Seq [146–148].
The following sections summarize the main function of each endocrine pancreatic cell
type as well as some key factors involved in their identity and physiological roles. As the
present study is focused on the transcriptome of pancreatic cells, some key transcript
markers will be presented.
1.1 Beta cells
Due to their role in both type I and type II diabetes, beta cells have been the most studied
pancreatic islet cell types. Many microarray or sequencing-based transcriptomic studies
have been performed on beta cells in both healthy or pathologic conditions making
the identity of the mature beta cell the most elucidated among pancreatic cells. The
maturation of beta cells has been associated with the expression of UCN3 [149] while
many transcription factors involved during endocrine cell dierentiation remain highly
expressed in mature beta cells. Cooperation between INSM1, NEUROD1 and FOXA2 has
been described to act on regulatory sequences to consolidate the maturation program
and the disruption of this association leads to an immature phenotype in beta cells [150].
PDX1, NGN3 and MAFA have been described as critical TFs for beta cell development
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[151] with PDX1 also associated with beta fate promotion and alpha fate repression [152].
Moreover, PDX1 plays a key role in beta cell survival by maintaining an adequate pool
of healthy Î2-cells in adults but the underlying mechanism is still not fully understood
[153, 154]. Transcription factors RFX6, NKX6.1 and PAX6 have also been associated
with maintaining the beta cell identity, by repressing genes of other cell types or by
maintaining functionality [155–157]. Recently, LDB1 (LIM domain-binding protein 1)
and its binding partner ISL1 (Insulin Gene Enhancer Protein ISL-1) have also been shown
to maintain a mature beta cell state [68, 158].
Physiologically, beta cell identity is mainly characterized by the ability to sense high
glycemia and secreting insulin in response, called Glucose Stimulated Insulin Secretion
(GSIS). Activation of this mechanism is a criterion that the cells have reached maturity.
Biochemical properties underlying this key function have been reviewed by Dr Guy
Rutter and his collaborators [56]. Firstly, it has been established that the glucose uptake
itself by the cell together with its subsequent metabolism trigger insulin secretion [159,
160]. Secondly, this process is also controlled by many other biochemical regulators
which can independently trigger insulin response (secretagogues), or they can modulate
sensitivity of insulin release (potentiators) [161]. The « GSIS » response relies on the
expression of key genes highly expressed in beta cells, notably at the transcriptomic level.
Beside the insulin coding gene INS, naturally strongly represented in beta transcriptome,
SLC2A2 (coding for GLUT2 glucose transporter) and GLP1R (coding receptor of incretin
hormone GLP1) are also highly expressed in beta cells. The same observation is done for
GCK gene coding glucokinase as glucose phosphorylation is a key step during GSIS and
it has been described to play a key role in insulin secretion [64, 162, 163]. Many critical
intermediates and cofactors, called metabolic coupling factors (MCFs), are involved in
the metabolic signaling of the insulin secretion [164]. It implies that many signaling
pathways regulate the beta cells activity. For example, the transcription factor TCF7L2
has recently been associated with PI3K/AKT signaling to regulate the function of beta cell
[165]. Calcineurin/NFAT signaling, through CNB1 (PPP3R1), has also been associated with
regulation of growth and function of beta cells [166]. In recent years beta cell physiology,
often associated to their identity, has been vastly investigated. For comprehensive reviews,
see [56, 164, 167].
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Finally, recent publications have highlighted the functional heterogeneity in pancreatic
beta cells population by identifying a hierarchical network of activation during GSIS
[168]. Specic beta cells, called “hub” (or “leader”) cells, initiate the response to glucose
before triggering and synchronizing response of “follower” cells [169]. Transcriptomic
signature underlying “hub” phenotype is still unclear but dierent expression levels
of important genes such as GCK, PDX1 or NKX6.1 have been observed. Hub cells are
representing a metabolically adapted subpopulation of beta cells which also show features
of immature cells [168]. Interestingly, a heterogeneity within beta cells has also been
described recently for the islet growth in zebrash [170, 171]
1.2 Alpha cells
Interest in glucagon-producing alpha cells, like the other endocrine cells, has been
relatively neglected compared to that of beta cells. For example, a lot is known about
the consequences following complete loss of beta cell mass but what happens if we
lose another endocrine cell type is relatively unknown [44]. The group of Herrera PL
performed the ablation of alpha cells in adult mice and they observed normal activity of
both the glucagon signaling and beta cell function [172]. Nevertheless, these non-beta
cells have recently been investigated for their potential ability to transdierentiate into
beta cells and some studies have already described this mechanism using alpha cells
[173–177]. Moreover, glucagon is secreted in response to hypoglycemia and an altered
response of alpha cells in pathophysiology of T2D has already been identied and is still
currently investigated [178–181]. Gromada and colleagues reviewed that in addition to
hypoglycemia, glucagon secretion is regulated by several paracrine factors [182].
From the transcriptomic perspective, recent outcomes from RNA-Seq and scRNA-seq
experiments have allowed to obtain insight of the transcriptome of alpha endocrine cells
[128–138, 140, 141]. Beside GCG expression, dierent transcription factors have been
identied with a conserved expression in mature alpha cells, such as ARX, IRX1 and IRX2
genes. The role of NEC2/PCSK2 in the conversion of pro-glucagon to glucagon explains
high expression of the gene in alpha cells [183]. DPP4 gene expression is also highly
enriched in alpha cells and encodes the dipeptidyl peptidase-4 responsible on glucagon
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degradation [184].
1.3 Delta cells
Less is known about this endocrine cell type. Beside SST gene expression, HHEX ex-
pression has been described to maintain delta cell fate [185]. Chera and colleagues also
highlighted delta cell potential to transdierentiate into beta cell [174]. Enriched expres-
sion of many receptors has also been described with notably the expression of leptin
receptor (LEPR) and ghrelin receptor (GHSR) [136].
1.4 Gamma cells
Also called PP cells or F-cells, gamma cells are characterized by the expression of pan-
creatic polypeptide (PP) and represent a very small portion of islet cell population in
human [186]. PP is secreted in response to food intake and has been described as a satiety
hormone which also acts as an inhibitor or the glucagon release [187]. Recent scRNA-seq
experiments highlighted the expression of pan-endocrine transcription factors but also
the expression of genes usually associated to neuronal cells [135], which is coherent with
previous observations about the role of nervous control on pancreatic polypeptide release
[188, 189].
1.5 Epsilon cells
These ghrelin expressing cells have recently been more investigated [190]. They are
mainly found in the gut but they are also present in a very low amount inside islet cell
population. Ghrelin expression rises during fasting and has been described as an inhibitor
of the insulin secretion in both human and rodents [191–193]. Transcriptome of epsilon
cells is nearly completely unknown; the recent scRNAseq experiments gave only few
insights of it due to the scarity of these cells. Interestingly, epsilon cells do not express
PAX6 gene and recent studies in mice highlighted that PAX6 inactivation in mature beta
cells led to loss of INS expression associated to a strong increase of GHRL expression
[156, 194].
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2 Pancreatic Development in zebrash
The next sections describe current knowledge of the pancreatic dierentiation program
in zebrash. References are presented for mecanisms that have also been described to
work similarly in humans or mice.
2.1 Organ morphogenesis
The pancreas emerges from the endoderm through the development of two dierent buds,
called dorsal and ventral buds, and this characteristic is conserved among vertebrates.
In zebrash, the two buds do not appear at the same time with the dorsal bud already
starting to rise at 24 hpf (hours post fertilization). Moreover, the dorsal bud in zebrash
will only contribute to form the initial pool of endocrine cells. This pool will give rise ti a
large part of the primary islet, a major principal islet of Langerhans found in zebrash
[195]. The ventral bud, emerging at 40 hpf, will develop and dierentiate into both
exocrine tissues (acini and ducts) and into the secondary pool of endocrine cells which
will be scattered in pancreas [196]. The group of Dr Nikolay Ninov (Dresden, Germany)
recently described that some cells also contribute to the primary islet [170]. After its
emergence, the ventral bud migrates posteriorly so that both buds merge around 52 hpf
[197, 198]. The exocrine tissue starts to grow posteriorly and will acquire a glandular
morphology with the formation of acini connected to the ductal tree (Figure 20).
The endoderm is specied at the beginning of gastrulation (shield stage, 6 hpf) [199–202]
through the action of the transcription factor sox32. The endoderm layer expressing
sox17 will relocate along the anterio-posterior axis during gastrulation to form the
endodermal rod which will give rise to the embryonic gut [203–207]. The patterning of
the endodermal layer along the antero-posterior axis is controlled by a series of signaling
pathways including Nodal [201, 202, 204, 205], Wnt [208], Fgf [209], BMP [210–212]
retinoic acid [213–215] and Hedhehog [216] during gastrulation (6 to 10 hpf) as well as
induction factors released by the mesoderm during somitogenesis stages (10 hpf to 30
hpf) [217–222].
The pancreatic specication starts well ahead of the morphogical constitution of the
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Figure 20: Schematic representation of zebrash pancreas development (from Tiso
et al., 2009). Sox4b and neuroD are the rst genes expressed in the pancreatic primordium
while pdx1 expression denes the future pancreatic region. The dorsal bud emerges at 27
hpf to give rise to rst endocrine cells. The ventral bud emerges at 40 hpf and is at the
origin of the majority of exocrine pancreas. The two buds merge around 52 hpf.
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gland through a complex sequential activation of parallel or interconnected pathways (as
reviewed by Tiso and collaborators [223]). This will lead to the creation of a dedicated
and precise Pdx1-positive endoderm region called the pancreatic primordium.
2.2 Key players in the pancreatic dierentiation program
Starting with genetic pathways, FGF signaling plays an important role during pancreatic
dierentiation, like in liver, as it controls fate decision between ducts and organ tissues
through fgf10 expression [224]. Evidence showed that Notch signaling is also greatly
involved during the process and notably through the dierent outcomes generated by
the dierent Notch ligands [225].
The dierentiation process relies on the sequential expression/repression of key genes,
quite conserved across vertebrates, which control the cell dierentiation and specic
endocrine/exocrine fate choices [226]. Some of them are also involved in dening or
maintaining only one specic pancreatic cell identity. As previously mentioned, Pdx1 is
essential during embryogenesis for the formation of the complete pancreas in vertebrates
but it also crucial later for beta cell dierentiation as for maintaining mature beta cell
identity and functions in mice [227, 228]. The same can be say for ptf1a whose expression
contributes to early pancreas specication, but later, its expression becomes restricted to
the acinar cells in vertebrates [142, 229, 230].
Three dierent intermediate stages during cell dierentiation have been described: mul-
tipotent progenitors, bipotential progenitors and endocrine precursors. In ze-
brash, multipotent progenitors only originate from the ventral bud as they can give
rise to all pancreatic cell types. These cells are characterized by the expression of ptf1a,
pdx1, nkx6.1 and sox9b regulatory genes. The bipotential progenitors, also restricted
to the ventral bud origin, are characterized by the loss of ptf1a expression and thus are
not able to dierentiate in acinar cells but will give rise to endocrine cells or ducts. In
zebrash, endocrine precursors specication is controlled by the expression of ascl1b, a
bHLH transcription factor. It is a dierence with mice/human in which it has been vastly
described to be the role of Ngn3 (Neurogenin-3) expression [231–234]. In both cases,
ascl1b or Ngn3 trigger expression of neurod1/Neurod1, also a bHLH transcription factor,
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to drive the dierentiation of endocrine cells. In zebrash, the bHLH factors appear rst
early in the dorsal bud to give rise to the rst endocrine cells and then in the bipotential
progenitors from the ventral bud for the emergence of secondary endocrine cells [235].
2.2.1 Exocrine fate during dierentiation
As already mentioned, multipotent progenitors are able to give rise to all pancreatic cell
types and particularly to acinar precursors. The ptf1a/nkx6.1 balance, in which each
gene represses the other, performs a major role in determining acinar fate. Ptf1a represses
Nkx6 genes (nkx6.1/nkx6.2) to initiate acinar precursors. Nkx6 genes, by repressing ptf1a,
promote the bipotential progenitor fate for endocrine and duct development [229, 236].
FGF and TGFβ signaling activation and inhibition, respectively, have also been described
to be required for the acinar specication [237, 238] while Notch and Wnt signaling have
been associated with an acinar cell fate repression [239, 240].
Contrary to what is observed for acinar or endocrine cells, there is not yet a well described
ductal precursor stage. Expression of a ductal fate marker, similar to ptf1a for acinar
precursors or ascl1b/Ngn3 for endocrine precursors, has not yet been highlighted making
it dicult to identify the specication of ductal cells from bipotent precursors [241].
Nevertheless, evidence has highlighted the role of transcription factors, such as hnf1b,
hnf6/onecut1 or meis1/2, in controlling specic aspects of duct development [242, 243].
Also, the conserved expression of nkx6.1 and sox9b in mature zebrash ductal cells
has recently been highlighted and has been associated to the potential progenitor role
of ductal cells during endocrine tissue regeneration and secondary islets development
[235, 244]. We recently highlighted novel genes with an enriched expression in ductal
transcriptome of adult zebrash compared to other pancreatic cells (see Results) [146].
Finally, the role of Notch signaling has also recently been identied to be important for
ductal fate in liver and pancreas in zebrash, as the inactivation of two Notch ligand
genes, jag1b and jag2b, leads to complete loss of duct cells in both organs [245].
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Figure 21: Dierentiation of pancreatic cells in zebrash. Pancreatic progenitors are
pdx1-expressing cells derived from endoderm region. They are also characterized by the
expression of ptf1a, nkx6.1 and sox9b. Mutual repression of ptf1a and nkx6.1 denes the
separation between acinar cell and bipotential progenitor fate. Ascl1b is the rst initiator
of endocrine precursor specication. Conversely, the expression of nkx6.1 and sox9b is
maintained in ductal cell fate. Endocrine cell subtype dierentiation is characterized
by the expression of pan-endocrine genes and the expression of genes specic to each
endocrine cell subtype.
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2.2.2 From endocrine precursors to all dierent endocrine populations
It has been mentioned previously that in zebrash, ascl1b is the rst initiator of the
endocrine precursors from progenitors (in the dorsal and ventral buds). Quickly, it triggers
neurod1 expression and together they induce the specication of endocrine fate [231].
The expression of sox4b starts nearly concomitantly in the ascl1b expression domain
and is restricted to endocrine precursors. Interestingly, sox4b expression is strongly
dependent on ascl1b while evidence have also shown the potential of neurod1 to active
sox4b expression. Indeed, in ascl1b morphants the expression of sox4b can be found
inside the neurod1 expression domain [231]. Expression of ascl1b and sox4b is transient
during endocrine dierentiation as it is restricted to endocrine precursors while neurod1
expression is maintained in rst hormone expressing cells and in dierentiated endocrine
cells [231, 246]. Finally, it has also been reported that nkx6.1/nkx6.2 play key role in
early stage of endocrine development in zebrash [247]. As they are already present in
early pancreatic progenitors, they have been described to act on both the establishment
and the size of the endocrine precursor pool. Only nkx6.2 expression is then maintained
in endocrine cells and progressively restricted to beta cells. Finally, the synergy between
nkx6 genes has been suggested to control both alpha and beta dierentiation [247].
After the initiation of endocrine fate by these factors, a complex network of transcription
factors is subsequentially activated to control and establish the formation of the dierent
endocrine cell type populations. Many of them described during endocrine development
in mice/human have been later associated with quite similar roles in zebrash, such as
pdx1, nkx2.2a, isl1, pax4, rfx6, mnx1, arxa or pax6b [195, 248–251].
Evidence has shown that pdx1 and mnx1 both cooperate to establish the beta cell fate in
zebrash [251, 252]. As previously mentioned, pdx1 is required and already expressed in
early pancreatic progenitors that give rise to all pancreatic cells. Its “endocrine” expression
is progressively restricted to beta cells to establish this fate and to later maintain beta
identity in adults [151–153]. Nevertheless, lower pdx1 expression has also recently been
detected in adult ductal cells [146]. The role of mnx1 in zebrash slightly diers from
that in mice as it is not required in early stages but it is only essential for the beta cell fate
[197]. Interestingly, Mnx1 deciency during development modies the fate of “pre-beta”
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cells towards an alpha cell fate [251]. In zebrash, the alpha cell fate is determined by
the action of Arxa which is antagonized by Pax4, another homeodomain transcription
factor. In mice, Pax4 has been reported to initiate the beta cell dierentiation through the
repression of Arx gene [253–256]. A slighty dierent mechanism is observed in zebrash
as pax4 also represses arxa expression to modulate the alpha cell generation but does not
participate to beta cell dierentiation [248].
Other transcription factors, such as nkx2.2a, rfx6,isl1 and hhex, are involved in the
dierentiation of several endocrine cell types and their actions have been maintained
from sh to mammals while some slight dierences can be noticed between species.
Expression of Nkx2.2 in mice starts early in endocrine precursors of the dorsal bud
and is later restricted to alpha, beta and gamma cells [257]. It acts on late stages of
dierentiation/maturation as the inactivation of Nkx2.2 expression leads to impaired
endocrine cell functions without aecting their respective specication [258, 259]. Similar
observations have been described for nkx2.2a in zebrash but additional expression in
ductal cells has been reported [260]. Isl1 has no inuence on the specication of endocrine
precursors. However its inactivation aects the generation of hormone producing cells
[261]. Recent evidence also highlighted in mice the role of ISL1 and its LIM partner LDB1
in maintaining the terminally dierentially state of endocrine cells [158]. Rfx6 expression
in zebrash starts in early pdx1-positive cells of the pancreatic buds and is soon restricted
to the endocrine lineage [249]. Finally, the role of hhex in the specication of delta cells
has recently been identied by the group of Stainier D [262]. The role of Pax6 during
endocrine pancreatic dierentiation will be discussed in the next section.
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3 Transcription factor Paired box 6 (Pax6)
3.1 Discovery and molecular description
The discovery of the DNA-binding transcription factor PAX6 was made in the early 90s
as part of an eort to highlight potential genes causing eye diseases in humans and mice.
Since then, Pax6 expression has been characterized in eye, central nervous system
and in endocrine pancreas, and 3 decades of PAX6 studies in various research elds
have provided insights about multiple PAX6 features [263]. PAX6 is labelled as a “master”
regulatory protein, just like GATA1, GATA2, SOX9 and others, which acts as a molecular
switch that controls specication/dierentiation programs in a gene dosage manner, such
as haploinsuciency can already generate broad spectrum of Aniridia forms and other
eyes defects.
PAX6 protein sequence and structure are highly conserved between species [248, 264]
(Figure 22). In human, PAX6 exons/introns assembly occupies 20 kilobases (kb) of genomic
region but studies have shown that PAX6 regulatory regions extend to 450 kb within
the chromosome 11, with mice presenting a syntenic region on chromosome 2 [145, 265,
266]. The two 5’-promoters, called P0 and P1, and the internal promoter (Pα) drive the
synthesis of dierent transcripts which are alternatively spliced leading to the production
of the predominant canonical Pax6 (p46) and Pax6(5a) (p48) proteins [267]. Two long
non-coding RNAs (lncRNAs) sequences are present in the region, Paupar and Pax6AS1
in humans. The rst has been described to be expressed in the brain associated notably
with a control on the expression of Pax6 [268].
In zebrash, the partial duplication of the genome has given rise to two pax6 paralogs,
pax6a and pax6b [269], associated with a subfunctionalization of their original ancestral
functions through loss and retention of specic cis-regulatory elements [270, 271] (Figure
23). Both paralogs are expressed during eye and brain development, but only pax6b is
expressed during endocrine pancreas development [145]. This is due to the retention of a
pancreatic regulatory element located upstream from the P0 promoter of the zebrash
pax6b gene [145, 272].
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Figure 22: (A) Alignment of the protein sequence of PAX6 and PAX4 between
human, mouse and zebrash (Djiotsa et al, 2012). Regions in yellow represent
residues conserved in all sequences while regions in blue represent residues conserved in
PAX6 sequences. Locations of PD and HD are displayed. Hs: Homo sapiens, Mm: Mus
musculus, Dr: Danio rerio.
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Figure 23: (A) The PAX6 duplication in the zebrash genome led to the distribu-
tion of its neighboring regions (Kleinjan et al, 2008) The pax6a paralog retained
synteny with wt1a and with most of the pax6 cis-regulatory elements (vertical arrows)
while the pax6b paralog conserved the relationship with elp4 and rcn1 but with less
regulatory elements. Dotted arrows are for the partially conserved elements. (B) The
PAX6 regulatory regions previously identied and the bioinformatic prediction
of putative regulatory regions (Hickmott et al, 2016). The alignment of the PAX6
locus across multiple genomes of vertebrates highlights the conserved regulatory regions
(red rectangles). These regions present a high sequence similarity between species (10
selected species).
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3.2 DNA recognition by PAX6 protein
PAX6 protein contains two DNA-binding domains, a paired domain (PD) and an home-
odomain (HD), which are highly conserved between vertebrates. The main Pax6 trancript
(p46) encodes both intact domains while the Pax6(5a) alternative spliced mRNA includes
exon 5a which adds 14 aa residues and alters DNA-binding properties of the PD [273, 274].
Moreover, PAX6 protein can recognize DNA using both domains together or separately
[144, 275], and, combined with alternative splicing, it allows the possibility to bind a
large spectrum of DNA-binding sequences. The recent identication of DNA sequences
bound by Pax6 in vivo during lens and forebrain development using ChIP-Seq has greatly
contributed to identify direct target genes of PAX6 [263, 276]. Similarly, Swisa and
collaborators identied Pax6 genomic binding sites in Min6 (mouse insulinoma) cells
[156]. These studies resulted to the identication of sets of comparable recognition and
consensus sequences (Figures 24). Pax6 seems to act either as an activator or repressor
and the hypothesis has been raised that dierent DNA-binding sequences can have an
inuence on this opposite regulation [156]. In zebrash, evidence has highlighted the
dispensable role of pax6b homeodomain during pancreatic endocrine dierentiation
[144].
Figure 24: Pax6 binding to DNA (Cvekl and Callaerts, 2016). (A) Pax6 consensus
motifs previously identied from in vivo and in vitro experiments. (B) 3D-structural
model of DNA Pax6-binding.
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3.3 Pax6b expression during pancreatic endocrine dierentia-
tion
The expression of pax6b appears in endocrine precursors and it is maintained in both
dierentiating and mature endocrine cells. In mice and human, PAX6 has been reported
to be expressed in all pancreatic endocrine cell types [277–280]. It has been described
that Pax6 exerts direct control on both glucagon and insulin expression through the
direct binding of their respective promoter regions [281–283]. Pax6 is involved in the
repression of the epsilon fate [280]. Indeed, in both mice and zebrash, the inactivation
of Pax6/pax6b leads to the loss of alpha and beta cells (they are dierently aected in both
species) associated with an increased number of ghrelin-expressing cells [144, 257]. The
loss/decreased expression of insulin, glucagon, somatostatin is concomitant to an increase
of ghrelin expression in the islet. The involved mechanisms remain relatively unknown
with notably only little information on the genes regulated by Pax6 during endocrine
cell dierentiation. However, recent studies have described that the inactivation of Pax6
in adult beta cells leads also to the loss of insulin expression and a strong increased of
ghrelin expression [156, 194]. A transcriptomic analysis of these adult beta cells after
Pax6 inactivation revealed a large set of PAX6 regulated genes, many of them being
involved in beta cell identity and glucose regulation.
In contrast, the PAX6-dependent Gene Regulatory Network (GRN) has not been inves-
tigated during pancreatic endocrine dierentiation in mice or zebrash embryos. PAX6
GRNs have been studied in mice during lens and forebrain development with the identi-
cation of direct Pax6 targeted genes in both tissues [276]. This study revealed that about
70% of PAX6 DNA-binding regions overlap between both tissues while a set of 13 genes are
directly regulated by Pax6 in both tissues; this group includes Aldh1a3/Raldh3, Ccnd1,
Dusp6, Epbh1, Foxp2, Lmo1, Mab21l1, Mrps28, Pax6, Slc39a11, Spsb4, Tenm2 and
Tspan7 .
Finally, Pax6 has been reported to be associated with metabolic diseases. Indeed, Pax6
heterozygous mutations are responsible for dierent degrees of glucose intolerance, are
associated with a disruption of GSIS and are involved in the development of early-onset




In previous sections, I have described the role of the pancreas in the digestive process
and the homeostasis of specic systems. This role is made possible by the presence of
dierent cell types which present specic functional properties and we are interested in
the transcriptomic signature underlying these properties.
In the context of research on diabetes mellitus, an important topic focuses on the in
vitro dierentiation of stem cells into pancreatic endocrine beta-like cells [286–288]. In
parallel, the plasticity of endocrine cells, and therefore the transdierentiation potential,
has also been the interest of many studies as a possible source for the generation of
new beta cells [174–176, 289]. These eorts are dependent on a better understanding of
the complete pancreatic endocrine dierentiation mechanisms. I have also described in
previous sections that maintaining the functional properties of mature cells is closely
linked to their identity. Characterization of mature beta cells in vivo is required to
determine all features that a “neo-generated” beta cell should possess to be considered
equally functional. Finally, with the purpose to identify keys elements for these topics,
we are interested in the comparison of observations and results obtained in dierent
species.
In this context, the present work focuses on two main topics:
1 The identication of conserved transcriptomic sig-
natures for all major pancreatic cell types
• The denition of the transcriptomic signature of the pancreatic cell types
in zebrash
“What genes are expressed by each pancreatic cell type in zebrash
?”
In order to answer that question, we rst analyzed RNA-Seq datasets produced in our
laboratory for ve majors pancreatic cell types [146, 235]. Then, we improved our
observations by analyzing publicly available scRNA-Seq data produced on adult zebrash
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pancreas [147] and we determined transcriptomic proles for seven pancreatic cell types.
• The evaluation of the conservation of the transcriptomic signature through
dierent vertebrates
“What are the genes underlying the identity of each endocrine cell
type across vertebrates ?”
In parallel, we retrieved publicly available RNA-Seq datasets for both mouse and human
pancreatic cell types [129–131, 133, 290, 291]. we dened a global endocrine and exocrine
signatures in both species. We were thus able to dene sets of orthologous genes pre-
senting conserved endocrine or exocrine enriched expression in all three species. Later,
we identied available RNA-seq datasets for mouse and human alpha and beta cells, and
for each we dened sets of genes with a conserved enriched expression among all three
species. At this point, we published our rst results.
Then, the emergence of available scRNA-Seq datasets for pancreatic tissue in human al-
lowed us to extend the analyses to all endocrine and exocrine cell types. For all endocrine
cell types, we highlighted sets of genes with a conserved enriched expression in both
zebrash and human. These sets of genes are likely to be responsible of the identity of
the associated cell type.
2 The role of Pax6b during pancreatic and intestinal
endocrine cells development in zebrash
• The identication of transcriptomic changes in endocrine cells following
pax6b loss-of-function
“What happens to the pancreatic endocrine transcriptome when
pax6b is not expressed ?”
In our laboratory, RNA-Seq datasets have been produced for pancreatic endocrine cells
isolated from 27 hpf embryos using the transgenic lines Tg(P0-pax6b:GFP), in both wild-
type and pax6b-mutant (sa0086 [144]) conditions. The similarity of Pax6b-dependent
gene regulatory network was determined by comparing the set of genes aected by pax6b
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inactivation in enteroendocrine cells and pancreatic cells.
“Is this network similar in enteroendocrine cells?”
To answer that question, the same RNA-seq analysis has been performed from enteroen-
docrine cells using 4 dpf embryos. We compared pax6b-dependent transcriptional net-
works obtained in each tissue, and we highlighted a signicant overlap between the two
sets of genes.
• The understanding of the alteration of the pancreatic endocrine dierenti-
ation process
“Which pancreatic endocrine cells are aected ? How is cell fate
inuenced ?”
This question was tackled by combining our results from transcriptomic signatures of
adult pancreatic endocrine cells with our list of transcriptomic changes occuring in the
pax6b mutant. We observed how each endocrine cell type signature is aected in the
pax6b mutant.
• The identication of the genes directly regulated by Pax6b
“What are the genomic DNA-binding sites of Pax6b ?”
We performed ChIP-Seq experiments using antibodies raised against Pax6b on whole
embryos at 27 hpf. We retrieved the DNA-binding sites of Pax6b and we identied a set of
consensus sequences associated. We classied pax6b “peaks” according to their genomic
localizations.
“Which are the genes near the Pax6b binding sites; are their expres-
sion regulated by Pax6b ?”
We annotated the pax6b peaks with the closest genes. To identify potential directly
regulated genes, we combined our ChIP-Seq results with the list of genes dierentially
expressed in pax6b mutant. This approach highlighted a set of candidate genes for the




1 Zebrash RNA-Seq for adult pancreatic cell types
We reanalyzed the previously published RNA-Seq data produced in the laboratory [146],
available on EMBL-EBI data repository (https://www.ebi.ac.uk/ena/browser/view/PRJEB10140).
2 Zebrash RNA-Seq of 27hpf and 4dpf embryos
(Credit to Estefania Tarifeño-Saldivia and Justine Pirson)
2.1 Zebrash transgenic and mutant lines, tissue dissection and
purication
We used dierent zebrash transgenic and mutant lines: Tg(pax6b:GFP) ulg515 [145]
and pax6b sa0086 [144]. Enteroendocrine cells (EECs) were isolated by dissecting the
gut from about 200 Tg(pax6b:GFP) larvae at 4 dpf. Cell dissociation was next performed
by incubation in HBSS 1x supplemented with 100 U/ml collagenase IV and 0.3 U/ml
Dispase (Life Technologies) for 10 minutes. Cells were washed in HBSS (Mg 2+ and Ca
2+ free) containing 1% BSA and GFP-expressing EECs were selected by two consecutive
FACS purications, the rst in the “yield mode” and the second in “the purity mode”,
using FACS Aria II. Four replicates of EEC containing about 3000 cells were prepared.
Pancreatic endocrine cells (PECs) were also obtained from the Tg(pax6b:GFP) ulg515
line by dissecting the dorsal pancreatic bud from about 200 27-hpf transgenic embryos.
FACS selection was performed as described for EECs except that cell dissociation was
performed in Tryple Select 1X (Gibco) supplemented with 100 U/ml collagenase IV (Life
Technologies) for 5 minutes. For the preparations of EECs and PECs from pax6b null
mutant embryos, the pax6 sa0086 line was rst crossed with the Tg(pax6b:GFP) line;
heterozygous pax6b sa0086 sh harboring the transgene (pax6b:GFP) were inbred to
generate homozygous pax6b sa0086 transgenic embryos which were selected based on
the absence or reduction of lens. The isolation of EECs and PECs from pax6b sa0086
homozygotes were performed in triplicates following the same procedure that for the
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wild-type larvae. The accuracy of pax6b sa0086 homozygotes selection was veried after
the RNA-seq by checking the presence of the null sa0086 allele in 100% of pax6b reads in
the mutant samples.
2.2 Library preparation
Each EEC or PEC samples obtained after FACS was directly pelleted by centrifugation and
resuspended in 3.5 µl of reaction buer, lysed by freezing in liquid nitrogen and stored at
-80°C according to the Smart-seq2 protocol [292]. cDNA was synthesised and amplied
by PCR reaction (13 cycles). Quality of cDNA was veried by 2100 High Sensitivity DNA
assay (Agilent technologies). 1 ng cDNA was used for preparing each cDNA library
using Nextera-XT DNA kit (Illumina) and sequenced on Hi-seq 2000 to obtain around 60
millions of reads (100 base paired-ends).
3 RNA-seq bioinformatic analyses
After trimming of adaptor sequences, reads were aligned to reference genome GRCz11,
from Ensembl release 92 (http://www.ensembl.org/index.html), using STAR v2.5.4b [293].
Gene expression matrix was directly obtained from STAR and we performed all pairwise
dierential expression (DE) analyses using DESeq2 R package [106]. We dened as gene
with enriched expression for a cell type all genes with a signicative (FDR <= 0.1) enriched
expression between the cell type with the highest expression for the gene compared
to the second cell type with the highest expression. Genes which failed this test were
evaluated for an endocrine or exocrine compartment specic expression by setting a
threshold of 10 times enrichment between both conditions. Genes with a low level of





Zebrash single-cell data have been generated by the group of Junker J.P. and Ninov
N. in the context of cell lineage tracing in zebrash and identication of cell type [147].
Sequencing data are available on Gene Expression Omnibus under accession number
GSE106121. We retrieved their adult pancreatic-associated datasets.
4.2 Human
Human single-cell data used in this work have been generated by three dierent groups.
Count matrices for each experiment were retrieved from their respective data reposito-
ries. Segerstolpe data: E-MTAB-5061 (EMBL-EBI ArrayExpress). Muraro data: GSE85241
(NCBI Gene Expression Omnibus). Baron data: GSE84133 (NCBI Gene Expression Om-
nibus).
5 scRNA-seq bioinformatic analyses
Analyses of scRNA-Seq data were performed using Seurat R package v3.1.0
(http://satijalab.org/seurat/) [119, 120].
5.1 Filtering of cells
We ltered out cell barcodes with low detection level (less than 1000 UMI counts) and
cell barcodes with high mitochondrial representation (> 5%). Clusters were evaluated for
the expression of key genes and we selected only clusters which could be associated with
a high condence to a pancreatic endocrine cell type, to acinar cells or to ductal cells.
5.2 Dierential expression analysis
Dierential expression analysis were performed using Seurat FindAllMarkers function.
This method compares each cluster against the pool of other clusters to dene lists of
genes with enrichment for the cluster evaluated, which we will refer to as “DE genes”
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in this work. To dene “marker genes”, we additionally evaluated for each DE gene if
there is a signicative enrichment (FDR <= 0.001) between the cell type with the highest
expression for the gene compared to the second cell type with the highest expression.
5.3 Datasets integration
Integration of all 3 human single-cell datasets was performed using the method proposed
by Seurat pipeline (https://satijalab.org/seurat/v3.1/integration.html) [120].
6 ChIP-Seq library preparation
6.1 Collecting embryos
We collected around 5000 zebrash 27 hpf WT embryos per replicate (n=2). Embryos
were extracted from their chorion using pronase and we removed yolk using Deyolking
buer (55mM NaCl, 1.8mM KCl, 1.25 mM NaHCO3, 1x protease inhibitor). Embryos
were then washed using Wash buer (100mM NaCl, 3.5 mM Kcl, 2.7 mM CaCl2, 10mM
Tris-Hcl pH 8.5, 1x protease inhibitor). Crosslinking was performed by placing embryos
in 1.85% PFA solution for 10 minutes at room temperature. We used glycine for quenching
PFA activity and embryos were washed multiple times with PBS 1x solution. Embryos
were then snap frozen and conserved at -80°C.
6.2 Chromatin preparation
We lysed mechanically embryos in Cell Lysis Buer (10mM Tris-HCl (pH7.5), 10mM
NaCl, 0.5% Igepal CA-630, 1x protease inhibitor) using tissue grinder. We centrifugated
and we resuspended the nuclei pellet in Nuclei Lysis Buer (50mM Tris-HCl (pH7.5),
10mM EDTA, 1% SDS, 1x protease inhibitor). We added 2 volumes of IP Dilution Buer
(16.7mM Tris-HCl (pH7.5), 167mM NaCl, 1.2mM EDTA, 0.01% SDS) to the extracted
chromatin. Sonication of the chromatin was performed using Diagenode Bioruptor Pico
device (10 cycles of 30s On/ 30s OFF). We added Triton 10% before centrifugation. The




Antibodies against Pax6b were puried in the laboratory from rabbit injected with the
recombinant Pax6b protein (gift of Frederic Biemar). DiaMag protein A-coated magnetic
beads (Diagenode) and antibodies were added to chromatin preparation. Immunoprecipi-
tation was performed by rocking samples overnight at 4°C. We washed multiple times the
magnetic beads-antibody-pax6b complexes using Wash Buer solution (50mM Tris-Hcl
pH8, 150mM NaCl, 2mM EDTA pH8, 1% Igepal CA-630, 0.5 % Sodium Deoxycholate,
0.1 % SDS). Complexes were then placed in Elution Buer (50mM Tris pH8 , 10mM
EDTA, 1% SDS) at 65°C in order to eluate protein-DNA complexes from the beads. Re-
verse cross-linking was performed by placing samples at 65°C overnight. Samples were
treated successively with Rnase A and Proteinase K before the Phenol–chloroform ex-
traction of DNA fragments. The retrieved DNA pellet was then resuspended in Illumina
Resuspension Buer.
6.4 Library preparation
ChIP-Seq libraries were prepared using NEBNext® Ultra™ DNA Library Prep Kit for
Illumina, with size selection steps performed using SPRIselect For Next Generation
Sequencing (Beckman Coulter).
7 ChIP-seq bioinformatic analyses
We used nf-core chipseq pipeline (https://nf-co.re/chipseq) for the QC and the analy-
sis of our ChIP-Seq samples. De novo motif anaylsis were performed using HOMER
(http://homer.ucsd.edu/homer/) [294]. GO and Pathways enrichment analysis were per-
formed using shEnrichR (https://amp.pharm.mssm.edu/FishEnrichr/) [114, 115].
8 In situ hybridization
Whole mount in situ hybridization and uorescent in situ hybridization (WISH and FISH)
were performed as described previously [246]. Stained embryos were mounted in Prolong




1 Transcriptomic landscape of major pancreatic cells
across vertebrates
The rst part of this thesis refers to our work determining the transcriptomic signature
of pancreatic cell types in the adult zebrash. We decided to investigate the evolution
of these signatures in vertebrates by comparing our zebrash results with mammals
using murine and human pancreatic transcriptomic data. This work was initiated by
Estefania Tarifeño-Saldivia who produced RNA-Seq datasets for ve pancreatic cell types
using specic transgenic lines: acinar cells (Tg(ptf1a:GFP)), beta cells (Tg(ins:GFP)), delta
cells (Tg(sst2:GFP)), alpha cells (Tg(gcga:GFP)/Tg(ins:NTR-mCherry)) and ductal cells
(Tg(nkx6.1:eGFP)). At least three biological replicates were produced for each cell type
with one additional for acinar cells.
Using those data, Estefania identied sets of genes with enriched expression in endocrine,
acinar or ductal cells. Then, genes enriched in endocrine cells were characterized for their
specic expression in one endocrine cell subtype or in two of them. Those bioinformatic
analyses led to determination of an atlas of genes with an enriched expression in each
cell type of the zebrash pancreas. The next step was to compare our atlas of genes with
what is found in mammals. Our strategy was to look for publicly available RNA-Seq
data for pancreatic cells and then to analyze them in the same way as we did for the
zebrash data. In this context, we retrieved dierent data sets obtained from murine and
human pancreatic islets but also from whole pancreas samples. Our rst interspecies
comparison showed conservation of endocrine-enriched and exocrine-enriched genes
across all three species. Then, we also collected alpha cells and beta cells RNA-Seq data
for mice and human samples, no data being available for delta cells at that moment. We
thus performed our second interspecies comparison on alpha-enriched and beta-enriched
genes in all three species.
From this work, we identied many novel markers for each pancreatic cell type and some
of them were validated by in situ hybridization and by functional experiments. These
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data contributed mainly to the article “Transcriptome analysis of pancreatic cells across
distant species highlights novel important regulator genes” published in BMC Biology
in 2017 [146]. Credit of the work: Estefania Tarifeño-Saldivia was the initiator of the
project, she generated zebrash RNA-seq data and performed the bioinformatic analysis
of these data. I joined her in the project performing the analysis of mammals datasets
and the comparison with zebrash results. Alice Bernard contributed to the project by
generating myt1 and cdx4 zebrash mutants. In situ hybridization were performed under
the collective eort.
This paper is presented in this section and is the foundation of the ongoing eort including
an upgraded bioinformatic approach using a more recent version of the zebrash genome
and several available pancreatic transcriptomic data produced with the recent scRNA-seq
technology.
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Abstract
Background: Defining the transcriptome and the genetic pathways of pancreatic cells is of great interest for
elucidating the molecular attributes of pancreas disorders such as diabetes and cancer. As the function of the different
pancreatic cell types has been maintained during vertebrate evolution, the comparison of their transcriptomes across
distant vertebrate species is a means to pinpoint genes under strong evolutionary constraints due to their crucial
function, which have therefore preserved their selective expression in these pancreatic cell types.
Results: In this study, RNA-sequencing was performed on pancreatic alpha, beta, and delta endocrine cells as well as
the acinar and ductal exocrine cells isolated from adult zebrafish transgenic lines. Comparison of these transcriptomes
identified many novel markers, including transcription factors and signaling pathway components, specific for each cell
type. By performing interspecies comparisons, we identified hundreds of genes with conserved enriched expression in
endocrine and exocrine cells among human, mouse, and zebrafish. This list includes many genes known as crucial for
pancreatic cell formation or function, but also pinpoints many factors whose pancreatic function is still unknown. A
large set of endocrine-enriched genes can already be detected at early developmental stages as revealed by the
transcriptomic profiling of embryonic endocrine cells, indicating a potential role in cell differentiation. The actual
involvement of conserved endocrine genes in pancreatic cell differentiation was demonstrated in zebrafish for myt1b,
whose invalidation leads to a reduction of alpha cells, and for cdx4, selectively expressed in endocrine delta cells and
crucial for their specification. Intriguingly, comparison of the endocrine alpha and beta cell subtypes from human,
mouse, and zebrafish reveals a much lower conservation of the transcriptomic signatures for these two endocrine cell
subtypes compared to the signatures of pan-endocrine and exocrine cells. These data suggest that the identity of the
alpha and beta cells relies on a few key factors, corroborating numerous examples of inter-conversion between these
two endocrine cell subtypes.
Conclusion: This study highlights both evolutionary conserved and species-specific features that will help to unveil
universal and fundamental regulatory pathways as well as pathways specific to human and laboratory animal models
such as mouse and zebrafish.
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Background
Pancreas is a vital organ playing crucial function in the
metabolism of all vertebrates. Acinar cells, the most
abundant cell type of the pancreas, produce the digestive
enzymes that are conveyed to the gut by the pancreatic
ducts. The pancreatic endocrine cells are grouped in the
Langerhans islets and secrete diverse hormones control-
ling metabolism and glucose homeostasis. Five endo-
crine cell subtypes (alpha, beta, delta, PP, and epsilon
cells) have been described in pancreatic islets, each char-
acterized by the expression of a particular hormone
(glucagon, insulin, somatostatin, pancreatic polypeptide,
and ghrelin, respectively). Many transcriptomic studies
have been focused on pancreatic endocrine cells, and
notably on beta cells, due to their implication in the de-
velopment of diabetes. Microarrays and RNA sequencing
(RNA-seq) were conducted on endocrine pancreatic cells
isolated from human (healthy or diabetic persons) or
rodents at adult and embryonic stages [1–9]. More
recently, RNA-seq performed on endocrine cell types
isolated by FACS or at single-cell level allowed to define
the genes enriched in each endocrine cell type in human
and mice [7, 10–21]. However, no comprehensive inter-
species comparison has been performed so far to define
the conserved signatures for each pancreatic cell type,
except for two studies comparing human and murine
beta cells and reporting some notable differences between
these two mammalian species [12, 21]. Comparison of
transcriptomes between species is a straightforward ap-
proach to identify tissue-specific or cell type-specific genes
playing crucial functions in the physiology of the studied
tissue or cell. Indeed, if a gene is essential in a differenti-
ated cell, strong constraints will maintain its expression
throughout evolution and its tissue-specific expression
will be detected in most species. In accordance to this
view, several studies have reported conservation of organ-
specific expression for a large set of genes among species
[22–24]. Nevertheless, there are also striking divergences
in gene expression patterns even between close vertebrate
species such as human and mice, which may contribute to
physiological adaptations [25, 26]. Comparative studies be-
tween evolutionary distant species are useful to identify
the set of genes displaying highly conserved cell type-
specific expression and likely playing a fundamental
function in the studied cells. Such analyses have not been
performed yet on pancreatic cells due to the lack of tran-
scriptomic data from pancreatic cells isolated from lower
vertebrates such as zebrafish. To tackle this lack of know-
ledge, we first determined the transcriptomic landscape of
the three major endocrine cell types (alpha, beta, and delta
cells) as well as of the acinar and ductal cells from zebra-
fish. Analysis of these zebrafish datasets allowed us to de-
fine the signature of each cell type. Then, comparison
with published human and murine pancreas data led to a
definition of the conserved signatures. Furthermore, by
determining the transcriptome of endocrine cells from
early stage embryos, we identified genes expressed
during endocrine cell differentiation and putatively in-
volved in this process; among them, myt1b and cdx4
are shown to be essential for endocrine cell differenti-
ation in zebrafish. Thus, our list of pancreatic con-
served genes represents a useful resource for studies
related to pancreatic development and disease such as
diabetes and pancreatic cancer.
Results
Transcriptomic profiles of the different pancreatic cell
types isolated from adult zebrafish
We purified the different pancreatic cell types from adult
zebrafish using a series of transgenic reporter lines allow-
ing the selection of these distinct cells by fluorescence-
activated cell sorting (FACS). Acinar cells were obtained
from the BAC transgenic lines Tg(ptf1a:GFP) [27]. The
endocrine beta and delta cells were isolated, respectively,
from the transgenic lines Tg(ins:GFP)ulg021Tg (see Methods
section) and Tg(sst2:GFP) [28]; the alpha cells were
obtained from the Tg(gcga:GFP)/Tg(ins:NTR-mCherry) line
through selection of GFP+/mCherry cells (as many beta
cells were found to express Tg(gcga:GFP) transgene at a
lower level, Additional file 1: Figure S1). RNA-seq was
performed on three independent preparations for each cell
type, except for acinar cells, for which four replicates were
prepared. About 60 million of paired-end reads were ob-
tained from each Illumina library, 80% of which mapped
to the zebrafish genome. We previously reported the tran-
scriptome of pancreatic ductal cells by using the same
procedure on the Tg(nkx6.1:GFP)ulg004Tg transgenic line
[29], and these data were compared in the present study
with endocrine and acinar cell transcriptomes.
Principal component analysis (PCA) of all these pan-
creatic RNA-seq datasets showed a tight clustering of all
replicates for each pancreatic cell type (Fig. 1a), under-
scoring the high reproducibility of the data. As expected,
the PCA also revealed a closer clustering of the three
endocrine cell subtypes compared to the ductal and aci-
nar cell types; however, when PCA is performed only
with the endocrine datasets, clear distinct transcriptome
profiles are observed for the alpha, beta, and delta cell
subtypes (Fig. 1b). Comparison of the expression levels
of various known markers of each pancreatic cell type
confirmed the high purity of each cell preparation.
Indeed, glucagon a (gcga), insulin (ins), and somatostatin
2 (sst2) were selectively detected at very high levels in
alpha, beta, and delta cell libraries, respectively, repre-
senting in average 24%, 10%, and 32% of the total reads
number in the corresponding libraries, while being
detected at much lower levels in the other libraries
(Table 1). The trypsin (try) and chymotrypsin-like
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elastase member1 (cela1) genes were the strongest
expressed genes in acinar cells representing each about
10% of all total reads of the acinar cell libraries. These two
acinar markers were not detected at significant levels in
endocrine datasets consistent with an accurate cell sorting.
Among the genes expressed at highest levels in ducts, we
find the cldnb, sdc4, and the epcam genes coding for cell
adhesion molecules, each representing less than 1% of
total reads of ductal datasets. All these results indicate an
accurate and reproducible sorting of the different pancre-
atic cells allowing the identification of genes selectively
expressed in each pancreatic cell type. Expression values
for all genes in all samples are shown in Additional file 2:
Table S1 and Additional file 3: Tables S2.
Identification of genes enriched in endocrine, acinar, and
ductal pancreatic cells
The clear distinct transcriptomic profiles observed for
endocrine, acinar, and ductal cells prompt us to identify,
in a first step, all genes presenting a differential expression
in these three pancreatic tissues (with at least a four-fold
enrichment and adjusted P < 0.05). By using these cut-off
values, 1853, 1430, and 492 genes were found to be
enriched in endocrine, ductal, and acinar cells, respectively
(Fig. 2a and b, gene lists are given in Additional file 4:
Table S3). As expected, the zebrafish endocrine-specific
genes include several orthologs of mammalian genes
known as endocrine markers such as those involved in
hormone regulation and secretion, like the proprotein
convertases (pcsk1 and pcsk2), carboxypeptidase E (cpe),
secretogranins (scg2a, scg3, and scg5), ATP-dependent po-
tassium channels (the kcnj11 and Sur1/abcc8 subunits),
and the voltage-dependent type calcium channels
(cacna1c and cacna1da), among others. Moreover, most
of the transcription factors previously shown to be crucial
for the differentiation of endocrine cells (neurod, isl1,
pax6b, insm1a, etc.) [30] are detected in the endocrine
signature validating our RNA-seq data. Interestingly,
many other transcription factors, whose function in endo-
crine cells is still not known, are present in this list such
as egr4, creb3l1, lmo1, cdx1b, or cdx4 (Fig. 2b). Gene
ontology (GO) enrichment analysis using DAVID revealed
known biological pathways in endocrine cells such as
“potassium ion transport”, “regulation of secretion” and
“regulation of exocytosis” as well as “response to glucose”,
and “G-protein coupled receptor signaling” (Fig. 2c).
Indeed, many G-couple protein receptors (GPCRs) and
several regulators of G-protein signaling, like gpr12, gpr22,
gpr27, or gpr63 as well as rgs4, rgs5a, rgs8, or rgs17, among
others, were found enriched in the endocrine cells. While
some of these regulatory proteins have been previously re-
ported to control pancreatic islet activity [31, 32], others
were not yet known to have a selective expression in pan-
creatic endocrine cells nor to play a role in islet physiology.
Similar observations were done for the acinar and
ductal cell transcriptomic signature. Indeed, as expected,
Fig. 1 Global analysis of the zebrafish pancreatic RNA-seq data. a Principal component analyses (PCA) of gene VSD (Variance stabilizing transformation)
calculated by DESeq package for the 16 zebrafish pancreatic datasets. b PCA of gene VSD for beta, alpha, and delta cells (nine samples in total). The
PCA plots show a close clustering of all replicates and distinct clusters for each pancreatic cell type. PCAs were calculated using all the 33,726 genes
annotated on Zv9 version 75 ensembl
Table 1 Percentage of the reads obtained for highest expressed
markers in each type of library
Gene Alpha Beta Delta Acinar Duct
gcga 23.8 0.5 0.9 0.0 0.0
ins 0.1 10.1 0.0 0.0 0.0
sst2 0.2 0.1 31.5 0.0 0.0
try 0.1 0.0 0.1 9.8 1.7
CELA1 0.1 0.0 0.1 12.7 1.7
cldnb 0.0 0.0 0.0 0.0 0.5
epcam 0.0 0.0 0.0 0.0 0.8
sdc4 0.0 0.0 0.0 0.0 0.5
Percentages of mapped reads obtained for some genes on the total number
of mapped reads in each type of libraries (Numbers are the means of
percentages obtained from replicates)
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many genes coding for digestive enzymes, such as
trypsin (try), elastase (i.e., ela and cela), trypsin-like
(tryl/zgc:66382), amylase (amy2a) as well as the known
acinar transcription factors ptf1a and rbpjl, were found
enriched in acinar cells. The acinar gene list also
includes novel markers such as genes encoding for the
Fig. 2 Transcriptomic signatures of zebrafish endocrine, ducta,l and acinar cells. a Venn diagram showing the number of genes with acinar-, endocrine-
and ductal-enriched expression obtained with DESeq2 using a cut-off ratio of four-fold and adjusted P< 0.05. b Heatmap plot showing the expression
pattern of all differentially expressed genes. Genes listed on the right side of the plot are examples of either known markers (black) or new genes with
endocrine-, acinar-, and ductal-enriched expression discovered by this analysis (red). The three endocrine samples were generated in silico by combining
the raw data obtained from alpha, beta, and delta cells as described in the Methods section. c and d Gene ontology enrichment analysis for the 1853
genes enriched in endocrine cells (c) and the 492 genes enriched in acinar cells (d) displaying the most enriched biological process
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transcription factors esr2a, klf15, or nr0b2a (Fig. 2b and
Additional file 4: Table S3). As expected, GO enrichment
analysis revealed, among the biological processes active
in acinar cells, “Gland development” and “Digestive sys-
tem development”, “Cellular amino acid metabolic
process”, “Proteolysis” as well as “ATP synthesis coupled
electron transport” (Fig. 2d). As for the duct transcrip-
tome, the analysis reveals novel markers such as id2a
and frzb in addition to known markers like sox9b,
nkx6.1, onecut1, and ctgfa, as we recently described [29].
All together, these analyses confirm that many known
markers and biological pathways display the same pan-
creatic enrichment in zebrafish as in mammals, and also
highlight many novel cell type-specific genes not previ-
ously reported to display such selective expression in
mammals. This led us to compare comprehensively the
endocrine- and exocrine-enriched genes across zebrafish
and mammalian species, thereby defining the conserved
specific signatures among vertebrates.
Comparison of the pancreatic endocrine and exocrine
transcriptomic signatures across zebrafish, mouse, and
human
The evolutionarily conserved expression of a gene in a
specific cell type is a strong argument for its crucial
function in that cell. This concept is widely supported
by numerous studies showing conserved expression of
many transcription factors in development and cell dif-
ferentiation [23, 33], including pancreatic cells [34, 35].
To perform interspecies transcriptome comparison, we
retrieved, from public databases, several RNA-seq data-
sets obtained on murine and human pancreatic islets,
whole pancreas [11, 36–38], as well as a human pancre-
atic sample enriched in acinar tissue [9]. While mouse
RNA-seq data are not presently available for acinar
enriched preparations, the genes with either endocrine-
enriched or exocrine-enriched expression (named here-
after as “endocrine or exocrine genes”) can nevertheless
be identified by comparing RNA-seq from purified
pancreatic islets versus RNA-seq from whole pancreas
(composed of more than 90% of exocrine cells). When a
global comparison of the zebrafish endocrine and acinar
datasets with the murine and human pancreatic data
was performed using a PCA plot analysis, we observed
that the data clustered according to the tissue type
(endocrine and acinar) in the first component (PC1:
representing 55% of variance), while the data tended to
cluster according to the species in the second compo-
nent (PC2: representing 22% of variance) (Fig. 3a). Thus,
this global analysis suggests the existence of sets of
genes displaying an evolutionary conserved endocrine
and exocrine expression. Endocrine and exocrine genes
were identified from human and murine datasets by
selecting all genes presenting at least four-fold
higher expression in each pancreatic tissue (with ad-
justed P < 0.05). Next, we compared the endocrine and
exocrine gene lists between the three vertebrate species.
The Venn diagram on Fig. 3b indicates that, while a large
fraction of endocrine-enriched genes are species-specific,
some sets of genes display a conserved endocrine-
enriched expression in two species or in the three species.
Indeed, among the 1853 zebrafish endocrine genes, 251
are also classified as “endocrine” in human and mice. This
endocrine signature, conserved between zebrafish, mice
and human (named “ZMH”), includes many factors
known to be involved in hormone maturation, secretion,
and regulation. Many transcription factors crucial for
endocrine cell differentiation [30, 39] are found in this
ZMH conserved endocrine signature (Table 2), thereby
validating this method to identify genes with important
physiological function. The ZMH endocrine genes (given
in Additional file 5: Table S4) also comprise components
of signaling pathways reported to control pancreatic endo-
crine cells in mammals such as the glutamate receptor
gria2a and gria2b [40], regulators of G-protein signaling
(rgs4 and rgs16) [32, 41], urocortin3 [5, 42], ion channels
(abcc8, cacna1, and scn1lab), and calcium dependent pro-
teins (c2cd4 and scgn). This indicates that many regulatory
processes controlling endocrine cell development and
physiology have been maintained from fish to human.
Interestingly, the ZMH endocrine genes include several
regulatory genes whose function in pancreatic cells is still
unknown or not well defined such as the kinases map3k15
and mast1, the signaling factor gpr158, as well as the tran-
scription factors npas4a, lmo1, fev, and etv1. Similarly, the
comparison of the exocrine-enriched genes across zebra-
fish, mice, and human shows that a fraction of genes
displays conserved exocrine enrichment (Additional file 6:
Figure S2) – among the 2361 zebrafish exocrine genes
(combined acinar and ductal genes from Fig. 2a), 127
show exocrine enriched expression also in human and
mice. This conserved exocrine signature (Additional file 7:
Table S5) includes, as expected, many digestive enzymes
as well as known exocrine transcription factors such as
ptf1a, rbpjl, and nr5a2 [36, 43], but also regulatory genes
with unknown pancreatic function, like klf15.
The interspecies comparison of both exocrine and
endocrine signature also indicates that many genes
display the same enrichment in only two species (e.g.,
“HM”: between human and mice; “ZM”: zebrafish and
mouse). As expected, the number of conserved HM
endocrine and exocrine genes is higher than the number
of conserved ZH and ZM genes. Overall, this global
analysis indicates that, while significant divergence is
observed between species at the level of endocrine and
exocrine signatures, hundreds of genes have nevertheless
maintained a common expression pattern, among which
are most of the known pancreatic regulatory genes.
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Identification of genes expressed in embryonic endocrine
cells
While many transcription factors controlling pancreatic
endocrine cell differentiation in embryos remain
expressed and functional in mature cells from adults,
there are nevertheless striking differences between the
transcriptomes of fetal and adult cells [5]. In order to
determine the fraction of the endocrine-enriched genes
in adult zebrafish that are already expressed in the first
embryonic endocrine cells, we determined the trans-
criptomic profile of endocrine cells isolated from
Tg(pax6b:GFP) embryos at 27 hpf. We detected 9919
genes expressed in embryonic pancreatic cells above the
threshold level of 100 Normalized count. By comparing
these data with adult endocrine data, we found that,
among the 1853 genes enriched in adult endocrine cells,
911 (49%) genes were already detected in embryonic
cells (full gene list shown in Additional file 8: Table S6).
The expression of some of these endocrine-enriched
genes was further characterized by in situ hybridization
(ISH) on whole zebrafish embryos (Fig. 4). We analyzed
genes identified as endocrine enriched in the three spe-
cies (the “ZMH” genes: pcsk1, pcsk2, fev, cpe, etv1,
map3k15, and lmo1), in two species (the “ZM” gene
cdx4 and the “ZH” gene tbx2b), or only in zebrafish (the
“Z” genes gpr22, dkk3b, pnoca, ppdpfb, scinlb, and
spon1b). All these genes were detected in the embryonic
endocrine pancreatic cells by ISH, validating the RNA-
seq data. Thus, these data indicate that the early embry-
onic endocrine cells from the dorsal pancreatic bud
express a large fraction of the genes constituting the
adult endocrine signature.
Characterization of the transcriptomic signatures for the
endocrine cell subtypes
In order to define the molecular signatures of alpha,
beta, and delta cell subtypes, the 1854 endocrine genes
identified in adult zebrafish (from Fig. 2a) were classified
according to their differential expression in the distinct
endocrine cell subtype (above the threshold of four-fold
enrichment, adjusted P < 0.05); 73, 70 and 192 endocrine
genes were found to be enriched in alpha, beta, and
delta cells, respectively (Fig. 5a). The heatmap plot in
Fig. 5b presents an overview of the expression pattern
for all differentially expressed genes (gene list available
in Additional file 9: Table S7). PCA using all 1854
endocrine-enriched genes displays a clear discrimination
of the alpha, beta, and delta cell transcriptomes (Fig. 5c).
GO enrichment analysis performed on beta cell-specific
genes identifies “response to organic substrate”, “ion
transport”, or “response to nutrient levels” as enriched
pathways among others (Additional file 10: Figure S3A).
The gene expressed at the highest level in the beta cells
after insulin is ppdpfb. This gene is the paralog gene of
the ppdpfa gene (pancreatic progenitor cell differenti-
ation and proliferation factor a), which was reported as
specifically expressed in acinar cells and controls their
differentiation [44]. Interestingly, the paralog ppdpfb is
specifically expressed in the endocrine pancreas and
mainly in beta cells. We verified the expression of
ppdpfb in 24 hpf zebrafish embryos by fluorescent ISH
(FISH) and, according to the RNA-seq data, we
confirmed its expression in many beta cells and in a few
alpha cells but not in delta cells (Fig. 6a–c). The RNA-seq
data also confirmed the selective expression of the
Fig. 3 Conservation of the pancreatic endocrine signature among vertebrates. a Principle component analysis (PCA) performed on human and
mouse whole pancreas and islet RNA-seq datasets and including the zebrafish endocrine and acinar datasets. The analysis was performed using the
9393 genes displaying 1-1-1 orthology relationship between zebrafish, mouse, and human using a total of 24 RNA-seq samples. The endocrine datasets
of zebrafish, mouse, and human cluster along the PC1 axis representing 55% of the variance, indicating a conserved endocrine signature. The human
pancreatic sample enriched in acinar tissue [9] clusters with the human whole pancreatic samples [37] due to the very high proportion of acinar cells
in pancreas. b Venn diagram showing the number of endocrine-enriched genes found only in zebrafish, mouse, or human and those displaying
conserved endocrine-enrichment in two species or in the three species (shown in intersections). Due to gene duplications in some species and often
in zebrafish, the number of corresponding murine (M) or human (H) orthologous genes is given in brackets in each intersection. The full list of
conserved endocrine-enriched genes is given in Additional file 5: Table S4
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zebrafish nkx6.2 gene in beta cells, as previously reported
[45]. Expression of the zebrafish pcsk2 gene is more
enriched in beta cells compared to the pcsk1 gene (beta/
alpha enrichment of 5.5- and 2.5-fold, respectively), while
in mouse and human, only PCSK1 was reported to be
more enriched in beta compared to alpha cells [4, 12, 46].
The enrichment of pcsk2 in beta cells was confirmed by
FISH on zebrafish embryos (Fig. 6d–f ). The zebrafish
estrogen receptor 1, esr1, is also strongly enriched in beta
cells (10575 normalized counts in beta cells versus 671 in
alpha and 71 in delta cells). Finally, the beta cell-selective
expression of spondin 1b (spon1b), an activator of the
Wnt pathway, was also validated by FISH on zebrafish
embryos (Additional file 11: Figure S4).
As expected, the genes specifically expressed in alpha
cells include those coding for the two zebrafish glucagon
hormones (gcga and gcgb) as well as for the Arx transcrip-
tion factor (arxa) but also novel markers including peptide
hormones such as prepronociceptin (pnoca) and neuropep-
tide B (npb) or the calcium regulated factor scinderin like
b (scinlb). The alpha-enriched genes also comprise the
transcription factors etv1 and si:ch211-145o7.3 (a forkhead
domain factor). The alpha-selective expression of pnoca
and scinlb was confirmed by FISH, validating the RNA-
seq data (Additional file 12: Figure S5).
As for the delta cells, besides the somatostatin genes
[47], the RNA-seq data revealed many novel markers,
which include genes coding for transcription factors such
as dlx3b, cdx1, cdx4, and tbx2b, as well as genes coding
for signaling factors like bmp7b or the kinase Map3k15.
Interestingly, as demonstrated by the GO enrichment
analysis (Additional file 10: Figure S3), many GPCR are
specifically enriched in delta cells such as npy8br (neuro-
peptide Y receptor), glra4a (glycine receptor), uts2r
(urotensin receptor), ptger1b & 2a (prostaglandin recep-
tor), adra1d (adrenoreceptor), grm3 (glutamate receptor),
oprd1b (opioid receptor), and gpr123, pinpointing these
endocrine cells as targets of diverse external metabolic sig-
nals. We confirmed the selective expression for several
genes, including the cdx4, cdx1, lamc2, and map3k15
genes, detected already at 24 hpf in delta cells (Additional
file 13: Figure S6). All these results validate the RNA-seq
data and show that many endocrine cell subtype markers
acquire their selective expression in the first embryonic
endocrine cells.
Comparison of transcriptomic signatures of alpha and
beta cells across species
The zebrafish RNA-seq data led to the identification of
many novel markers for each endocrine cell subtypes
raising the question of whether such markers display the
same cell subtype-specific expression in other species.
As the transcriptome of human and murine alpha and
beta cells have been determined by a similar approach
using highly purified FACS cell preparations [12, 48],
this allowed us to perform an interspecies comparison.
In order to identify all alpha and beta cell differentially
expressed genes (with no restriction on endocrine
enriched genes), we performed exactly the same proced-
ure on the zebrafish, mouse, and human RNA-seq data-
sets, namely a comparison of the entire alpha and beta
cell transcriptomes within each species using the same
software and selection criteria (ratio of alpha vs. beta
cells above four-fold enrichment, with adjusted P < 0.05).
This led to the identification of 747, 1330, and 1102
alpha-enriched genes as well as 544, 381, and 465 beta-
Table 2 List of conserved endocrine-enriched transcription factors
Gene Endocrine Acinar Duct Conservation
runx1t1 535 2 7 ZHM
isl1 8613 41 76 ZHM
myt1la 96 0 4 ZHM
fev 5884 128 44 ZHM
neurod1 28467 260 300 ZHM
ascl1a 86 0 1 ZHM
rfx6 1517 26 5 ZHM
pax6b 8059 47 23 ZHM
insm1b 1200 6 39 ZHM
npas4a 4497 11 114 ZHM
arxa 1697 38 1 ZHM
myt1a 532 0 17 ZHM
insm1a 3419 10 248 ZHM
lmo1 1425 4 1 ZHM
etv1 284 0 0 ZHM
esrrga 159 8 2 ZM
rfx2 1590 46 253 ZM
sim1a 164 2 1 ZM
mnx1 1368 144 3 ZM
cdx4 144 0 16 ZM
bhlhe41 2984 712 640 ZM
lmx1bb 145 2 18 ZM
znf516 219 3 31 ZM
esr1 1701 10 59 ZH
tbx2b 1246 7 8 ZH
pgr 399 4 15 ZH
nkx3.2 293 0 26 ZH
nr0b1 284 14 8 ZH
sox11b 49 1 10 ZH
Transcription factors enriched in endocrine cells in zebrafish, human and/or
mouse. The level of expression in endocrine, acinar, and ductal cells is shown
for each gene in the second, third, and fourth column, respectively. The
degree of expression pattern conservation is shown in the last column as ZHM:
endocrine-enriched in zebrafish, human, and mouse; ZM: endocrine-enriched in
zebrafish and mouse; ZH: endocrine-enriched in zebrafish and human
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enriched genes in human, mouse, and zebrafish, respect-
ively. Surprisingly, the interspecies comparison of these
sets of genes revealed that the large majority of alpha-
and beta- enriched genes are species specific (Fig. 7).
Indeed, among the 465 zebrafish beta-enriched genes,
only three have maintained beta cell preferential ex-
pression in human and mice, namely insulin, the tran-
scription factor pdx1, and the glucagon receptor gcgra
(Table 3 and Additional file 14: Table S8 for all ZH, ZM,
and HM beta-enriched genes). Similarly, among the 1102
zebrafish alpha cell-enriched genes, only 20 have human
and murine orthologs with alpha cell-enriched expression
(Fig. 7, Table 3 and Additional file 15: Table S9). As ex-
pected, glucagon and arx are part of the conserved alpha
cell genes. The adcy2 and adcy7 genes coding for adenyl-
ate cyclase are also alpha-enriched in the three vertebrate
species supporting the important role of cAMP in alpha
cells [49]. The gc gene (coding for vitamin D binding pro-
tein) [14] and fev (coding for a Ets transcription factor)
are among the conserved alpha cell signatures, suggesting
a specific function in this endocrine cell subtype. Taken
together, all these analyses indicated that, while hundreds
of genes display conserved expression in endocrine and
exocrine cells, there is much less conservation for the
genes differentially expressed between the endocrine cell
subtypes alpha and beta. These data confirm the striking
differences between species as previously reported for the
human and murine alpha- and beta-enriched genes
[12, 21]. Importantly, many of the conserved alpha- and
beta-specific genes identified in the present study were also
recently highlighted as enriched in these endocrine cell
types in several single cell RNA-seq studies [19–21]
(Additional file 14: Table S8 (beta cells) and Additional
file 15: Table S9 (alpha cells) for comparison).
Role of the zebrafish myt1b and cdx4 genes in endocrine
cell differentiation
To validate our cross-species approach to identify im-
portant pancreatic regulatory factors, we selected two
transcriptional regulators that were expressed at high
levels in endocrine cells at the early developmental stage
(27 hpf) and performed loss of function studies. Muta-
tions of myt1b gene (“ZMH” conserved endocrine genes)
and of the cdx4 gene (“ZM” conserved endocrine gene)
were found to affect endocrine cell differentiation. As
cdx4 is selectively expressed in delta cells, we analyzed
the expression of several novel delta cell markers in the
cdx4tv205 null zebrafish mutant [50]. A previous study
has shown that the zebrafish cdx4 mutant displays
defects in the anterio-posterior patterning of the endo-
derm, with notably a posteriorly-shifted pancreas and an
increase of pancreatic beta cell number [51]; however,
Fig. 4 Expression of genes in endocrine cells of the dorsal pancreatic bud. Whole-mount in situ hybridization on zebrafish embryos showing
endocrine pancreatic expression of some new zebrafish endocrine markers (n > 15). Genes with conserved endocrine-enriched expression in
zebrafish, human, and mouse (ZHM), or endocrine-enriched in zebrafish and mouse (ZH), or in zebrafish and human (HM) are indicated. Z: Gene
endocrine enriched only in zebrafish. N-orth: Endocrine enriched zebrafish gene with no obvious human or mouse ortholog. Arrowheads indicate
the location of the dorsal pancreatic bud containing embryonic endocrine cells and insets at the top-right display higher magnification view of
the pancreatic bud
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the selective expression of cdx4 in delta cells was un-
known as well as its function in this endocrine cell type.
Analysis of the null cdx4tv205 mutant embryos revealed a
complete loss of somatostatin2 gene expression (Fig. 8a).
Similarly, expression of the new delta cell markers lamc2
and slc7a7 was almost undetectable in the mutant em-
bryos, in contrast to the increase of insulin expression
(Fig. 8b, c). Expression of map3k15 gene in delta pancre-
atic cells was also specifically abrogated by cdx4 muta-
tion, while expression of this gene was not affected
anteriorly at the level of the pronephric glomeruli (white
arrows Fig. 8d). All these data demonstrate the import-
ant role of cdx4 for delta cell differentiation.
Our transcriptomic analyses show that embryonic pan-
creatic cells express both myt1a and myt1b paralogs,
with myt1b being expressed at much higher levels. This
was confirmed by ISH revealing expression of myt1b in
the dorsal pancreatic bud of zebrafish embryos
(Additional file 16: Figure S7), while the paralog myt1a
was barely detectable (data not shown). The adult RNA-
seq data indicate that the myt1a/b genes are expressed
in alpha, beta, and delta cells. Simultaneous inactivation
of the two zebrafish myt1 genes was performed by multi-
plex CRISPR/Cas9 mutagenesis through injection of four
guide RNA (two different guides targeting each gene, see
Methods). Injected embryos revealed a significant de-
crease of glucagon expression and no significant effect
on insulin expression (Additional file 16: Figure S7). To
confirm these data obtained in F0 embryos, a line har-
boring a null mutation in myt1b (myt1bulg029) was raised.
Fig. 5 Zebrafish genes differentially expressed in the endocrine cell subtypes. a Venn diagram displaying the number of endocrine genes with
alpha-, beta- and delta-enriched expression identified with DESeq algorithm based on a cut-off ratio of four-fold and adjusted P < 0.05. b Heatmap
plot showing the expression pattern of all differentially expressed genes. Genes listed at the right side of the plot are some examples of either
known (black) or new (red) markers identified in this analysis. c Principal component analysis performed on the nine zebrafish endocrine RNAseq
datasets using the 1853 endocrine-enriched genes. Compared to the PC plot of Fig. 1b performed on all annotated zebrafish genes (33,726
genes), this plot shows a tighter clustering of all replicates and better discrimination between the three endocrine cell subtypes
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Alpha cell mass was decreased in the myt1bulg029–/–
embryos compared to the wild-type and heterozygous
siblings (Fig. 9).
Discussion
In this study, we have explored the transcriptomic land-
scape of the major pancreatic cell types in zebrafish,
thereby defining the transcriptomic signature of acinar
and endocrine cells, as well as of the three major
endocrine cell subtypes alpha, beta, and delta. By this
analysis, we identified many novel cell type-specific
markers with still unknown pancreatic function. By com-
paring the endocrine and exocrine transcriptomic signa-
tures from zebrafish, human, and mouse, we could
define an evolutionarily conserved signature for these
two pancreatic tissues, pinpointing genes and pathways
that likely represent key players in the pancreas of verte-
brates. Consistent with this notion, more than half of all
transcription factors in these endocrine or exocrine con-
served signatures are known regulators of pancreatic cell
differentiation, such as the transcription factors neuroD,
isl1, pax6, insm1, ptf1a, and rbpjl, among others. Myt1 is
part of the endocrine conserved signature and we show
here that inactivation of the myt1b gene in zebrafish
leads to a decrease of alpha cell mass in 2 dpf embryos.
Additionally, cdx4, which is selectively expressed in delta
cells, is also necessary for their differentiation.
The endocrine signature conserved among the three
vertebrate species reveals that several signaling pathways
regulating hormone secretion and cellular homeostasis
are commonly used by pancreatic cells from fish to
mammals. For example, the evolutionarily conserved sig-
nature comprises the RNA binding protein Elavl4/Hud
and the ionotropic glutamate receptor Gria2, shown to
regulate hormone synthesis and secretion in rodents
[40, 52, 53]. Similarly, the glucose response system regu-
lating insulin and glucagon secretion in mammals seems
to be also used in zebrafish as various components of this
pathway are found in the conserved endocrine genes such
as the ATP sensitive K+ channels abcc8 and kcnj11 and
the voltage-dependent Ca++ channel cacna2d2. The use of
this pathway in zebrafish is further strengthened by the
very high expression of the glucose transporter glut2
(slc2a2) and the glucokinase (gck) in zebrafish beta-
endocrine cells. Additionally, some GPCR receptors which
have been reported to control the activity of pancreatic
islet cells in mice, such as the Sstr3 (somatostatin recep-
tor) [54], CasR [55], or Celsr3 [56], are included in the
conserved endocrine signature. Thus, this list of conserved
endocrine-enriched genes strongly suggests that the func-
tion of several signaling pathways controlling the forma-
tion and activity of pancreatic cells has been maintained
from fish to humans. This is consistent with many studies
using zebrafish as a model for pancreas development and
diabetes that revealed conserved physiological regulations
(reviewed in [34, 35]). The conserved endocrine and exo-
crine pancreatic signatures also pinpoint to many novel
candidate regulatory genes that deserve special attention
for future studies. For instance, the transcription factors
lmo1 and npas4a, or the signaling factors gpr158, rgs7,
and rgs17, all selectively expressed in pancreatic endocrine
cells in zebrafish, mice, and human, more than likely play
an important role in pancreatic cells.
Fig. 6 Expression of ppdpfb and pcsk2 genes in zebrafish beta cells.
Co-labeling by fluorescent in situ hybridization (FISH) of ppdpfb and
pcsk2 with insulin, glucagon, and somatostatin. a–c ppdpfb is mainly
expressed by beta cells (a, arrows) and in few alpha cells (b, arrows).
No expression of ppdpfb was observed in delta cells (c). Beta cells
specifically expressed pcsk2 (d, arrows) while no expression was
detected in alpha or delta cells (e and f). (Analyzed embryos > 10)
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In the present study, we identified the human and
murine endocrine- and exocrine-enriched genes by com-
paring transcriptomic data from purified islets with data
obtained from whole pancreas as well as from one hu-
man pancreatic sample enriched in acinar tissue. While
this approach identified almost all expected endocrine
and exocrine markers, some markers may have been
missed due to the low purity of tissue preparations. For
example, the human MNX1 and murine Esr1 (Estrogen
receptor alpha) genes were not enriched in the human
or murine endocrine samples, respectively, while these
two genes were reported to be important for endocrine
beta cells in both species [57–60]. These misclassifica-
tions may be due to the use of RNA-seq data obtained
from whole pancreas instead of highly purified exocrine
cells; such potential errors will be corrected when RNA-
seq data from purified ductal and acinar cells will be
available. The recent single cell transcriptomic data re-
ported for human and murine pancreas bypass the need
for purified cells and will probably constitute a useful re-
source for doing such interspecies comparison. However,
murine acinar cells have not been captured in these
single-cell studies preventing the identification of acinar-
enriched and endocrine-enriched genes. When such data
is available, it will be interesting to perform a global ana-
lysis of all pancreatic single cell transcriptomic studies
and compare it with the zebrafish pancreatic data. In the
meantime, genes classified in our list of conserved “ZM”
or “ZH” endocrine genes should be also considered as
they indeed include mnx1 and esr1, indicating that im-
portant genes fall in these two categories. For proof,
cdx4, classified as endocrine-enriched in zebrafish and
mice (i.e., “ZM”), was found here to be crucial for endo-
crine delta cell differentiation as many novel delta cell
makers were drastically reduced in the cdx4 mutant zeb-
rafish embryos. Our findings warrant future analyses on
the murine (and human) Cdx4 gene to decipher its
expression and function during pancreas development in
mammals. Interestingly, the loss of delta cells with the
concomitant increase of beta cells observed in the zebra-
fish cdx4 mutant suggests that Cdx4 could act on the
balance of delta versus beta cells by determining the fate
of endocrine precursors.
The present study also provides a comprehensive list
of new markers of the zebrafish endocrine alpha, beta,
and delta cell subtypes. An overall view indicates that
the alpha and beta cells are slightly more similar to each
other compared to delta cells, as shown by the PC ana-
lysis (Figs. 1b and 5c). This is also supported by the
Venn diagram (Fig. 5a) showing that (1) the number of
genes with enriched expression in both alpha and beta
cells and not in delta cells (“alpha-beta” enriched genes)
is higher than those of the “alpha-delta” enriched and
“beta-delta” enriched genes (123 genes vs. 28 and 68
genes, respectively), and (2) the number of delta cell
markers is higher than the alpha and beta cell marker
(192 vs. 70 and 73 genes, respectively). These observa-
tions are consistent with a recent study in zebrafish larva
showing the higher capacity of alpha cells to trans-
differentiate to beta cells compared to delta cells [61].
Whether this is also true in adult zebrafish must be veri-
fied as it has been demonstrated in mice that the trans-
differentiation competence of alpha or delta cells toward
beta cells is age dependent [62].
An unexpected observation of our study is the low
conservation of the alpha and beta cell transcriptomic
signatures between zebrafish, mice, and human. Indeed,
only 20 and three genes defined the conserved alpha and
Fig. 7 Identification of genes with conserved enriched expression in alpha and beta cells. Venn diagrams showing the number of genes presenting
enriched expression in alpha cells (right panel) and beta cells (left panel) and displaying this enrichment in zebrafish, mice, and/or human (shown in
intersections). Due to gene duplications in some species and often in zebrafish, the number of corresponding murine (M) or human (H) orthologous
genes is given in brackets in each intersection. The alpha- and beta-enriched genes were selected by DESeq2 with fold change > 4 and adjusted
P< 0.05 using two murine alpha and beta cell preparations [12], six human alpha and beta cell preparations [48], and three zebrafish alpha and beta cell
preparations (this study). The full list of conserved beta- and alpha-enriched genes is given in Additional file 14: Table S8 and Additional file 15: Tables S9
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beta cell signatures, respectively. Such low conservation
cannot be attributed to a low quality of cell samples or
RNA-seq data because, for the three species datasets,
there is a very high enrichment of alpha and beta cell
markers in the corresponding libraries confirming the
good purity of alpha and beta cell preparations. Further,
it is noteworthy that this low conservation is not only
observed between zebrafish and the two mammalian
species but also between human and mouse (see Venn
diagram in Fig. 8). Differences between human and
mouse alpha- and beta-enriched genes have also been
previously noticed [12, 21]. Several non-exclusive expla-
nations can be proposed for this apparent low conserva-
tion of the alpha- and beta-signatures in both distant
and closer species. First, as the alpha and beta cells have
relatively similar transcriptomes, as shown on Fig. 1a,
the identity of these two cell subtypes could rely on the
action of only few regulatory genes. This hypothesis is
supported by the presence of Arx among the few con-
served alpha cell genes, which is the key determinant of
alpha cell identity and its inactivation in mice is
sufficient to transdifferentiate alpha to beta cells [63].
Similarly, Pdx1, one of the three conserved beta cell
genes, is required to maintain beta cell identify and
Table 3 List of genes with evolutionary conserved alpha and
beta cell-enriched expression
Conserved beta cell-specific genes
Zebrafish Log2FC Mouse Log2FC Human Log2FC
pdx1 5.4 Pdx1 2.9 PDX1 6.4
gcgra 5.1 Gcgr 2.6 GCGR 4.2
ins 5.7 Ins2 5.4 INS 6.9
ins 5.7 Ins1 5.3 INS 6.9
Conserved alpha cell-enriched genes
Zebrafish Log2FC Mouse Log2FC Human Log2FC
arxa 12.1 Arx 6.7 ARX 6.0
nrxn3a 4.3 Nrxn3 3.1 NRXN3 2.5
adrb1 2.3 Adrb1 4.3 ADRB1 4.8
fap 2.4 Fap 3.0 FAP 7.1
adcy2a 6.0 Adcy2 5.7 ADCY2 3.2
grap2a 5.6 Grap2 2.3 GRAP2 2.4
ptprz1b 2.3 Ptprz1 5.0 PTPRZ1 4.6
gcgb 7.4 Gcg 5.6 GCG 7.5
gcga 5.5 Gcg 5.6 GCG 7.5
adcy7 3.5 Adcy7 3.7 ADCY7 2.2
adamts18 3.5 Adamts18 5.4 ADAMTS18 5.0
gata6 6.8 Gata6 3.0 GATA6 4.3
gc 4.9 Gc 2.5 GC 6.6
fev 4.3 Fev 5.0 FEV 5.5
tgfbr2 5.6 Tgfbr2 2.6 TGFBR2 2.3
kcnc2 7.8 Kcnc2 4.0 KCNC2 4.9
fgb 2.9 Fgb 2.5 FGB 3.0
marcksl1a 5.4 Marcksl1 2.7 MARCKSL1 2.1
mrc1b 5.5 Mrc1 2.2 MRC1L1 2.9
tgm2b 4.2 Tgm2 2.6 TGM2 2.1
Expression enrichment in alpha and beta cells is given as the Log2 fold-change in
the three species Fig. 8 Delta cell differentiation is disrupted in the cdx4 mutant
embryos. Analysis of wild-type and cdx4tv205–/– mutant embryos at
48 hpf by WHISH (a) and FISH (b–d) using delta cell markers (sst2,
lamc2, slc7a7, and map3k15) as well as gcga and insulin. cdx4tv205
mutants display a loss of sst2 (a), lamc2 (b), and slc7a7 (c) pancreatic
expression and an increase of beta cells. Map3k15 expression is
strongly reduced in the pancreatic islet (yellow arrows) while not
affected in the presumptive pronephric glomeruli (white arrows) (d).
No obvious effect is observed on gcga expression. Nuclei are stained
with DAPI (grey staining). (Analyzed embryos > 10)
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repress the alpha cell program [64]. This first hypothesis
is also supported by the ability of alpha and beta cells to
transdifferentiate into each other [65, 66]. A second ex-
planation can be the relatively stringent threshold that
we used to select differentially expressed genes (four-fold
enrichment, adjusted P < 0.05). For example, the mnx1
gene, known to be involved in beta cell differentiation
[67, 68], is enriched in beta cells in the three vertebrate
species but was not classified as beta-enriched in human
and zebrafish due to a rather low beta versus alpha cell
enrichment (three-fold in human, 1.9-fold in zebrafish
versus 70-fold in mice). These differences in enrichment
between human and mouse Mnx1 is confirmed in the
recent single cell RNA-seq data [18–21]. Similarly, the
prohormone convertase 1 gene pcsk1 required for insulin
hormone maturation was only 2.7-fold enriched in zeb-
rafish beta cells versus alpha cells. It is possible that
small differences in expression levels may be sufficient
for some genes to give a different physiological response.
A third explanation of the low cell subtype conservation
could stem from functional switches occurring between
homologous genes able to perform the same function.
For example, Nkx6.1 is expressed in beta cells in mice
and human but not in zebrafish, where its paralog
nkx6.2 instead of nkx6.1 is selectively expressed in ma-
ture beta cells [45]. nkx6.2 may fulfill the function of
Nkx6.1 as Nkx6.1 and Nkx6.2 have equivalent biological
activities [69]. Another example is the Zn++ transporter
scl30a8, which is strongly expressed in beta cells in
mammals but not in zebrafish, which instead strongly
expresses the homologous Zn++ transporter scl30a2.
Such functional switches may be difficult to identify as
they can occur between genes of the same superfamily
but belonging to different subclasses. For example, we
have shown that, in zebrafish, the role of the bHLH
Neurog3 as pancreatic endocrine cell fate determinant is
fulfilled by two other bHLH factors Ascl1b and Neurod1
[70]. A functional switch is also observed for the specifi-
cation of the secretory cell of the intestine, played by
Atoh1 in mice and by Ascl1a in zebrafish [71]. The cap-
acity of homologous factors to fulfill the same function
is also supported by the observations that many null
mutations can be compensated by a homologous gene
[72–74]. Such compensations seem to occur for the
murine Myt1 gene as the Myt1 KO mice only display
very mild pancreatic defects with no decrease of endo-
crine cells [75], while more drastic defects are observed
by expression of a dominant negative Myt1-Eng protein
[1, 76]. Furthermore, adult murine endocrine pancreatic
cells express the homologous Myt1l and Myt3/St18
genes [77] and their expression increases in the Myt1
KO mice [75]. In zebrafish, myt1a, myt1l, and myt3/st18
are expressed at much lower level compared to myt1b;
this probably explains the decrease in alpha cell mass
observed in the single myt1b mutant. Further experi-
ments will be required to determine whether some com-
pensation occurs through myt1a and if the defects are
more drastic in the double myt1a/b mutant.
The stronger expression of glucagon receptor in the
beta cells of the three vertebrate species highlights the
importance of paracrine regulations between alpha and
beta cells and indicates a role of glucagon on beta cell
physiology, as previously reported in rodents [78] and in
zebrafish for beta cell regeneration [61]. Interestingly,
our transcriptomic analyses highlight fev as an endocrine
conserved gene as well as an alpha cell conserved gene,
suggesting a role of this transcription factor in alpha
cells. Glucose tolerance test in Fev knockout mice previ-
ously revealed a slower response apparently due to a
reduction in insulin production while the level of most
crucial transcription factors of beta cells were un-
changed [79]. As our transcriptomic analysis indicates
that fev is expressed more than 20-fold higher in alpha
cells versus beta cells in zebrafish, mice, and human, this
argues for an important function in alpha cells and war-
rants further phenotypic analyses.
Conclusions
The present transcriptomic analysis of the distinct zebra-
fish pancreatic cell types identifies novel pancreatic
regulatory genes and thereby constitutes a valuable
resource for future studies of the pancreas not only in
zebrafish but also in mammals giving interesting clues
on genes and signaling pathways active in these cells.
Fig. 9 Reduced glucagon expression in the myt1b zebrafish
mutant embryos. Glucagon expression was analyzed by
immunofluorescence in F2 myt1bulg019 homozygous mutant larvae and
in sibling +/+ (WT) and +/– larvae at 2 dpf. The volume of the alpha cell
mass was determined in each embryo by the imaging software Imaris.
The graph shows the quantification measured for all myt1b–/– embryos
and for +/– or +/+ siblings, indicating a slight by statistical significant
decrease of alpha cell mass (each point is the alpha cell mass
measured in one embryo)
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The comparison of the present zebrafish pancreatic
RNA-seq data with the recent single cell pancreatic tran-
scriptomic data or with future data of pure pancreatic
cells obtained not only from human and mouse but also
from other species will help to better define gene regula-
tory networks controlling pancreas ontogeny and physi-
ology in vertebrates. This will be useful for studies
aimed at understanding dysfunction of pancreatic endo-
crine cells in human diseases like diabetes and to design
novel drugs or therapies.
Methods
Generation of the Tg(Insulin:GFP)ulg021 Tg line
The (Insulin:GFP) transgene was generated by first
cloning a 897 pb PCR fragment, amplified with O97 and
O98 primers (Additional file 17: Table S10), that in-
cludes 745 bp of the insulin promoter, the exon 1 and
intron 1 and 7 bp of exon 2 just upstream of the ATG of
the insulin ORF, into the gateway vector pCR8/GW/
TOPO to produce pMV90-G2a plasmid. Second, a triple
LR recombination using p5E-MCS, pMV90-G2a, and
p3E-EGFP-PA inserted into pDestTol2pA2, provided by
the tol2kit [80], generated the transgene Tg(insulin:GFP)
that has been introduced into AB embryos by
coinjection with the Tol2 transposase to generate the
Tg(insulin:GFP)ulg021 Tg line.
Preparation of zebrafish pancreatic cells by FACS
The endocrine cells were prepared using the zebrafish
transgenic lines Tg(Insulin:GFP)ulg021Tg, Tg(gcga:GFP/
ins:mCherry)ia1, and Tg(st22:GFP) to isolate beta, alpha,
and delta cells, respectively [28, 81]. Acinar and ductal
cells were isolated by using Tg(ptf1a:GFP) [27] and
Tg(nkx6.1:GFP)ulg004Tg [29], respectively. The endocrine
tissue was dissected under an epifluorescence stereomicro-
scope before dissociation by enzymatic treatment for
30 min at 28 °C with 1× Tryple Select (Life Techologies),
40 μg/mL proteinase K (Roche), and 10 μg/mL collagenase
IV (Life Technologies), combined with mechanical disrup-
tion by pipetting every 5 minutes. For acinar cell prepara-
tions, pancreata were digested with a mix of collagenase IV
(500 μg/mL), collagenase P (350 μg/mL), and dispase II
(1 mg/mL) for 15 min at 28° with mechanical disruption
every 5 minutes. After dissociation, cells were washed twice
with 1× PBS containing 1% BSA and pelleted at 4 °C for
5 min at 300 g and immediately sorted by FACS. Cells were
selected based on GFP expression using FACS Aria II by
two consecutive sorting steps: the first sorting was done in
the “yield” mode and the second in the “purity” mode.
Purity was estimated by FACS Aria II after cell sorting
(more than 99% purity of GPF+ cells) and by fluorescence
microscopy (from 95–99% purity). Each replicate sample
was prepared from four adult zebrafish. Approximately
10,000–20,000 endocrine cells, 20,000–40,000 acinar cells,
and 2000–10,000 ductal cells were obtained after FACS
and used for library preparations.
RNA extraction, cDNA amplification, library preparation,
and sequencing
Total RNA was extracted from FACS sorted cells using
the RNeasy plus micro kit (Qiagene). RNA from endo-
crine and acinar cells was eluted in 10 μL with a concen-
tration of 100–400 pg/μL. RNA integrity was assessed by
a capillary electrophoresis using Agilent RNA 6000 pico
chip (Agilent technologies), the RIN value for each
sample was from 8 to 10. The Smarter Ultra low RNA in-
put kit (clontech) [82] was used to for the synthesis and
amplification of cDNA synthesis using up to 10 ng of total
RNA following the manufacturer’s instructions and per-
forming no more than 12 cycles of PCR in order to
minimize amplification biases. The quality of cDNA was
verified by 2100 High Sensitivity DNA assay (Agilent
technologies). Truseq DNA Illumina libraries were pre-
pared and sequenced to obtain approximately 90 million
reads (100 bp paired-end reads) per library using the
Hiseq 2000 Illumina sequencer.
RNA-seq data analysis
Sequences were trimmed in order to remove adaptors and
low quality bases. Trimmed reads were mapped in to the
genome (Zv9, Ensembl genome version 75) using Tophat
v.2.0.9 [83]. Tophat’s options were set according to the
library features (-r 220 –mate-std-dev 82 –segment-length
18) and the option –min-intron-length was set up to 30
nucleotides according to the intron length described by
Moss et al. [84]. For the mouse and human datasets, raw
data were downloaded from the public databases: human
pancreas (four samples from Fagerberg et al. [37] and one
acinar cell-enriched sample from Morán et al. [9]: the
E-MTAB-1294 dataset), human islets (three samples from
Nica et al. [46] and four samples from Morán et al. [9]),
murine pancreas (two samples from Holmstrom et al.
[36]), and murine islets (three samples from Morán et al.
[9]). The alpha and beta cell RNA-seq datasets were
obtained from Benner et al. [12] for mouse (two samples
of each) and from Blodgett et al. [48] for human (six
samples each) [48]. Reads were mapped into the mouse
GRCm38 and the human GRCh37 genomes (Ensembl
genome version 75) using default options. Gene expres-
sion was measured from the mapped reads by using HT-
seq-count [85]. PCA, using princomp function of R, was
calculated for the whole dataset using the variance
stabilization transformation values obtained by DESeq R
package from the gene expression values [86]. For differ-
ential expression analysis, we used the R package DESeq2
[87]. DESeq2 employs shrinkage estimation for disper-
sions and fold change; it uses Wald test for significance
with posterior adjustment of P values using the procedure
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of Benjamini and Hochberg (giving adjusted P values).
Genes differentially expressed were selected with an ad-
justed P < 0.05 and a fold change > 4. For the comparison
of the acinar, ductal and endocrine cell data, in-silico
endocrine datasets were simulated by combining alpha,
beta and delta RNA-seq data. This approach was taken to
decrease the number of pairwise comparisons and could
be used since the sequencing deepness of each library was
in a similar range (below of a factor 2). Endocrine
dataset #1 was obtained by combining the mapped
reads of alpha1 (47 × 106 reads), beta1 (48 × 106 reads),
and delta1 (31 × 106 reads) datasets; endocrine dataset #2
is a mix of alpha2 (46 × 106 reads), beta2 (29 × 106 reads),
and delta2 (30 106 reads); endocrine dataset #3 is the com-
bination of alpha3 (59 × 106 reads), beta3 (62 × 106 reads),
and delta3 (59 × 106 reads) datasets. The RNA-seq raw
data have been deposited on ENA under the accession
number PRJEB10140.
Comparison of the human, murine, and zebrafish
pancreatic transcriptomes
The predicted orthologs among zebrafish, mouse and
human were obtained from Ensembl [88]. The informa-
tion from the three species was retrieved using Biomart
tool [89]. Two different orthology tables were generated
(tables available upon request). The first table contains
all zebrafish, murine and human genes with 1-1-1
orthology relationship. Orthology table two comprises
all 1-1-1 orthologs as well as the genes presenting 1-
many-many orthology relationships and thus includes all
duplicated genes (paralogs), which are notably found in
the zebrafish genome. The interspecies PC analysis was
performed using only the genes with a 1-1-1 orthology
relationship. The genes presenting an endocrine-
enriched or an exocrine-enriched expression were iden-
tified in mouse and in human by using DESeq2 software
selecting genes with at least four-fold higher expression
in islet dataset or in whole pancreas dataset (adjusted
P < 0.05). The interspecies comparison of endocrine-
and exocrine-enriched genes was performed using the
orthology table two.
GO enrichment analysis
Tissue- and cell type-enriched genes were converted and
uploaded to DAVID bioinformatics resource [90]. Using
the Functional annotation tool, we run a GO enrichment
analysis for endocrine and acinar enriched genes as well
as for the alpha-, beta- and delta-enriched genes.
Enriched processes were identified by GOTerm_BP_FAT
with a P < 0.1.
In situ hybridization
Antisense RNA probe for the different genes were
prepared as described by Thisse et al. [91], except for fev
[92]. Briefly, primers were designed to amplify a part of
the transcript that is used as a template to synthesize the
probe. The reverse primer at the 5’ end contains the
minimal promoter sequence for T3 RNA polymerase
(5’-AATTAACCCTCACTAAAGGGAG-3’), templates
were amplified by RT-PCR using the set of primers shown
in Additional file 17: Table S10. Whole mount in situ
hybridization and fluorescent in situ hybridization (WISH
and FISH) were performed as described by Mavropoulos
et al. [93], applying some modification to this protocol.
Briefly, larvae of 3 dpf or older were incubated during
20 minutes in methanol and 3% H2O2 at room tem-
perature, prior to dehydration. Antisense probe hybrid-
ization was performed using 10–50 ng of DIG- and
DNP-probes in hybridization buffer containing 5% dex-
tran sulfate (MW: 500,000) at 65 °C overnight. Antibodies
were pre-absorbed on homogenized larvae (mix of differ-
ent developmental stages) for 2 h at room temperature
and then diluted to 1/3000 DIG-AP, 1/1500 DIG-HRP,
and 1/800 DNP-HRP (PerkinElmer).
Inactivation of myt1a and myt1b genes by multiplex
CRISPR/cas9 mutagenesis
Mutations in the myt1a and myt1b genes were generated
by multiplex CRISPR/Cas9 technology essentially as de-
scribed previously [94, 95]. The nls-zCas9-nls mRNA
was synthesized by transcription of the plasmid pT3TS-
nCas9n (Addgene). CRISPR guide RNAs were selected
using CRISPR design and chopchop software to target
the beginning of Myt1a and Myt1b coding regions
(guides 1) and the regions coding for the first zinc finger
domain (guides 2). The following target sites were used:
GCCAAGACGCAGATGATAAGCGG and GATGGTT
TAGGCCATGTCAGTGG for myt1a, and GTCTGA
GGGAGGGCCGGCAGCGG and TGCCATTGCATCC
TGGAGTGGGG for myt1b (PAM motifs are under-
lined). The DNA templates were prepared by annealing
and filling two oligonucleotides containing the T7 pro-
moter sequence and the target sequences as previously
described [95]. After synthesis and purification of gRNA,
fertilized zebrafish eggs were injected with approxi-
mately 1 nL of a solution containing 50 ng of the four
gRNA and 300 ng of nls-zCas9-nls mRNA. The effi-
ciency of mutagenesis was verified by genotyping using
Heteroduplex Migration Assays after amplification of
targeted genomic sequences. A few injected embryos
were fixed in PFA at 48 hpf for phenotypic analysis and
the others were raised until adulthood. Founder fish
transmitting a germline mutation in myt1b were out-
crossed with wild type fish; F1 fish harboring a 5 bp in-
sertion in myt1b (myt1bulg039 allele) causing a frameshift
in the coding sequences were incrossed to generate
myt1b–/– embryos and +/–, +/+ siblings, which were ana-
lyzed by immunohistochemistry.
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Immunohistochemistry
Expression of insulin and glucagon was analyzed by im-
munofluorescence on whole-mount zebrafish embryos.
After overnight fixation in 2% PFA at 4 °C, 1 hour incu-
bation in PBS 1% Triton X-100 for 2 hours at room
temperature in blocking solution (4% BSA, 10% DMSO,
0.3% Triton X-100 in PBS), embryos were incubated
with the primary antibodies anti-Mouse Glucagon 1/200
(Sigma, G2654) and Anti-Guinea Pig Insulin 1/300 (MP,
64714). After washing, embryos were incubated with the
secondary antibodies Anti-Mouse Alexa 568 or 633
(Invitrogen, A-11004 and A-21052) and Anti-Guinea Pig
Alexa 568 or 633 (Invitrogen, A-11075 and A-21105)
diluted 1/300. After washing and mounting, embryos
were scanned with a Leica SP5 confocal microscope and
images were analyzed using Imaris 7.2.3 software. Alpha
and beta cell mass was measured using Imaris based on
3D reconstitution of Fluorescence signal obtained by
immunofluorescence; the same confocal and Imaris
parameter settings were used for wild-type and mutant
embryos. To compare the number of alpha cells and beta
cells in wild-type and mutants, glucagon+ and insulin+ cells
were counted in every 6-μm optical section throughout the
whole principal islet. Expression of GFP and mCherry in
the pancreas of Tg(gcga:GFP);(ins:NTR-mCherry) adult
transgenic fish as well as of Tg(sst2:GFP) adult fish was an-
alyzed by immunofluorescence on cryosections (Additional
file 1: Figure S1). The antibodies used are the same
than described above and also include the anti-Rabbit
Somatostatin 1/300 (Dako, a0564) and Anti-Rabbit Alexa
568 or 633 1/300 (Invitrogen, A-11011 and A-21070).
Expression of GFP in beta cells was also verified for the
Tg(insulin:GFP) larvae (Additional file 1: Figure S1).
Additional files
Additional file 1: Figure S1. Expression of the transgenes Tg(ins:GFP),
Tg(gcga:GFP), Tg(sst2:GFP), and Tg(ins:NTR:mCherry) in the endocrine
pancreatic cell types. (A–C) Whole mount immunostaining of 3 dpf
transgenic larvae Tg(ins:GFP) demonstrating the selective expression of
GFP in beta cells. (D–I) Immunostaining of pancreas sections from adult
transgenic fish Tg(gcga:GFP/ins:NTR:mCherry). Glucagon+ cells (see arrows
in D–F) express high level of GFP and are not labelled by mCherry, while
many insulin expressing cells are labelled by mCherry and by GFP (at
slightly lower levels) (see arrowheads in G–I). These data reveal a leaking
expression of the gcga:GFP transgene in beta cells. (J–L) ISH performed
on pancreas section of adult Tg(sst2:gfp) with sst2 probe followed by
immunofluorescence using the GFP antibody; the expression of
endogenous sst2 gene co-localize with GFP staining confirming the
specific expression of the transgene in delta cells [28]. (TIF 8638 kb)
Additional file 2: Table S1. Gene expression levels in alpha, beta, and
delta cell subtypes. The expression is given in Normalized counts for the
three replicates of alpha, beta, and delta cell libraries. (XLSX 4416 kb)
Additional file 3: Table S2. Gene expression levels in endocrine, acinar,
and ductal cells. The expression is given in Normalized counts for the
four replicates of acinar cells, the three replicates of ductal and endocrine
cells. The three endocrine datasets were obtained by combining the
reads obtained with alpha, beta and delta cell libraries as described in
Methods (e.g., endocrine1 data is a mix of alpha1, beta1 and delta1;
endocrine2 data is a mix of alpha2, beta2 and delta2) (XLSX 4433 kb)
Additional file 4: Table S3. Classification of genes according to their
enriched expression in endocrine, acinar, or ductal cells. Expression levels
were compared for each gene between endocrine, acinar, and ductal
cells (pair-wise comparison with DEseq2). Classification was performed
using the cut-off values of fold change > 4 and adjusted P < 0.05. The
enrichment is given for each gene as Log2 of fold change and with the
adjusted P value. (XLSX 2192 kb)
Additional file 5: Table S4. Genes presenting conserved endocrine
expression. The ZMH excel page shows the genes with endocrine-enriched
expression in zebrafish, mice and human. The ZM, ZH and HM excel pages
show genes with endocrine-enriched expression in two species (ZM: zebrafish
and mice; ZH: zebrafish and human; HM: human and mice). The tables give
the expression mean in endocrine cells (Normalized counts) and the
enrichment (FC: fold change) in the three species. (XLSX 123 kb)
Additional file 6: Figure S2. Identification of genes with evolutionary
conserved and enriched expression in pancreatic exocrine cells. Venn diagram
showing the number of exocrine-enriched genes found only in zebrafish,
mouse or human, and those displaying conserved endocrine-enrichment in
two species or in the three species (shown in intersections). Due to gene
duplications in some species and often in zebrafish, the number of
corresponding murine (M) or human (H) orthologous genes is given in
brackets in each intersection. The full list of conserved exocrine-enriched
genes is given in Additional file 7: Table S5. (PDF 4 kb)
Additional file 7: Table S5. Genes presenting conserved exocrine
expression. The ZMH excel page shows the genes with exocrine-enriched
expression in zebrafish, mice and human. The ZM, ZH and HM excel pages
show genes with endocrine-enriched expression in two species (ZM: zebrafish
and mice; ZH: zebrafish and human; HM: human and mice). The tables give
the expression mean in endocrine cells (Normalized counts) and the
enrichment (FC: fold change) in the three species. (XLSX 101 kb)
Additional file 8: Table S6. List of endocrine-enriched genes with an
expression level above 100 counts in embryonic endocrine cells at 27
hpf. List of 911 genes with endocrine-enriched expression in adult and
showing an expression level above 100 Normalized counts. Gene expression
is provided for the three replicates (selection of pancreatic cells at 27 hpf
from Tg(pax6:GFP)) as well as the mean expression level. (XLSX 99 kb)
Additional file 9: Table S7. Classification of endocrine-enriched genes
according to their expression in alpha, beta, and delta endocrine cells.
Gene expression ratio was calculated for all pair-wise comparison (alpha
versus beta: A&B; beta versus delta: B&D and alpha versus delta: A&D).
The enrichment is given as Log2 fold change with the adjust value.
Classification was done using the cut-off threshold of Log2 fold
change > 2 and adjusted P < 0.05. (XLSX 265 kb)
Additional file 10: Figure S3. Gene ontology (GO) enrichment analysis
for endocrine cell subtypes. Left. Bar plot displaying the number of genes
constituting enriched GO terms. P values are denoted on the bars. Right.
Fold of change (in Log2) of genes constituting the most enriched GO
terms, (A) GO enrichment for the 70 beta-enriched genes. (B) GO
enrichment for the 73 alpha-enriched genes. (C) GO enrichment for the
192 delta-enriched genes. (B-A: pairwise beta versus alpha; B-D: pairwise
beta versus delta). (TIF 13089 kb)
Additional file 11: Figure S4. Expression of spon1b gene in beta
pancreatic cells of zebrafish embryos. Co-labeling by FISH of spon1b with
insulin (ins) (A, arrows show colocalization), while no expression was
detected in delta cells (B) (n > 10). ins: insulin, sst2: somatostatin 2, N-orth:
Endocrine enriched zebrafish gene with no described ortholog in human
and/or mouse. (TIF 5116 kb)
Additional file 12: Figure S5. Expression of pnoca and scinlb genes in
alpha pancreatic cells of zebrafish embryos. Co-labeling by in situ
hybridization at 30 hpf of new discovered genes with cell type-specific
markers for alpha and beta cells (n > 10). A and B. pnoca is expressed in
alpha cells (A, arrows) while no expression was detected in beta cells (B).
scinlb was detected specifically in alpha cells (C, arrows) but not detected
in beta cells (D). gcga: glucagon a, ins: insulin, Z: no endocrine gene with
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no conserved expression, N-orth: Endocrine-enriched zebrafish gene with
no described ortholog in human and/or mouse. (TIF 8027 kb)
Additional file 13: Figure S6. Validation of the selective expression of
some genes in zebrafish delta cells. cdx1b, cdx4, lamc2, and map3k15 are
specifically expressed in delta cells at 24 hpf (A, C, E, G, arrows show
colocalization with delta cell-specific markers, somatostatin 2; n > 10). No
expression was detected for none of the genes in beta cells (B, D, F, H).
ins: insulin, sst2: somatostatin 2, ZHM: Gene expression conserved in
zebrafish, human and mouse, ZM: Gene expression conserved in zebrafish
and mouse, Z: Endocrine gene with no conserved expression, N-orth:
Endocrine-enriched zebrafish gene with no described ortholog in human
and/or mouse. (TIF 12250 kb)
Additional file 14: Table S8. Conserved beta cell markers. The ZMH
excel page shows the genes with beta cell-enriched expression in
zebrafish, mice and human. The ZM, ZH, and HM excel pages show
genes with beta cell-enriched expression in two species (ZM: zebrafish
and mice; ZH: zebrafish and human; HM: human and mice). Beta cell
versus alpha cell expression ratio is given as fold change (FC) for each
species. The ZMH, ZH, and HM genes also detected as enriched in
specific pancreatic cell types in the human single-cell transcriptomic studies
[19–21] are also noted in the columns on the right part. (XLSX 18 kb)
Additional file 15: Table S9. Conserved alpha cell markers. The ZMH
excel page shows the genes with alpha cell enriched expression in
Zebrafish, Mice and Human. The ZM, ZH and HM excel pages show
genes with alpha cell-enriched expression in two species (ZM: Zebrafish
and Mice; ZH: Zebrafish and Human; HM: Human and Mice). Alpha cell
versus beta cell expression ratio is given as fold change (FC) for the three
species. The ZMH, ZH and HM genes also detected as enriched in specific
pancreatic cell types in the human single cell transcriptomic studies
[19–21] are also noted in the columns on the right part. (XLSX 35 kb)
Additional file 16: Figure S7. Expression and function of myt1b in
zebrafish pancreas. A: Whole-mount ISH showing expression pattern of
myt1b in zebrafish embryos at 27 hpf. High expression is detected in the
dorsal pancreatic bud (indicated by the arrow) and in the central nervous
system. B: Quantification of glucagon and insulin expression at 48 hpf in
wild-type (non-injected) embryos and in embryos injected with the 4
CRISPR myt1a/b guide RNA and Cas9. Graph B shows the volume of all
gcga+ cells and all ins+ cells measured in each embryo by the imaging
software Imaris (see Methods) (each point is the volume measured in
one embryo). This quantification indicates a statistically significant
reduction of the volume of alpha cell mass while beta cell mass is not
drastically affected in the injected (F0) embryos (results of one experiment).
(TIF 2416 kb)
Additional file 17: Table S10. Primers used for RNA probe synthesis.
List of primers used for the synthesis of the RNA probes for in situ
hybridization, antisense primers contain the T3 minimal promoter
sequence. (XLSX 10 kb)
Abbreviations
dpf: Days post fertilization; FISH: Fluorescent in situ hybridization; gcga: Glucagon
a; GPCRs: G-couple protein receptors; hpf: Hours post fertilization; ins: Insulin;
PCA: Principal component analysis; sst2: Somatostatin 2; WISH: Whole-mount in
situ hybridization; ZH: Genes with conserved expression pattern in zebrafish and
human; ZM: Genes with conserved expression pattern in zebrafish and mice;
ZMH: Genes with conserved expression pattern in zebrafish, mice and human
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1.1 Overview of the zebrash RNA-Seq data
We actively continued to use our zebrash bulk RNA-Seq data from major pancreatic cell
types to perform further analyses. This section presents a brief summary and an update
of the previous results, also covering dierent aspects not highlighted in the publication.
We performed an update of our analyses by using a new pipeline and a more recent
version of the reference genome and its annotations (see methods 4.3). As presented in
the paper, each library was rstly evaluated by looking at their respective expression
of key genes specic of each pancreatic population. Hormone genes were evaluated,
and results showed they were the highest represented transcripts in each corresponding
endocrine cell types. Gcga and gcgb transcripts represent 16.77% (± 0.66) of all reads in
alpha samples (Table 1). Ins transcripts cover 16.32% (± 5.19) of beta samples while sst2
and sst1.2 share 33.37% (± 8.86) of all reads in delta samples. Samples for ductal cells
display a dierent distribution as they don’t strongly express a specic gene. Two of the
most expressed genes, tmsb4x and actb2, cover together only 2.53% (± 0.32) of all reads.
They are involved in cytoskeleton organization. Finally, acinar samples have 6 genes
coding for digestive enzymes whose combined transcripts cover 44.46% (± 1.26) of reads.
These data conrm the good purity of each sample as specic markers of other cell types
were not signicantly detected (previously described in the paper). We also compared
all RNA-seq data sets by performing Principal Component Analysis (PCA) and cluster-
ing analysis. This rst highlighted a strong separation between endocrine, acinar and
ductal samples. This observation conrms that endocrine cells present a more similar
transcriptome between them compared to ductal or acinar cells. These two are both
exocrine-associated cell types but they present signicative transcriptomic dierences
underlying their distinct functions. By focusing the analysis on endocrine cells, we
highlighted a clear distinction between alpha, beta and delta samples (Fig 25).
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Name Alpha Beta Delta Acinar Ductal
Table 1: Most expressed genes by cell type. Expressions are
displayed in percentage of total reads detected by sample.
Name Alpha Beta Delta Acinar Ductal
gcga 12,49 0,17 0,32 0,00 0,00
gcgb 4,29 0,02 0,14 0,00 0,00
ins 0,11 16,32 0,07 0,00 0,05
sst2 0,14 0,04 19,53 0,00 0,00
sst1.2 0,10 0,04 13,85 0,00 0,00
prss1 0,08 0,00 0,07 9,24 0,08
cpa5 0,07 0,00 0,05 8,12 0,04
prss59.1 0,07 0,00 0,06 8,39 0,12
prss59.2 0,06 0,00 0,05 7,93 0,11
cpb1 0,06 0,00 0,04 5,63 0,03
ela2l 0,06 0,00 0,06 5,20 0,09
tmsb4x 0,02 0,05 0,03 0,01 1,24
actb2 0,14 0,21 0,15 0,18 1,28
Using RNA-Seq, we can explore the transcriptome by looking at dierent aspects of the
data. Our rst approach was to consider the set of genes which present an enriched
expression in each cell type as they highlight the transcriptional specicity. Based on
our data, these lists of enriched genes for each population has been updated and we set
up lists of 47, 57, 172, 842, 634 enriched genes for alpha, beta, delta, ductal and acinar
cells, respectively (see methods 4.3). We also highlighted 482 and 133 genes with 10
times enrichment in endocrine (alpha, beta, delta) and exocrine (ductal, acinar) tissue,
respectively (Fig 26 + Supplemental table 1).
The most common approach with RNA-Seq is to dene a set of genes with enriched
expression in one condition compared to another. This method is dependent of the set
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Figure 25: Overview of the analysis of data. (A) PCA of the ve pancreatic cell types
which highlights separation between endocrine, ductal and acinar cells. (B) PCA focusing
on the 3 endocrine cell subtypes which shows distinct clusters. (C) Hierarchical clustering
of all the samples.
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Figure 26: Expression prole of genes in zebrash bulk RNA-seq data. Each group
contains genes with a signicative enriched expression for this group. The fontsize of
the gene names represents their relative expression levels.
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of dierent conditions that we have at our disposal. When comparing cell types, these
subsets of genes represent potential marker genes of each cell type. The accuracy of these
lists is directly correlated with the amount of cell types which are considered.
The transcriptomic signature of a cell type is not only restricted to the set of enriched
markers. It represents the global set of RNAs found in a cell and by extension regarding
at mRNA, the global set of genes expressed. Using a reference set of 25106 protein
coding genes (Ensembl release 92), we evaluated the transcriptomic signature of the ve
pancreatic cell types. We detected for endocrine cells 14565 (58.01%) genes expressed in
alpha cells (Counts Per Million (CPM) ≥ 1), 13450 (53.57%) genes in beta cells and 14398
(57.34%) genes in delta cells. For exocrine tissue, we detected 12534 (49.92%) and 6421
(25.57%) genes expressed in ductal and acinar cells, respectively. Endocrine and ductal
cells have similar distribution of expression levels: 5.52% (± 0.85) of genes with CPM ≥
100, 27.12% (± 2.80) of CPM ≥10, 8.21% (± 0.79) of CPM ≥ 5 and 13.85 % (± 0.89) of genes
with CPM ≥ 1 (Fig 27). The acinar samples present a lower complexity meaning that
many sequenced reads correspond to the same molecules implying a level of redundancy
in the data [295]. This aects the distribution of expression levels which is therefore
dierent from other cell types: 0.72% of genes with CPM ≥ 100, 3.60% of CPM ≥ 10, 3.80%
of CPM ≥ 5 and 17.45% of CPM ≥ 1. This means that most of the reads cover very few
genes and implies that in some extend these libraries are less balanced than the others.
As our previous results showed that each pancreatic endocrine cell type does not express
many specic genes when compared one to another, it implies that they should have
high similarities between them. We decided to quantify this by comparing their global
transcriptomes. We considered total expressed genes (CPM > 1) and we observed that
around 85% (87.18 ± 3.79) of genes expressed by one endocrine cell type is also expressed
in the two others (Figure 28). This value rises to around 95% (95.23 ± 2.04) for genes
expressed in at least two endocrine cell types. We then estimated the overlap between
genes expressed in ductal cells and genes expressed in each endocrine cell type taken
separately. In comparison, we observed an average overlap around 75% (76.56 ± 1.69)
between any endocrine cell and ductal cell transcriptomes.
In conclusion, we described each pancreatic cell type by dening sets of representative
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Figure 27: General comparison of transcriptomes. (A) Distribution of genes accord-
ing to their CPM levels. (B) Values associated. It shows that acinar samples present a
dierent prole, probably due to a lower complexity of the library.
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Figure 28: Comparison of endocrine transcriptomes. (A) The transcriptomes of
endocrine cells present a strong overlap between them. Around 95% of all genes expressed
(CPM > 1) in an endocrine cell subtype is expressed in at least 1 of the others. AB =
expressed in alpha and beta; AD = expressed in alpha and delta; BD = expressed in
beta and delta. (B) When comparing the transcriptome of each endocrine cell subtype
separately with the transcriptome of ductal cell, the overlap decreases to ~75%.
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genes for each but also by the complete set of expressed genes. We highlighted a close
similarity between the three endocrine cell signatures.
1.2 Zebrash scRNA-Seq from adult pancreatic tissues
In order to update and complete our atlas of all pancreatic cell transcriptomes, we decided
to use available Single-Cell RNA-Seq data produced in adult pancreatic tissues from
zebrash by the group of Ninov N. [147]. We retrieved the adult pancreatic datasets
from their study and we reanalyzed them to determine if they t with our previous bulk
RNA-Seq work. After multiple ltering steps (see Methods 4.5.1), we kept an amount
of 6515 single cells to use with average 1222 (± 496) expressed genes detected per cell.
Cell clustering highlighted 7 major groups of pancreatic cells based on transcriptomic
signal. We evaluate expression pattern of key genes across the dierent clusters in order
to determine their pancreatic cell identities (Figure 29-A). As with our bulk RNA-Seq we
only isolated 5 pancreatic cell types using specic transgenic lines (alpha, beta, delta,
ductal and acinar cells), scRNA-Seq data present two more clusters. One of these is
characterized by the specic expression of sst1.1 gene, that we refer as delta 1.1 cells. The
second cluster correspond to ghrelin-expressing epsilon cells. Using combinations of
specic markers for each group, we created “cell-score” to dene and annotate accurately
each pancreatic cell population. After this process, we obtained the following distribution
of cells: 618 alpha cells, 1383 beta cells, 2255 delta (sst2) cells, 746 delta (sst1.1) cells, 91
epsilon cells, 875 ductal cells and 547 acinar cells (Figure 29-B).
To evaluate this annotation, we decided to screen expression of pancreatic cell type
markers that we determined in our bulk RNA-Seq in order to estimate in which proportion
they can also be validated with the single-cell (SC) data. We observed that a large majority
of these markers were assigned to the same cell type (Figure 30-A). But as two additional
pancreatic cell transcriptomes are detected with the SC data, some genes need to be
reassigned to appropriate cell type. This is the case for genes such as pcsk2 and spon1b
that we previously assigned to beta cells but seem to be preferentially expressed in delta
1.1 cells. Similarly, pdx1 which is vastly described as beta marker but seems to be highly
expressed in delta 1.1 cells in zebrash.
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Figure 29: Analysis of Zebrash scRNA-Seq data. (A) Expression of key genes of each
cell type on the UMAP embedding from SC data. (B) Annotation of the SC clusters with
the corresponding cell type.
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Figure 30: Validation of marker genes. (A) DotPlot of previously described marker
genes from our bulk RNA-seq data. Some genes presented enrichment for the two
additionnal signature. (B) DotPlot of endocrine cells marker genes identied from the
scRNA-seq data. Size of the dot represents the proportion of cells in a cluster expressing
the gene. Color of the dot represents the relative expression level of the gene in a celltype
compared to the celltype with the highest expression.
103
RESULTS
These observations indicate that the SC data may complement our bulk data in dening
cell type specic gene signatures. We started by determining all genes expressed in each
cluster before performing the dierential expression analysis. In single-cell experiments,
only a small part of the global transcriptome is detected for a cell. After the identication
of the dierent clusters, each cell contributes to reconstruct the global transcriptome of
the cell type to which it belongs. The amount of cells in a cluster impacts the covering of
the associated transcriptome. We observed an average of 13681 (± 1803) expressed genes
detected by cluster which is consistent with the average of 12273 (±3371) genes that we
detected with bulk data. We determined new lists of markers for each pancreatic cell
type according to SC particularity. Indeed, the dierential expression of a gene can be
related to two parameters: the percentage of cells expressing the gene in each cluster,
and the expression level of the gene in both clusters (Figure 31).
After dierential expression analysis we identied 22, 30, 116, 168, 20, 180 and 61 enriched
genes for alpha, beta, delta 1.2, delta 1.1, epsilon, ductal and acinar cells, respectively
(with the threshold of being expressed in at least 50% of cells of a cluster in order to be
considered as marker of this group). We determined also a set of 227 endocrine enriched
genes (Figure 32 + Supplemental table 2). Similarly to our bulk data, for each endocrine
cell type, the associated hormone is found in the marker list. Concerning acinar cells, we
found multiple genes coding for digestive enzymes. Results also validate some markers
we previously identied such as pnoca and fev for alpha cells, ndufa4l2a and tagln3b for
beta cells or nmba and slc7a7 for delta 1.2 cells. We also dened markers for epsilon cells
with genes such as mboat4, acsl1a, abhd17c and brd1b which seem highly specic. The
rst three are known to play a role in fatty acid metabolism with acsl1a coding for an
enzyme involved in the conversion of long-chain fatty acids into acyl-CoA. Acyl-CoA
is required for ghrelin acylation with mboat4 encoding the acyltransferase responsible
for this process and also responsible for the octanoylation of ghrelin at ‘Ser-3’ [296,
297]. Mlnl expression is strongly enriched in epsilon cells and this hormone is known
to be strongly expressed in enteroendocrine cells in the gut. Finally, as we obtained the
transcriptome of delta 1.1 cells, we highlighted unknown markers for this population
mainly dened by the specic expression of sst1.1 gene. It is also interesting to observe
that some genes previously associated with other cell types seem now more enriched
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Figure 31: Characteristics of scRNA-seq data. Two parameters are important with SC
data: the expression level and the percentage of cells expressing the gene in a cluster.
Genes highly expressed such as ins gene, are detected nearly in all cells by SC but the
expression level allows to dene the correct prole of expression. ndufa4l2a prole is
easily identiable as both parameters indicate the same cell type. pdx1 prole is interesting




in this group such as dkk3b or pyyb (Figure 30-A). As mentioned previously, the most
surprising result is pdx1 expression which is enriched in delta 1.1 cells compared to beta
cells (~1.5x). Pdx1 has been widely described as a beta identity gene (notably in mammals)
with a key role in the regulation of insulin gene transcription. Interestingly, PDX1 was
initially identied as a transcription factor involved in the activation of somatostatin gene
[298]. This raises questions about the role of this subpopulation in zebrash pancreas as
a similar subpopulation of “delta” cells is not described in mouse or human pancreas.
1.3 Atlas of endocrine pancreatic cell transcriptomes in Ze-
brash
Based on the results obtained in our bulk RNA-seq and in available scRNA-seq, we dened
set of key marker genes for each endocrine cell type in zebrash. Hormone coding genes
are obviously strong markers to identify each endocrine cell type. For beta cells, genes
such as ndufa4l2a, cxcl14, mnx1, ppdpfb, nkx6.2 and tagln3b showed enrichment in both
experiments and their concomitant expression can be used to recognize beta-cell identity
in pancreas (Figure 33). We decided not to include pdx1 as its expression is signicantly
higher in delta 1.1 cells. Beside both glucagon genes, we can use pnoca, npb, etv1, scinlb,
fev and olfm1b expression as an alpha identity signature in zebrash. Arxa is generally
associated with alpha cell type but our results showed a strong expresion in epsilon cells
as well and we decided not to keep it for the alpha cell identity. For the delta 1.2 cell
identity, somatostatin coding genes sst2 and sst1.2 are the strongest markers but we also
added map2k6, nmba, slc7a7, map3k15, cdx4 and lamc2 genes to dene the signature.
Signature for epsilon identity could only be dened based on scRNA-seq results as we
didn’t produce RNA-seq for this cell type in the laboratory. The highest markers of
epsilon cells are the hormone coding genes ghrl and mlnl to which we also added mboat4,
acsl1a, abhd17c, brd1b and plcxd3. Finally, the most dicult signature to dene was for
delta 1.1 cells. These cells express many genes also with enriched expression in another
endocrine cell subtypes such as pdx1, dkk3b or pyyb. Nevertheless, 4 genes display specic
expression in delta 1.1 cells: sst1.1, sox11b, nsg2 and srd5a2b.
As we did with bulk RNA-seq, we compared the whole transcriptomes of each endocrine
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Figure 32: Expression prole of genes in zebrash SC data. Each group contains
genes with a signicative enriched expression for this group. The size of the gene names
represents their relative expression levels.
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cell type and we observed that more than 85 % of expressed genes by one endocrine
cell type are also expressed by all other endocrine cell types (excluding epsilon signal as
low number of cells only partially cover transcriptome). On the opposite, less than 2%
of expressed genes in an endocrine cell type are only expressed in this cell type. These
results highlight the close similarity of transcriptomes between endocrine cells.
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Figure 33: Identication of marker genes. The combinations of genes dened for each




1.4 Characterization of pancreatic cell signatures across human
and zebrash
1.4.1 Human scRNA-Seq from adult pancreatic tissues
The interspecies comparison of the pancreatic signatures that we previously performed
indicated that there is a relatively low conservation of the cell-identity signatures for
the endocrine cell subtypes [146]. While we were condent with the good quality of the
bulk RNA-seq data used for this interspecies analysis, we got several feed-backs from
scientists that this low conservation could be due to low quality RNA-seq data (i.e. low
purity of cell types). As scRNA-seq data were recently performed for human pancreatic
cells, we decided to use these data to verify our previous conclusions. We reanalyzed
them with the same methods as for zebrash in order to be coherent within the two
species. In the following sections, I will present key results from separate processing of
each dataset before comparing them. Multiple experiments were publicly available from
public depositories, and we decided to use three of them to perform cross validation of
the signatures obtained in each one.
1.4.1.1 Segerstolpe et al.[136] We retrieved scRNA-Seq data from all 6 healthy
individuals used in the study. After cell validation we kept an amount of 1246 cells with
on average 5587 (± 2113) genes detected by cell. We rst observed how the expression
of key markers of dierent pancreatic population were distributed. We then established
scores for each population (see Methods), and we evaluated their pattern within the
clusters. By this method, we identied clusters for all 7 major pancreatic cell types with
the following cell distribution: 125 acinar cells, 188 ductal cells, 563 alpha cells, 209 beta
cells, 64 delta cells, 92 gamma cells and 5 epsilon cells (Figure 34). We obtained on average
16703 (± 3055) genes detected by cluster. We used the same threshold as for zebrash
data to perform dierential expression analysis. We identied 39, 46, 8, 9, 10, 293 and
156 genes with signicative enriched expression for alpha, beta, delta, gamma, epsilon,
ductal and acinar cells respectively and we dened those as marker genes according to
our denition (see Methods).
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Figure 34: UMAP embedding of human datasets. Each dataset is represented by a
cell population of 1246 (Segerstolpe), 1815 (Muraro) and 7558 cells (Baron). Cell clusters
were labeled according to the key genes they express.
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1.4.1.2 Muraro et al.[135] Data regroup cells from 4 dierent donors. We validated
1815 cells with on average 5287 (± 1419) genes detected by cell. After clustering, cells
were distributed between populations: 283 acinar cells, 187 ductal cells, 778 alpha cells,
335 beta cells, 165 delta cells, 64 gamma cells and 3 epsilon cells. An average of 14674 (±
3011) genes are detected by cluster. We performed dierential expression analysis and
we identied 35, 130, 29, 14, 4, 369 and 186 marker genes for alpha, beta, delta, gamma,
epsilon, ductal and acinar cells, respectively.
1.4.1.3 Baron et al.[134] We processed data from 4 dierent donors, and we vali-
dated a total of 7558 cells which represents the biggest dataset we retrieved for human
adult tissue. The average of genes detected by cell was 1857 (± 596), and after clustering
process we obtained the following cell distribution: 977 acinar cells, 908 ductal cells,
2301 alpha cells, 2498 beta cells, 597 delta cells, 260 gamma cells and 17 epsilon cells.
The clusters present on average 13368 (± 2328) expressed genes and after performing
dierential expression analysis, we dened a list of 31, 37, 9, 14, 6, 218 and 110 marker
genes for alpha, beta, delta, gamma, epsilon, ductal and acinar cells, respectively.
1.4.2 Cross-validation of Human pancreatic cell markers
The rst reason we retrieved data from multiple studies was to evaluate how results can
vary depending on the dataset we used. Morever, the dierent single-cell technologies
developed in recent years present some variations. The number of cells they allow to
work with or the eciency of the RNA detection for a single cell are two parameters
that can impact the results. For identical costs, the choice of a single-cell technology or
another will depend on which of the two parameters you want to promote.
A second aspect to consider is that between the dierent single-cell experiments we
used, they do not present the same amount of cells and we also observed heterogeneity
between cell types distribution. This has eect on dierential expression analysis as we
are dependent on what we compare. Data from Segerstolpe and Muraro groups were
produced with similar protocols which allow to detect more RNA molecules per cell but
for a lower amount of them. Baron group samples are based on a dierent approach
which promotes higher number of cells over RNA detection per cell.
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When comparing the three experiments, our concern was to minimize the impact of these
sources of variation (batch eect). We decided rst to compare the set of marker genes
obtained from the analysis of each dataset separately.
1.4.2.1 Comparing scRNA-Seq results between experiments We started by per-
forming comparison of the lists of markers from all 3 experiments and we observed that
only an average of 6.92 % (± 5.09) of all dened marker genes for a cell type are common
between all 3 datasets. This value rises up to 26.67 % (± 12.72) by considering genes found
in at least 2 experiments. It highlights that working with an experiment or another can
have signicative inuence on results.
Using all 3 sources, we determined sets of pancreatic markers for each endocrine cell
type in human. By starting with beta cells, 9 marker genes were identied by all 3
experiments: MAFA, INS, ADCYAP1, IAPP, G6PC2, SURF4, MEG3, CDKN1C, EIF4A2.
The rst 5 have already been described to be beta cell marker genes and the 4 others have
been presented in the originating papers. We identied 5 markers for alpha cells: PCSK2,
COTL1, GPX3, SLC7A2, CAMK2G. Surprisingly, GCG did not pass our threshold for the
Muraro group experiment. PCSK2 has been described to be responsible on hormone
precurors processing and specically for the release of glucagon from proglucagon [183,
299]. All 4 others genes have been described to be expressed in pancreas. Interestingly,
CAMK2G is a calcium/calmodulin-dependent protein kinase which could play role in
glucagon release [300]. For delta cells, we highlighted only 3 marker genes: SST, RBP4
and RGS2. RBP4 has been associated with obesity and type 2 diabetes [301–303]. Finally,
only GHRL and PPY have been identied by all 3 datasets as markers of epsilon and
gamma cells respectively.
Next, we performed the comparison at the level of genes with an enriched expression
(DE genes - Methods 4.5). The average gene overlap between all 3 datasets rise up to
14.69 % (± 7.59) and up to 38.24 % (± 13.09) between at least 2 experiments. We also
expected the overlap between gene lists of each experiment to be higher. As results, we
obtained 144 genes found to be enriched in beta cells (FIGURE). Among them are PDX1,
PCSK1, HOPX, TAGLN3 and TSPAN1. For alpha cells, we identied 139 DE genes and
we retrieved notably genes like FEV, ARX, MAFB or GC. We identied 38 delta enriched
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genes among which we found HHEX, LEPR, SSTR1 or PKIB. Epsilon cells are represented
by 5 genes: BHMT, TM4SF5, GHRL, ASGR1 and VTN. TM4SF5 has been described to be
overexpressed in pancreatic cancers. Finally, we obtained 66 genes enriched in gamma
cells with genes such as ETV1, ARX, PAX6 or PRKACB.
1.4.2.2 Integration of human single-cell datasets We decided to perform a sec-
ond approach to extract the information from all 3 datasets. After each datasets were
analyzed and annotated separately, we integrated all cells together before doing dif-
ferential expression analysis on this large combined datasets (see Methods 4.5). The
global UMAP embedding we obtained allows to observe a strong colocalization of each
cell type cluster between all 3 experiments (Figure 35-A & B). The total of 10619 cells
presents the following distribution: 3645 alpha, 3048 beta, 820 delta, 413 gamma, 26
epsilon, 1362 acinar and 1305 ductal cells. We dened a novel list of marker for every
cell type and we obtained 23, 39, 9, 18, 11, 114 and 344 marker genes respectively (Figure
35-C + Supplemental table 3). Many of these markers were repordted in at least one of
the three studies.
Beta cell markers include all 9 marker genes validated by the previous comparison but
also many beta-cell enriched known genes such as human beta marker PDX1. The
gene list also contains ERO1B which has be linked to the oxidative protein folding of
proinsulin [304]. SLC6A6 encodes taurine and beta-alanine transporter and taurine has
been described with potential role in insulin gene expression and glucose homeostasis
[305, 306]. PPP1R1A gene encodes protein working as an inhibitor of protein-phosphatase
1 which may be important in hormonal control of glycogen metabolism [307].
We identied the same 5 alpha cell marker genes as presented above but we retrieved also
known genes like GCG, MAFB or IRX2 [308, 309]. PDK4 gene encodes a kinase playing a
key role in regulation of glucose and fatty acid metabolism and homeostasis [310]. TTR
gene is found to be marker of alpha cells and has been associated with endocrine tumors
of both pancreas and gut [311]. RGS4 gene has been described as a negative regulator of
insulin release [312].
For delta cells, we retrieved SST, RBP4 and RGS2 as previously but also HHEX, NLRP1,
PSIP1, DHRS2, SEC11S and PCP4. Notably, HHEX encodes a TF which has been rst
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Figure 35: UMAP embedding of the integrated dataset. (A) Visualization of the cell
type clusters. (B) Visualization of the origin of the dataset. (C) Marker genes identied
for each cell type.
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described to be linked to T2DM before being identied as specically expressed in delta
cell [185].
We highlighted 11 marker genes for epsilon cells in which we found TM4SF5, ACSL1,
SPTSSB, NNMT, VTN, CDKN2A, FRZB, PLAC8, HEPACAM2 and ACOT7 along GHRL.
Finally, we identied 18 marker genes for gamma cells. Beside PPY, we found PAX6
and ETV1 as marker genes, but also SERTM1, STMN2, SLC6A4, SCG2, CARD11, ID2,
SCGB2A1, PPY, AQP3, C16orf45, DDR1, INPP5F, PTP4A3, ID4, MALAT1 and FXYD2.
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1.4.3 Validation of pancreatic endocrine markers across zebrash and human
An important objective of this work was to dene conserved set of genes to be used to
identify each endocrine cell type through dierent species. These sets of genes with
conserved expression in a cell type are expected to be responsible on the identity and the
function of this cell type.
As we previously showed in our publication, the overlap between marker genes identied
in zebrash and mammals for beta and alpha cells was surprisingly very low, only few en-
riched genes for one endocrine cell type were conserved between species. Using available
scRNA-seq information for human and zebrash, we decided to perform comparison of
signature genes identied in both datasets in order to validate some identity genes across
species. If we simply cross the lists of marker genes obtained in each specie for one cell
type, the overlap is still very low. For example, only the insulin gene can be highlighted
for beta cells in both species. We can mention that expression of genes such as MNX1
and PDX1 showed enrichment in beta cells but as we previously presented pdx1 is more
enriched in delta 1.1 cells in zebrash and MNX1 in human is not expressed by enough
cells (less than 50% of beta cells) to have been considered as beta marker. Meanwhile
epsilon identity seems to be highlighted by similar genes in both human and zebrash.
Beside ghrelin expression in both, we found ACSL1 (human) gene and its ortholog acsl1b
(zebrash) as interesting epsilon marker, underlying that the acylation of ghrelin has been
conserved during the evolution. An other interesting gene is TM4SF5 gene for which
ortholog tm4sf5 did not pass threshold in zebrash but still showed enriched expression
in epsilon cells. If we considered all endocrine cell signals, we observed that expression
of hormone genes are conserved as expected in correct cell types between species. The
dierences in cell population between human and zebrash make harder the detection
of cell signature between them: we identied two somatostatin-expressing cell types in
zebrash while gamma cell type is only present in human. Moreover, these dierences
led some functions to be remixed and performed by dierent cell types between species.
We decided to take all sets of identity genes we determined in zebrash for endocrine
cells and we looked at their projection in human map of transcriptomes (Figure 36). We
didn’t use hormone genes as we wanted to identify new conserved specic genes. Results
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showed that alpha signature determined in zebrash highlighted alpha cluster in human
but also gamma cluster. ETV1 and FEV are among genes with enriched expression in
human gamma cell. Zebrash beta signature showed enrichment in human beta cells but
also projection into ductal, gamma and delta cells. Surprisingly, delta 1.2 identity didn’t
present any projection in human delta cells together with slight turn on of ductal cluster.
Interestingly, epsilon identity looked like the most conserved of all but low amount of
epsilon cells in human datasets limited interpretation of results. Finally, delta 1.1 identity
through only SOX11 and SRD5A2 expression did not highlight any particular cluster in
human datasets.
Altogether, these results showed that dening a set of markers for each endocrine cell
type which display an inter-species conservation is not an easy task. We expected to
identify a core of key genes with specic expression in each cell type. However, results
suggest that the specicity (or the identity) of these cells could rather be due to dierences




Figure 36: Projection of the zebrash endocrine sets of marker genes on human
datasets. Each zebrash combination has been evaluated for highlighting the expected
endocrine cell type in h.
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2 Pax6b Gene Regulatory Network during endocrine
development in Zebrash
The second part of this work focused on the transcription factor Pax6b in zebrash
and its role in the endocrine dierentiation of both pancreatic and enteric tissue. We
observed signicant similarities between the Pax6-dependent Gene Regulatory Network
of both tissues. Notably, the disruption of pax6b in pancreatic endocrine cells (PECs) and
enteroendocrine cells (EECs) aects the expression of hormones and the cell fate choice,
highlighted by an increase of ghrelin/motilin-like expressing cells in both tissues with a
concomitant decrease of other endocrine cell subtypes. PECs and EECs in pax6b-/- mainly
display tissue-specic transcriptomic changes. However, we highlighted a signicative set
of genes presenting a similar regulation in both tissues. These results have been combined
in a publication presented here, entitled “Pancreatic and intestinal endocrine cells
share common transcriptomic signatures and regulatory programs”, submitted
to BMC Biology (currently under reviewing).
Credit of the work: The study and the characterization of enteroendocrine cells have
been conducted by Justine Pirson, Anne-Sophie Reuter and Marianne Voz. They per-
formed the in situ hybridization experiments in EECs. Estefania Tarifeño-Saldivia and
Justine Pirson carried out the RNA-seq experiments for WT and pax6b-/- mutant PECs
and EECs. I joined them by performing all bioinformatic analyses concerning the tran-
scriptomes comparison, dierential gene expression analysis and cell subtype markers
identication. I performed the ISH experiments in PECs and EECs of the pax6b mutants.
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Abstract  
Background: Endocrine cells of the digestive system, including the pancreatic 
endocrine cells (PECs) clustered in the islets of Langerhans and the enteroendocrine 
cells (EECs) scattered in the intestinal epithelium, play an important role in metabolism. 
Although EECs and PECs are located in distinct organs, they share many features and 
several common genes control their differentiation.  In this study, we investigated 
comprehensively the similarity of EECs and PECs by defining their transcriptomic 
landscape and comparing the regulatory programs controlled by pax6b, a key player 
in both EECs and PECs. 
Results: RNA-sequencing was performed on EECs and PECs isolated from wild-type 
and pax6b mutant zebrafish. Data mining of wild-type zebrafish EEC data confirmed 
the expression of orthologs for most known mammalian EEC hormones but also 
revealed the expression of three additional neuropeptide hormones (Proenkephalin-a, 
Calcitonin-a and Adcyap1a) not yet reported to be expressed by EECs in any species. 
Comparison of transcriptomes from EECs, PECs and other zebrafish tissues highlights 
a very close similarity between EECs and PECs, with more than 70 % of genes being 
expressed in both endocrine cell types. Comparison of Pax6b-regulated genes in 
EECs and PECs revealed a significant overlap.  pax6b loss-of-function does not affect 
the total number of EECs and PECs but instead disrupts the balance between 
endocrine cell subtypes, leading to an increase of ghrelin- and motilin-like expressing 
cells in both the intestine and pancreas at the expense of other endocrine cells such 
as beta- and delta-cells in the pancreas and pyyb-expressing cells in the intestine. 
Finally, we show that the homeodomain of Pax6b is dispensable for its action in both 
EECs and PECs.  
Conclusion:  This study highlights the close relatedness of EECs and PECs at the 
transcriptomic and regulatory levels, supporting the hypothesis of a common 
phylogenetic origin and underscoring the potential implication of EECs in metabolic 
diseases such as Type 2 diabetes. 
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The enteroendocrine cells (EECs) and pancreatic endocrine cells (PECs) play a crucial 
role in the control of metabolism of all vertebrates. The PECs, notably via the antagonistic 
action of glucagon and insulin, secreted respectively by the alpha- and beta-endocrine cells, 
regulates glycemia. The EECs also participate in this control through the release of some 
hormones, like glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic 
polypeptide (GIP), which display incretin effect, enhancing the glucose-stimulated insulin 
secretion.  The EECs secrete more than 15 hormones that modulate many physiological 
processes including  the release of digestive enzymes and bile from the exocrine pancreas 
and gallbladder, control of intestinal motility, sensing of nutrients and microbial metabolites and 
stimulation or suppression of appetite [1].  The EECs were initially classified into distinct 
subtypes according to the hormone they secrete; however, subsequent analyses revealed that 
there is an extensive co-expression of several hormones in individual EEC [2]. Recent single-
cell RNA-seq studies have indeed confirmed this co-expression in murine EECs thereby 
identifying at least 9 EEC subtypes expressing various combinations of neuropeptides or 
hormones [3, 4].  
EECs display similarities with pancreatic endocrine cells (PECs). Some hormones are 
produced from both pancreatic and intestinal endocrine cells, like  Somatostatin (Sst), Ghrelin 
(Grhl) or Peptide YY (Pyy) [5, 6]. Also, many transcription factors are involved in the 
differentiation of both EECs and PECs such as NeuroD, Pax6, Isl1, Nkx2.2, Insm1 and Arx [7–
10].  For example, Pax6 is crucial for the differentiation of PECs and its inactivation disturbs 
the adequate proportion of the different endocrine cell subtypes. Indeed, in Pax6 KO mice [11, 
12] and in pax6b-/- zebrafish [13],  the number of alpha-, beta- and delta- pancreatic cells is 
significantly reduced while epsilon-cells are increased. In the small intestine, Pax6 has been 
reported to be required for the differentiation of some EEC subtypes [14, 15]; however, it is still 
not known which set of genes are regulated by Pax6  during  EECs and PEC differentiation 
and whether the Pax6-regulated network is shared by these two tissues . 
EECs have been detected in the gut of many vertebrate and invertebrate species and 
their formation appears early during animal evolution dating back to the cnidarian-bilaterian 
ancestor  [16–18]. In contrast, the pancreas and the PECs appeared much later with the first 
vertebrate species [19, 20]. The similarity between EECs and PECs could be due to several 
reasons. A first possibility could be a common phylogenetic origin; the PECs could have indeed 
derived from some EECs and moved out from the gut to form clusters and to secrete other 
hormones like insulin and glucagon. This scenario is compatible with the “sister-cell-type 
model” [21] where two cell types derived from an ancestral cell type by segregation of function 
(e.g. secretion of distinct hormones) due to the gain or loss of transcription factors. In this 
model, the two sister cell types still share many characteristics and can display similarities in 
their transcriptomes [22].  Another reason of the PECs and EECs similarities could be the co-
option of EEC (or neuronal) regulatory pathways by the pancreatic cells [23].  To approach this 
matter, we have measured in the present study the degree of similarity between EECs and 
PECs at the genome-wide expression level and determined whether they share regulatory 
programs. We previously determined the transcriptomic landscape of zebrafish PECs [24]. In 
contrast, the EECs from zebrafish have not yet been fully characterized and only a few 
hormones have been shown be expressed in these cells [25–29]. The first objective of this 
study was to perform a detailed characterization of zebrafish EECs by determining their 
transcriptomic profiles and identifying all neuropeptide hormones and regulatory genes 
expressed in these cells.  Secondly, the transcriptomic landscape of zebrafish EECs was 
compared with those of zebrafish PECs to measure the degree of similarity. Finally, we 
analysed the consequences of pax6b inactivation on the transcriptome of both pancreatic and 
intestinal endocrine cells and show that Pax6b controls a large set of genes identical in both 
EECs and PECs further supporting their close relatedness.  Finally, we discuss our findings in 
light of evolution of EECs and pancreatic cells, supporting the model of a common phylogenetic 




Characterization of the enteroendocrine cells in zebrafish 
In mice, at least 15 different hormones have been described to be expressed in the gut  
[1, 30]. Out of these, we identified in the zebrafish genome at least one orthologue for 11 of 
them, 9 showing syntenic conservation at their genomic loci with the murine/human genes, 
thereby validating orthology relationship (Table 1).   We did not find any orthologous genes 
coding for gastrin (gast), secretin (sct), the pancreatic polypeptide (pp) nor motilin (mln); 
however, a motilin-like (mlnl) gene, proposed to be the functional equivalent of motilin, is 
present in the zebrafish genome [31].   In order to identify all peptide hormones expressed in 
the gut of zebrafish larva, we performed RNA-seq on isolated EECs. This was achieved by 
microdissection of intestines from 4dpf zebrafish transgenic Tg(pax6b:GFP)ulg515tg larvae, 
which express GFP in the EECs [32], followed by cell dissociation and selection of GFP+ EECs 
by FACS.  The restricted expression of Pax6b:GFP in the EEC and not in the enteric neurons 
(EN) was confirmed by immunohistochemistry showing a total absence of colocalisation 
between the Hu enteric marker and pax6b:GFP (Fig S1).   RNA-seq was performed on four 
independent EEC preparations and about 40 million paired-end reads were obtained from each 
Illumina library, 70-80% of which mapped to the zebrafish genome.  Table S1 gives the 
expression level of all genes in CPM (counts per million) and in FPKM (fragments per kilobase 
of exon model per million reads mapped). This expression profiling allowed us to determine 
that, amongst the 12 zebrafish genes corresponding to EEC hormones, 11 are expressed in 
the zebrafish EECs at significant levels (above 100 CPM or 100 FPKM), neurotensin (nts) 
being the only hormone not expressed in EECs (Table 1).   The expression of many of these 
hormones was further validated by whole-mount in situ hybridization (WISH) thereby locating 
the region of the gut displaying strongest expression and defining the onset of their expression 
(Fig.1 and Table1). The number of EECs detected in the gut of 4dpf zebrafish larvae by WISH 
varies for each hormone; for example, more than 20 cells expressing peptide YY-b (pyyb), 
cholecystokinin-a (ccka), preproglucagon-a (gcga), galanin (galn) or insulin-like 5a (insl5a) 
transcripts were detected (Fig. 1A,B,G,H,I; Fig.S2 and Table1) while only few cells express 
ghrelin (ghrl), glucose-dependent insulinotropic polypeptide (gip) and  peptide YY-a (pyya) 
(Fig. 1D-F and Table1).  These differences of expression are also reflected in the RNA-seq 
data : gcga, ppyb,  ccka, and insl5a  reaching more than 2000 CPM while ghrl and gip range 
around 100 CPM (Table 1).   
Data mining of the zebrafish EEC RNA-seq with the GO term “hormone” also revealed 
a strong expression of three neuropeptide transcripts not described so far as expressed in 
mammalian EECs: adenylate cyclase-activating polypeptide 1a (adcyap1a)(previously named 
PACAP), proenkephalin-a (penka) and calcitonin (calca) (Table 1).  Fluorescent in situ 
hybridization experiments (FISH) confirmed the expression of these transcripts in the zebrafish 
EECs (Fig. 1 J-L). An average of  68 penka+  and 12 calcitonin+ EECs were detected in the 
bulb and the mid-gut and more than 80 cells expressing adcyap1a were found all over the gut  
(Table1 and Fig.S2).  As enteric neurons (ENs) surround the gut at that stage and express a 
variety of neuropeptides, some being expressed also by EEC, we next determined whether 
some of the hormone expressed by EEC would be also detected in ENs.  For that purpose, we 
retrieve the  transcriptomic data of zebrafish ENs, recently determined by RNA-seq after 
sorting the ENs by FACS from Tg(phox2b::GFP) larvae at 7 dpf [33]. Comparison of the ENs 
and EECs RNA-seq data indicate that most EECs hormones display a much higher expression 
in EECs compared to ENs, except for sst1.2, sst2 and vipb (see Table 1).  FISH using the EN 
specific marker Phox2b confirms the strong expression all over the gut of vipb in ENs while the 
vipb+ EECs are mostly located in the posterior gut (Fig. S3A and B).  Interestingly, RNAseq 
data indicate that adcyap1a is exclusively expressed by EECs while adcyap1b is restricted to 
ENs.  FISH confirms the strong expression of adcyap1a in EECs and not in phox2b+ ENs (Fig 
S3 C).  However, IHC using an anti-ADCYAP1 antibody reveals staining in pax6b:GFP+ EECs 
as well as at the level of EN axon fibers in larvae, as previously shown [34] (Fig.2B).  Similar 
results were observed in the adult intestine (Fig. 2D).  Taken together, all these data confirm 
the expression of the Adcyap1a in EECs and of Adcyap1b in ENs.  As for the two other new 
hormones Calca and Penka, RNAseq comparison indicate that they are exclusively expressed 
by EECs and this was confirmed for Penka for which we  observe strong Enkephalin 
immunostainings in EECs but not  in ENs  at larva stage as well as in adults (Fig. 2 A and C).   
 
Close relatedness between the enteroendocrine and pancreatic endocrine cells.  
 Although EECs and PECs are known to share common features, we wanted to evaluate 
the degree of similarity at a more global level. Thus, we compared the RNA-seq data of the 
zebrafish PECs and EECs as well as of other zebrafish cell types and organs used as control 
(Fig 3A). The heatmap shows that all endocrine cells cluster together apart from other 
pancreatic or intestinal cells and other tissues. Indeed, the EEC cluster is much closer to the 
PEC cluster than to the ductal or the acinar pancreatic cells or even to the whole intestine 
tissue which is mainly composed of enterocytes and of only 1-2% of EECs.   In agreement with 
previous reports showing shared features between pancreatic cells and neurons  [23, 35], this 
clustering analysis reveals also transcriptomic similarities of brain tissue not only with 
pancreatic but also with intestinal endocrine cells.  
The close relatedness of EECs and PECs is also illustrated by the high percentage of 
genes expressed in both tissues: among all genes expressed in pancreatic or intestinal 
endocrine cells above the threshold of 10 normalized CPM (8326 and 8264 genes, 
respectively), 74% of them are expressed in both tissues (Fig. 3B), while if the same analysis 
is done for genes expressed in EECs and liver, only 45% of them are expressed in both tissues 
(data not shown).  Similar percentages are obtained when considering genes coding for 
transcription factors (TF): 72% of all expressed TF-coding genes are detected in both PECs 
and EECs, while only 45% are expressed in both pancreatic endocrine cells and liver.  The list 
of 481 TF expressed in both PECs and EECs (given in Table S2) includes notably most of the 
transcription factors reported to be important for zebrafish PEC differentiation (Table 2). For 
example, arxa and pax4, known to be important determinant of cell fate of pancreatic endocrine 
cells [36, 37], are also expressed in the zebrafish gut and, like in pancreas, their expression is 
mainly non-overlapping (Fig 4A).  Fev, known to be highly expressed in pancreatic endocrine 
cells [38]  is also among of the most highly expressed transcription factors in the zebrafish 
EECs (Table 2) and is detected by FISH in many cells all over the gut (Fig. 4B).  Similarly, 
insm1b [9] is also highly expressed in zebrafish EECs (Fig. 4 C-D and table 2) in addition to 
its expression in enteric neurons (labelled with asterisk in Fig. 4D) as described in mouse. 
Expression of pdx1, visualised using the tg(BAC pdx1:GFP) [39], is also detected in scattered 
EECs of the mid- and posterior-gut (Fig 4E and G), in addition to a  widespread expression in 
cells of the rostral part of the intestine as previously described [40] (Fig. 4 E and F). The 
expression of pdx1 in EECs of the mid and posterior gut was confirmed by WISH (figure 4H) 
and by immunohistochemistry (Fig. 4 I)   As expected, ascl1a was barely detected in the 
transcriptome of 4 dpf EECs (Table 2) as we have previously shown that its expression in the 
secretory precursors cells turns off as soon as the cells pursue their differentiation process 
[27]. In the same way, sox4b, coexpressed with ascl1a in the secretory precursor cells, is 
hardly detected in the transcriptome of the EECs at 4 dpf (Table 2 ), indicating that sox4b is 
also switched off with the maturation of the EECs.  In contrast,  Nkx6.1, Nkx6.2 and Mnx1 are 
the only 3 transcription factors involved in zebrafish PEC differentiation that are not expressed 
in EECs.  Many of these EEC/PEC transcription factors are expressed at lower levels in enteric 
neurons as revealed by the ENs RNA-seq data (Table 2) with the exception of insm1b, neurod1 
and ascl1a which are expressed above 50 CPM.  
The number of genes which are selectively expressed in PECs or in EECs is relatively low 
(gene lists available in Table S3). Gene ontology (GO) enrichment analyses of the PEC-
specific genes highlight terms such as “cell adhesion” due to the enriched expression of many 
cadherins and other cell adhesion molecules.  This enrichment makes senses as the PECs 
are clustered into islets while EECs are scattered in the gut. The EECs-specific genes display 
an enrichment of GO terms including “drug transmembrane transport”, “ABC transporter” or 
“oxidation process” due to the enriched expression of many transmembrane transporters and 
cytochrome P450 type molecules (Table S3).   
In conclusion, all these data indicate a close relatedness between PECs and EECs at the 
level of their transcriptomes and of their regulatory factors, suggesting the involvement of 
similar regulatory programs in these two cell types.     
 
Shared Pax6-dependent regulatory programs between pancreatic and intestinal 
endocrine cells.     
 To investigate whether pancreatic and intestinal endocrine cells are controlled by 
similar regulatory programs, we analysed the effect of Pax6 inactivation on the transcriptome 
of both cell types. Zebrafish has two pax6 paralogs; however, only pax6b is expressed in PECs 
and EECs. To isolate pax6b mutant EECs and PECs, pax6bsa0086 heterozygous fish harbouring 
the Tg(pax6b:GFP) transgene were inbred and pax6bsa0086 homozygous embryos were 
selected based on lens abnormalities [13]. The expression of the transgene Tg(pax6b:GFP) 
was not perturbed in the homozygous mutants (data not shown), allowing us to isolate by 
FACS the PECs or  EECs from pax6b-/- mutant larvae after microdissection of the dorsal 
pancreatic bud or intestine, respectively.   RNA-seq was performed on three independent 
preparations of EECs or PECs purified from pax6bsa0086 mutant and from wild-type zebrafish 
(see Materials and Methods). Principal component analysis shows a tight clustering of 
replicates underscoring a good reproducibility of the data and showing distinct clusters for 
mutant and wild-type cells for both PECs and EECs (Fig. 5A). Differential expression analyses 
identified 2824 and 1634 Pax6b-regulated genes in PECs and in EECs, respectively, 
(FDR<0.1)(Fig. 5 B,D)(expression of all genes and of Pax6b-regulated genes are given in 
Table S4 and S5, respectively). Comparison of these two sets of genes reveals that there is a 
large set of 517 genes which are altered by pax6b inactivation in both organs (Fig. 5C); this 
overlap is statistically significant according to the Fisher’s Exact test ( p-value < 2.2e-16).   
Furthermore, most of these genes (424 genes) are regulated in the same way in the pancreas 
and in the intestine (215 up-regulated and 209 down-regulated genes)(Fig. 5C), indicating that 
a part of the Pax6-dependent gene regulatory network is thus identical in EECs and PECs.  To 
explore the pathways and biological processes regulated by Pax6b, we performed a gene 
ontology analysis on these 3 sets of Pax6b-regulated genes : the common set for PECs and 
EECs (517 genes) or the specific one for PEC  (2307  genes) or EECs (1117 genes)(see Table 
S5).  GO terms associated to “cell-cell signalling”, “regulation of appetite” or “hormone activity” 
were enriched significantly in the common set  as several hormones expressed in PECs and 
EECs are affected in the pax6 mutant (e.g. pyya, sst2, pyyb,… ; see below).  Such an effect 
results probably from a change in the expression of several transcription factors (e.g. pdx1, 
neurod1, rfx6, nkx2.2, …; see below) as revealed in the GO lists “endocrine pancreas 
development” and “sequence-specific DNA binding”. Also, the GO analysis highlights the role 
of Pax6b in the control of ion transport (K+, Ca++ and Cl-) as well as calcium signalling. 
Interestingly, “ion transport” and “calcium channel / binding activity“ were also GO enriched 
terms among the genes regulated by Pax6b only in PECs or in EECs, supporting an important 
role of Pax6b for controlling these pathways.    
 
Drastic increase of ghrelin/motilin-like expressing cells in pax6b-/- pancreatic and 
intestinal endocrine cells with a concomitant decrease of other endocrine cell subtypes.  
 The above analyses indicate a regulation by Pax6 of the expression of several 
hormones in PEC and EEC. Among them, ghrelin (ghrl) and motilin-like (mlnl) genes are 
strongly up-regulated in both the pancreas and intestine of pax6b mutants (Fig. 5 E and F, 
Table 3). FISH experiments confirmed an increase of the number of ghrl+ cells and mlnl+ cells 
in both pancreas and intestine (Fig. 6 A-H). Furthermore, double fluorescent staining 
demonstrated that these two hormones are often co-expressed in the same endocrine cells 
(Fig. 6 I and J).  In both tissues, the increase of ghrl and mlnl gene expression is concomitant 
to a decrease of other hormones :  galn, pyyb and calca genes are indeed significantly down-
regulated in EECs of pax6bsa0086 mutants, while in the pancreas, expression of notably the 
insulin (ins) and somatostatin-1.1, -1.2 and 2 genes is strongly decreased (Fig. 5E and Table 
3). To determine whether these modifications in hormone expression result from a change in 
cell subtype proportion in pax6b mutant PECs, we analysed the expression of markers of these 
different pancreatic cell subtypes that we and others have previously identified (Table S6) [24, 
41].  We found that about 40% of genes showing an enriched-expression in beta-cell (with a 
fold enrichment > 4-fold) were  down-regulated in the islet of pax6b-/- embryos,  while only 2% 
were up-regulated (Fig 7 upper panel), strongly suggesting a loss of beta-cells. This loss was 
further confirmed by FISH experiments: firstly, ndufa4l2, a gene showing a restricted 
expression in zebrafish pancreatic beta-cells, was not detected anymore in the pax6b mutants 
(Fig. 7A-D). Similarly, expression of the two beta-cell enriched transcription factors pdx1 and 
nkx6.2 were strongly decreased in PECs of pax6b mutants while could still be detected at low 
levels in the ventral pancreatic progenitors (Fig. 7E-H, Table 3). All these data indicate the loss 
of beta-cells in pax6b-/-sa0086 embryos.  Concerning the pancreatic delta-cells, 35% of delta-
enriched genes were down-regulated in the pax6bsa0086 mutants and 12% were up-regulated 
(Fig 7 upper panel).  The decreased number of delta-cells in pax6b mutants was further 
supported by FISH through the strong reduction of cells expressing somatostatin2 (sst2) as 
well as the loss of the delta-specific markers laminin C2 (lamc2) and the hormone peptide 
Neuromedin Ba (nmba)(Fig 7 I-L, Table 3). The two delta-specific transcription factors Cdx4 
and Hhex were also down-regulated in PECs of pax6b mutants (Table 3). Inversely, 40% of 
genes with enriched-expression in pancreatic epsilon-cells are up-regulated in pax6b mutants 
while only 2% are decreased (Fig. 7 upper panel). Like ghrelin and motilin-like, mboat4, 
another epsilon-specific marker is strongly stimulated following pax6b inactivation as revealed 
by FISH (Fig 7 M,N) and by the RNA-seq data (Table 3).  Thus, these data also indicate an 
increase of epsilon-cells in pax6bsa0086 mutant embryos.  Finally, the alpha-cells in pax6b 
mutants display an “ambiguous” phenotype with a respective decrease and increase of 26% 
and 12% of alpha-enriched genes (Fig 7 upper panel). The RNA-seq data indeed reveal a 
strong decrease of the alpha-cell markers gcgb and pnoca while others like gcga, arx and 
scinlb are even increased (Table 3). FISH confirmed these results. Indeed, although gcga and 
gcgb are detected in the same alpha-cells in wild-type embryos, gcgb expression was severely 
reduced in the pax6b mutants in contrast to gcga that remained highly expressed (Fig 7 I and 
J).  Like gcgb, the alpha cell marker pnoca (prepronociceptin a) was drastically down-regulated 
(Fig 7 Q, R).  On the other hand, the alpha cell marker scindl (Fig 7 U,V) and the alpha-cell 
determinant arxa (Fig 7 S,T) were still expressed. Double labelling of arxa and scinlb with 
ghrelin revealed that these two markers are actually expressed in both alpha and epsilon cells 
in zebrafish (Fig 7 S-X).  Regarding the pan-endocrine markers, which are not enriched in a 
specific endocrine cell subtype,  only  a minority (about 15%) are either down- or up-regulated 
in the pax6b-/- mutants (Fig 7 upper panel).    Altogether, our data indicate that there is a loss 
of beta-cells and a strong reduction of delta-cells in the pax6b-/- mutants with a concomitant 
increase in the number of epsilon-cells. Alpha-cells are still generated in the pax6bsa0086 
mutants but these cells are misdifferentiated.   
 To verify that the increase of ghrl+/mlnl+ endocrine cells in the intestine of pax6b-/- 
larvae (Fig. 6) is also concomitant to a decrease of other EECs, we analysed by FISH the 
expression of pyyb, a gene highly expressed in the intestine and strongly down-regulated in 
pax6b mutants (Table 3).  The number of EECs expressing pyyb was indeed drastically 
reduced in the intestine of pax6bsa0086 mutants (Fig 8 D and E).   Thus, all these FISH confirms 
that pax6b has a similar role in the control of the proportion of the various endocrine cell types 
in both intestine and pancreas. 
 
Like in the pancreas, the homeodomain of Pax6b is not crucial for the differentiation of 
the endocrine cells of the intestine.  
Previous studies have shown that a missense mutation in the homeobox of pax6b 
(sunrise allele) gene causes eye developmental defects but does not perturb the development 
of pancreatic endocrine cells [13, 42], indicating that the homeodomain of Pax6b is not crucial 
for endocrine cell differentiation in pancreas in contrast to eye development. To get a clue 
whether the mode of action of Pax6b is also similar between EECs and PECs, we next 
investigated whether the EEC differentiation was affected in the sunrise mutants. FISH 
revealed no effect of the sunrise mutation on the expression of pyyb and of mlnl in contrast to 
the null pax6bsa0086 mutation (Fig 8 C and F). This indicates that the homeodomain of Pax6b is 
not crucial for the differentiation of endocrine cells both in intestine and in pancreas. 
        
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Discussion 
 
By RNA sequencing of FACS-purified cells, we report in this study the transcriptome of 
enteroendocrine cells (EECs) from zebrafish highlighting the repertoire of peptide hormones 
and regulatory factors expressed by these cells. The comparison of these RNA-seq data with 
other zebrafish tissues confirms the close similarity of EECs with pancreatic endocrine cells 
(PECs). Furthermore, we show that Pax6b is required for the proper expression of many 
hormones in both the pancreas and intestine, acting via a large set of common gene targets.  
Inactivation of zebrafish Pax6b does not affect the total number of endocrine cells but affects 
the balance between endocrine cell subtypes, leading to an increase of ghrelin+/motilin-like+ 
cells and a reduction of other endocrine cell subtypes in both tissues. The Pax6b 
homeodomain is also dispensable in the two organs. All these data highlight the high similarity 
between EECs and PECs. 
The present study reveals also that the zebrafish EECs express most of the hormones 
known to be secreted by mammalian EECs. Only 4 EEC hormones were not detected in 
zebrafish.  Secretin (Sct), Pancreatic polypeptide (PP) and Gastrin could not be detected as 
no orthologous gene is present in the zebrafish genome. The absence of sct and pp genes is 
in agreement with previous studies indicating the lack of these two genes in teleost [43–45]. 
The detection of PP by immunofluorescence at the level of zebrafish EECs [29] and zebrafish 
PECs [46] is probably due to cross-reactions of the antibodies with Pyya and/or Pyyb as 
significant sequence similarities is observed between Pyy and PP mature peptides (see Fig. 
S4).  Although the neurotensin gene is present in the zebrafish genome, no expression was 
detected in EECs, at least in 4 dpf larvae. On the other hand, the present transcriptomic 
profiling of zebrafish EECs reveals the identification of three neuropeptide  transcripts not 
described so far in EECs : proenkephalin-a (penka), calcitonin (calca) and adenylate cyclase 
activating polyeptide 1a (adcyap1a).  We could confirm at the protein level the  expression of 
two of them, Enkephalin and Adcyap1 (figure 2). Further studies should be performed to 
confirm the expression of Calca at the protein level and determine the role of these 3 
neuropeptides on the digestive tract. To get a hint whether these hormones could be also 
expressed in the mammalian intestine, we searched into the NCBI GEO repository and into 
the human protein atlas database (https://www.proteinatlas.org/humanproteome/tissue)[47] 
for the presence of these transcripts in the gut.   We found that Penk is expressed in the colon 
of 8 week-old male mice [48] and at low level in the human colon. Similarly, human CALCA 
and more specially CALCB (Calcitonin related polypeptide B) transcripts can be detected in 
bulk RNA-seq of the gastrointestinal tract mainly at the level of the colon.  Finally, ADCYAP1 
expression is detected in the human gastrointestinal tract mostly in the colon as well as in beta 
pancreatic cells [49].  Furthermore, the recent single-cell RNAseq data from the small murine 
intestine reveal that some enterochromaffin cells express Adcyap1 at low levels [3]. Thus, all 
these data suggest that the three hormones Penk, Calca(/b) and Adcyap1 could also be 
expressed in some mammalian EECs and their expression should be verified by 
immunostaining notably at the level of the colon. 
 Some similarity between EECs and PECs has been previously recognized notably thanks 
to the shared expression of markers including some hormones and transcription factors. Using 
the zebrafish, the present study demonstrates the similitude at the transcriptomic level and by 
identifying a common Pax6b-dependant gene regulatory network. When considering the 
ontogeny and evolutionary aspects of EECs and PECs, it is tempting to speculate that these 
two endocrine cell types not only share developmental pathways but also have a common 
ancestor. Indeed, on the ontogeny aspect, both EECs and PECs derive from the endoderm 
layer and their specification is controlled by lateral inhibition via the Delta/Notch signaling 
pathway, leading to the formation of scattered endocrine cells within the epithelium. Inhibition 
of the Notch pathway allows the activation of proneuronal bHLH factors in endocrine 
precursors that drive the formation of EECs and PECs [50, 51]. As proposed by others [52], 
the EECs have probably co-opted for these neuronal gene programs to trigger their 
differentiation early during evolution of metazoa.  While the EECs are present in the gut of 
invertebrates, the first signs of the pancreatic organ appears much later with the first 
vertebrates : the agnathan species, such as lampreys or hagfishes, possess at the adult stage 
one or two aggregate(s) of insulin-expressing cells just next to the intestine and near the bile 
duct without associated exocrine tissue while other endocrine cells expressing glucagon, 
somatostatin or PYY-like peptides are present within the intestinal epithelium [19, 20, 53].  
Furthermore, at larva stage, some of these insulin+ cells are still detected within the intestinal 
epithelium of lampreys [54]. Thus, these observations suggest that, when the first vertebrate 
species appeared, some enteroendocrine cells could move out from the gut to form clusters, 
possibly through the up-regulation of cell adhesion molecules (Table S3), that have led to the 
formation of pancreatic endocrine islets. This hypothesis is supported by studies on sea urchin 
larvae showing the presence  of cells expressing insulin-like peptide in the gut region located 
at the  stomach-intestine boundary and expressing the pdx1 orthologous gene [18, 55]. 
Furthermore, the generation of the first PECs in the zebrafish embryos is also consistent with 
this idea : indeed, the first insulin expressing cells appear scattered within the anterior 
endodermal gut epithelium at an early stage (14 hpf) and subsequently migrate dorsally from 
the embryonic gut to form a cluster and generate the principal pancreatic islet (named the 
dorsal pancreatic bud)[46]. Thus, all these observations entail the notion that PECs are in fact 
EEC-like cells, explaining why PECs share so many features with EECs. This concept is also 
supported by previous reports showing the conversion of EECs into insulin-expressing beta-
like cells upon targeted expression or inactivation of some transcription factors [56–58].  The 
close relatedness between EECs and PECs underlined in our study has also important 
implications for the interpretation of GWAS for type 2 diabetes (T2D). Indeed, as many of the 
genomic variants linked to T2D are near (or in) genes expressed in PECs [59, 60], it is widely 
considered that at least part of the defects causing T2D stems from PEC dysfunctions. 
However, as the transcriptomes of PECs and EECs are highly similar, the defects causing T2D 
may also have their origin from EECs. 
The present study confirms that Pax6 is required for the proper expression of many 
hormones from EECs and PECs and change the proportion of the endocrine cell subtype 
without affecting the total number of endocrine cells in both the pancreas and intestine. The 
pancreatic phenotype of zebrafish pax6b null mutants is comparable to the Pax6 mutant mice 
as the same major pancreatic hormones are up- and down-regulated in the two species, 
although the effect on beta-cells looks more drastic in zebrafish than in mice (Pax6 KO mice 
displaying only 70% reduction)[11, 61]. The almost complete loss of beta-cells in zebrafish 
may derive from a stronger decrease in the expression of the beta-specific factor Pdx1 (as well 
as Mnx1 and Nkx6.2) in zebrafish pax6b mutants.   On the other hand, in the intestine, there 
is a striking contrast between zebrafish and mice Pax6 mutants : while Pax6 is required for the 
expression of several EEC hormones in both species, the identity of these hormones is 
strikingly divergent. Indeed, among the 8 EEC hormones analyzed in Pax6 mutant mice, Gcg 
(GLP1 and 2), Sst and Gip genes were strongly downregulated while Pyy was not significantly 
affected (Ghrelin and Motilin were not analyzed in Pax6 KO murine intestine). In zebrafish, 
pax6b inactivation causes a drastic down-regulation of pyyb and does not affect significantly 
gcga, sst2 and gip gene expression. The reason for such differences between mice and 
zebrafish is unclear and probably rely on changes during vertebrate evolution either at the level 
of genomic Pax6 binding sites or of downstream regulatory programs. Further studies including 
ChIP-seq experiments will be required to answer that question. 
 
Methods 
 Zebrafish maintenance, transgenic and mutant lines, isolation of EECs and PECs by 
FACS.  
Zebrafish (Danio rerio) were raised according to standard protocols and staged according to 
Kimmel [62].  The following zebrafish transgenic and mutant lines were used :  
Tg(pax6b:GFP)ulg515 [63],  TgBAC(pdx1:EGFP)bns13 [39] , Tg(-8.5nkx2.2a:GFP)ia2 [64],  
pax6bsa0086  and pax6bsunrise [13].  Enteroendocrine cells (EECs) were isolated by dissecting 
the gut from about 200 Tg(pax6b:GFP)ulg515 larvae at 4 dpf, taking care of not including 
pancreatic tissue. Cell dissociation was next performed by incubation in HBSS 1x 
supplemented with 100 U/ml collagenase IV and 0.3 U/ml Dispase (Life Technologies) for 10 
minutes. Cells were washed in HBSS (Mg2+ and Ca2+ free) containing  1% BSA and GFP-
expressing EECs were selected by two consecutive FACS purifications, the first in the “yield 
mode” and the second in “the purity mode”, using FACS Aria II. Four replicates of EEC 
containing about 3000 cells were prepared. Pancreatic endocrine cells (PECs) were also 
obtained from the Tg(pax6b:GFP)ulg515 line [63] by dissecting the dorsal pancreatic bud from 
about 200 27-hpf transgenic embryos. FACS selection was performed as described for EECs 
except that cell dissociation was performed in Tryple Select 1X ( Gibco) supplemented with 
100 U/ml collagenase IV (Life Technologies) for 5 minutes. For the preparations of EECs and 
PECs from pax6b null mutant embryos, the pax6sa0086 line [13] was first crossed with the 
Tg(pax6b:GFP)ulg515 line; heterozygous pax6bsa0086 fish harboring the transgene (pax6b:GFP) 
were inbred to generate homozygous pax6bsa0086  transgenic embryos which were selected 
based on the absence or reduction of lens. The isolation of EECs and PECs from pax6bsa0086 
homozygotes were performed in triplicates following the same procedure than for the wild-type 
larvae. The accuracy of pax6bsa0086 homozygotes selection was verified after the RNA-seq by 
checking the presence of the null sa0086 allele in 100% of pax6b reads in the mutant samples.  
 
cDNA synthesis, library preparation and sequencing. 
Each EEC or PEC sample obtained after FACS was directly pelleted by centrifugation and 
resuspended in 3.5 µl of reaction buffer, lysed by freezing in liquid nitrogen and stored at -80°C 
according the the Smart-seq2 protocol [65]. cDNA was synthesised and amplified by a 13 
cycles PCR reaction. Quality of cDNA was verified by 2100 High Sensitivity DNA assay (Agilent 
technologies). 1 ng cDNA was used for preparing each cDNA library using Nextera-XT kit 
(Illumina) and sequenced on Hi-seq 2000 to obtain around 40-60 millions of reads (100 base 
paired-ends).  
 
RNA-seq data analyses 
Sequences were trimmed in order to remove adaptors and low quality bases. Trimmed reads 
were mapped in to the zebrafish genome GRCz11 (Ensembl Release 92, www.ensembl.org) 
using STAR software v.2.5.4b [66]. Gene expression was measured from the mapped reads 
by using built-in STAR module (--quantMode GeneCounts) and are expressed in counts of 
reads per million (CPM) [67]. The RNA-seq raw data have been deposited in the Gene 
Expression Omnibus (GEO) under the accession number GSE149081.  The comparison of the 
transcriptome of EECs and PECs with other zebrafish tissues was performed using DESeq2 
R package [68]. This comparison includes RNA-seq data from the heart (ArrayExpress: E-
MTAB-460; GEO: GSE71755), brain (ArrayExpress: E-MTAB-460), pancreatic cells [24, 69] , 
liver (GEO: GSE82246) and intestine (GEO: GSE83195). The reproducibility of RNA-seq data 
from wild-type and pax6b mutants was verified by a principal component analysis (PCA) 
obtained using the DESeq R package [70]. Differential expression (DE) analysis was 
performed using the R package DESeq2 [68], to identify all genes displaying significant change 
in expression between wild-type and pax6b mutants (with Fold-Discovery-Rate < 10%).  The 
significance in the overlap of the sets of genes regulated by Pax6b in EECs and in PECs was 
determined with the R built-in statistical Fisher's Exact Test. 
 
Gene Ontology enrichment analysis. 
Gene Ontology (GO) enrichment analysis was performed on the different gene sets (genes 
selectively expressed either in EECs or in PECs, pax6b-regulated genes only in PECs, only in 
EECs and in both PECs and EECs) using the DAVID bioinformatics resources 6.8 [71] taking 
as background all the zebrafish genes. The enrichment analysis was focused on the GO 
biological process, molecular function and KEGG pathways with a statistical Fisher exact test 
p-value<0.05.  
 
In situ hybridization and immunohistochemistry. 
Antisense RNA probe for the different genes were prepared as described by Thisse et al 2008 
[72]. Briefly, primers were designed to amplify a part of the transcript that is used as a template 
to synthesize the probe. The reverse primer at the 5' contains the minimal promoter sequence 
for T3 RNA polymerase (5'-AATTAACCCTCACTAAAGGGAG-3'), templates were amplified by 
RT-PCR. Whole mount in situ hybridization and fluorescent in situ hybridization (WISH and 
FISH) were performed as described previously [73] on wild-type (AB strain), pax6sa0086 null 
mutant or pax6bsunrise mutant embryos/larvae [13].  Immunohistochemistry (IHC) on whole-
mount embryos/larvae was performed as described [74]. The antibodies used are the guinea 
pig polyclonal anti-PDX1 antibody (ab47308, abcam) used at a dilution of 200X, the chicken 
anti-GFP (Aves lab) used at a dilution of 1000 X, the rabbit anti-Enkephalin (T4294 ; Peninsula 
Laboratories International, Inc) used at a 400X dilution, the rabbit anti-PACAP (Adcyap1)( T-
4473.0050; from Peninsula Laboratories International, Inc ) used at a 300X dilution, the 
monoclonal mouse Hu antibody (16A11 : invitrogen Cat. #A-21271) used at a 1000X dilution, 
and Alexa Fluor secondary antibodies at 1000X dilution. Stained embryos were mounted in 
Prolong (Invitrogen) with DAPI and imaged using SP5 confocal microsope (Leica).  For the 
immunostainings on adult tissue, the intestine of transgenic Tg(-8.5nkx2.2a:GFP)ia2 adult 
zebrafish was dissected and fixed for 1 day in PFA 4% rinsed in PBS and embedded in TEK 
using standart procedures and sectioned using cryostat for generating 10µm sections which 
were mounted on glass slides. The primary and secondary antibodies were used as the same 
dilution as described above for whole-mount larvae. 
 
List of abbreviations 
EEC : enteroendocrine cell 
PEC : pancreatic endocrine cell 
EN : enteric neuron  
WISH : whole-mount in situ hybridization 
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FPKM : fragments per kilobase of exon model per million reads mapped 
S.E :  standard errors  
Gcg :Glucagon 
Sst : Somatostatin   
Ghrl : Ghrelin 
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Ckk : Cholecystokinin  
Gip : Glucose-dependent insulinotropic polypeptide 
Vip : Vasoactive intestinal peptide  
mlnl : Motilin-like  
Insl5 : Insulin-like peptide 5  
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Adcyap1 : Adenylate cyclase-activating polypeptide 1  
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Penka : Proenkephalin-a 
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Figure 1: Expression of different enteroendocrine hormones in the zebrafish gut.  
Whole-mount in situ hybridization (WISH) obtained with different hormonal probes at 3 dpf (A-
H and K) or 4 dpf (I and K). Ventral views of embryos with anterior on the left. The dotted lines 
represent the location of the gut. Probes used are : sst2: Somatostatin 2.  adcyap1a: adenylate 
cyclase activating polypeptide 1a; vip2: vasoactive intestinal peptide 2; ccka: cholecystokinin 
a; gcga: Glucagon a. pyya/b: Peptide YYa/b. ghrl: Ghrelin. gip: glucose-dependent 
insulinotropic polypeptide. insl5a: Insulin-like peptide 5a.  calca: Calcitonin. Scale bars: 50 μm. 





Figure 2: Immunostaining of Enkephalin and Adcyap1 in the zebrafish intestine. 
(A-B) Confocal images of intestines from 5-dpf Tg(pax6b:GFP) zebrafish larva stained with 
antibodies directed against GFP (green), Hu (white), ENKEPHALIN (A; red) or ADCYAP1 (B; 
red). (C-D) Confocal images of intestine of adult Tg(8.5nkx2.2:GFP) stained with antibodies 
directed against GFP(green), ENKEPHALIN (C; red) or ADCYAP1 (D;red). Arrows show 
location of some EECs expressing Adcyap1 (B and D) or Enkephalin (C). Adcyap1 
immunostaining is also observed at level of EN axon fibers in gut larva (B) and in the muscularis 
layer of adult intestine (shown by * in D). The zebrafish Adcyap1a and Adcyap1b display 
respectively 6 and 3 mismatches with human ADCYAP1 at the level of the epitope reacting 
with the Adcyap1 antibody, explaining the stronger signal of Adcyap1b in EN fibers. (The 








Figure 3: Similar gene expression profiles between zebrafish EECs and PECs. 
(A) Global comparison of transcriptomic profiles (RNA-seq) from distinct zebrafish 
tissues/organs. Clustered heatmap displaying Euclidean distance matrix between every pair 
of zebrafish RNA-seq datasets. The order of the different tissues is identical for the two axes 
(rows and columns) as shown by the different colors on the upper part and left part of the 
matrix. Each zebrafish tissue (analysed in triplicate) was compared with the other samples as 
presented in the matrix. Darker colour indicates closer distance (i.e. more similar 
transcriptomes). EEC transcriptome is mostly similar to the transcriptome of embryonic 
pancreatic endocrine cells (PECs) or to the adult alpha, beta or delta pancreatic cells. The 
accession number of all used RNA-seq datasets are given in Materials and methods (B) Venn 
diagram showing the overlap (74%) of genes expressed in both EECs and PECs above the 
threshold of 10 CPM. 8264 genes and 8326 genes were expressed above 10 CPM (counts 
per million) respectively in EECs and in PECs.  
 
 
Figure 4: Expression profiles of pax4, arx, pdx1 and fev in the zebrafish gut. 
Fluorescent in situ hybridization (FISH) performed on 66hpf (A), 72hpf (B-D) or 96 hpf (E-I) 
embryos. Views of the gut (delimited by dotted lines; anterior to the left) showing the non-
overlapping expression of pax4 (green) and arxa (red) (A), numerous EECs expressing fev (B) 
and insm1b. (D) Higher magnification showing insm1+ EECs located within the gut epithelium 
and insm1+ enteric neurons (shown by asterisks) outside but juxtaposed to the epithelium. (E) 
View of the gut from the tg(BAC pdx1:GFP) larvae (GFP immunostaining) with higher 
magnification of the anterior (F) and posterior (G) parts. FISH using pdx1 probe (H) and 
immunostaining using Pdx1 antibody.  P: pancreas. Scale bars: 20µM. 
 
Figure 5: RNA-seq analysis of EECs and PECs from wild-type and pax6b mutants 
identifies a set of genes displaying similar Pax6b-regulation in both pancreas and 
intestine. 
(A) Principal component analysis (PCA) on all EEC and PEC RNA-seq data obtained from 
wild-type and pax6bsa0086 mutants. The close clustering of the triplicate wild-type and mutant 
samples demonstrates the high reproducibility of the data. (B, D) MA plots showing all the up-
regulated (in blue) and down-regulated (in red) genes in the pax6bsa0086 mutant PECs (B) and 
EECs (D). (C) Venn diagrams showing the overlap of genes regulated in both EECs and PECs; 
among the 517 regulated genes, 215 and 209 genes are respectively up- and down- regulated 
in both cell types as shown in the blue and red Venn diagrams. (E,F) Expression ratio (in log2 
of Fold Change from pax6b mutant versus wild-type) of hormones expressed in PECs (E) and 
in EECs (F); down-regulated hormones are in red, up-regulated hormones are in blue, and not 
statistically affected in grey; RNA-seq values are shown in Tables 3 and S4. 
 
Figure 6: Increase in the number of cells co-expressing ghrl and mlnl in the pax6b-/- 
PECs and EECs. 
FISH using ghrelin (ghrl, labelled in red) and motilin-like (mlnl, labelled in green) probes on 2.5 
dpf (A,B,E,F and I) and 4.5 dpf (C,D,G,H,J) zebrafish larvae. Confocal views of the pancreatic 
islet (A,B,E,F) and of the gut (C,D,G,H). I and J images are overlays of ghrl (I’ and J’) and mlnl 
(I’’ and J’’) stainings demonstrating co-labelling with the two probes. A,E, I, I’ and I’’ pictures 
are views of the pancreatic islet from a wild-type larva while B and F are pancreatic islet from 
pax6b-/-. C and G are views of intestines from wild-type larvae; D, H, J, J’ and J’’ show views 







Figure 7: pax6b inactivation leads to a loss of pancreatic beta-cells, reduction of delta-
cells, increase of epsilon-cells and abnormal alpha-cells. 
(Upper panel) percentage of markers from beta-, delta-, alpha-, epsilon- and pan- endocrine 
cells which are down-regulated (in red) or up-regulated (in blue) in the pax6b-/- PECs. The list 
of markers for each cell subtype is shown in Table S6. The up- or down- regulation was 
determined from RNA-seq data from pax6bsa0086 mutant versus wild-type. (Lower panel) 
Expression analysis of cell subtype markers by WISH (A,B) and FISH (C-X) on 2dpf zebrafish 
pax6b mutant and wild-type embryos as noted on the top of the panel; probes are indicated on 
the left of each picture. 
 
Figure 8: The effect of Pax6b on the number of EEC expressing pyyb and mlnl does not 
depend on its homeodomain. 
FISH showing the respective increase of mlnl+ EECs and decrease of pyyb+ EECs in the 
pax6bsa0086 null mutants (B,E), while the hypomorphic pax6bsunrise mutants harbouring a 












Supplemental figure legends 
 
Figure S1:  The pax6b:GFP transgene is not expressed in enteric neurones. 
Immunofluorescence on 5 dpf Tg(pax6b:GFP) larva using antibodies against GFP (green) and 
against the enteric neurone marker Hu (red). Confocal vues of the bulb intestine (upper 
panels), mid-intestine (middle panels) and posterior intestine (lower panels) showing no 






Figure S2: Quantification of EECs expressing different neuropeptide transcripts in 4 dpf 
zebrafish larvae.  
The number of EECs expressing each hormones was determined by counting the labelled cells 
after WISH using the corresponding hormone probes on 4 dpf larvae. Each point in the graph 




Figure S3: Expression of vipb and adcyap1a transcripts in zebrafish EECs. 
Confocal images of the zebrafish gut from larvae stained by double fluorescent in situ 
hybridization (FISH) using the enteric neurone marker phox2b (green) and the vipb or 
adcyap1a probes (red). (A) general vue of the gut showing co-localisation of vipb and phox2b 
in ENs at the level of anterior intestine (upper left part of the image) and vipb+ EECs in the 
posterior intestine (bottom right of image). (B) higher magnification of the gut showing three 
vipb+ phox2b+ ENs and two vipb+ EECs. (C) adcyap1a+ cells are distinct from phox2b+ ENs 
which are located outside the intestinal epithelium (Dapi staining in blue). 
 
 
Figure S4 : Sequence similarity between pancreatic polypeptide and of peptide YY. 
Alignment of the amino-acid sequence of pancreatic polypeptide (PP) from mice and rat with 




















EN    
RNAseq 




1  Gcg 
gcga yes 3.5 dpf - ✔ ✔ 33±1.4 2058 57 
gcgb yes N.T         177 14 
2  Sst 
sst1.1 yes - - - -   20 13 
sst1.2 yes N.T         88 1519 
sst2 yes   3 dpf  ✔ ✔ - 2.8±0.4 103 933 
3 Ghrl ghrl no   3 dpf  ✔ - - 2.1±0.4 163 40 
4 Pyy 
pyya yes 4 dpf ✔ - -   437 1 
pyyb yes   3 dpf  ✔ ✔ - 41±2.6 32011 4 
5 Cck ccka yes 3 dpf ✔ - - 23±3.0 6390 1 
6  Gip gip yes 4 dpf  ✔ - - 2.4±0.4 100 4 
7 Vip 
vip yes N.T         0 511 
vipb no 4 dpf - - ✔ N.D* 927 868 
8 Nts nts yes   -  - - -   0 3 
9 Insl5 
insl5a no 4 dpf - ✔ ✔ 39±2.2 5602 14 
insl5b no N.T         178 1 
10 Nmb 
nmba yes N.T         45 116 
nmbb no 3 dpf ✔ - - 14±2.0 2150 0 
11 Galn galn yes 3.5 dpf - ✔ ✔ 26±1.8 824 157 
12 Mln / / / / / /   /   
    mlnl no 3 dpf ✔ / / 5.9±0.7 708 18 
13 Gast / / / / / /   /   
14  Sct / / / / / /   /   
15 Pp / / / / / /   /   
                        
B 
16 Adcyap1 
adcyap1a no 3 dpf ✔ ✔ ✔ 84±6.9 6927 2 
adcyap1b no N.T         6 251 
17 Calca calca yes 4 dpf ✔ ✔ - 12±0.7 2161 1 
18 Penk 
penka yes 3 dpf  ✔ ✔ - 68±3.6 12544 2 
penkb yes N.T         2   
 
  
(Upper panel, lanes 1-15) Identification of the zebrafish orthologs for the 15 mammalian genes 
coding for enteroendocrine hormones by “in silico” search of the zebrafish genome. (Lower 
panel, lanes 16-18) Identification of the 3 novel hormones expressed in zebrafish EECs by 
screening the RNA-seq data with the Gene Ontology term “hormone activity”(GO: 0005179) 
and selecting hormones expressed at high levels (>2.000 CPM).  Column 3 indicates the 
Ensembl ID of the zebrafish genes. Column 4 displays whether a synteny conservation is 
observed between mouse and zebrafish loci. Column 5 indicates the expression onset time 
determined by WISH for each hormone transcripts and their localization in the zebrafish 
gastrointestinal tract (column 6).  Bulb corresponds to the enlarged rostral part of the intestine; 
the mid-gut is located posterior to the bulb and contains the majority of goblet cells at 5 dpf; 
the posterior gut corresponds the most caudal part of intestine containing few goblet cells [29].  
Column 7 indicates the mean (± standard errors (SE) of the EEC numbers detected by WISH 
at 4 dpf.   The number of EEC counted for each individual larvae is provided in Fig. S2.  N.D* 
: not determined; the number of  vipb+ EEC cells could not be quantified as most of the vipb+ 
cells detected in the gut are vipb+ enteric neurons.   Column 8 indicates the expression levels 
determined by RNAseq of EEC in CPM (counts per million).  Column 9 indicates the expression 
levels determined by RNAseq of enteric neurons in CPM [33].  – : not detected by WISH; ѵ : 
detected by WISH. 
The abbreviations used are Glucagon (Gcg), Somatostatin (Sst), Ghrelin (Ghrl), Peptide YY 
(Pyy), Gastrin (Gast), Cholecystokinin (Ckk), Glucose-dependent insulinotropic polypeptide 
(Gip), Vasoactive intestinal peptide (Vip), Motilin (Mln), Motilin-like (mlnl), Pancreatic 
Polypeptide (Pp), Neurotensin (Nts), Secretin (Sct), Insulin-like peptide 5 (Insl5), Neuromedin 
B (Nmb), Adenylate cyclase-activating polypeptide 1 (Adcyap1), Galanin (Galn), Calcitonin 
(Calca).   
 
  





in the gut 
Expression in the gut EEC   
RNAseq 
(CPM) 
EN    
RNAseq 
(CPM) 
Bulb Mid gut Posterior gut 
ascl1b - - - - 2 3 
ascl1a* 36hpf  ✔ ✔ ✔ 25 55 
sox4b* 38hpf  ✔ ✔ ✔ 36 22 
insm1b  ≤52hpf** ✔ ✔ ✔ 638 189 
insm1a ≤52hpf** N.D N.D N.D 123 38 
foxo1a ≤52hpf** ✔ ✔ ✔ 504 33 
neurod1* 52hpf  ✔ ✔ ✔ 474 67 
nkx2.2a* 52hpf  ✔ ✔ ✔ 195 2 
pax4 58hpf ✔ ✔ ✔ 225 0 
pax6b* 60hpf  ✔ ✔ ✔ 826 23 
rfx6* 62hpf  ✔ - - 13 8 
fev 62hpf  ✔ ✔ ✔ 951 3 
isl1* 65hpf  ✔ ✔ ✔ 134 31 




- ✔ ✔ 614 4 
nkx6.1 - - - - 1 2 
nkx6.2 - - - - 5 1 
mnx1 - - - - 1 0 
 
Recapitulation of the WISH data performed on zebrafish embryos from 36 to 72hpf showing 
the expression onset time and the distribution profile in the gut determined by WISH for 17 
transcription factors known to be involved in pancreatic endocrine cell (PEC) differentiation. 
**Based on RNAseq data from FACS-sorted sox17:dsRED cells of the microdissected intestine 
at 52 hpf, insm1a, insm1b and foxo1a are already expressed in the gut at 52 hpf  (Reuter et 
al., article in preparation). The two last columns indicate the expression level in EECs and in 
enteric neurons (ENs) as determined by RNA-seq in normalized CPM. (N.D.: not determined; 
- : not detected by WISH; ѵ : detected by WISH). All these TF are expressed at significant 
levels in EEC, except ascl1b, nkx6.1, nkx6.2 and mnx1. Expression data of genes labelled with 
* are from [27].  
  
Table 3: Expression level of some selected markers in EEC and PEC isolated from wild-
type and pax6bsa0086 mutant larvae. 
markers Gene PEC wildtype  PEC pax6b-/- EEC wildtype EEC pax6b-/- 
epsilon PEC  ghrl 996 3156 184 876 
  mlnl 7,6 385 785 4604 
  mboat4 0,7 201 0,02 1,3 
beta PEC ins 13111 112 1,1 2,9 
  ndufa4l2a 1729 82 1,8 1,2 
  nkx6.2 330 10 5,5 7,7 
  pdx1 1377 37 453 46 
delta PEC sst2 24070 6287 107 440 
  sst1.1 668 37 27 0,2 
  sst1.2 33282 4375 89 37 
  lamc2 153 16 4 31 
  nmba 1640 110 46 15 
  hhex 95 27 0,5 0,1 
  cdx4 181 64 40 32 
alpha PEC gcgb 15002 42 179 2,4 
  gcga 1776 3791 1982 1526 
  pnoca 144 14 11 2,2 
alpha and epsilon scinlb 83 1374 476 1365 
alpha and epsilon arxa 67 290 42 57 
EEC hormones galn 0,05 0,19 758 12 
  pyyb 32 20 34323 3746 
  calca 57 24 1933 349 
  adcyap1a 0,58 0,41 6201 2672 
  vipb 0,07 0,17 737 190 
  ccka 0,43 1,01 6257 7212 
 
The expression level (given in normalized CPM) was obtained from the RNA-seq data. The 
values are the expression mean of triplicate samples. Table S4 provides the expression level 
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2.1 Characterization of genomic DNA-binding sites of Pax6b in
zebrash embryos
In order to identify genomic regions bound by Pax6b protein in zebrash, we performed
ChIP-Seq experiments on whole embryos at 27 hpf for two biological replicates. We
identied 15792 and 14412 peaks for replicate 1 and 2 respectively, corresponding to
genomic region enriched in Pax6b ChIP-seq data. 10811 peaks were detected in the two
replicates (Figure 38-A) . The prole of the genomic locations of these peaks is highly
similar between replicates with most of them located in intergenic regions (~38%), introns
(~46%) and promoter-TSS regions (~10%) (Figure 37-A). Moreover, around 55% of genes
have a peak located within 10kb from their genomic region (Figure 37-B). These results
are coherent with what the group of Sun J. and Cvekl.A observed in mouse forebrain and
lens [276]. Moreover, Pax6 is known to regulate its own expression and we observed the
location of peaks inside P0 promoter region of pax6b and inside most of the regulatory
regions described in the neighborhood of pax6b region (Figure 37-C).
We performed de novo DNA sequence motifs detection within the Pax6b peaks. The
top de novo motif identied in consensus peaks (P-value 1e-930) is a 12 bp sequence
and analysis of this motif revealed Pax6 known motif as the best match. Indeed, this
sequence is highly similar to the in vivo motif previously identied in mice lens and
forebrain [276] (Figure 38-B) and similar to the Pax6 associated motif on JASPAR database
as well (http://jaspar.genereg.net/). This highlights the conservation of Pax6 consensus
recognition sequence which is coherent with the strong conservation of PAX6 protein
sequence across species (see Introduction 2.3.1). Analysis of the location of the top motif
inside peaks showed that it is preferentially located in the center of peaks (Figure 38-C).
Interestingly, the following best matches associated to the motif are PAX8, PAX1, PAX9
and PAX5 consensus sequences respectively. These 4 members of the PAX family lack
or present a partial homeodomain, supporting the idea that the identied consensus
sequence is preferentially associated to the paired domain (PD) [276, 313].
The association of a peak to a neighboring gene is quite challenging. Without additional
data, it is dicult to associate ChIP-Seq peaks localized in a genomic region containing
multiple close genes. Moreover, some regulatory regions have been described for being
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Figure 37: General analysis of pax6b peaks. (A) Distribution of peaks between specic
genomic regions. (B) Overview of distances between a gene and its closest peak. (C)
Identication of pax6b peaks in promoter and regulatory regions of pax6b.
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Figure 38: Validation of peaks. (A) Identication of consensus peaks between both
replicates. (B) Comparison of the top de novo motif enriched in consensus peaks with
previous in vitro and in vivo consensus sequence of Pax6. (C) Top motif is enriched in
center of the peaks.
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very distant of the genes they regulate and evidences have shown that regulatory regions
of a gene are sometimes located inside the genomic region of other neighboring genes.
We decided to focus on peaks located at less than 10kb of a gene TSS (Transcriptional
Start Site) location which reduced our set of identied peaks to 3657 peaks. We linked
these selected peaks to their closest gene and we identied 2366 dierent protein coding
genes.
2.2 Pax6b-dependent Gene Regulatory Network (GRN) in en-
docrine dierentiation
As presented in the paper, RNA-Seq datasets have been produced for pancreatic endocrine
cells (PECs) isolated from 27 hpf embryos using the transgenic lines Tg(P0-pax6b:GFP),
in both wild-type and pax6b-mutant (sa0086 [144]) conditions. The same experiment
has been performed for enteroendocrine cells (EECs) using 4 dpf embryos. We compared
transcriptomes between wild-type and mutant datasets in order to determine the pax6b
regulated genes. Dierential expression analyses identied 2824 and 1625 Pax6b-regulated
genes in PECs and in EECs, respectively, (FDR<=0.1). Comparison of these two sets of
genes reveals that there is a large set of 517 genes which are altered by pax6b inactivation
in both organs. These results indicate that a part of the Pax6-dependent GRN is thus
identical in EECs and PECs.
We decided to identify genes, inside the Pax6 GRN of both tissues, which are linked
to a Pax6b peak from the ChIP-seq experiment as these genes are good candidates to
be directly regulated. We compared successively our list of 2366 genes linked to pax6b
peaks with the list of genes regulated in both tissues, in PECs only and in EECs only.
Among the 517 genes regulated in both tissue, 70 (~13.5%) are associated to a close Pax6
peak. Similar ratio of ~15.6% (361/2305) and ~12.2% (136/1116) are observed for genes only
regulated in PECs or EECs, respectively (Supplemental table 4). We highlight 11 genes
encoding transcription factors bound by Pax6b and regulated in both tissues: meis1b,
rorab, scrt1a, arid5b, pou3f3a, sox4a, atf2, etv5b, hmx4, sp8a and neurod1 (Supplemental
table 5). Interestingly, mice orthologs of neurod1 (Neurod1), pou3f3a (Pou3f1) and arid5b
(Arid5b) were previously associated with Pax6 direct regulation in forebrain or lens [276].
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We performed gene set enrichment analysis against WikiPathways (WP) and GO Bio-
logical Process (GO BP) databases. Considering all 70 targeted genes regulated in both
tissues, we identied signicative enrichment for MAPK, BMP and FGF signaling path-
ways and we observed an enrichment of GO terms associated to regulation of multiple
metabolic processes (Figure 39). We also looked at targeted genes regulated only in PECs
or EECs. For the rst group (PECs), we identied many GO terms associated with brain
and neuronal development while pathways enrichment highlighted the Delta-Notch
Signaling. From EECs list, we observed enrichment for both canonical and noncanonical
Wnt pathways. Interestingly, GO terms enrichment analysis of EECs genes additionally
highlighted “enteroendocrine cell dierentiation”, “pancreatic alpha cell dierentiation”
and “eye morphogenesis” terms (Figure 39).
These results indicate that Pax6b directly controls multiple signaling pathways involved
in endocrine dierentiation. The similarities between lists of targeted genes with those
described in mice forebrain and lens suggest that the Pax6 GRN could be relatively
conserved across tissues and species. This is supported by the observation that genes




Figure 39: Gene Set Enrichment Analysis. WikiPathways and GO BP terms enriched




1 Transcriptomic signatures of pancreatic cells
In this thesis, we rst determined the transcriptomic proles of pancreatic cell types in
zebrash. We took advantage of using both RNA-seq and scRNA-seq data simultaneously
to complete our previous work. The use of scRNA-seq data allowed us to dene two
supplementary signatures for ghrelin-expressing epsilon cells and for the subpopulation
of delta cells expressing specically sst1.1 gene. The comparison of all cell type signatures
highlighted sets of genes with enriched expression in each cell subtype and validated
most of our previous observations [146]. Among these observations, we previously
described a set of genes presenting enrichment in endocrine cells compared to ductal and
acinar cells and we highlighted that only a small proportion of these genes are specic of
an endocrine cell subtype. We performed interspecies comparisons with mammals in
order to identify genes with a conserved enriched expression in endocrine cells. Indeed,
these genes are expected to be important for endocrine cell functions as their expression
has been maintained during evolution of vertebrates. We determined that a set of 251
genes share an endocrine prole through zebrash, mice and human pancreatic cells.
This list contained several transcription factors known for their crucial role in endocrine
dierentiation such as runx1t1, isl1, myt1la, fev, neurod1, ascl1a, rfx6, pax6b, insm1b,
npas4a, arxa, myt1a, insm1a, lmo1 and etv1 [146]. We applied a similar approach with
genes enriched specically in alpha and beta cells and we observed that very few genes
were conserved between species in this case. Beside the insulin gene, only pdx1 and gcgra
were conserved for beta cells. Similarly for alpha cells, only a set of 20 genes was found.
These results were surprising as they suggest that the identity of the same cell type across
species rely on a set of very few conserved genes.
We decided to collect additional data to pursue this analysis and we took advantage of
the availibility of scRNA-seq data for pancreatic tissues. As mentioned above, zebrash
scRNA-seq data [147] completed our previous results by lling the remaining gaps. After
identication of two supplemental endocrine cell subtype transcriptomes, we reassigned
some genes to the corresponding prole. Using human scRNAseq data [134–136], we
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obtained transcriptomic signatures for all major pancreatic cell types and we dened all
lists of genes with enriched expression in a particular cell type.
For both species, we made a distinction between the enriched genes and the marker
genes which are genes presenting a high enrichment in a specic cell type. The strong
similarities between the endocrine cell subtypes led to reduced lists of marker genes
in both species. Furthermore, the comparison of these lists almost only identied the
hormone genes as conserved marker genes in corresponding cell subtype. Thus, this
conrmed our previous observations. Nevertheless, we identied acsl1b/ACSL1 as an
evolutionary conserved marker of epsilon cells which indicates that this enzyme has
been conserved in epsilon cell for Acyl-CoA production and making the link with the
acylation of ghrelin [297].
We observed an interesting situation with the expression of pdx1 in zebrash. Many
studies have highlighted the role of PDX1 in pancreatic development, and notably its
signicance for beta cell dierentiation, survival and identity in mice and human [151–
154]. In our previous work, we also associated pdx1 expression to beta cell in zebrash.
However, we obtained the signature of sst1.1-expressing delta cell subtype from scR-
NAseq data and we observed a stronger expression in this cluster. In human scRNA-seq
datasets, the expression of PDX1 gene is also detected in delta cells and this observation
is coherent with the identication of PDX1 originally as a transcription factor involved in
the activation of SST gene [298]. These results suggest that despite its important role in
beta cells, PDX1 expression is not restricted to their transcriptome and therefore should
not be considered as a marker gene.
Altogether, these results indicate that it is dicult to dene a list of genes that highlights
specically an endocrine cell type across species. We evaluated our lists of zebrash
marker genes on human datasets and we could not identify accurately the same cell types.
This suggests that looking for specic conserved marker genes is not the best approach and
that dening specicity of the dierent endocrine cell types could also be found in several
key genes they express in common. In other words, we suggest that the combination
between many endocrine genes expressed in several endocrine cell types could dene
the specity of each endocrine cell subtypes. The perspectives to this work would be to
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study further the balance between the expression of these endocrine marker genes inside
each cell type. Exploring dierent combination of endocrine genes and evaluating their
expression in each endocrine cell subtype could be a more suitable approach. Then, this
combination should also be evaluated through interspecies comparison.
1.1 On the importance of datasets
This work relies on the meta-analysis of multiple datasets, meaning the combination of
the results of multiple scientic studies. An important aspect to consider is the impact
of working with a dataset or another can have on the results. We analyzed all 3 human
scRNAseq datasets separately using the same method and we were interested in the
overlap between the lists of enriched genes. We observed that around 7% of marker
genes of the endocrine subtypes dened for a dataset were validated by the two others
datasets. This value rises to around 15% if we consider genes with an enriched expression.
Nevertheless, this observation is made under some restrictive conditions as we made the
choice to be relatively stringent with our thresholds for the analysis. As we previously
described, these 3 scRNAseq datasets were produced by dierent groups with dierent SC
platforms. Single-cell technology is still in active development and all current platforms
suer from dierent limitations. Thus, the exact same information is not expected to
be covered by the dierent datasets. We mentioned that from a dataset to another, the
distribution of cell populations was heterogeneous and a dierent amount of cells was
used. This experimental variability also contributes to the dierences observed in the
results.
After we compared the results of each experiment, we decided to proceed through a
second method. We integrated all cells together before dening gene enrichment analysis
as we expected the aggregation of information to lead to more robust observations.
After using batch eect correction of both experimental and technical dierences, we
highlighted the similarity between datasets and we were able to dene lists of enriched
genes across platforms for all endocrine cell types.
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1.2 On the importance of resources
The eld of “Omics” studies has evolved quickly in recent years, and the bioinformatic
eld followed the same evolution. It implies that the tools and the resources are constantly
improving. Online databases allow extracting all sort of available datasets and information
while the increasing community of bioinformaticians continually develop tools more
suitable for a specic analysis. This work is part of this dynamic and is dependent
of dierent resources like the annotation of the dierent genomes, the database of
orthologous genes across species or the eciency of genome aligners. A global perspective
for this sort of work is to stay up to date with available resources and tools while looking
for new datasets in order to increase the robustness of results.
2 The DNA-binding transcription factor PAX6
Most of the results of the second part of this work have been combined in a publication
called “Pancreatic and intestinal endocrine cells share common transcriptomic
signatures and gene regulatory networks” submitted to BMC Biology and currently
under reviewing.
In order to understand the mechanisms underlying the Pax6-dependent Gene Regulatory
Network in endocrine dierentiation, we performed ChIP-seq experiments for Pax6b in
zebrash. We highlighted signicative genomic binding sites of Pax6b in whole embryos
at 27 hpf and we annotated all peaks with the closest neighboring genes. De novo motif
detection identied a top motif found in our peaks displaying high similarities with
previously identied in vivo and in vitro Pax6 motifs. The distribution of the genomic
locations of Pax6b peaks is coherent with the previous observations [276].
We compared the lists of regulated genes in pax6b-/- mutant with the annotated peaks
and we identied a set of potential directly targeted genes. The majority of the annotated
peaks are not associated to the regulated genes. It suggests that these peaks are inactive
or are associated to genes regulated at another stages or in dierent tissues. Another
explanation could be due to the wrong annotation of peaks located in the neighbourhood
of several genes. Gene Set Enrichment Analysis on endocrine targeted genes linked
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Pax6b to the regulation of many signaling pathways previously described in endocrine
dierentiation. Furthermore, this analysis also pointed out that several genes directly
targeted are associated with brain, neuronal and eye development. This suggests that
pax6 mechanism of regulation could be partially similar between tissues where it is
expressed. This is coherent with previous observations of Sun J. and Cvekl A. [276] on
the regulatory network of Pax6 during the development of forebrain and lens in mice.
Indeed, this study also presented that there is an overlap (around 70%) between peaks
identied in the two tissues. Interestingly, we highlighted several transcription factors
regulated by Pax6 in endocrine dierentiation which they also identied in forebrain
or lens development. More recently, the group of Swisa A. and Dor Y. described Pax6
binding-sites in human beta cells close to important endocrine genes such as PDX1, INS,
GCG and NKX2.2 [156]. We did not detect any similar peaks close to these genes in
our zebrash ChIP-Seq experiments. It is possible that the amount of pancreatic cells
expressing pax6b in 27 hpf zebrash whole embryos is relatively insignicant compared
to the mass of pax6b-expressing cells found in other tissues such as brain or eyes. It
results that the genomic Pax6-binding sites specic of pancreatic cells are not detected
in our ChIP-seq dataset. To address this issue, we performed ChIP-seq experiments on
adult zebrash pancreatic tissues. Unfortunately, we did not get any results as we did not
retrieve any ChIP-seq signal.
Altogether, these results could indicate that we did not recover pancreatic specic peaks
in our datasets and that we may have identied only a part (around 70% based on number
of Sun and Cvekl) of Pax6 sites in endocrine cells. It is also reasonable to propose that the
signicant overlap between the annotated peaks and the genes regulated in endocrine
tissues suggests that a part of the Pax6 GRN is similar in the dierent tissues.
Perspectives for this work would be to successfully identify specic endocrine pancreatic
binding-sites of pax6b to identify most direct Pax6b target genes and to complete our
analysis. This could be performed using most sensitives techniques such as “Cut & Run”
[314]. Chromosome conformation capture data, such as Hi-C, would also be of valuable
interest in order to eciently associate a peak to the correct regulated gene(s). In parallel,
the comparison of the genomic binding and regulation of Pax6 across species could also
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be a strong approach to understand the evolution of Pax6 function and to better resolve





Set of signicative marker genes (pvalue adjusted <= 0.1) identied for alpha, beta and
delta cells based on zebrash bulk RNA-seq data. Genes with an enriched expression in
global endocrine cells are also displayed.
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Gene_Name Alpha Beta Delta Ductal Acinar Cluster Padj
gpsm1a 5557,4 13,2 25,0 2,2 14,7 Alpha 4,79E-08
zgc:194312 4092,4 99,8 241,9 150,7 282,8 Alpha 3,50E-07
arxa 6780,9 0,3 43,6 7,1 61,2 Alpha 1,01E-05
pcsk5b 2813,9 434,9 399,2 14,2 630,4 Alpha 4,36E-05
epas1b 9982,0 133,5 3323,7 298,6 217,8 Alpha 6,33E-05
etv1 4857,9 50,9 83,9 1,1 9,8 Alpha 1,50E-04
gch2 10977,8 419,3 69,9 30,1 205,3 Alpha 1,70E-04
elovl5 4513,0 288,8 61,0 104,3 76,7 Alpha 2,08E-04
gcga 2238867,1 34692,6 81463,9 97,1 7651,7 Alpha 3,51E-04
pltp 3010,9 26,4 87,4 6,7 53,4 Alpha 3,98E-04
fam107b 8805,1 803,0 1572,8 1086,5 418,8 Alpha 1,16E-03
adora2ab 2062,0 7,3 43,3 6,1 17,6 Alpha 1,49E-03
ptpn11b 3598,3 887,6 548,3 45,0 845,9 Alpha 2,56E-03
tp53i11a 3556,9 50,6 264,4 33,6 27,8 Alpha 2,63E-03
pnoca 249498,5 850,0 13193,0 32,2 978,6 Alpha 3,79E-03
gcgb 768900,3 3866,1 38229,0 57,4 2790,9 Alpha 6,97E-03
dlg1 4270,3 486,1 336,3 478,0 269,5 Alpha 7,23E-03
CABZ01058222.1 1134,4 42,6 182,6 23,3 56,9 Alpha 7,90E-03
pleca 8140,5 817,1 1635,7 1062,6 781,6 Alpha 8,11E-03
sim1a 2050,5 127,7 47,1 103,7 9,8 Alpha 8,82E-03
npb 12456,5 668,1 905,8 28,1 51,0 Alpha 1,05E-02
dzip1 1294,9 0,7 276,2 2,7 2,5 Alpha 1,15E-02
si:dkey-156n14.5 2635,9 534,3 667,9 890,3 620,2 Alpha 1,40E-02
lfng 3223,9 17,9 286,3 127,0 28,2 Alpha 1,43E-02
lingo4b 2138,2 18,8 7,6 1,3 7,4 Alpha 2,16E-02
si:dkey-194e6.1 2110,3 3,2 131,4 57,1 11,4 Alpha 2,54E-02
dusp6 9622,5 921,2 4094,4 1148,6 324,1 Alpha 2,68E-02
fap 1718,0 281,9 43,5 3,8 3,7 Alpha 2,97E-02
slc25a14 6827,6 2938,3 2202,2 1515,6 1927,0 Alpha 3,17E-02
grip1 1174,7 392,5 169,9 5,3 415,5 Alpha 3,28E-02
crhr1 2077,4 47,1 180,6 3,7 4,9 Alpha 3,72E-02
gab1 4709,9 1874,6 642,4 1190,5 917,6 Alpha 3,84E-02
prox1b 2104,4 709,9 677,6 10,5 2,5 Alpha 4,12E-02
si:dkey-172h23.2 1168,9 421,8 579,2 544,1 503,3 Alpha 4,72E-02
robo1 3326,8 1066,6 924,1 51,0 68,3 Alpha 4,95E-02
phkg1a 1504,7 423,0 476,5 17,5 1,6 Alpha 5,07E-02
dpp6a 4028,9 528,7 244,9 0,6 455,1 Alpha 6,17E-02
snrkb 1847,1 194,0 520,8 119,2 372,7 Alpha 6,63E-02
spoplb 1949,6 973,2 668,6 330,1 669,7 Alpha 6,91E-02
mst1 8019,4 1898,9 2,3 439,6 1330,9 Alpha 7,18E-02
gpr142 3098,2 1115,4 120,9 7,3 7,4 Alpha 7,25E-02
pdk2b 14486,1 136,3 700,3 2915,9 1494,3 Alpha 8,32E-02
snap91 5701,1 1209,8 1580,6 164,2 38,0 Alpha 8,34E-02
rasl11a 1056,9 9,6 96,0 7,6 4,9 Alpha 8,39E-02
ptprz1b 1350,9 229,6 116,9 7,8 201,7 Alpha 8,88E-02
pyyb 7428,7 1290,7 622,7 269,0 81,4 Alpha 9,10E-02
mapk14b 2356,7 1043,7 899,5 1212,6 1075,2 Alpha 9,82E-02
srpx 265,8 2321,5 24,5 104,4 4,9 Beta 2,53E-13
ndufa4l2a 245,9 24138,4 104,2 125,3 12,7 Beta 7,87E-10
tmeff2a 204,7 2909,9 32,5 2,2 0,9 Beta 4,34E-09
esr1 393,1 5961,2 40,8 45,8 17,9 Beta 1,39E-07
ins 20304,6 3427305,3 17150,6 11323,1 3799,2 Beta 1,60E-07
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fgfr1b 149,6 2173,2 40,5 29,7 0,0 Beta 8,98E-07
nkx6.2 32,3 2512,3 4,6 8,3 0,0 Beta 3,34E-06
ngfra 225,4 2374,8 37,1 8,3 5,8 Beta 9,30E-06
ca12 144,8 4171,0 32,2 50,9 6,0 Beta 1,76E-05
rrad 65,2 1884,9 43,2 64,8 67,1 Beta 4,16E-05
rasd4 447,1 3279,9 53,2 19,2 0,0 Beta 1,14E-04
CABZ01085139.1 58,7 1741,6 90,7 22,0 48,2 Beta 1,34E-04
tagln3b 947,4 11943,9 1122,3 691,6 507,8 Beta 3,87E-04
kcnj2a 244,4 7506,3 373,9 5,0 31,4 Beta 4,07E-04
wif1 1191,0 9273,0 206,2 1346,5 108,4 Beta 4,25E-04
prkcbb 43,9 2682,2 204,5 31,5 22,7 Beta 5,61E-04
zgc:154058 404,5 2323,5 384,2 109,6 176,2 Beta 6,70E-04
grapb 254,5 1110,0 3,2 180,5 1,6 Beta 7,88E-04
ACVR1C 110,1 2611,8 385,3 11,5 12,5 Beta 2,12E-03
otc 92,3 3031,0 43,7 1,4 46,9 Beta 2,80E-03
ucn3l 41,7 5036,6 145,9 6,4 0,0 Beta 3,15E-03
SLC5A10 11283,3 40227,2 438,3 584,6 231,3 Beta 4,17E-03
dpp6b 129,5 2829,1 205,5 8,1 25,4 Beta 4,24E-03
ca7 62,9 6931,1 20,2 40,2 129,1 Beta 4,28E-03
pcdh10a 1435,6 17274,0 3142,8 24,4 4,6 Beta 4,68E-03
ace 28,0 1717,2 44,6 4,9 27,5 Beta 5,97E-03
fstl1b 180,6 6201,3 49,7 377,7 225,3 Beta 6,06E-03
ppdpfb 120746,7 822689,0 29145,1 18155,7 36335,1 Beta 6,15E-03
nptna 750,7 5272,8 97,1 39,1 5,7 Beta 6,65E-03
idh3a 2471,6 4220,3 2464,7 2754,2 1893,5 Beta 7,75E-03
phyhiplb 587,6 2192,5 650,3 1,4 5,8 Beta 8,99E-03
hdac9b 2478,5 7069,7 1939,4 679,5 17,6 Beta 1,04E-02
rnd1b 131,8 1114,4 3,1 2,0 1,3 Beta 1,10E-02
nkx3.2 171,3 1049,0 1,1 74,8 0,0 Beta 1,55E-02
ergic1 322,9 1930,3 377,0 681,8 554,5 Beta 1,56E-02
man2c1 375,4 2246,7 192,0 159,1 135,3 Beta 1,63E-02
g6pcb 2023,6 19787,6 232,7 63,3 20,3 Beta 1,95E-02
stmn4 58,3 1333,5 1,6 62,4 23,0 Beta 2,16E-02
tmtc1 397,1 2168,0 340,1 162,8 90,7 Beta 2,41E-02
slc38a11 72,9 1332,3 217,4 0,3 0,9 Beta 3,30E-02
btc 1650,4 5879,5 1719,0 507,1 558,6 Beta 3,70E-02
nudcd2 355,2 1410,9 382,0 543,8 367,1 Beta 4,07E-02
klb 439,8 2173,9 328,5 12,9 12,9 Beta 4,31E-02
tmsb2 353,3 1032,0 373,5 5,9 0,0 Beta 4,80E-02
sec23a 1410,8 2398,3 961,3 944,9 1418,8 Beta 5,41E-02
BX927333.1 270,7 1115,7 335,4 5,4 2,5 Beta 5,74E-02
prkdc 338,3 2537,5 211,9 57,8 86,6 Beta 5,92E-02
emc10 3632,1 7598,2 2438,1 2231,2 3355,7 Beta 6,29E-02
tmem163b 86,5 1505,2 380,1 5,9 1,6 Beta 6,45E-02
calua 948,5 3044,0 1234,9 603,4 1228,2 Beta 6,83E-02
si:dkey-57n24.6 543,9 1016,8 346,7 253,6 329,4 Beta 6,83E-02
osbpl5 471,7 1317,0 430,5 279,5 35,9 Beta 7,45E-02
clstn3 203,6 1631,1 82,7 596,7 140,5 Beta 7,46E-02
golga7ba 508,7 1478,1 686,7 11,2 0,0 Beta 7,80E-02
nansa 1236,2 3144,0 1010,2 1422,3 1558,4 Beta 8,52E-02
crtac1a 459,3 1872,3 253,7 15,5 1,6 Beta 8,59E-02
pcsk2 4894,1 28108,2 164,9 65,9 25,3 Beta 9,46E-02
LO017791.1 29,0 0,4 1293,0 0,3 0,0 Delta 5,59E-27
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UTS2R 0,7 0,1 1009,3 1,0 0,0 Delta 3,62E-25
arl3l2 16,4 5,5 2277,2 9,2 5,8 Delta 4,47E-21
lamc2 90,7 8,5 8680,5 12,6 109,2 Delta 7,16E-18
mkxa 58,9 0,2 3493,7 1,3 0,0 Delta 2,51E-15
LO018309.1 17,5 9,9 8669,8 5,2 4,1 Delta 5,72E-13
cdx1b 131,1 5,6 10738,8 12,4 11,1 Delta 1,38E-12
map2k6 2770,2 2450,1 45161,8 998,3 755,2 Delta 2,11E-12
TMEM179 (1 of many) 224,5 77,9 4235,6 0,0 0,0 Delta 5,50E-12
map6b 66,7 45,1 1522,2 0,3 0,0 Delta 2,23E-11
sgcd 17,1 0,3 2075,4 0,5 0,0 Delta 4,05E-11
ppp1caa 3881,9 4661,3 24959,5 4981,2 2208,3 Delta 3,60E-10
stxbp6 2020,0 608,3 18576,7 1274,5 1552,7 Delta 4,45E-10
marcksl1b 132,1 115,8 13629,0 271,9 118,8 Delta 6,34E-10
si:dkey-206p8.1 230,8 130,6 5843,1 1,5 1,3 Delta 7,77E-10
rnd2 154,4 0,0 1261,8 0,0 0,0 Delta 1,39E-09
anxa11a 2226,5 1867,9 27540,2 3172,2 2991,7 Delta 5,81E-09
ddc 18,8 0,5 2759,8 0,8 11,0 Delta 6,21E-09
sall4 57,3 28,6 1444,7 131,1 109,9 Delta 1,05E-08
napbb 587,9 421,5 3126,0 9,6 5,7 Delta 1,74E-08
tub 122,3 2,1 1841,7 5,1 13,8 Delta 2,86E-08
sst2 24375,0 8862,7 4878574,5 359,9 4261,7 Delta 3,20E-08
nrcama 168,4 107,9 3171,1 6,7 0,0 Delta 7,12E-08
mdkb 106,4 41,4 10653,0 310,3 77,8 Delta 9,51E-08
aebp1 459,2 18,1 42924,0 4,9 77,7 Delta 1,99E-07
chgb 94,9 94,2 1790,3 139,8 12,3 Delta 2,15E-07
ttc6 31,5 0,5 1198,2 34,2 31,9 Delta 2,78E-07
adra1d 29,4 8,0 3887,1 2,9 2,5 Delta 6,04E-07
gulp1b 104,8 47,4 11926,3 129,5 56,1 Delta 9,20E-07
kcnt1 43,7 5,2 2402,1 0,1 0,0 Delta 1,36E-06
ifitm5 14,1 3,8 1122,5 20,0 22,0 Delta 1,42E-06
spegb 54,1 18,0 6694,5 9,7 30,6 Delta 2,01E-06
rprma 55,8 24,6 1095,5 1,0 0,9 Delta 2,08E-06
pear1 18,3 1,8 1182,0 78,0 5,4 Delta 2,29E-06
mmp2 26,1 0,4 2169,4 21,9 19,2 Delta 3,53E-06
avpr2l 13,7 2,4 2067,8 0,7 0,0 Delta 3,54E-06
phkg2 650,3 603,5 3117,3 86,4 250,1 Delta 5,03E-06
gng3 83,0 225,3 3097,6 5,9 0,0 Delta 8,29E-06
syt10 85,7 0,0 2120,2 20,5 0,0 Delta 9,15E-06
mertka 3,5 1,3 2836,6 224,9 8,0 Delta 1,10E-05
map3k15 329,8 10,4 18042,8 130,8 52,6 Delta 1,15E-05
sst1.2 17742,4 8187,0 3429815,4 392,7 3916,2 Delta 1,30E-05
ptger2a 116,8 5,8 8558,1 0,8 1,6 Delta 1,71E-05
srpx2 181,4 439,9 2927,6 82,4 0,0 Delta 2,62E-05
bmp7b 12,1 1,8 1535,1 22,3 6,5 Delta 2,65E-05
cldni 165,3 9,6 17568,3 3,3 7,4 Delta 2,72E-05
nmba 338,8 90,7 19070,6 11,0 8,5 Delta 2,81E-05
SBSPON 3,5 3,9 1088,0 63,6 0,0 Delta 3,33E-05
rxfp2a 128,7 221,7 2592,4 265,2 432,6 Delta 5,33E-05
mapk14a 3232,3 1812,2 16045,0 3457,5 960,6 Delta 6,17E-05
zgc:195023 303,7 55,5 44732,6 2,6 82,8 Delta 6,94E-05
ugp2b 3358,8 1697,1 10913,2 1029,3 927,1 Delta 8,87E-05
aqp4 52,6 3,2 3797,7 0,3 0,0 Delta 9,14E-05
carhsp1 600,8 121,8 15840,7 128,1 1791,0 Delta 9,20E-05
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st3gal3a 327,9 250,3 1303,3 209,2 202,9 Delta 9,35E-05
pfas 280,7 469,6 5069,7 193,6 410,3 Delta 1,02E-04
sema3fa 78,8 6,9 5020,6 8,2 109,4 Delta 1,07E-04
GALNTL6 10,1 0,8 1182,9 1,5 28,4 Delta 1,24E-04
tbx2b 99,2 30,4 6639,2 4,0 15,9 Delta 1,31E-04
glra1 28,4 2,2 1554,0 51,3 1,6 Delta 1,44E-04
si:ch211-195b15.8 635,2 143,8 11930,9 910,3 131,3 Delta 1,62E-04
fabp6 72,5 58,6 12285,3 16,4 24,6 Delta 1,86E-04
inpp5kb 123,2 6,5 2195,7 0,3 154,2 Delta 2,11E-04
cpamd8 236,0 41,9 7657,6 8,3 1,6 Delta 2,50E-04
ank2a 38,7 39,6 1731,8 2,0 24,3 Delta 2,54E-04
srd5a2b 114,9 72,1 5788,9 106,8 9,8 Delta 3,45E-04
CABZ01088484.1 33,5 7,9 1862,9 34,1 32,0 Delta 4,12E-04
agtr1b 74,2 55,2 1509,4 0,0 9,0 Delta 4,21E-04
cdh11 69,5 6,2 4528,1 2,5 58,6 Delta 4,63E-04
si:dkey-166d12.2 15,4 0,5 1718,6 134,7 7,7 Delta 4,91E-04
plppr5a 20,9 0,6 1830,3 0,3 90,4 Delta 5,35E-04
wnk4b 279,5 615,2 4477,1 9,6 6,6 Delta 5,41E-04
prnpb 39,8 14,2 1001,3 1,1 0,0 Delta 5,55E-04
prkg1b 55,9 36,8 2940,3 202,6 52,4 Delta 5,59E-04
CABZ01068367.1 15,6 0,1 1308,2 209,1 164,0 Delta 7,09E-04
ca6 24,5 3,8 2267,6 5,6 141,1 Delta 8,34E-04
CU019662.1 26,5 2,9 1790,8 0,5 14,6 Delta 9,45E-04
lrrc39 89,6 56,1 1251,0 30,3 45,2 Delta 1,03E-03
amd1 5764,3 3267,4 25930,8 4961,3 1691,1 Delta 1,09E-03
zgc:100906 274,1 322,6 3538,5 72,6 96,3 Delta 1,15E-03
slc26a3.2 130,8 97,5 12841,0 898,0 38,8 Delta 1,35E-03
ghrl 5476,0 487,3 123262,0 6318,3 6749,1 Delta 1,38E-03
ncf1 159,6 91,3 3786,1 269,1 403,7 Delta 1,70E-03
itga11b 38,8 6,9 1227,2 3,7 161,4 Delta 1,77E-03
smoc2 15,3 0,1 2269,9 76,1 9,7 Delta 1,94E-03
serpini1 619,0 550,9 9917,2 9,6 69,4 Delta 1,99E-03
zgc:153615 103,6 704,9 1957,4 0,5 0,0 Delta 2,08E-03
nrbp2a 62,2 31,8 1690,1 10,1 30,8 Delta 2,18E-03
HHEX 92,1 55,0 8850,1 626,0 62,4 Delta 2,20E-03
srgap3 362,9 725,9 1969,6 53,1 241,6 Delta 2,97E-03
trpm3 36,0 0,0 1124,7 5,4 41,7 Delta 3,12E-03
ptger1b 17,2 5,3 2830,7 0,4 0,0 Delta 3,27E-03
kctd12.2 1380,0 181,2 66319,7 5043,6 257,2 Delta 3,32E-03
ak5 107,5 417,8 2183,5 13,4 1,7 Delta 3,35E-03
atp1a1b 69,6 4,5 12517,8 6,8 528,7 Delta 3,48E-03
tspan4b 17,0 0,0 2233,2 7,1 92,4 Delta 3,55E-03
irs1 108,2 202,6 1498,2 228,3 236,6 Delta 3,58E-03
slc7a14a 338,2 309,3 3888,2 21,6 119,5 Delta 3,72E-03
slc7a7 965,2 94,2 17935,0 26,7 41,2 Delta 3,75E-03
zgc:198419 535,7 566,5 2222,6 193,0 143,9 Delta 3,83E-03
si:dkey-280e21.3 262,4 106,6 3753,5 14,7 0,0 Delta 4,22E-03
slmapb 670,8 100,1 6707,6 15,0 35,5 Delta 4,26E-03
pcdh9 184,9 161,8 2475,5 1,9 0,0 Delta 4,35E-03
mrap2a 261,9 2,9 7126,1 1,7 18,4 Delta 4,59E-03
slc8a1b 25,1 171,4 1243,2 1,3 0,0 Delta 4,98E-03
prss23 16,4 6,7 1240,2 6,7 182,1 Delta 5,31E-03
npy8br 135,9 1,0 2776,7 26,2 45,7 Delta 5,91E-03
Zebrafish RNA-seq Enriched Genes
Page 5
oaz2a 2677,6 1530,2 17597,6 2098,5 1105,5 Delta 6,59E-03
FO904977.1 25,1 32,9 1244,1 2,6 2,5 Delta 6,69E-03
olfm2a 447,8 24,9 10411,2 4,6 4,9 Delta 7,35E-03
fgfr1a 375,2 101,5 4338,5 9,7 3,3 Delta 8,53E-03
adcyap1r1a 56,2 108,5 1486,3 10,1 18,8 Delta 9,06E-03
pitpnaa 441,2 1212,2 20193,7 2432,1 1178,7 Delta 9,87E-03
TMEM8B 161,5 125,9 1041,8 2,1 0,9 Delta 1,01E-02
si:dkey-85k7.7 117,0 107,0 3517,3 323,5 256,9 Delta 1,03E-02
trib2 1007,1 743,0 4684,4 91,2 923,7 Delta 1,06E-02
tmed3 328,6 384,3 1806,3 115,1 522,3 Delta 1,11E-02
yjefn3 135,0 3,2 3089,0 1,7 9,0 Delta 1,16E-02
mpped2a 587,5 402,9 1217,8 429,1 397,4 Delta 1,20E-02
tmcc3 216,5 64,3 1922,8 134,5 381,7 Delta 1,37E-02
DUT 364,3 678,9 2162,1 163,4 20,1 Delta 1,37E-02
slc35g2b 71,3 30,0 3062,0 18,8 0,0 Delta 1,44E-02
edil3a 72,1 4,9 4802,0 651,8 105,6 Delta 1,46E-02
rasgef1ba 1725,6 1959,3 11170,9 2997,2 1901,8 Delta 1,49E-02
kcnk3b 850,2 1092,3 15042,5 13,8 41,7 Delta 1,59E-02
apaf1 382,8 283,5 1230,9 264,0 490,9 Delta 1,66E-02
ppp6c 2127,9 2715,0 7828,9 2852,0 1391,8 Delta 1,67E-02
csrnp2 199,5 182,4 1549,7 42,5 2,9 Delta 1,69E-02
stom 347,4 349,5 2017,2 337,0 73,1 Delta 1,86E-02
map1ab 1341,8 1003,6 12744,2 14,6 546,3 Delta 1,97E-02
hmx4 22,9 2,5 1405,6 6,4 84,0 Delta 2,00E-02
hopx 428,1 699,5 3192,8 437,1 307,9 Delta 2,06E-02
cyp3a65 477,8 208,1 1226,8 18,6 0,0 Delta 2,13E-02
nhsb 303,3 115,3 2325,4 25,3 6,2 Delta 2,27E-02
brd1b 1458,7 1532,4 2729,0 702,2 1308,7 Delta 2,51E-02
stk3 336,9 572,6 1608,2 691,4 561,4 Delta 2,77E-02
iba57 263,8 280,6 1141,2 382,9 441,0 Delta 2,84E-02
loxl2a 100,0 49,3 1842,4 1,6 12,2 Delta 2,86E-02
skib 451,7 337,9 1250,9 159,0 1,6 Delta 2,91E-02
lancl2 720,9 578,9 1751,3 223,1 243,1 Delta 2,93E-02
tspan7 2505,4 2323,5 6459,3 1911,0 368,8 Delta 3,24E-02
si:dkey-250k15.7 35,1 10,1 1400,3 418,9 103,8 Delta 3,48E-02
alcamb 19090,5 11010,3 66011,6 1536,9 484,4 Delta 3,62E-02
CABZ01079192.1 147,4 28,6 8129,1 480,4 129,6 Delta 3,63E-02
tenm3 932,0 982,8 2235,2 58,2 18,3 Delta 3,98E-02
nr0b1 49,2 186,9 1416,2 26,6 21,2 Delta 4,06E-02
tshz3a 63,5 0,6 2713,5 4,8 265,4 Delta 4,08E-02
pygma 182,5 52,7 3034,7 13,3 129,7 Delta 4,14E-02
spock3 447,0 1794,8 7789,7 147,4 2,5 Delta 4,80E-02
cdh13 423,3 1,3 1782,1 4,3 0,0 Delta 5,00E-02
maptb 203,1 599,1 3496,4 64,8 22,6 Delta 5,03E-02
prkag1 1299,8 1178,3 3343,6 1098,9 793,2 Delta 5,21E-02
adgrv1 142,8 241,1 1193,9 14,1 64,8 Delta 5,23E-02
bsnb 618,2 683,0 1665,3 26,2 0,0 Delta 5,24E-02
ckbb 1954,2 3046,3 18489,4 129,4 472,9 Delta 5,31E-02
rnf19a 1285,0 702,2 3395,4 1160,6 965,8 Delta 5,39E-02
gldc 964,4 21,6 3384,0 313,4 679,2 Delta 5,97E-02
rab30 293,5 272,1 1913,2 75,3 74,2 Delta 6,02E-02
tfcp2 1586,3 1854,5 5536,5 1370,8 357,8 Delta 6,21E-02
lamb2 535,9 0,6 3843,1 11,2 9,7 Delta 6,46E-02
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slc26a5 1945,1 495,9 5188,0 1192,5 1822,0 Delta 6,48E-02
casr 263,9 237,5 1153,2 7,7 2,6 Delta 6,52E-02
scube2 692,4 267,5 3580,2 759,5 47,0 Delta 6,80E-02
zgc:55733 475,5 333,2 1560,0 671,1 327,8 Delta 6,84E-02
gpr4 297,6 13,4 2091,9 1,0 2,5 Delta 6,87E-02
p3h4 171,7 20,9 2299,6 8,6 411,5 Delta 7,04E-02
stx2a 57,9 44,5 1780,5 703,8 14,0 Delta 7,08E-02
nucb2b 6185,7 7984,4 18667,0 351,0 6027,1 Delta 7,20E-02
stmn1b 2273,1 486,9 14825,5 44,8 275,1 Delta 7,47E-02
cplx2 369,5 742,7 2515,6 19,0 1,6 Delta 7,93E-02
mfge8a 289,7 300,1 1085,9 108,8 317,8 Delta 8,88E-02
hepacam2 365,1 10,3 4919,7 53,4 66,5 Delta 8,94E-02
aatka 1154,2 811,1 404,6 17,2 2,5 Endocrine -
abca2 1040,4 1084,3 530,9 124,1 9,8 Endocrine -
abcc5 13528,1 3901,8 4878,6 425,3 626,9 Endocrine -
abcc8 3289,3 7471,2 5124,6 46,8 21,2 Endocrine -
abhd15a 1669,7 10188,0 28,7 173,2 131,3 Endocrine -
adam19b 1467,1 147,8 0,1 4,1 20,3 Endocrine -
adgrb1a 948,3 905,8 2645,3 12,0 85,5 Endocrine -
adgrb1b 2370,0 854,2 3024,0 14,8 29,6 Endocrine -
adgrb3 1140,0 858,5 1284,1 10,9 15,9 Endocrine -
adm2a 100664,2 59441,0 29395,1 604,5 2342,6 Endocrine -
ajap1 342,4 1206,4 886,0 4,5 11,7 Endocrine -
ak5l 10777,8 3521,9 308,2 25,6 39,2 Endocrine -
aldocb 34716,1 36156,2 18672,4 207,9 578,7 Endocrine -
amigo1 573,9 667,2 2137,0 0,8 0,0 Endocrine -
amigo3 2787,3 3566,0 392,4 37,1 20,3 Endocrine -
amph 2908,2 2325,1 2313,1 9,1 209,9 Endocrine -
angptl3 6709,1 1161,7 35,1 9,3 19,6 Endocrine -
ank2b 4632,1 1294,8 1190,2 148,6 71,0 Endocrine -
ank3b 1446,7 1205,8 1357,3 6,5 37,6 Endocrine -
ankrd13d 1313,9 1304,2 1010,4 5,7 41,7 Endocrine -
anks1b 563,2 133,9 1117,8 14,7 2,6 Endocrine -
ano8a 1074,7 386,6 351,6 1,2 11,4 Endocrine -
anxa13l 175,7 772,1 1125,3 13,7 0,0 Endocrine -
anxa5a 1046,2 2061,2 1547,7 208,2 24,2 Endocrine -
ap1s2 2680,2 5364,9 3563,5 167,0 169,7 Endocrine -
apba1b 1967,4 1156,5 1490,2 25,2 156,6 Endocrine -
apof 10216,8 1501,3 4791,8 7,6 27,0 Endocrine -
arf3a 386,7 754,0 1002,0 3,8 124,8 Endocrine -
arhgef12a 2973,6 2762,5 1894,1 186,4 161,9 Endocrine -
arhgef9a 1284,0 384,9 605,6 2,9 28,1 Endocrine -
arvcfb 3207,4 968,8 2082,4 133,9 49,0 Endocrine -
astn1 3437,2 2486,5 3600,0 13,5 85,9 Endocrine -
atcaya 2034,2 3067,0 5429,9 24,7 2,5 Endocrine -
atp10a 1422,9 1304,2 1290,9 162,2 35,7 Endocrine -
atp1a3a 16861,1 10052,4 4426,7 116,2 196,5 Endocrine -
atp1b2a 2266,3 1183,8 1269,2 75,2 23,6 Endocrine -
atp2b1b 940,8 500,4 1102,3 8,3 20,3 Endocrine -
atp2b3a 2308,8 1762,8 795,1 8,6 40,5 Endocrine -
atp6ap1a 1676,5 2395,0 2070,6 31,8 2,5 Endocrine -
atp6v0a1b 699,2 710,0 1353,3 8,4 30,6 Endocrine -
atp6v1c1b 1057,4 1204,5 1046,5 96,0 114,9 Endocrine -
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ATP8A1 1179,2 192,1 238,1 1,1 30,1 Endocrine -
avpr1aa 1272,7 2175,7 1137,4 0,3 0,0 Endocrine -
bean1 1332,0 1522,3 854,6 5,8 6,2 Endocrine -
bin1a 1009,6 726,8 376,0 1,2 44,8 Endocrine -
c2cd4a 12840,7 5796,8 18816,3 936,1 137,6 Endocrine -
ca16b 555,4 1596,5 389,8 52,6 0,9 Endocrine -
CABZ01038494.1 506,3 1028,6 320,3 11,1 19,4 Endocrine -
CABZ01073265.1 22760,9 23448,1 15864,5 457,1 341,1 Endocrine -
CABZ01102528.1 535,4 890,5 1100,9 80,4 14,5 Endocrine -
cacna1c 1512,4 576,5 700,1 3,8 80,2 Endocrine -
cacna1da 1373,5 447,8 227,5 3,5 10,6 Endocrine -
cacna2d2a 1450,6 1057,8 528,2 9,0 3,3 Endocrine -
cacnb4b 2838,5 1029,5 820,9 7,3 9,8 Endocrine -
cadm1a 1158,9 1487,3 262,5 3,1 2,5 Endocrine -
cadm2a 2349,3 6898,6 3594,7 226,5 216,8 Endocrine -
caly 518,8 595,9 1742,5 1,4 33,9 Endocrine -
camk1da 663,8 870,2 1196,5 35,6 13,9 Endocrine -
camk2n1a 8677,2 2551,8 10097,1 30,9 68,5 Endocrine -
camkvb 1802,1 1,2 2461,8 5,1 31,0 Endocrine -
camta1b 1438,2 655,4 996,7 31,3 2,5 Endocrine -
ccdc85al 1281,8 1165,4 92,2 31,9 2,5 Endocrine -
cdh18a 43,5 673,5 1316,7 3,7 0,0 Endocrine -
cdh4 178,3 341,5 1291,6 3,9 3,2 Endocrine -
cdh6 1721,4 2321,8 676,3 11,5 7,4 Endocrine -
CDHR2 1568,5 565,8 1778,1 7,8 4,9 Endocrine -
cdk5r2b 2393,2 7,4 3343,5 2,3 4,9 Endocrine -
celf3a 1615,4 1609,2 1456,4 32,7 21,2 Endocrine -
celf5a 1009,9 590,2 2041,1 2,2 17,8 Endocrine -
cers6 2720,2 1461,8 1703,3 15,8 14,7 Endocrine -
chd5 489,6 1217,6 1407,4 11,4 17,0 Endocrine -
chga 27414,8 10010,4 3946,7 89,8 116,6 Endocrine -
chrnb3b 2232,1 1071,4 3226,1 1,1 9,0 Endocrine -
clip3 3818,2 2815,9 2689,4 5,0 21,4 Endocrine -
cntn4 249,0 1257,3 19,3 1,2 3,3 Endocrine -
cntn5 1721,2 2627,9 47,3 1,0 15,4 Endocrine -
cntnap2a 5988,0 9779,0 369,9 50,2 110,8 Endocrine -
coro1cb 671,9 735,2 1923,3 4,4 2,5 Endocrine -
cpe 68496,0 87167,6 42017,2 1090,1 862,3 Endocrine -
cplx2l 4447,9 3033,4 2086,3 305,4 44,9 Endocrine -
creb3l1 1494,4 1367,6 2610,4 39,8 47,4 Endocrine -
CSDC2 (1 of many) 1040,0 368,2 384,3 17,9 84,2 Endocrine -
ctnna2 1813,3 1577,7 1843,3 3,7 18,4 Endocrine -
ctnnal1 904,6 1144,4 850,8 110,6 36,5 Endocrine -
ctnnd2b 2100,7 1280,4 868,9 14,4 7,4 Endocrine -
CU855878.1 4511,8 1736,8 928,7 162,7 6,2 Endocrine -
cyb561 2212,9 3528,3 2432,1 15,8 34,8 Endocrine -
cyfip2 2601,6 2147,0 2908,0 38,7 17,5 Endocrine -
cyp27c1 1232,4 1562,9 2,4 52,8 6,5 Endocrine -
cyr61l2 2015,1 1086,2 9,9 44,3 7,4 Endocrine -
cyth1b 4083,9 3680,9 5697,0 232,1 299,1 Endocrine -
dab2ipa 1078,0 979,7 431,3 21,9 11,7 Endocrine -
dachd 1239,6 908,2 239,8 93,8 2,5 Endocrine -
dclk1a 1981,9 2109,1 1692,0 12,9 31,9 Endocrine -
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desi1a 1389,6 2092,7 1567,3 260,3 60,8 Endocrine -
dgkaa 2528,4 5201,9 30,7 108,5 134,0 Endocrine -
dgkh 2401,2 865,1 132,1 47,3 79,2 Endocrine -
disp2 8471,7 10007,9 6914,3 27,6 89,4 Endocrine -
dkk3b 115090,2 8093,6 59550,0 2329,0 648,6 Endocrine -
dnajc5aa 1133,5 1086,3 1192,3 21,8 155,9 Endocrine -
doc2d 1117,2 552,7 51,7 0,6 4,1 Endocrine -
dock9b 456,8 1250,8 1015,7 8,5 3,3 Endocrine -
dpysl2b 1165,9 2044,6 1315,2 2,6 11,3 Endocrine -
dpysl3 504,3 1065,3 334,5 14,7 56,0 Endocrine -
dscama 6875,3 3226,2 193,7 11,4 109,3 Endocrine -
ECE2 1268,4 426,7 1039,0 46,8 50,3 Endocrine -
efnb2a 1825,5 3774,1 2354,4 270,7 258,3 Endocrine -
egr4 38275,4 35511,9 69064,9 341,0 706,0 Endocrine -
ehd4 1418,4 922,5 1986,5 59,4 225,7 Endocrine -
ek1 2133,6 864,6 920,1 128,5 67,0 Endocrine -
elavl4 2911,8 1668,5 2096,1 17,0 4,9 Endocrine -
elmod1 696,5 306,1 1182,4 2,6 13,0 Endocrine -
elovl1a 7621,2 5325,7 7017,2 1079,9 32,3 Endocrine -
eno1a 8408,6 19506,0 11738,2 923,7 1086,1 Endocrine -
epdr1 2034,6 3986,7 1535,4 23,8 89,6 Endocrine -
epha4b 1899,8 2092,3 1519,8 16,3 4,9 Endocrine -
etv4 111,8 3,5 1269,5 4,3 70,9 Endocrine -
etv5a 6424,3 3120,3 1950,4 392,6 272,9 Endocrine -
etv5b 7712,1 1804,9 2786,1 502,6 256,1 Endocrine -
eva1a 1223,7 1666,9 1848,4 30,6 5,8 Endocrine -
fam131c 965,4 1426,4 33,6 12,6 11,7 Endocrine -
fam19a5a 1110,2 81,5 305,6 1,1 0,0 Endocrine -
fam212aa 149,8 988,4 4348,6 51,2 21,2 Endocrine -
fam43a 2313,2 1061,0 14,0 61,1 26,3 Endocrine -
FAM46A 2641,5 1244,6 1536,6 13,8 13,9 Endocrine -
fam49bb 8810,7 7522,8 6157,3 333,5 277,4 Endocrine -
fam69c 943,0 1560,7 46,6 18,5 0,0 Endocrine -
fam83fa 1646,5 702,2 266,8 154,7 5,7 Endocrine -
FBLN1 1349,3 69,8 658,2 1,5 7,6 Endocrine -
fev 16239,0 687,0 8412,6 58,9 198,4 Endocrine -
fez1 2691,0 3292,5 1803,9 8,4 22,0 Endocrine -
flot1b 3979,5 4629,3 1322,9 108,5 53,0 Endocrine -
flrt3 5208,5 906,4 2826,3 132,4 304,1 Endocrine -
fndc4b 1885,5 1156,7 39,3 15,4 4,2 Endocrine -
fndc5b 2562,5 1589,4 1132,1 1,8 45,9 Endocrine -
fryb 2666,3 806,4 2751,4 45,9 174,7 Endocrine -
fstl4 609,4 309,8 1244,9 4,1 0,0 Endocrine -
fut8a 1999,0 876,3 1688,7 22,2 231,3 Endocrine -
fyna 1678,2 797,7 982,5 16,8 54,4 Endocrine -
gabra2a 1166,4 6,0 328,2 1,5 0,0 Endocrine -
gabrb1 935,4 1,9 1069,5 22,8 6,2 Endocrine -
galnt16 2623,4 918,9 682,9 6,0 4,9 Endocrine -
gch1 1795,6 1785,2 1621,8 211,3 9,1 Endocrine -
gdf6a 5590,3 4531,6 6243,1 76,0 39,4 Endocrine -
gdi1 5722,8 6560,2 6130,0 705,8 63,1 Endocrine -
gfra3 9805,8 6,5 590,4 12,2 178,6 Endocrine -
ghrhrb 24,2 434,8 1104,6 27,6 0,0 Endocrine -
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glrbb 1308,8 1131,5 1617,7 11,8 57,2 Endocrine -
glsa 1002,8 880,3 385,5 15,6 76,0 Endocrine -
gnai2b 5567,9 4985,1 1434,4 66,4 110,2 Endocrine -
gnao1a 3149,2 3334,6 2133,9 29,2 67,1 Endocrine -
gnao1b 3150,5 3865,4 1490,1 52,7 34,1 Endocrine -
gnb5a 307,1 923,2 1156,9 5,4 6,5 Endocrine -
gnb5b 1255,7 1667,3 525,4 4,5 0,0 Endocrine -
gng13b 2071,7 2347,4 530,8 80,7 9,1 Endocrine -
gpc1a 2297,1 7184,6 8131,9 12,3 48,5 Endocrine -
gpc6a 250,2 1272,6 1082,7 0,5 139,2 Endocrine -
gpd1b 10226,7 8143,9 4040,9 323,9 660,7 Endocrine -
gpm6aa 4694,3 3693,1 2706,3 24,9 9,8 Endocrine -
gpr137bb 1039,9 6414,3 780,0 57,3 148,6 Endocrine -
gpr158a 1127,2 2312,1 31,9 1,6 0,0 Endocrine -
gpr186 192,4 5,8 1128,2 0,3 0,0 Endocrine -
gpr22a 4295,7 7566,7 686,9 45,3 139,5 Endocrine -
gpt2l 17890,3 38313,2 2244,9 75,5 581,0 Endocrine -
gpx3 61231,4 32432,4 9161,7 129,4 4692,8 Endocrine -
gria1a 1791,7 282,2 39,6 21,5 49,9 Endocrine -
gria2b 7115,1 3504,4 789,8 39,1 39,2 Endocrine -
gria4a 1313,6 843,6 993,3 5,1 9,1 Endocrine -
gria4b 1615,1 822,2 58,7 2,6 9,0 Endocrine -
grid1a 1428,7 2351,0 684,2 10,1 10,7 Endocrine -
grid1b 3690,3 1587,7 42,0 5,0 11,4 Endocrine -
GRIK2 832,1 1155,9 3275,0 12,7 7,3 Endocrine -
hhla2a.2 778,5 1697,2 937,5 9,8 28,4 Endocrine -
hmgcra 475,3 2296,9 224,3 102,9 44,5 Endocrine -
hprt1l 723,1 444,3 1020,6 12,8 9,7 Endocrine -
hrh2b 6508,0 2871,5 151,2 18,9 76,7 Endocrine -
hrh3 1206,0 1079,9 238,0 5,6 14,6 Endocrine -
hs3st3b1b 5224,4 8253,5 4179,5 680,8 59,3 Endocrine -
hsd17b12a 1474,1 1074,1 1063,4 45,2 4,1 Endocrine -
hspa4l 1826,2 1366,7 1819,0 10,5 36,9 Endocrine -
igfbp2b 2216,8 3410,0 1230,2 21,2 55,5 Endocrine -
il11ra 4120,7 3628,1 3120,9 111,7 432,6 Endocrine -
impdh1a 744,3 1095,3 907,6 1,9 3,2 Endocrine -
inpp4b 235,3 603,0 1168,9 7,0 22,7 Endocrine -
insm1a 4462,3 2355,9 9094,5 179,4 17,1 Endocrine -
insm1b 1796,4 1563,9 1238,0 35,1 8,1 Endocrine -
irf2bpl 6674,8 6147,7 5813,7 848,3 94,4 Endocrine -
irs2a 4908,4 1227,9 3318,7 93,3 378,9 Endocrine -
isl1 7091,0 12062,4 19012,2 59,3 67,4 Endocrine -
itga1 431,2 44,3 1185,8 5,4 25,7 Endocrine -
itga6a 1662,3 816,3 159,1 12,3 5,8 Endocrine -
itm2ca 5526,4 4985,5 3224,3 16,4 9,0 Endocrine -
itm2cb 2628,5 214,3 2554,8 160,8 59,4 Endocrine -
jagn1a 486,8 1278,1 945,0 10,7 3,3 Endocrine -
jam3b 2948,2 1587,8 1388,9 99,1 26,7 Endocrine -
kcnc1a 2293,8 1040,8 1504,4 24,5 6,5 Endocrine -
kcnc4 1652,8 757,1 853,8 1,3 11,4 Endocrine -
kcnd3 301,9 499,2 1172,2 4,7 3,3 Endocrine -
kcnh6a 1921,2 340,2 787,8 42,6 4,9 Endocrine -
kcnip1b 791,1 5,0 1962,5 117,8 2,5 Endocrine -
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kcnip3b 2002,2 1193,5 523,3 71,9 66,6 Endocrine -
kcnj11 454,2 2673,0 584,4 17,9 65,1 Endocrine -
kcnj19a 2183,0 8494,2 410,8 7,9 55,3 Endocrine -
kcnj19b 4388,1 3361,7 2521,6 152,8 26,9 Endocrine -
kcnk9 1477,7 806,2 1164,3 3,6 2,5 Endocrine -
kcnn3 1692,7 597,7 1335,2 10,0 78,1 Endocrine -
kctd8 794,5 1055,1 858,4 14,2 7,5 Endocrine -
kdm7ab 3873,1 4439,3 6092,3 579,9 307,9 Endocrine -
kiaa1549la 1255,7 1697,9 1647,8 18,2 98,9 Endocrine -
kif5bb 4135,2 5568,1 3765,5 151,0 634,8 Endocrine -
kl 1137,3 16,3 8299,2 0,7 61,8 Endocrine -
klf7a 842,7 1656,1 647,7 17,2 71,7 Endocrine -
kremen1 1748,9 240,2 663,2 0,5 18,6 Endocrine -
lepr 6664,2 3203,0 1699,6 245,1 219,8 Endocrine -
lgi2a 4936,3 1654,2 193,1 0,2 127,0 Endocrine -
lhfpl3 2021,0 863,1 1153,4 31,7 4,1 Endocrine -
lin7a 1196,9 1345,0 1139,0 17,0 2,5 Endocrine -
lmo1 1847,9 2318,7 1919,7 1,2 7,0 Endocrine -
LO017739.1 665,9 903,4 1264,9 1,5 6,5 Endocrine -
LO018188.1 409,6 374,2 1305,1 107,0 13,0 Endocrine -
lrfn4a 2296,3 1923,3 1717,7 16,1 30,9 Endocrine -
lrrc4ba 3709,1 1454,1 729,2 3,4 29,4 Endocrine -
LRRC75A 1032,1 458,3 449,8 11,6 25,4 Endocrine -
lrrn1 3469,4 824,6 4035,9 227,4 8,1 Endocrine -
lrrn3b 308,5 91,8 1172,3 1,3 0,0 Endocrine -
luzp2 1158,6 18,9 844,0 10,8 8,6 Endocrine -
MANEAL 1138,4 391,1 630,2 10,5 6,5 Endocrine -
map2 5365,5 3254,8 2798,4 20,3 34,5 Endocrine -
map7d2b 2248,4 1507,6 1179,5 5,9 23,5 Endocrine -
mapk4 2519,5 854,8 4101,5 21,3 56,3 Endocrine -
mapk8ip3 4210,9 2007,3 1490,0 39,1 50,1 Endocrine -
mast1b 1754,6 2099,5 539,1 8,8 6,5 Endocrine -
mc5ra 129,9 1116,7 4188,0 0,9 4,9 Endocrine -
meis1a 2211,4 3991,9 67,6 64,6 231,3 Endocrine -
mical3a 1200,5 702,3 813,5 73,0 78,0 Endocrine -
mllt11 356,4 3417,3 3701,9 18,3 13,6 Endocrine -
mmp11b 1383,2 1287,9 227,7 5,5 0,0 Endocrine -
mnx1 2595,1 4825,3 45,0 8,6 343,7 Endocrine -
mtmr1a 1067,5 912,1 887,2 71,7 7,4 Endocrine -
myo3b 1247,6 379,7 513,8 26,8 70,3 Endocrine -
myo5aa 1896,4 1029,1 642,5 10,6 16,3 Endocrine -
myt1b 1091,5 800,6 408,3 7,6 8,1 Endocrine -
nalcn 3566,3 3307,4 3464,5 15,5 65,7 Endocrine -
nav2b 3665,9 1827,6 2005,4 17,5 226,4 Endocrine -
ncam1a 702,8 135,1 1004,7 4,6 54,2 Endocrine -
ncam1b 998,8 1607,5 506,1 2,9 5,4 Endocrine -
nckap5l 1153,9 571,4 403,1 44,1 0,0 Endocrine -
ndrg4 1439,1 1904,2 1691,0 3,8 12,7 Endocrine -
nell2a 252,2 3769,7 1705,3 0,8 0,0 Endocrine -
neo1b 1009,5 624,3 426,3 30,6 4,1 Endocrine -
neurod1 55043,8 31981,4 19794,5 215,9 373,9 Endocrine -
nexmifb 1296,1 1972,4 659,1 51,1 53,2 Endocrine -
nfasca 4272,1 3944,2 1234,3 213,5 81,2 Endocrine -
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nhsl2 789,5 242,4 1263,6 31,8 14,8 Endocrine -
nmnat2 1768,3 2400,1 2833,2 13,3 19,7 Endocrine -
nova2 812,2 384,7 1240,9 23,7 29,3 Endocrine -
npas4a 8011,6 1182,0 10074,8 45,8 14,7 Endocrine -
npffr1l3 25,3 1578,4 311,4 1,5 0,0 Endocrine -
npr1a 4065,4 230,9 2561,8 167,6 20,3 Endocrine -
nptx1l 1406,9 414,7 10,3 36,8 9,0 Endocrine -
nrip2 3360,8 1131,5 75,6 74,7 67,4 Endocrine -
nrsn1 4204,9 4235,7 3173,9 44,9 17,2 Endocrine -
nrxn1a 6827,6 4259,7 5808,5 13,6 36,0 Endocrine -
nrxn3a 1004,6 35,5 1252,3 10,4 7,5 Endocrine -
nsfa 3101,0 2548,0 6593,2 10,3 29,4 Endocrine -
nsg2 7334,1 4172,7 2358,6 111,6 55,0 Endocrine -
ntrk3b 1219,5 2112,7 56,0 21,5 2,5 Endocrine -
olfm1b 22292,1 16012,7 9466,5 69,7 124,0 Endocrine -
oprd1b 890,4 3,8 4386,2 7,9 28,5 Endocrine -
oprk1 2863,7 2338,3 1300,6 2,5 21,1 Endocrine -
osbp2 1902,2 1679,5 158,6 12,9 0,0 Endocrine -
osgin2 1595,0 502,9 1950,7 3,4 7,4 Endocrine -
pacsin1a 1553,8 804,2 708,2 6,2 4,9 Endocrine -
palm1a 80,8 427,9 1138,9 2,3 18,7 Endocrine -
palm1b 621,5 1396,0 574,3 16,9 70,5 Endocrine -
pax6b 18264,3 14624,1 30380,7 100,1 103,7 Endocrine -
pcdh15b 1207,4 1429,1 48,9 17,0 6,5 Endocrine -
pcdh20 1834,5 2119,2 656,6 49,8 5,4 Endocrine -
pcloa 3531,3 1834,4 3582,3 42,4 17,6 Endocrine -
pclob 1194,6 831,2 1403,5 23,2 16,1 Endocrine -
pcnxl2 589,6 1009,3 263,0 73,1 12,7 Endocrine -
pcp4a 852,6 1452,6 581,0 6,2 16,1 Endocrine -
pcsk1 33776,7 89403,6 8955,9 26,2 350,4 Endocrine -
pcsk1nl 26052,6 24221,9 22939,4 174,8 358,9 Endocrine -
pcxb 38928,1 23444,4 869,8 5,3 82,4 Endocrine -
pde4bb 1097,3 366,0 275,2 2,5 10,5 Endocrine -
pde4cb 402,9 1586,0 150,4 12,2 42,6 Endocrine -
pdyn 554,9 5,8 2342,4 5,8 6,6 Endocrine -
pgr 867,7 22,1 1293,3 22,7 6,2 Endocrine -
phgdh 1574,4 4085,1 1736,0 30,5 391,9 Endocrine -
phyhipla 2158,6 2009,0 2057,8 12,6 8,1 Endocrine -
pik3ip1 6720,1 10914,8 5095,4 685,2 93,8 Endocrine -
pitpnab 2091,5 1566,2 980,1 4,9 22,7 Endocrine -
plekhg5a 1367,9 1124,2 299,3 13,8 54,9 Endocrine -
plppr5b 2014,0 3289,9 791,0 4,4 12,3 Endocrine -
ppp3ca 827,5 1669,9 1985,4 6,0 31,1 Endocrine -
prickle2a 356,8 357,1 1220,8 40,6 5,7 Endocrine -
prkar1b 1712,1 1502,7 1877,6 12,4 53,2 Endocrine -
prkcea 2803,2 2720,1 2781,0 219,0 118,6 Endocrine -
prlra 5713,9 11470,6 7809,4 665,0 20,7 Endocrine -
prokr1a 2313,7 1147,3 249,2 5,6 80,9 Endocrine -
prune2 1260,5 708,5 672,6 63,8 0,0 Endocrine -
ptger3 408,0 2308,3 3628,8 30,7 44,3 Endocrine -
ptgs2a 125,1 37,9 8018,0 38,3 25,6 Endocrine -
ptn 18354,2 12996,6 515,8 27,6 161,6 Endocrine -
ptpn20 1744,9 1026,2 791,0 50,1 23,4 Endocrine -
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ptprdb 1992,5 1089,0 402,0 12,9 27,5 Endocrine -
ptprn2 1506,4 1855,0 1955,4 12,6 10,9 Endocrine -
ptprna 8502,4 3931,5 4498,2 131,4 928,5 Endocrine -
ptprnb 9457,5 10428,1 3069,5 31,3 60,5 Endocrine -
ptprua 812,9 2172,8 54,9 195,2 4,1 Endocrine -
qpct 1652,3 1596,2 937,8 5,4 11,4 Endocrine -
rab3c 78,2 2515,0 792,6 11,6 33,2 Endocrine -
rab3da 1824,4 1397,1 3470,1 7,8 295,1 Endocrine -
rab3db 1268,6 7,9 10041,2 194,1 63,7 Endocrine -
rai1 1038,9 579,0 281,2 66,0 13,8 Endocrine -
rapgef4 4024,4 2419,4 1712,2 27,0 13,9 Endocrine -
rassf2a 1091,5 358,8 609,7 38,0 53,1 Endocrine -
rcan2 3026,0 6758,0 1123,2 11,4 18,9 Endocrine -
rcan3 1547,9 497,1 1990,8 20,0 18,0 Endocrine -
renbp 3241,8 1017,0 448,7 8,3 187,7 Endocrine -
ret 8341,0 4611,2 1997,9 89,6 26,1 Endocrine -
rfx2 2916,7 1662,3 1613,8 299,1 65,8 Endocrine -
rfx6 3409,6 2035,2 1723,2 9,2 37,1 Endocrine -
rgs16 4817,8 8344,6 316,1 29,1 72,1 Endocrine -
rgs3a 6615,1 5028,4 6100,7 86,4 139,1 Endocrine -
rgs3b 1766,7 505,6 220,2 19,0 36,3 Endocrine -
rgs4 10664,1 2783,8 197,1 453,1 91,0 Endocrine -
rgs5a 132834,4 136957,5 18952,0 1469,9 1043,2 Endocrine -
rgs8 1691,6 3078,1 414,8 13,4 24,3 Endocrine -
rims2a 10474,8 16521,9 2795,9 83,4 61,4 Endocrine -
rims4 1058,9 836,6 571,6 1,0 4,9 Endocrine -
rnasekb 5194,6 13159,1 5830,6 444,1 953,5 Endocrine -
rnf130 4375,0 2373,7 4883,8 214,2 518,2 Endocrine -
rnf145a 2760,3 1534,0 1332,8 13,5 7,5 Endocrine -
RNF157 1244,6 854,2 826,1 1,4 0,0 Endocrine -
robo3 1550,2 1633,2 674,8 52,0 182,1 Endocrine -
rprmb 2826,0 5898,6 3370,6 52,5 27,6 Endocrine -
rps6ka1 4217,2 3378,7 3275,5 111,9 43,9 Endocrine -
rtn1b 2487,2 8145,0 7888,0 30,9 108,6 Endocrine -
rtn4rl2b 2389,2 17191,2 323,2 58,2 87,1 Endocrine -
runx1t1 1172,2 275,4 576,6 6,9 6,5 Endocrine -
rxfp3 1499,5 2202,1 445,8 16,4 9,8 Endocrine -
scdb 3361,9 4139,9 4161,2 27,0 19,6 Endocrine -
scg2b 8878,2 17782,6 3286,7 95,2 38,4 Endocrine -
scg3 82967,3 153053,3 77077,8 1391,8 703,8 Endocrine -
scg5 23909,0 30267,1 13266,8 218,0 148,2 Endocrine -
scg5 2502,9 2352,2 1786,9 21,3 20,4 Endocrine -
scgn 30225,3 64803,6 16607,7 545,9 384,4 Endocrine -
scin 4078,0 910,9 2722,4 3,0 248,6 Endocrine -
scinlb 24356,2 28,4 3515,6 265,3 441,4 Endocrine -
scn3b 1363,7 891,2 570,5 5,4 4,9 Endocrine -
sept5a 777,5 2189,1 632,3 16,4 13,8 Endocrine -
sept9b 1733,9 2207,9 2384,9 14,4 227,8 Endocrine -
serpina10a 4331,1 3969,6 2962,6 10,5 122,7 Endocrine -
sesn3 18373,9 12501,1 14110,5 290,0 1654,1 Endocrine -
sgpp1 1468,0 325,0 200,0 15,0 89,8 Endocrine -
sgsm1a 3722,6 5127,6 1012,0 19,5 134,1 Endocrine -
sgtb 1426,7 1244,3 1471,2 75,7 183,9 Endocrine -
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sh3bp5b 1482,4 316,2 504,4 6,0 10,6 Endocrine -
sh3gl2a 9082,7 7024,3 3753,3 40,8 14,7 Endocrine -
sh3glb2b 2152,8 2351,9 2577,3 168,0 11,2 Endocrine -
shisa4 1869,8 1636,4 1275,6 148,2 41,9 Endocrine -
shisal1a 1557,9 1692,5 639,6 19,1 58,3 Endocrine -
si:ch211-106h4.9 2033,3 849,3 14,7 16,4 8,2 Endocrine -
si:ch211-10a23.2 973,3 858,5 1217,7 10,6 31,5 Endocrine -
si:ch211-113g11.6 7760,4 2844,6 2498,6 8,4 22,1 Endocrine -
si:ch211-133n4.4 1825,0 2454,3 1869,0 10,3 2,5 Endocrine -
si:ch211-137a8.4 1195,0 313,2 117,2 28,9 8,1 Endocrine -
si:ch211-181d7.3 1235,6 18,4 708,4 5,2 7,4 Endocrine -
si:ch211-195b13.1 10752,5 3433,8 1638,6 308,0 72,2 Endocrine -
si:ch211-237l4.6 4843,3 7957,2 5495,9 92,4 161,6 Endocrine -
si:ch211-242e8.1 1691,2 459,3 992,0 5,9 0,0 Endocrine -
si:ch211-253p2.2 834,7 1201,6 52,7 83,6 0,0 Endocrine -
si:ch211-255i3.4 2603,3 3121,1 971,8 121,3 140,9 Endocrine -
si:ch73-119p20.1 1686,3 906,1 2133,1 1,5 7,4 Endocrine -
si:ch73-287m6.1 2538,5 2456,2 1204,8 1,7 6,5 Endocrine -
si:ch73-288o11.5 5885,2 1003,1 51,6 82,1 55,2 Endocrine -
si:ch73-335m24.5 930,6 1624,8 1230,3 32,4 1,3 Endocrine -
si:dkey-110c1.10 1855,0 1510,7 1094,5 202,9 14,1 Endocrine -
si:dkey-110c1.7 2506,3 1149,2 1116,6 3,7 160,4 Endocrine -
si:dkey-153k10.9 9504,7 13531,0 3976,7 143,9 314,2 Endocrine -
si:dkey-183i3.9 1865,9 894,2 50,4 9,2 2,5 Endocrine -
si:dkey-201i24.6 718,7 808,4 2091,8 17,5 17,5 Endocrine -
si:dkey-238c7.16 119,3 804,9 1568,6 5,6 2,6 Endocrine -
si:dkey-253d23.4 1128,7 1080,3 386,3 21,9 68,9 Endocrine -
si:dkey-40m6.8 1105,1 672,1 614,3 22,7 13,4 Endocrine -
si:dkey-81l17.6 226,1 639,6 1133,4 36,2 4,1 Endocrine -
si:dkey-91m11.5 1303,4 248,3 1769,0 24,8 49,2 Endocrine -
si:dkeyp-14d3.1 1328,1 2,3 448,9 0,7 0,0 Endocrine -
sipa1l2 1257,7 907,6 482,8 47,5 37,3 Endocrine -
slc12a7b 1173,0 495,7 1538,4 102,6 57,2 Endocrine -
slc16a9b 5772,8 1685,8 1481,9 128,5 82,4 Endocrine -
slc18a2 2691,8 1639,8 43,6 0,3 9,9 Endocrine -
slc25a25b 1735,6 1516,3 315,7 102,0 132,3 Endocrine -
slc25a6 2059,6 1388,9 1034,4 14,7 142,1 Endocrine -
slc30a2 4437,5 8632,9 126,9 12,0 36,5 Endocrine -
SLC35G1 2402,6 1748,9 835,3 194,8 37,5 Endocrine -
slc35g2a 3392,4 2661,1 4891,7 29,5 47,5 Endocrine -
slc43a2a 912,4 641,1 5722,4 23,0 40,8 Endocrine -
slc43a2b 15413,2 13296,2 3231,1 420,1 101,8 Endocrine -
slc6a11b 218,7 5,4 1474,0 0,4 9,7 Endocrine -
slc6a17 484,2 1177,2 5129,3 17,2 55,3 Endocrine -
slc7a4 910,7 1047,6 1782,3 15,1 10,1 Endocrine -
slc9a7 1133,5 739,5 753,0 70,7 17,0 Endocrine -
slco5a1a 3937,9 1508,6 952,9 6,7 25,1 Endocrine -
slit2 1558,0 217,9 772,8 67,1 101,8 Endocrine -
smarcd3a 1694,6 859,2 552,1 2,0 4,3 Endocrine -
snap25a 10189,3 5956,1 9878,4 82,4 192,7 Endocrine -
SNAP91 (1 of many) 2856,9 3137,2 2248,9 26,9 9,8 Endocrine -
sncgb 2280,4 1903,5 100,3 1,2 7,4 Endocrine -
snx10a 14,1 1820,0 2042,0 25,5 11,6 Endocrine -
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SORCS3 1074,3 516,2 18,6 2,3 5,0 Endocrine -
spata22 1920,0 2471,6 1084,9 120,6 52,7 Endocrine -
spon1b 782,4 22791,7 4990,1 414,2 191,3 Endocrine -
sprn2 1737,8 665,5 154,1 4,0 2,5 Endocrine -
spsb4a 731,6 562,4 1034,9 140,0 11,5 Endocrine -
st6gal2a 1220,9 358,1 875,5 45,4 6,6 Endocrine -
stat5a 1366,2 1725,5 1285,9 70,2 214,9 Endocrine -
stk17a 918,9 780,4 1559,5 10,4 82,1 Endocrine -
stmn2a 1532,7 1654,0 248,6 7,6 6,5 Endocrine -
stx12l 1223,5 584,4 1161,9 6,5 2,5 Endocrine -
stx1b 2755,7 2183,6 2317,0 20,6 12,0 Endocrine -
stxbp1a 5298,2 3913,9 3863,0 13,4 68,1 Endocrine -
stxbp5a 2738,0 1420,5 6874,3 36,4 125,9 Endocrine -
stxbp5l 1122,3 320,2 735,7 3,7 7,4 Endocrine -
sv2a 4440,9 2989,1 433,4 20,7 50,9 Endocrine -
sv2bb 3702,4 3,0 1918,2 12,0 13,2 Endocrine -
sybu 8363,3 367,3 2998,3 0,2 64,6 Endocrine -
syngr3b 4664,9 4507,7 5964,9 49,4 59,1 Endocrine -
sypa 411,4 1018,1 1041,1 65,7 2,5 Endocrine -
syt11a 5203,7 4027,8 6897,0 46,0 19,6 Endocrine -
syt14a 579,9 1054,8 742,6 2,9 0,0 Endocrine -
syt1a 6541,3 6062,2 6579,9 136,3 83,9 Endocrine -
syt4 12739,1 2642,2 14570,6 13,0 97,2 Endocrine -
tanc2a 6578,7 8749,3 6988,8 324,1 87,2 Endocrine -
TENM3 321,9 27,5 1070,9 32,2 2,5 Endocrine -
tfeb 1194,6 1720,5 605,8 180,3 50,2 Endocrine -
thsd7ba 1399,5 80,3 593,7 1,7 4,9 Endocrine -
tle2a 543,5 259,6 1251,9 21,9 64,0 Endocrine -
tmem106bb 1321,8 1037,8 757,7 65,6 103,3 Endocrine -
tmem145 2269,4 750,7 379,7 22,1 20,1 Endocrine -
tmem178b 629,2 1112,9 1054,7 26,9 96,9 Endocrine -
tmem35 2325,6 4026,7 3225,6 42,0 16,6 Endocrine -
tmem59l 2194,2 1800,5 2495,9 17,5 56,3 Endocrine -
tmem63c 4332,7 1820,9 4638,4 581,2 7,4 Endocrine -
tnc 2931,2 1189,9 10645,4 5,1 9,8 Endocrine -
tnfaip2a 2244,6 1620,2 3272,2 48,4 20,5 Endocrine -
tox 7194,8 4264,5 9093,9 39,0 26,1 Endocrine -
trim2b 325,2 207,3 1644,1 31,0 87,6 Endocrine -
trmt9b 2092,2 39,0 732,2 18,3 2,5 Endocrine -
tshz2 704,4 635,8 1257,8 88,7 1,6 Endocrine -
tspan7b 16184,7 12888,8 11789,7 121,8 111,1 Endocrine -
ttll10 3266,5 2132,1 4390,2 309,5 138,5 Endocrine -
ugcg 1518,9 1008,9 1024,6 59,3 123,7 Endocrine -
ulk1b 1797,7 770,5 841,7 32,3 105,5 Endocrine -
unc80 1016,0 948,9 956,1 4,7 7,5 Endocrine -
ush1c 609,6 63,8 2066,5 3,2 0,0 Endocrine -
uts1 32,9 3308,4 3533,7 9,6 0,0 Endocrine -
vamp1 1642,9 3207,1 2629,9 246,1 12,3 Endocrine -
vamp2 2460,9 1989,9 2769,3 19,1 12,8 Endocrine -
vat1 5973,6 4971,3 7311,4 44,9 152,5 Endocrine -
vat1l 262,6 1158,3 567,1 9,0 0,0 Endocrine -
vcla 709,6 1536,6 151,8 11,3 16,2 Endocrine -
vil1 2639,7 2996,0 33,3 91,4 17,8 Endocrine -
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vill 3828,7 774,2 0,3 13,6 6,5 Endocrine -
vwa5b2 18012,7 9067,8 8773,0 29,1 136,4 Endocrine -
wdfy3 1244,2 889,3 2307,6 34,5 195,0 Endocrine -
XKR4 1924,4 716,7 1123,9 6,2 4,9 Endocrine -
ywhag1 367,8 1281,0 511,7 9,4 123,8 Endocrine -
zbtb16a 605,1 1000,8 2158,2 163,8 71,2 Endocrine -
zcchc24 1172,9 295,9 203,5 19,8 13,3 Endocrine -
zgc:101731 1014,5 1450,8 649,1 190,2 2,6 Endocrine -
zgc:122979 2237,2 515,5 869,0 18,7 21,8 Endocrine -
zgc:153031 1023,7 1248,1 1541,0 70,7 4,9 Endocrine -
zgc:153704 1842,5 521,0 19,9 8,0 0,0 Endocrine -
zgc:171566 936,5 2152,7 1424,5 13,2 8,5 Endocrine -
zgc:194578 1207,7 658,4 437,1 119,3 12,2 Endocrine -
zgc:194678 1454,7 2793,1 88,2 4,3 2,5 Endocrine -
zgc:194990 540,5 4396,2 27,5 15,5 27,2 Endocrine -
zgc:92658 2396,3 3,5 489,0 0,0 2,5 Endocrine -
znrf1 942,2 1504,7 567,4 107,3 13,0 Endocrine -
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Set of signicative marker genes (pvalue adjusted <= 0.1) identied for all cell types based




Gene Pct.Cluster Pct.Others Avg_LogFC Pval_Adjusted Cluster
gcga 1 0,992 3,9922223746 9.99988867182683e-321 Alpha
gcgb 0,995 0,98 3,9742613696 9.99988867182683e-321 Alpha
pnoca 0,995 0,806 3,0534211386 9.99988867182683e-321 Alpha
npb 0,985 0,189 2,4564321914 9.99988867182683e-321 Alpha
pcp4a 0,896 0,231 1,1966969441 9.99988867182683e-321 Alpha
rgcc 0,62 0,068 1,1632647947 9.99988867182683e-321 Alpha
cfap58 0,683 0,046 0,7541059995 9.99988867182683e-321 Alpha
ak5l 0,642 0,056 0,6053846592 9.99988867182683e-321 Alpha
scinlb 0,642 0,103 0,4966394895 5,7069477676218E-247 Alpha
slc7a2 0,819 0,208 0,6617015782 8,8597729150749E-235 Alpha
olfm1b 0,989 0,727 0,8660939351 1,5163030057432E-223 Alpha
rgs4 0,604 0,11 0,4772948987 2,0333582841976E-198 Alpha
krt15 0,791 0,259 0,8256715789 2,9108325815209E-185 Alpha
bckdk 0,837 0,335 0,7642668853 6,6955364353264E-181 Alpha
tdh 0,536 0,116 0,9419574269 2,2734725027731E-156 Alpha
fev 0,911 0,429 0,7335422041 1,9544854835083E-155 Alpha
cntnap2a 0,62 0,161 0,4068948778 9,9027964959245E-142 Alpha
pkib 0,51 0,108 0,3056064614 1,0801809105089E-138 Alpha
pcxb 0,521 0,134 0,3394822113 2,2232418133087E-114 Alpha
gpd1b 0,804 0,465 0,3484684325 8,38063064501721E-57 Alpha
slc43a2b 0,811 0,516 0,324188032 2,20355707856382E-40 Alpha
ssr3 0,871 0,662 0,3116076241 3,36828241783608E-40 Alpha
ins 1 0,998 3,0457515849 9.99988867182683e-321 Beta
ndufa4l2a 0,939 0,161 1,1661070909 9.99988867182683e-321 Beta
cxcl14 0,87 0,244 1,0010330525 9.99988867182683e-321 Beta
mnx1 0,59 0,091 0,5168111414 9.99988867182683e-321 Beta
krt8 0,821 0,375 0,4118310248 4,7446617919164E-227 Beta
herpud1 0,595 0,176 0,5831301573 7,7531270355501E-214 Beta
ctsla 0,819 0,429 0,5363587426 1,428575886763E-182 Beta
gstp1 0,581 0,186 0,4207569673 6,623216798577E-170 Beta
rims2b 0,518 0,15 0,4512205264 2,0873731324191E-159 Beta
tcima 0,663 0,272 0,3648225482 5,1900121217159E-157 Beta
zfand2a 0,647 0,264 0,4427341148 1,5902128664272E-142 Beta
tagln3b 0,796 0,477 0,4791217862 6,4134397476433E-139 Beta
hsp90b1 0,879 0,654 0,5730491216 3,2900829318446E-138 Beta
hspa5 0,97 0,878 0,5770665963 5,5363673399933E-136 Beta
tspan36 0,53 0,208 0,3252240741 6,9829036510921E-121 Beta
pim3 0,707 0,413 0,4658207084 9,4951094030096E-108 Beta
mknk2b 0,775 0,477 0,3641803261 4,19122690363861E-98 Beta
ctsd 0,63 0,341 0,4073548477 2,9246825093755E-95 Beta
tp53inp1 0,542 0,258 0,29972038 5,26338333841936E-86 Beta
syngr2b 0,614 0,324 0,2985894556 1,37142391962322E-81 Beta
zgc:153981 0,542 0,264 0,2904604035 6,05504214494373E-80 Beta
cebpd 0,63 0,34 0,3127547445 5,05354266800697E-77 Beta
si:ch211-260e23.9 0,562 0,316 0,3630309118 7,25445734223115E-69 Beta
uts1 0,616 0,36 0,4081044475 2,90007756724264E-65 Beta
fkbp4 0,764 0,483 0,3225404347 3,60582328985037E-61 Beta
calr 0,81 0,633 0,3098398402 1,24890582656971E-59 Beta
cbx7a 0,8 0,554 0,3894188718 7,67561813219104E-59 Beta
hspd1 0,742 0,499 0,2576995669 3,5726034924776E-58 Beta
sqstm1 0,64 0,424 0,3593469259 2,48524260191634E-55 Beta
manf 0,639 0,447 0,2860978785 1,58375049883526E-47 Beta
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sst2 0,991 0,989 3,884100018 9.99988867182683e-321 Delta1.2
sst1.2 0,99 0,987 3,4429698023 9.99988867182683e-321 Delta1.2
zgc:195023 0,957 0,105 2,242272583 9.99988867182683e-321 Delta1.2
jun 0,986 0,68 2,1294358632 9.99988867182683e-321 Delta1.2
cldni 0,94 0,099 2,1009597854 9.99988867182683e-321 Delta1.2
nmba 0,937 0,345 2,0241965602 9.99988867182683e-321 Delta1.2
kctd12.2 0,968 0,138 2,0092972494 9.99988867182683e-321 Delta1.2
map2k6 0,968 0,274 1,9615129098 9.99988867182683e-321 Delta1.2
fabp6 0,929 0,091 1,8567017861 9.99988867182683e-321 Delta1.2
si:ch211-195b15.8 0,868 0,106 1,6281827914 9.99988867182683e-321 Delta1.2
pitpnaa 0,914 0,146 1,6052440566 9.99988867182683e-321 Delta1.2
serpinh1b 0,827 0,341 1,4187821777 9.99988867182683e-321 Delta1.2
ccl20b 0,795 0,067 1,2886570223 9.99988867182683e-321 Delta1.2
slc7a7 0,813 0,09 1,2278603428 9.99988867182683e-321 Delta1.2
mdkb 0,824 0,054 1,2191732422 9.99988867182683e-321 Delta1.2
ier2b 0,822 0,308 1,1196915724 9.99988867182683e-321 Delta1.2
dhrs1 0,841 0,425 1,0897615832 9.99988867182683e-321 Delta1.2
ifitm5 0,749 0,031 1,0890340406 9.99988867182683e-321 Delta1.2
slc3a2a 0,846 0,527 1,0883897748 9.99988867182683e-321 Delta1.2
carhsp1 0,827 0,209 1,0543883077 9.99988867182683e-321 Delta1.2
alcamb 0,9 0,542 1,0293041578 9.99988867182683e-321 Delta1.2
gulp1b 0,75 0,039 1,0286438235 9.99988867182683e-321 Delta1.2
hopx 0,761 0,124 1,00744725 9.99988867182683e-321 Delta1.2
mrap2a 0,708 0,039 0,8825116519 9.99988867182683e-321 Delta1.2
olfm2a 0,632 0,031 0,8371611041 9.99988867182683e-321 Delta1.2
marcksl1b 0,587 0,07 0,8015057669 9.99988867182683e-321 Delta1.2
oaz1a 0,975 0,927 0,7861686976 9.99988867182683e-321 Delta1.2
oaz2a 0,799 0,362 0,7857090967 9.99988867182683e-321 Delta1.2
sesn1 0,908 0,653 0,7508903891 9.99988867182683e-321 Delta1.2
slc26a3.2 0,624 0,039 0,7417819507 9.99988867182683e-321 Delta1.2
map1ab 0,635 0,115 0,7354795562 9.99988867182683e-321 Delta1.2
kl 0,632 0,057 0,7325813457 9.99988867182683e-321 Delta1.2
slmapb 0,569 0,039 0,7081592868 9.99988867182683e-321 Delta1.2
rab3db 0,682 0,143 0,7006097037 9.99988867182683e-321 Delta1.2
anxa11a 0,624 0,132 0,693570985 9.99988867182683e-321 Delta1.2
ppp1r1b 0,515 0,024 0,6466681054 9.99988867182683e-321 Delta1.2
spock3 0,581 0,098 0,583371343 2,5349875547627E-303 Delta1.2
stxbp6 0,64 0,173 0,6313687882 7,4220880877898E-293 Delta1.2
phkg2 0,514 0,101 0,5419895279 1,9083098864295E-253 Delta1.2
junbb 0,846 0,585 0,7404483874 2,4480210733261E-241 Delta1.2
ier2a 0,645 0,264 0,9620217812 2,4322929701645E-232 Delta1.2
amd1 0,585 0,173 0,5882352011 1,0513357170062E-229 Delta1.2
si:ch211-131k2.3 0,571 0,172 1,0509175208 3,8888879446922E-225 Delta1.2
ppp1caa 0,667 0,292 0,5921906121 1,1263927400837E-217 Delta1.2
nt5dc2 0,581 0,181 0,525225098 1,3095310515855E-212 Delta1.2
oaz1b 0,939 0,878 0,453757496 1,0484057373548E-211 Delta1.2
BX548077.1 0,652 0,235 0,5657354234 4,3843837093807E-210 Delta1.2
nr4a1 0,845 0,592 0,6050968329 3,7282846578082E-207 Delta1.2
egr2a 0,553 0,157 0,7133580196 5,8953367497539E-206 Delta1.2
ckbb 0,71 0,359 0,5844794594 5,9297026617625E-205 Delta1.2
tob1a 0,811 0,589 0,6032691549 1,3301396138971E-198 Delta1.2
rasgef1ba 0,565 0,194 0,5181886617 2,8617976088577E-195 Delta1.2
ndrg3b 0,552 0,195 0,4958341249 7,5328208984055E-192 Delta1.2
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c2cd4a 0,955 0,91 0,516648926 8,5804997124468E-184 Delta1.2
mapk14a 0,532 0,18 0,442604873 1,0417275413136E-181 Delta1.2
syt4 0,655 0,35 0,5747066972 1,0934844272204E-175 Delta1.2
midn 0,598 0,276 0,5140169129 4,2298104001536E-162 Delta1.2
ppp6c 0,536 0,215 0,4581453692 5,5253476096817E-160 Delta1.2
fam107b 0,621 0,294 0,5185508089 1,4736026417449E-157 Delta1.2
ap3s2 0,691 0,427 0,5058688388 6,2181892308983E-156 Delta1.2
atf3 0,707 0,44 0,9394503623 1,0286809315307E-153 Delta1.2
ugp2b 0,519 0,215 0,4184550531 2,040516927324E-147 Delta1.2
fosb 0,603 0,292 0,5161366045 3,6553601129342E-142 Delta1.2
jund 0,595 0,29 0,4886736621 8,3990202091599E-142 Delta1.2
ubc 0,812 0,682 0,4849166656 1,8749767105906E-124 Delta1.2
srsf5a 0,855 0,752 0,4007805165 3,4711781886646E-121 Delta1.2
gabarapl2 0,784 0,615 0,3951574058 4,0875693958728E-116 Delta1.2
atpv0e2 0,68 0,461 0,3763132417 1,4631708826032E-109 Delta1.2
cd81a 0,537 0,272 0,3823933281 1,531171418262E-108 Delta1.2
uchl1 0,732 0,533 0,8219733077 1,0940035907321E-106 Delta1.2
hmgb1b 0,653 0,424 0,3955330224 1,1080143190755E-105 Delta1.2
ier5 0,547 0,298 0,418279689 9,2492212886545E-102 Delta1.2
mcl1a 0,988 0,967 0,4972126934 4,7943981951077E-101 Delta1.2
pax6b 0,794 0,64 0,378077821 1,81939150984608E-96 Delta1.2
sdcbp2 0,714 0,538 0,3533926635 4,16441228146524E-95 Delta1.2
hnrnpa0b 0,857 0,78 0,3893749005 1,17327312239255E-88 Delta1.2
fxyd1 0,977 0,969 0,2734805519 3,04409147273386E-86 Delta1.2
sat1a.2 0,783 0,691 0,5059847377 4,94018947893218E-86 Delta1.2
skp1 0,838 0,753 0,3171958055 1,17034451749601E-81 Delta1.2
pkma 0,597 0,395 0,3355623678 3,05473574686707E-81 Delta1.2
dynll1 0,94 0,907 0,3174744246 3,69070965609798E-81 Delta1.2
pim1 0,82 0,701 0,3810148458 4,53198373453945E-79 Delta1.2
dusp2 0,897 0,816 0,3066843611 1,61860031075438E-77 Delta1.2
rsrp1 0,972 0,949 0,3756942211 5,29686249851609E-75 Delta1.2
isl1 0,652 0,454 0,2920681246 6,50564719871874E-75 Delta1.2
zgc:77650 0,757 0,671 0,3842274221 7,82097305192622E-75 Delta1.2
rtn1b 0,647 0,495 0,3631985835 5,12700470555677E-74 Delta1.2
sik1 0,562 0,348 0,4001582039 1,02380742900437E-73 Delta1.2
mapkapk2a 0,566 0,361 0,3307679437 5,49842418697407E-73 Delta1.2
csnk1a1 0,66 0,511 0,3397982364 8,9848998763007E-72 Delta1.2
tspan7 0,713 0,579 0,3087215642 7,44677088318959E-71 Delta1.2
ndrg3a 0,644 0,485 0,3197898804 2,09993208553601E-70 Delta1.2
camk2n1a 0,875 0,786 0,3112179595 2,43279263050367E-70 Delta1.2
gstm.1 0,607 0,425 0,3434264897 6,08026175897209E-70 Delta1.2
calm2a.1 0,843 0,783 0,2873495823 2,75016840777609E-69 Delta1.2
cd164 0,673 0,479 0,3260009191 8,27064042843123E-69 Delta1.2
h3f3c 0,729 0,588 0,2730143493 1,19655889856968E-65 Delta1.2
vegfaa 0,517 0,315 0,2798905872 3,75279803310632E-64 Delta1.2
hist2h2l 0,908 0,847 0,3037062913 1,1889902417973E-62 Delta1.2
aplp2 0,507 0,313 0,3018592026 1,27626212026922E-62 Delta1.2
laptm4a 0,733 0,622 0,3111452754 1,7679583233776E-62 Delta1.2
pcbp2 0,593 0,424 0,2897448763 6,39565387575862E-60 Delta1.2
ip6k2a 0,515 0,329 0,2949809892 6,41859562664971E-60 Delta1.2
cope 0,749 0,663 0,2849060401 7,90695492248558E-60 Delta1.2
itm2ba 0,907 0,877 0,2546386333 6,15449684041699E-59 Delta1.2
arl6ip1 0,729 0,624 0,2875897815 2,45128178376801E-58 Delta1.2
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selenot2 0,518 0,34 0,2823135635 5,39981286094768E-58 Delta1.2
ufc1 0,617 0,465 0,2737575134 5,71389238114984E-54 Delta1.2
laptm4b 0,706 0,628 0,5265036432 3,79207196794046E-53 Delta1.2
si:dkey-4p15.3 0,742 0,589 0,5592280276 5,63636865285829E-48 Delta1.2
mcl1b 0,748 0,634 0,2980754592 3,68295037415755E-47 Delta1.2
oser1 0,589 0,458 0,3065560571 1,72026288511628E-44 Delta1.2
hsp70.2 0,992 0,989 0,3063200658 5,97538504441614E-43 Delta1.2
cdc42 0,57 0,464 0,2573007839 9,25745483356273E-35 Delta1.2
hspa4a 0,738 0,672 0,3455517382 9,22602346083941E-32 Delta1.2
hsp70.1 0,915 0,963 0,7236476333 2,6506780776101E-24 Delta1.2
sst1.1 0,999 0,992 4,186508731 9.99988867182683e-321 Delta1.1
sox11b 0,723 0,09 1,2762714636 9.99988867182683e-321 Delta1.1
srd5a2b 0,909 0,378 1,2853012252 1,8544905700256E-273 Delta1.1
nme2b.1 0,993 0,98 0,6668912929 6,6663339786322E-229 Delta1.1
hsp90ab1 0,999 0,992 0,6189268929 1,6734783284758E-218 Delta1.1
scgn 0,98 0,904 0,9651982297 3,8133192038658E-214 Delta1.1
faua 0,997 0,988 0,587356555 7,9891703966758E-201 Delta1.1
RPL41 0,999 0,999 0,6407766916 1,0095284333163E-198 Delta1.1
uba52 0,977 0,951 0,6647058601 1,1484229127645E-196 Delta1.1
zgc:114188 0,989 0,98 0,6222493354 6,1613185908957E-196 Delta1.1
eef1g 0,992 0,963 0,6102363184 2,8721374236198E-185 Delta1.1
btf3 0,962 0,913 0,6904776868 9,4536287837855E-174 Delta1.1
tpt1 1 0,997 0,4416527455 3,0916017423532E-163 Delta1.1
ppiaa 0,979 0,959 0,5696166628 7,0298565156052E-162 Delta1.1
meis1b 0,524 0,13 0,5867672003 7,4654834928525E-162 Delta1.1
eef1a1l1 1 0,999 0,4904196956 1,1982804700987E-158 Delta1.1
eef1b2 0,993 0,984 0,4892854922 3,254196669307E-157 Delta1.1
scg3 0,996 0,976 0,6399573983 2,3652905395389E-154 Delta1.1
mtbl 0,698 0,309 0,8176060731 1,6599803565462E-153 Delta1.1
rsl24d1 0,957 0,896 0,6425284896 1,3697965944893E-151 Delta1.1
atp5mc3b 0,956 0,867 0,6302341643 1,4716209311961E-150 Delta1.1
aldocb 0,929 0,813 0,7201929558 2,3213884348176E-148 Delta1.1
ptmab 0,936 0,77 0,7557448116 8,1185754009283E-145 Delta1.1
eif3f 0,969 0,917 0,6056674193 6,4528927289105E-142 Delta1.1
mt-atp6 0,992 0,981 0,6252546551 3,4583839941209E-138 Delta1.1
b2ml 0,945 0,828 0,6599143793 1,726757595325E-136 Delta1.1
tmsb4x 0,976 0,909 0,5767598606 1,4584385905767E-135 Delta1.1
rack1 0,993 0,986 0,471074484 2,4536269376443E-131 Delta1.1
pcsk1nl 0,96 0,925 0,6827020606 6,9420427816288E-128 Delta1.1
ppiab 0,996 0,987 0,4084906435 3,3364631204259E-119 Delta1.1
eef1db 0,936 0,862 0,6007588612 3,6361532388609E-117 Delta1.1
ndufa4l 0,883 0,711 0,618617543 4,042364057748E-117 Delta1.1
fabp3 0,799 0,549 0,6346931273 2,6270465693315E-107 Delta1.1
cfl1 0,964 0,93 0,4841951158 7,2093879012358E-107 Delta1.1
mibp2 0,885 0,726 0,6010971616 9,7870016964269E-107 Delta1.1
gck 0,84 0,619 0,7560787329 1,2300615101371E-103 Delta1.1
rtn4rl2b 0,574 0,228 0,7322824574 1,5420437359228E-103 Delta1.1
cox6b2 0,938 0,86 0,5270498659 3,9116838489364E-103 Delta1.1
sec61g 0,989 0,991 0,3947582506 9,6572102077875E-102 Delta1.1
g6pcb 0,543 0,211 1,0006157712 5,1948830165968E-101 Delta1.1
rims2a 0,772 0,514 0,7796868892 6,9027724605319E-100 Delta1.1
SLC5A10 0,515 0,193 0,5626128144 1,19671745138187E-96 Delta1.1
rrad 0,529 0,199 0,7147978045 6,80672746144623E-96 Delta1.1
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gtpbp4 0,83 0,668 0,6003109547 4,89728317163348E-94 Delta1.1
ybx1 0,966 0,927 0,4946906104 8,19407386333051E-91 Delta1.1
cox4i1 0,894 0,847 0,4592027955 4,13084279105441E-79 Delta1.1
mt-nd5 0,735 0,51 0,5772171015 2,78101546572265E-78 Delta1.1
pfkfb4b 0,555 0,274 0,6551644894 7,01499488420036E-77 Delta1.1
nsa2 0,744 0,522 0,5320870238 4,94752782813291E-76 Delta1.1
mgst3b 0,917 0,862 0,5931175015 9,55658306656575E-70 Delta1.1
ppt1 0,708 0,47 0,5278149387 9,98424756086194E-69 Delta1.1
eif3i 0,804 0,658 0,4690499235 2,49769304575603E-65 Delta1.1
hsp70l 1 0,999 0,4012444267 1,38890533063583E-63 Delta1.1
cpe 0,765 0,639 0,5445207476 2,7181161817986E-62 Delta1.1
hspa8 0,981 0,972 0,3505474812 4,33767115655552E-62 Delta1.1
serbp1a 0,84 0,729 0,4442943566 9,8481413964913E-60 Delta1.1
atp5l 0,869 0,817 0,4207426514 4,51813081937697E-59 Delta1.1
xbp1 0,928 0,903 0,5005595886 3,87523191612703E-58 Delta1.1
zgc:175264 0,515 0,265 0,4131500358 5,76327835288916E-58 Delta1.1
cox7b 0,869 0,82 0,3988117148 1,30228606657936E-57 Delta1.1
emc10 0,727 0,56 0,5002147402 3,42926593850052E-56 Delta1.1
eif4a1b 0,818 0,678 0,439152072 7,34439273176059E-56 Delta1.1
hmgn6 0,902 0,841 0,4151905366 5,02435530599691E-53 Delta1.1
ola1 0,708 0,53 0,4612235959 5,1930643027313E-52 Delta1.1
fth1a 0,942 0,925 0,3575825369 2,50047793237434E-51 Delta1.1
eif3m 0,826 0,735 0,4347521206 3,61472670302496E-51 Delta1.1
zgc:56493 0,925 0,912 0,3266874 4,79791944144688E-51 Delta1.1
cited4a 0,855 0,773 0,4896200209 7,16606312828823E-51 Delta1.1
cox5aa 0,827 0,769 0,4120887246 4,1072144494011E-50 Delta1.1
tpi1b 0,78 0,657 0,4125643366 8,47666335237439E-50 Delta1.1
COX5B 0,851 0,779 0,3880314448 9,73764298844409E-50 Delta1.1
alcama 0,688 0,526 0,4222564321 8,30164480446044E-46 Delta1.1
pno1 0,743 0,618 0,4043098363 1,89525879719582E-45 Delta1.1
epcam 0,59 0,347 0,5383528642 5,20356360454771E-44 Delta1.1
nop53 0,634 0,45 0,4320316713 5,29848808272669E-44 Delta1.1
ier3ip1 0,784 0,713 0,4228622484 7,67277482490181E-43 Delta1.1
atp5pd 0,898 0,88 0,3355250678 2,32466767488508E-42 Delta1.1
actb1 0,89 0,811 0,590061228 5,58508200146979E-42 Delta1.1
cd63 0,847 0,809 0,3932408732 3,31659186641468E-41 Delta1.1
eif5a 0,891 0,866 0,3466948794 9,82547620313025E-41 Delta1.1
ube2al 0,55 0,357 0,4026784968 3,71311785039036E-40 Delta1.1
adh5 0,532 0,334 0,3583156989 7,55977221800288E-40 Delta1.1
nap1l1 0,615 0,442 0,41236586 8,76992644969263E-40 Delta1.1
cox7c 0,818 0,737 0,3444033248 2,21066558788012E-39 Delta1.1
cited4b 0,751 0,636 0,628152354 3,67582060197941E-39 Delta1.1
eif3g 0,709 0,573 0,3890784213 2,80776788545778E-38 Delta1.1
atp5f1d 0,791 0,72 0,3663405639 1,62362550946771E-37 Delta1.1
pcbd1 0,783 0,712 0,3502177931 1,64066844202639E-36 Delta1.1
atp5pb 0,772 0,686 0,3796678296 1,04820453083691E-35 Delta1.1
lygl1 0,515 0,328 0,4141780592 9,37696571931914E-35 Delta1.1
ubb 0,95 0,949 0,3465822084 5,12334193179055E-34 Delta1.1
pnrc2 0,973 0,975 0,251398258 1,07720118692973E-33 Delta1.1
eif3ba 0,631 0,485 0,3913733724 2,68434828030993E-33 Delta1.1
cirbpb 0,92 0,905 0,3191796542 2,29420690072292E-32 Delta1.1
eif3ha 0,609 0,449 0,3499689036 3,34762208396659E-32 Delta1.1
eif5a2 0,74 0,628 0,3709552753 5,22089863080853E-32 Delta1.1
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fkbp5 0,698 0,594 0,4165436044 1,09837003958107E-30 Delta1.1
ndufs4 0,529 0,364 0,3448233207 3,31856744125821E-30 Delta1.1
tmed7 0,712 0,636 0,4031240564 9,8671896136901E-30 Delta1.1
atp5pf 0,786 0,716 0,3376497835 4,1057014444937E-29 Delta1.1
cox6c 0,765 0,705 0,3312366195 2,07297684582399E-27 Delta1.1
SMIM30 0,643 0,524 0,3483336983 2,52013686639179E-27 Delta1.1
npc2 0,767 0,696 0,3494736718 3,31568454009388E-27 Delta1.1
pam 0,507 0,35 0,3147524885 2,86960052076289E-25 Delta1.1
gabarapb 0,855 0,846 0,2784421262 3,78212125825896E-25 Delta1.1
higd1a 0,839 0,833 0,3188180855 3,78743567790449E-25 Delta1.1
CABZ01079011.1 0,615 0,469 0,3105606931 6,52665625761616E-24 Delta1.1
cox6a1 0,806 0,776 0,2879356112 1,94625588959139E-23 Delta1.1
ppib 0,814 0,787 0,3065060231 2,96140059517276E-23 Delta1.1
eif2s3 0,625 0,513 0,3401246978 3,893790398148E-23 Delta1.1
DNAJA4 0,858 0,823 0,3617605974 7,1120414544018E-23 Delta1.1
si:ch211-222l21.1 0,863 0,838 0,2742552246 7,49850100979604E-23 Delta1.1
si:ch211-202a12.4 0,96 0,966 0,300127994 2,16598145045166E-21 Delta1.1
capns1b 0,823 0,807 0,2964594601 4,19481653404272E-21 Delta1.1
pitpnbl 0,583 0,47 0,3406401746 7,18902330091054E-21 Delta1.1
eif3d 0,588 0,471 0,3222759812 2,69020594924282E-20 Delta1.1
cox7a2a 0,674 0,609 0,3096231078 9,69120814802723E-20 Delta1.1
hsp70.3 0,991 0,992 0,2592799528 1,20086133167912E-19 Delta1.1
atp5meb 0,866 0,852 0,2580648776 1,23833408676916E-19 Delta1.1
atp5f1c 0,727 0,671 0,27548721 2,7616983516582E-19 Delta1.1
zgc:158852 0,668 0,576 0,3139762095 1,09513965363577E-18 Delta1.1
atp1b1a 0,796 0,759 0,2751352555 1,48785431305161E-18 Delta1.1
cox5ab 0,736 0,699 0,2850146436 2,9088799507855E-18 Delta1.1
mid1ip1b 0,606 0,483 0,4724534578 5,17457666303466E-18 Delta1.1
hmgn2 0,627 0,545 0,285786604 2,60511376494984E-17 Delta1.1
spcs3 0,673 0,618 0,2780459103 1,06952877358014E-16 Delta1.1
eif2s1b 0,525 0,416 0,2855359423 1,12140354914218E-16 Delta1.1
chchd2 0,747 0,705 0,2700760027 1,81121760150586E-16 Delta1.1
tomm20b 0,554 0,439 0,2640923441 1,87826975596512E-16 Delta1.1
pfdn5 0,548 0,435 0,2717067991 4,2481855986793E-16 Delta1.1
atf4a 0,546 0,427 0,2773417844 4,76525844743586E-16 Delta1.1
fam46c 0,558 0,448 0,3587027685 5,02139820492712E-16 Delta1.1
slc25a3b 0,702 0,639 0,2876295791 8,13168723541345E-16 Delta1.1
atp5f1e 0,747 0,689 0,2671578463 1,09703074828693E-15 Delta1.1
pabpc1a 0,783 0,751 0,2770096791 1,45352415427817E-15 Delta1.1
bzw1b 0,617 0,51 0,3585626677 9,14431992939935E-15 Delta1.1
atox1 0,668 0,609 0,2811898087 2,26741393788252E-14 Delta1.1
edf1 0,783 0,741 0,2504939476 2,65831707979864E-14 Delta1.1
ucp2 0,771 0,718 0,3594449775 2,7587981490473E-14 Delta1.1
ifrd1 0,751 0,706 0,3499966353 3,21517598738126E-14 Delta1.1
dnajb1b 0,981 0,987 0,2531123134 4,72117001530474E-14 Delta1.1
ndufa1 0,609 0,53 0,2842262284 5,69085139085367E-14 Delta1.1
slc1a4 0,692 0,631 0,2727282133 6,26238263709773E-14 Delta1.1
mdh2 0,747 0,712 0,2758623311 6,70941288501487E-14 Delta1.1
ndufb8 0,664 0,605 0,2529634081 6,73730073782619E-14 Delta1.1
eif3ea 0,655 0,609 0,2921727943 1,24054682654065E-13 Delta1.1
cct7 0,654 0,609 0,2776202718 1,25364876340145E-13 Delta1.1
hmgb2a 0,727 0,645 0,2745686193 1,32041039668302E-13 Delta1.1
eif4a1a 0,529 0,421 0,2651685483 2,4851989988212E-13 Delta1.1
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fkbp2 0,646 0,577 0,2515535033 3,10132741488388E-13 Delta1.1
vdac2 0,626 0,549 0,2667595919 5,23039295044665E-13 Delta1.1
jpt1b 0,52 0,425 0,2808935579 1,00809816288888E-12 Delta1.1
vdac3 0,765 0,731 0,2733331403 3,46278905911303E-12 Delta1.1
atp5po 0,704 0,672 0,2618667924 4,55708078720781E-12 Delta1.1
khdrbs1a 0,807 0,797 0,2690077658 4,79935820424846E-12 Delta1.1
eif1axb 0,665 0,615 0,2506688391 6,30221000871283E-12 Delta1.1
cct6a 0,536 0,444 0,2698799437 7,53430172598287E-12 Delta1.1
h2afx1 0,95 0,964 0,283487183 1,86206308447378E-11 Delta1.1
zgc:162944 0,696 0,644 0,265882131 4,49704670565151E-11 Delta1.1
ell2 0,646 0,607 0,2522304863 8,18086761598099E-11 Delta1.1
sh3gl2a 0,579 0,515 0,2788895424 1,18290074125351E-10 Delta1.1
ndufb10 0,614 0,558 0,2510625115 3,55131700447821E-09 Delta1.1
atp6ap2 0,704 0,698 0,2892024021 4,17460596834873E-09 Delta1.1
zgc:158463 0,684 0,653 0,2533343329 4,7958661796307E-09 Delta1.1
fam46ba 0,59 0,549 0,3176164035 0,000000019 Delta1.1
myl12.1 0,682 0,669 0,2719730851 6,35567367219967E-08 Delta1.1
adm2a 0,611 0,605 0,2920914845 0,0001429431 Delta1.1
hspb1 0,605 0,573 0,4674046328 0,0009154574 Delta1.1
mboat4 0,758 0,004 1,7376400207 9.99988867182683e-321 Epsilon
plcxd3 0,703 0,043 1,131205266 3,7845011753036E-174 Epsilon
acsl1a 0,56 0,048 1,0312424754 8,81541116409968E-101 Epsilon
mlnl 1 0,229 5,7352373604 1,3794428137748E-100 Epsilon
brd1b 0,604 0,058 1,0408315523 6,49114664404083E-99 Epsilon
abhd17c 0,637 0,077 1,0012490949 1,38805892744594E-85 Epsilon
si:rp71-17i16.6 0,857 0,219 1,4292022326 6,17471856440673E-66 Epsilon
ghrl 1 0,966 4,6585683428 7,25439536830945E-56 Epsilon
ndrg2 0,692 0,191 0,9586179315 3,34269178295137E-41 Epsilon
asah1b 0,67 0,212 1,1806034446 1,95369435363391E-34 Epsilon
zgc:92818 0,901 0,714 1,0467636982 1,64978506142297E-24 Epsilon
ca6 0,516 0,147 0,6384668617 3,84573484880463E-22 Epsilon
plp1b 0,56 0,216 0,5938315476 2,23457348932627E-15 Epsilon
mt-cyb 0,989 0,99 0,4359051771 3,777167376015E-12 Epsilon
spry4 0,527 0,258 0,5540572431 1,3832960919365E-08 Epsilon
snap25a 0,725 0,606 0,6768997695 4,18306135918936E-07 Epsilon
gpx4a 0,626 0,49 0,661245991 0,0001234105 Epsilon
neurod1 0,659 0,564 0,5812035391 0,016414716 Epsilon
dynlrb1 0,681 0,623 0,3474299851 0,0706567628 Epsilon
ndufb9 0,56 0,434 0,4051691951 0,0915816999 Epsilon
dkk3b 0,828 0,214 2,1005364681 9.99988867182683e-321 Endocrine
rgs5a 0,803 0,158 1,9632503717 9.99988867182683e-321 Endocrine
egr4 0,765 0,098 1,7476977874 9.99988867182683e-321 Endocrine
ppdpfb 0,963 0,685 1,714522831 9.99988867182683e-321 Endocrine
scg5 0,923 0,088 1,5166076369 9.99988867182683e-321 Endocrine
nucb2b 0,888 0,203 1,429064657 9.99988867182683e-321 Endocrine
clu 0,894 0,272 1,2296846761 9.99988867182683e-321 Endocrine
chga 0,665 0,037 1,0626069643 9.99988867182683e-321 Endocrine
CABZ01073265.1 0,748 0,088 0,9932767295 9.99988867182683e-321 Endocrine
rnasekb 0,813 0,059 0,9869206608 9.99988867182683e-321 Endocrine
eno1a 0,767 0,069 0,9176268982 9.99988867182683e-321 Endocrine
gapdhs 0,975 0,551 0,7895745305 9.99988867182683e-321 Endocrine
lgals2a 0,702 0,094 0,7387337446 9.99988867182683e-321 Endocrine
calm1b 0,741 0,11 0,7265749688 9.99988867182683e-321 Endocrine
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vamp2 0,625 0,023 0,6937383357 2,0501620149612E-299 Endocrine
atp6v0cb 0,679 0,102 0,6669925994 3,4289587121972E-287 Endocrine
vat1 0,629 0,051 0,6204011486 9,5844938535978E-272 Endocrine
arl4ab 0,72 0,151 0,7600352444 7,0459935720932E-257 Endocrine
scg2b 0,584 0,039 0,7634752431 7,2329382345719E-252 Endocrine
cplx2l 0,596 0,046 0,6283599886 5,3667090261522E-250 Endocrine
vamp1 0,569 0,03 0,5787011872 1,066570670819E-247 Endocrine
atp6v1g1 0,753 0,23 0,6229517973 1,5319374892054E-244 Endocrine
tox 0,548 0,025 0,5797945354 5,6137354675393E-241 Endocrine
si:ch211-237l4.6 0,635 0,084 0,5611531194 2,5962505425054E-233 Endocrine
lysmd2 0,602 0,07 0,5614014803 3,2461501747633E-233 Endocrine
pbxip1b 0,71 0,193 0,7070399055 9,4707730750032E-229 Endocrine
syt1a 0,533 0,026 0,5347010479 3,4413580814582E-227 Endocrine
tspan7b 0,527 0,024 0,5328503983 1,0845734796185E-226 Endocrine
nsg2 0,53 0,03 0,7031034632 7,4487474417936E-224 Endocrine
sec11a 0,802 0,327 0,5658974951 6,2001477127917E-223 Endocrine
pdyn 0,516 0,036 1,4865746117 5,399173535341E-216 Endocrine
calm3a 0,901 0,419 0,6409466843 6,8412451297327E-213 Endocrine
pik3ip1 0,594 0,084 0,5699974543 1,6042527994828E-212 Endocrine
ptn 0,512 0,03 0,8423084891 5,6235885794934E-209 Endocrine
rnaseka 0,64 0,128 0,4988021993 7,2017743616944E-208 Endocrine
reep5 0,773 0,31 0,5522741221 7,1465373902567E-204 Endocrine
spcs2 0,707 0,237 0,5300037049 7,2167488908468E-198 Endocrine
rpl22l1 0,961 0,788 0,5320513697 4,1340248292849E-197 Endocrine
eef1a1a 0,478 0,024 0,4508272599 9,2151311778287E-193 Endocrine
si:dkey-13i19.8 0,806 0,321 0,5143461299 1,8914196243825E-189 Endocrine
ap1s2 0,464 0,022 0,45178185 5,5703159438825E-188 Endocrine
rab2a 0,772 0,291 0,5211128031 1,9353791775235E-187 Endocrine
tmem35 0,453 0,015 0,4914196459 2,39516942545E-187 Endocrine
atp6v1e1b 0,597 0,116 0,4696840469 1,8457123644732E-185 Endocrine
bhlhe41 0,499 0,048 0,4759953277 5,1125852048772E-185 Endocrine
stmn1b 0,46 0,027 0,7806169406 3,506775135016E-183 Endocrine
eef2l2 0,486 0,049 0,4652131873 6,0125005968128E-183 Endocrine
tusc3 0,511 0,06 0,4773694461 1,5691637775618E-182 Endocrine
sdf4 0,599 0,146 0,4991495091 3,0682700805698E-178 Endocrine
atcaya 0,43 0,011 0,4262579722 7,5265422615035E-177 Endocrine
si:ch211-133n4.4 0,434 0,015 0,4328120362 2,5471193740014E-175 Endocrine
zgc:92606 0,58 0,128 0,4710247556 5,1245787468012E-172 Endocrine
serpina10a 0,443 0,026 0,4331834319 7,4914953095212E-172 Endocrine
calm1a 0,881 0,43 0,5062775964 4,2211927781007E-166 Endocrine
tsc22d1 0,533 0,098 0,4359135511 2,9187967252053E-161 Endocrine
fam49bb 0,431 0,029 0,4119125969 4,5206685210682E-160 Endocrine
ufm1 0,592 0,165 0,4283917398 2,1125979146407E-159 Endocrine
rprmb 0,395 0,011 0,4294351514 1,6734142003389E-157 Endocrine
elocb 0,707 0,262 0,4207021367 8,0982349628881E-157 Endocrine
zgc:65894 0,403 0,016 0,4280410381 8,5730007024381E-156 Endocrine
hint1 0,746 0,34 0,4371512197 2,6694777167117E-155 Endocrine
tuba2 0,417 0,027 0,4395515616 5,6724560545953E-155 Endocrine
ctsf 0,536 0,117 0,4303512569 5,8863770606867E-154 Endocrine
rgs16 0,422 0,032 0,6261598299 7,6575081623306E-153 Endocrine
dnajb4 0,566 0,138 0,483966886 3,7322479972004E-149 Endocrine
spon1b 0,42 0,037 0,4591239965 9,6066748854772E-149 Endocrine
bnip3lb 0,505 0,094 0,3854894943 6,8071506865761E-148 Endocrine
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epdr1 0,386 0,015 0,3679751322 3,5365388689612E-147 Endocrine
prdx5 0,617 0,169 0,3960755165 5,5877269062528E-147 Endocrine
elovl1a 0,529 0,105 0,461275359 8,1182688874892E-147 Endocrine
atp5mc3a 0,699 0,295 0,4126539434 2,1502434128875E-145 Endocrine
cst3 0,944 0,654 0,7063579904 2,0147820792449E-144 Endocrine
tspan3a 0,685 0,237 0,4254198168 2,1773510182647E-144 Endocrine
ywhag2 0,381 0,021 0,3656870009 2,1713419712971E-140 Endocrine
gtf2h5 0,524 0,123 0,3873068682 1,0134662903019E-136 Endocrine
tuba1c 0,365 0,021 0,3881340522 1,1937639039844E-131 Endocrine
tspan13b 0,387 0,039 0,3407410088 1,2807685730518E-129 Endocrine
sec62 0,512 0,125 0,3720236325 2,3903618630064E-129 Endocrine
gpt2l 0,416 0,065 0,4915404627 3,7722025458953E-129 Endocrine
selenof 0,778 0,378 0,3712551856 3,8231789077235E-128 Endocrine
ap2s1 0,457 0,083 0,3420600873 6,8865907324381E-128 Endocrine
pfn2l 0,707 0,324 0,377916273 7,5077439348402E-128 Endocrine
tmbim4 0,607 0,2 0,3527405106 2,1237876273621E-127 Endocrine
fundc1 0,475 0,094 0,332994369 1,3540144573714E-126 Endocrine
ostc 0,606 0,226 0,3561691841 7,883813655303E-126 Endocrine
syngr3b 0,355 0,02 0,3401609539 1,6824523546767E-125 Endocrine
pdia6 0,496 0,124 0,379663889 2,1603506381035E-125 Endocrine
pyyb 0,375 0,039 1,1249678389 3,5108810082449E-125 Endocrine
apof 0,35 0,021 0,3739687312 5,6618452827563E-124 Endocrine
syt11a 0,332 0,013 0,3338640171 4,4063689841769E-122 Endocrine
ube2na 0,585 0,188 0,3104130329 3,0017234828289E-121 Endocrine
uqcc3 0,558 0,186 0,3542232881 2,2207349162749E-120 Endocrine
gng13b 0,331 0,015 0,3362829185 4,11671933572548E-119 Endocrine
pde6ha 0,33 0,015 0,7095437793 9,11446108859159E-119 Endocrine
slc35g2a 0,331 0,015 0,3413975217 5,2857947441367E-118 Endocrine
sub1a 0,755 0,341 0,3621281163 9,904786433669E-118 Endocrine
si:dkey-33c12.4 0,585 0,203 0,3464051313 1,3594004262768E-116 Endocrine
serinc1 0,478 0,118 0,3346779821 1,3631820352583E-116 Endocrine
si:dkey-81l17.6 0,327 0,015 0,3052620759 1,7789993944995E-116 Endocrine
si:ch211-199o1.2 0,346 0,027 0,4948988209 1,4305384249946E-115 Endocrine
tmed9 0,513 0,151 0,3332241569 6,0541587323305E-115 Endocrine
calr3b 0,461 0,102 0,331791293 9,6404215441221E-115 Endocrine
ube2v2 0,757 0,362 0,3367070981 2,0980970853376E-114 Endocrine
si:dkeyp-75h12.5 0,36 0,04 0,3665407536 7,4359166777202E-114 Endocrine
FP101882.1 0,343 0,029 0,3311042523 2,1801045667421E-113 Endocrine
anp32a 0,62 0,226 0,3341866218 7,1638860219446E-113 Endocrine
gng7 0,421 0,076 0,3030255015 7,2393861633786E-113 Endocrine
cox8a 0,834 0,406 0,3370163139 8,1258080323404E-113 Endocrine
dnajc5aa 0,322 0,017 0,2918753623 1,1080189640774E-112 Endocrine
map1lc3b 0,543 0,165 0,3145823559 1,3925214642247E-112 Endocrine
atp6v1h 0,382 0,054 0,3061094901 2,7168803230794E-112 Endocrine
sigmar1 0,423 0,085 0,2906146155 6,2904594655327E-112 Endocrine
elof1 0,569 0,188 0,3098808906 7,5171677602397E-112 Endocrine
rnf144ab 0,335 0,026 0,3298097863 9,11670003686508E-112 Endocrine
tmed3 0,331 0,025 0,3110490937 2,35922489261078E-111 Endocrine
trappc1 0,515 0,15 0,331872277 2,54792980493728E-111 Endocrine
grn1 0,36 0,045 0,4412459434 9,20030215083507E-111 Endocrine
sub1b 0,527 0,161 0,3188142745 6,3402464445829E-110 Endocrine
fkbp1aa 0,835 0,437 0,3543264476 1,5635598032797E-109 Endocrine
acbd7 0,333 0,025 0,2813642666 1,7357955865747E-108 Endocrine
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lin7a 0,297 0,01 0,3092679433 3,2700201334948E-106 Endocrine
med30 0,423 0,1 0,3079392892 1,0458109109573E-105 Endocrine
tefa 0,51 0,146 0,299498699 6,773908275373E-105 Endocrine
gstk1 0,597 0,219 0,314412568 4,0906931542101E-104 Endocrine
hmgb1a 0,844 0,463 0,3679671832 6,4671599683088E-104 Endocrine
fam32a 0,742 0,364 0,3083449144 4,2131458503987E-103 Endocrine
necap1 0,389 0,067 0,2653494332 4,314887570123E-103 Endocrine
cplx2 0,297 0,013 0,3033951269 6,0222433501695E-103 Endocrine
ppme1 0,414 0,091 0,2913303607 2,1984259613515E-102 Endocrine
oaz2b 0,289 0,011 0,2929263746 6,965222490789E-102 Endocrine
atp5mc1 0,861 0,531 0,2951245315 9,9202583667051E-102 Endocrine
sox4a.1 0,4 0,074 0,3189257832 3,66719366691111E-101 Endocrine
stk35 0,318 0,028 0,3160079552 5,8432205805545E-101 Endocrine
tcp11l2 0,322 0,032 0,2931748336 5,134249756774E-100 Endocrine
krtcap2 0,696 0,352 0,3018978333 1,01387122756925E-99 Endocrine
gb:bc139872 0,336 0,044 0,2819464322 9,68442341105481E-99 Endocrine
atp5mea 0,468 0,15 0,3046717919 1,75665426403051E-98 Endocrine
si:dkey-188i13.11 0,532 0,199 0,2892754799 4,97864807197451E-98 Endocrine
si:dkey-153k10.9 0,294 0,018 0,2855618582 7,5709192477802E-98 Endocrine
cnpy1 0,584 0,26 0,3332654465 2,7481865094996E-97 Endocrine
otulina.1 0,328 0,042 0,3136271031 3,35276985187093E-96 Endocrine
nrsn1 0,28 0,013 0,2565666151 4,93411500697093E-96 Endocrine
nsfa 0,284 0,014 0,2625339394 5,06860326475108E-96 Endocrine
si:ch211-196l7.4 0,843 0,515 0,3164756575 7,76097248068376E-96 Endocrine
paip2b 0,752 0,365 0,2907062667 1,61176482118143E-95 Endocrine
znrf1 0,295 0,023 0,2598138854 1,86046491382178E-95 Endocrine
selenom 0,356 0,063 0,2637685902 5,7489739405296E-95 Endocrine
calm2a 0,361 0,064 0,2763913662 1,00057988583283E-94 Endocrine
smim7 0,372 0,074 0,2500837867 1,27724254385755E-93 Endocrine
srpr 0,564 0,226 0,2794307071 1,51045265907397E-93 Endocrine
slc16a9b 0,279 0,015 0,2993027753 1,78685082011386E-93 Endocrine
glrx 0,656 0,286 0,2701630732 3,22720324947445E-93 Endocrine
si:ch211-255i3.4 0,285 0,018 0,2645420927 7,79858748351101E-93 Endocrine
bhlhe40 0,518 0,172 0,2559985936 2,32813944614507E-92 Endocrine
phyhiplb 0,267 0,01 0,2765284081 7,85458092358207E-92 Endocrine
dpp7 0,418 0,105 0,2660700089 4,87291939436171E-91 Endocrine
anapc16 0,468 0,149 0,2556719215 2,19366801676396E-90 Endocrine
rab1ab 0,561 0,219 0,2651962283 2,40281879261527E-90 Endocrine
crebzf 0,62 0,251 0,2669325481 2,81836528254606E-90 Endocrine
cwc25 0,424 0,117 2,8225107339 2,6080068957506E-89 Endocrine
si:ch73-1a9.3 0,796 0,385 0,2858612674 1,76298218717498E-88 Endocrine
lamtor2 0,404 0,101 0,2520296408 3,74426379567975E-88 Endocrine
large2 0,3 0,034 0,2599469452 1,70185241120116E-87 Endocrine
hepacam2 0,277 0,023 0,3352311917 5,17952788952738E-86 Endocrine
clta 0,466 0,149 0,2556883978 2,30461972201974E-85 Endocrine
mllt11 0,251 0,011 0,3074738102 1,52903836084635E-84 Endocrine
sdhc 0,595 0,262 0,2570365418 8,6288136944611E-84 Endocrine
ptp4a3 0,334 0,072 0,2567504842 9,94278435893196E-83 Endocrine
fam133b 0,579 0,275 0,2733882022 4,93746874321707E-82 Endocrine
dnajc1 0,518 0,224 0,2585978607 9,02157149886234E-81 Endocrine
dedd1 0,453 0,149 0,2610175025 4,40157665515387E-79 Endocrine
rab11ba 0,442 0,153 0,2565779738 2,14893001725024E-76 Endocrine
spcs1 0,731 0,458 0,280912815 1,05917476636482E-74 Endocrine
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gpx3 0,385 0,129 0,2610578438 5,03758937806654E-72 Endocrine
arrdc3a 0,302 0,061 0,2607545962 7,6519286569879E-71 Endocrine
pabpc1b 0,509 0,233 0,2559588206 6,76592296196229E-70 Endocrine
fosab 0,99 0,895 0,2889837902 2,44359815084663E-67 Endocrine
slc16a12b 0,252 0,037 0,2871807795 5,78949947606009E-67 Endocrine
calm2b 0,608 0,29 0,2691606303 1,81868606951738E-65 Endocrine
TPM1 (1 of many) 0,253 0,068 0,2683971932 1,87243483685644E-47 Endocrine
gadd45ga 0,339 0,143 0,4316751623 2,13791637163742E-44 Endocrine
nupr1 0,916 0,318 1,7840820229 1,1561174885165E-252 Endocrine
ponzr1 0,807 0,333 0,4115996631 1,7784351625359E-101 Endocrine
npm1a 0,807 0,381 0,4924225077 2,396403758034E-93 Endocrine
eef2b 0,951 0,77 0,4118810963 2,03704052936308E-67 Endocrine
rpl12 0,998 0,994 0,3266345536 2,12354215527814E-66 Endocrine
aldob 0,906 0,606 0,3705595969 2,84059484408985E-51 Endocrine
prdx4 0,911 0,683 0,3019215565 1,07830923168051E-49 Endocrine
pklr 0,725 0,378 0,2687534689 2,10705230638528E-46 Endocrine
anxa4 0,663 0,405 0,272882826 1,2841210511134E-14 Endocrine
tmsb1 0,998 0,792 0,9667243519 9.99988867182683e-321 Endocrine
pdx1 0,893 0,305 0,3398122405 3,6579523197094E-237 Endocrine
krt18 0,666 0,283 0,5948089191 1,1922587007788E-162 Endocrine
hsp90aa1.2 0,999 0,992 0,5061586714 2,6209608401995E-158 Endocrine
rpl13a 1 0,991 0,2731490625 1,1996239841683E-134 Endocrine
rpl5a 0,991 0,934 0,2951388364 4,1794641891832E-114 Endocrine
hspe1 0,96 0,804 0,3816453738 1,1337805444727E-113 Endocrine
rpl14 0,993 0,944 0,2691638148 5,4872322417004E-109 Endocrine
zgc:92066 0,901 0,745 0,2871577941 2,69482621817269E-64 Endocrine
rps27.1 0,999 0,997 0,6231980487 1,8508343723031E-250 Endocrine
b2m 0,991 0,964 1,0431018501 1,6812744946152E-238 Endocrine
slc25a5 1 0,993 0,6467302774 6,3317660537517E-237 Endocrine
mt-co1 0,999 0,99 0,7120631666 8,1101386031921E-236 Endocrine
naca 0,999 0,985 0,648370628 6,016368727571E-210 Endocrine
rpl29 0,981 0,967 0,6891681232 7,85681105121174E-200 Endocrine
mt-nd4 0,968 0,913 0,7773973519 2,1516106594218E-192 Endocrine
mt-nd1 0,937 0,781 0,8325265511 2,853502685913E-178 Endocrine
zgc:171772 1 0,996 0,5602750344 1,2597184284147E-171 Endocrine
rps21 0,993 0,978 0,6473282156 8,6019986307014E-170 Endocrine
mt-co2 1 0,999 0,4537950602 7,7386680264347E-133 Endocrine
mt-nd2 0,929 0,81 0,6140364695 6,247351118981E-113 Endocrine
romo1 0,92 0,818 0,5929272782 4,8848075334622E-104 Endocrine
selenow1 0,878 0,804 0,4831612516 5,27395821403322E-69 Endocrine
actb2 0,966 0,919 0,4403768298 3,45435165789356E-65 Endocrine
ccni 0,81 0,707 0,434060116 1,47143881061555E-52 Endocrine
mt-nd3 0,822 0,759 0,3995027305 6,68520502712465E-39 Endocrine
ran 0,882 0,836 0,2971869636 7,43927971007101E-28 Endocrine
cirbpa 0,834 0,835 0,2751191858 4,69836323268849E-15 Endocrine
h3f3b.1 0,621 0,528 0,2889228428 6,28723906848707E-15 Endocrine
zgc:162730 0,832 0,471 0,8755178587 9.99988867182683e-321 Endocrine
cebpb 0,675 0,293 0,8367961185 1,6509970509145E-213 Endocrine
btg2 0,936 0,795 0,4980649651 1,2483105258007E-183 Endocrine
nfkbiab 0,826 0,569 0,5038267119 1,4375131146645E-154 Endocrine
cox8b 0,537 0,226 0,3625294417 8,3623932812256E-123 Endocrine
mdh1aa 0,809 0,704 0,4209651599 3,1253236989972E-117 Endocrine
glula 0,535 0,241 0,3771465379 3,8759991984636E-117 Endocrine
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egr1 0,54 0,303 0,2854283676 1,58939008078539E-69 Endocrine
lgals2b 0,993 0,058 4,7354754106 9.99988867182683e-321 Ductal
zgc:193726 0,75 0,032 4,2141242589 9.99988867182683e-321 Ductal
phlda2 0,895 0,095 3,4806889093 9.99988867182683e-321 Ductal
si:dkey-96g2.1 0,963 0,012 3,1664138031 9.99988867182683e-321 Ductal
cnn2 0,902 0,032 2,8916973593 9.99988867182683e-321 Ductal
si:ch211-153b23.5 0,749 0,06 2,8830519446 9.99988867182683e-321 Ductal
cfl1l 0,682 0,136 2,6857546924 9.99988867182683e-321 Ductal
BX855618.1 0,531 0,014 2,6634639513 9.99988867182683e-321 Ductal
cldn15a 0,897 0,083 2,5784907482 9.99988867182683e-321 Ductal
cldnc 0,944 0,108 2,4290335256 9.99988867182683e-321 Ductal
cd9b 0,889 0,01 2,4280055355 9.99988867182683e-321 Ductal
tagln2 0,826 0,11 2,3766663984 9.99988867182683e-321 Ductal
si:ch73-335l21.4 0,801 0,029 2,3728117761 9.99988867182683e-321 Ductal
hbegfa 0,841 0,115 2,343787887 9.99988867182683e-321 Ductal
f3b 0,76 0,182 2,2504374158 9.99988867182683e-321 Ductal
zgc:158343 0,689 0,041 2,2406693142 9.99988867182683e-321 Ductal
elf3 0,842 0,045 2,228300206 9.99988867182683e-321 Ductal
s100a10b 0,911 0,259 2,2221787335 9.99988867182683e-321 Ductal
her9 0,674 0,065 2,1731175367 9.99988867182683e-321 Ductal
krt94 0,555 0,037 2,1645131086 9.99988867182683e-321 Ductal
ccl19a.1 0,749 0,024 2,162425685 9.99988867182683e-321 Ductal
cldn7b 0,782 0,037 2,1491790766 9.99988867182683e-321 Ductal
spint2 0,912 0,191 2,0748153091 9.99988867182683e-321 Ductal
gpx1b 0,767 0,032 2,0227309424 9.99988867182683e-321 Ductal
jdp2b 0,759 0,096 1,9969955534 9.99988867182683e-321 Ductal
fosl1a 0,821 0,266 1,9898756564 9.99988867182683e-321 Ductal
dusp5 0,738 0,101 1,9677255871 9.99988867182683e-321 Ductal
her6 0,651 0,096 1,9617304634 9.99988867182683e-321 Ductal
pfn1 0,867 0,204 1,9382429125 9.99988867182683e-321 Ductal
hmox1a 0,687 0,011 1,9085683513 9.99988867182683e-321 Ductal
ctgfa 0,629 0,007 1,9048457673 9.99988867182683e-321 Ductal
ftr82 0,803 0,012 1,8909585004 9.99988867182683e-321 Ductal
cdh1 0,817 0,055 1,8629659131 9.99988867182683e-321 Ductal
krt4 0,554 0,017 1,8312289849 9.99988867182683e-321 Ductal
zgc:64022 0,535 0,014 1,7355757031 9.99988867182683e-321 Ductal
fam213b 0,754 0,093 1,7097460621 9.99988867182683e-321 Ductal
hnrnpa0l.1 0,933 0,728 1,6963998256 9.99988867182683e-321 Ductal
rpz5 0,741 0,195 1,6884556923 9.99988867182683e-321 Ductal
efna1b 0,633 0,012 1,682879957 9.99988867182683e-321 Ductal
myl9b 0,783 0,136 1,6814837539 9.99988867182683e-321 Ductal
f11r.1 0,87 0,435 1,6783324327 9.99988867182683e-321 Ductal
sdc4 0,883 0,543 1,6767276117 9.99988867182683e-321 Ductal
btg1 0,984 0,901 1,6137830781 9.99988867182683e-321 Ductal
cyr61 0,648 0,071 1,5982111124 9.99988867182683e-321 Ductal
pdlim1 0,771 0,058 1,5944736504 9.99988867182683e-321 Ductal
mych 0,679 0,099 1,5788776086 9.99988867182683e-321 Ductal
krt91 0,515 0,013 1,5644332792 9.99988867182683e-321 Ductal
rassf7b 0,755 0,055 1,557165847 9.99988867182683e-321 Ductal
klf6a 0,691 0,077 1,5439882206 9.99988867182683e-321 Ductal
serpinb1 0,797 0,259 1,5370950831 9.99988867182683e-321 Ductal
tpm3 0,774 0,181 1,5295037621 9.99988867182683e-321 Ductal
cd74a 0,506 0,033 1,5198118171 9.99988867182683e-321 Ductal
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lxn 0,682 0,107 1,5095604005 9.99988867182683e-321 Ductal
arl5c 0,675 0,098 1,499078573 9.99988867182683e-321 Ductal
id2a 0,67 0,06 1,4943265354 9.99988867182683e-321 Ductal
zgc:198329 0,715 0,013 1,4939284651 9.99988867182683e-321 Ductal
selenop 0,723 0,165 1,4918272024 9.99988867182683e-321 Ductal
si:ch73-86n18.1 0,61 0,02 1,4896901333 9.99988867182683e-321 Ductal
ccl19b 0,587 0,005 1,4692936929 9.99988867182683e-321 Ductal
adh8b 0,722 0,127 1,4055643999 9.99988867182683e-321 Ductal
sgk1 0,654 0,059 1,3864609044 9.99988867182683e-321 Ductal
s100v2 0,682 0,016 1,3800799471 9.99988867182683e-321 Ductal
sb:cb1058 0,673 0,038 1,3634481629 9.99988867182683e-321 Ductal
cx30.3 0,595 0,005 1,2658810833 9.99988867182683e-321 Ductal
si:dkey-16l2.20 0,542 0,004 1,2260542925 9.99988867182683e-321 Ductal
cdh17 0,565 0,004 1,1298734399 9.99988867182683e-321 Ductal
zgc:92313 0,643 0,123 1,1176450549 9.99988867182683e-321 Ductal
trib3 0,593 0,095 1,1055040654 9.99988867182683e-321 Ductal
spint1a 0,607 0,051 1,0696087802 9.99988867182683e-321 Ductal
tspan35 0,52 0,023 1,0675943612 9.99988867182683e-321 Ductal
cbln17 0,529 0,05 1,0533991827 9.99988867182683e-321 Ductal
dhrs9 0,519 0,025 0,9832081984 9.99988867182683e-321 Ductal
perp 0,529 0,05 0,9636086566 9.99988867182683e-321 Ductal
zfp36l2 0,523 0,036 0,9570733954 9.99988867182683e-321 Ductal
lrrfip1a 0,547 0,096 0,9413287555 9,380158406709E-298 Ductal
pdzk1ip1 0,686 0,201 1,1730614663 1,637385677853E-294 Ductal
rhoab 0,651 0,174 1,3124018648 3,5379955806393E-293 Ductal
ecm1b 0,549 0,1 1,0748198863 1,4049974311381E-289 Ductal
prdx2 0,84 0,503 1,4831330549 8,1092596643588E-287 Ductal
si:dkey-180p18.9 0,509 0,085 0,8282826496 2,1170854479804E-280 Ductal
chac1 0,865 0,613 1,6346788648 5,9410172165703E-276 Ductal
tubb4b 0,894 0,713 1,243469769 4,2877190466417E-274 Ductal
gadd45bb 0,666 0,199 1,6315807611 4,4446972803214E-270 Ductal
eno3 0,715 0,272 1,2669325864 9,045599711595E-263 Ductal
eif1b 0,949 0,913 1,0128817639 6,8823557175272E-261 Ductal
tuba8l 0,697 0,26 1,2285265442 8,3983090157847E-256 Ductal
tpm4a 0,557 0,123 1,0925390855 2,2971957458881E-255 Ductal
zgc:109934 0,624 0,179 1,1079302887 3,2051504228094E-254 Ductal
socs3a 0,578 0,136 1,0083814648 4,7699790682418E-254 Ductal
maff 0,661 0,221 1,2352787771 4,1009068090584E-251 Ductal
jupa 0,518 0,104 0,8964654705 2,6407663531447E-250 Ductal
serinc2 0,585 0,148 0,9208009589 1,7909900864657E-249 Ductal
oclna 0,582 0,158 1,052390964 6,5287144311961E-235 Ductal
tob1b 0,854 0,713 1,2849434939 9,5243804108216E-230 Ductal
zfand5a 0,61 0,196 1,0599139002 5,0189446044514E-222 Ductal
cotl1 0,653 0,249 1,3306276575 3,8762195649406E-221 Ductal
mycb 0,623 0,211 1,1515498291 5,9144672288371E-212 Ductal
foxp4 0,682 0,293 1,140100816 2,6970654395154E-209 Ductal
ppp1r10 0,673 0,29 1,1812507539 1,5097546927301E-204 Ductal
glulb 0,606 0,208 1,0738370521 3,5365712919379E-204 Ductal
prelid3b 0,815 0,621 1,1954970066 1,1869114234491E-200 Ductal
dap1b 0,674 0,309 1,1213379331 7,1387799318622E-197 Ductal
alas1 0,51 0,14 0,9807181068 8,3736033396274E-195 Ductal
cox6a2 0,695 0,333 1,0890139052 1,967347322222E-191 Ductal
zgc:153867 0,818 0,68 1,0080534869 4,0429312699564E-191 Ductal
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gstr 0,705 0,369 1,0465478009 8,8054907307037E-187 Ductal
arg2 0,586 0,215 1,43459626 4,6569402001972E-185 Ductal
fosl2 0,711 0,377 1,1135518465 1,1038369441432E-183 Ductal
pfn2 0,79 0,582 0,9826442191 1,4563767132817E-182 Ductal
eif4ebp1 0,642 0,291 1,2838385771 1,6136604144782E-182 Ductal
brdt 0,544 0,172 0,8970994806 6,1707475996236E-182 Ductal
tspo 0,514 0,159 0,8534937787 6,2441006297341E-174 Ductal
brd2a 0,665 0,331 1,043449735 1,2322804036149E-172 Ductal
slc25a25a 0,582 0,23 1,0146334748 9,092000843631E-171 Ductal
atf4b 0,816 0,703 1,0099841937 2,1779982452018E-167 Ductal
cycsb 0,781 0,609 1,1293247095 6,9326946708985E-167 Ductal
slc25a55a 0,603 0,247 0,8982725226 8,9828252738925E-166 Ductal
nocta 0,662 0,353 1,0806893797 3,7890530402339E-155 Ductal
arpc2 0,656 0,383 0,870553623 2,8633023089315E-139 Ductal
cxcl20 0,552 0,233 0,9235134583 2,9239171081939E-136 Ductal
tmem176l.1 0,552 0,244 0,78595103 2,1599029321449E-131 Ductal
basp1 0,503 0,183 0,7874294043 8,9796796588714E-131 Ductal
ccng1 0,777 0,693 0,9763280539 2,5155947570895E-124 Ductal
itm2bb 0,531 0,228 0,7661944572 1,4209259752065E-123 Ductal
aldh9a1a.1 0,558 0,269 0,776183044 5,2679158073466E-123 Ductal
si:ch211-212k18.7 0,552 0,247 0,7373870038 1,5433435035443E-122 Ductal
elovl1b 0,694 0,482 0,7922756483 1,463546891886E-117 Ductal
ddit3 0,575 0,283 0,8862543198 7,6338873793322E-115 Ductal
ncl 0,655 0,418 0,8133575213 4,4373089889263E-114 Ductal
zgc:92027 0,504 0,224 0,6552795558 2,816148160499E-102 Ductal
ets2 0,551 0,291 0,818200236 7,9882009020166E-102 Ductal
uqcrb 0,666 0,516 0,6944564221 2,38026189151146E-90 Ductal
hnrnpa1b 0,599 0,385 0,6803705747 2,38129692215463E-83 Ductal
ip6k2b 0,667 0,533 0,8403093264 9,26594653259439E-83 Ductal
ak2 0,615 0,44 0,6978902403 1,07529159985629E-82 Ductal
atp5f1b 0,873 0,863 0,4962685557 7,2970273346929E-82 Ductal
pdia3 0,789 0,797 0,6133503977 6,45802012898519E-81 Ductal
arpc1a 0,538 0,309 0,6537319391 5,52845607076961E-80 Ductal
si:dkey-177p2.6 0,722 0,679 0,7904609467 6,63392488065705E-78 Ductal
ranbp1 0,597 0,419 0,6741677728 6,15228648039056E-75 Ductal
rca2.1 0,545 0,349 0,6912319459 1,18886381543151E-70 Ductal
ahsa1b 0,609 0,442 0,768989361 5,28549842472573E-69 Ductal
erh 0,792 0,79 0,5596520398 5,97394965366622E-69 Ductal
atp5if1a 0,598 0,458 0,6848116 2,39273296875626E-66 Ductal
arpc3 0,513 0,316 0,6418136455 6,27274414682996E-66 Ductal
psap 0,535 0,351 0,6160778581 3,32484072649068E-64 Ductal
bsg 0,738 0,699 0,5156538649 2,08635460669714E-62 Ductal
stip1 0,654 0,547 0,7730506273 4,40449399224995E-59 Ductal
zfand5b 0,586 0,457 0,7209892993 6,57266533697229E-56 Ductal
aldoaa 0,57 0,429 0,6049088831 3,52244585424201E-54 Ductal
hspbp1 0,746 0,675 0,7727691638 7,93516072550358E-53 Ductal
tsc22d3 0,569 0,425 0,6514068441 8,71128017814074E-52 Ductal
CCT2 0,546 0,41 0,5761055424 3,83418136808866E-50 Ductal
prdx6 0,541 0,405 0,5501181326 1,09684199070943E-48 Ductal
si:dkey-7j14.6 0,603 0,51 0,541308195 4,94954075723444E-47 Ductal
tcp1 0,555 0,434 0,5754282586 1,62461092984967E-46 Ductal
tomm5 0,574 0,461 0,5342121894 1,98983421308803E-45 Ductal
seta 0,565 0,449 0,539827659 3,71556945804348E-44 Ductal
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eif3k 0,565 0,458 0,5694568767 3,89596922381467E-43 Ductal
ndfip1 0,513 0,371 0,4940551571 1,5141515634233E-42 Ductal
psma1 0,529 0,398 0,5180329821 1,57381791857066E-42 Ductal
bag3 0,649 0,544 0,607121634 5,29410975951538E-38 Ductal
hnrnpabb 0,581 0,495 0,5374098869 6,09705317205249E-38 Ductal
cct3 0,575 0,498 0,4810451923 9,83080842086823E-37 Ductal
tuba8l4 0,614 0,554 0,5424480457 2,10763522635417E-36 Ductal
cct4 0,569 0,515 0,5334310122 1,007962804729E-35 Ductal
cnbpb 0,691 0,682 0,439481148 1,21999262879867E-35 Ductal
serf2 0,737 0,777 0,4121928176 1,0323266041155E-34 Ductal
atp5fa1 0,645 0,623 0,4781972776 4,32287754521286E-33 Ductal
rbm4.3 0,584 0,529 0,5228109799 9,96602237544173E-32 Ductal
atp5mf 0,616 0,619 0,5086287828 1,22570965471005E-29 Ductal
setb 0,523 0,446 0,4882508051 9,26238704679112E-28 Ductal
uqcrh 0,64 0,677 0,4135271915 8,34986517852917E-25 Ductal
cct5 0,567 0,555 0,4217825814 9,11771160887317E-19 Ductal
pgrmc1 0,53 0,513 0,3980081151 2,56441781640847E-14 Ductal
ldhba 0,568 0,582 0,4097358901 3,95981937636002E-14 Ductal
ywhaba 0,521 0,502 0,380066492 2,4405055093968E-12 Ductal
hmgn7 0,653 0,705 0,2801099746 8,13595437104151E-09 Ductal
ywhabb 0,522 0,545 0,3136010184 0,000004005 Ductal
ywhae1 0,559 0,605 0,2846180127 0,0007994639 Ductal
spink4 0,987 0,291 4,3052089436 9.99988867182683e-321 Acinar
ctrl 0,998 0,676 4,203908781 9.99988867182683e-321 Acinar
si:ch211-240l19.8 0,998 0,837 3,8546715477 9.99988867182683e-321 Acinar
cpa5 0,998 0,587 3,846381946 9.99988867182683e-321 Acinar
CELA1 (1 of many).1 0,995 0,372 3,8233267606 9.99988867182683e-321 Acinar
cel.1 0,991 0,594 3,748973483 9.99988867182683e-321 Acinar
amy2a 0,995 0,364 3,7204132208 9.99988867182683e-321 Acinar
zgc:92590 0,998 0,651 3,65028612 9.99988867182683e-321 Acinar
cel.2 0,995 0,407 3,624424639 9.99988867182683e-321 Acinar
si:ch211-240l19.6 0,993 0,603 3,5877116138 9.99988867182683e-321 Acinar
si:ch211-240l19.7 0,984 0,277 3,50764717 9.99988867182683e-321 Acinar
cpa1 0,991 0,244 3,4542659925 9.99988867182683e-321 Acinar
si:ch211-240l19.5 0,996 0,54 3,43130585 9.99988867182683e-321 Acinar
zgc:112368 0,984 0,213 3,151342391 9.99988867182683e-321 Acinar
si:dkey-14d8.6 0,991 0,382 3,1473839222 9.99988867182683e-321 Acinar
sycn.2 0,991 0,394 3,1146479782 9.99988867182683e-321 Acinar
c6ast3 0,993 0,399 3,0482208009 9.99988867182683e-321 Acinar
zgc:136461 0,954 0,221 2,9919195279 9.99988867182683e-321 Acinar
si:dkey-14d8.7 0,982 0,223 2,9330275856 9.99988867182683e-321 Acinar
pla2g1b 0,976 0,173 2,8579912602 9.99988867182683e-321 Acinar
sycn.1 0,984 0,446 2,8463031313 9.99988867182683e-321 Acinar
pglyrp6 0,934 0,065 2,8393861581 9.99988867182683e-321 Acinar
zgc:92137 0,952 0,052 2,5335246051 9.99988867182683e-321 Acinar
CELA1 (1 of many).4 0,938 0,08 2,4814513293 9.99988867182683e-321 Acinar
pdia2 0,971 0,061 2,3970504739 9.99988867182683e-321 Acinar
si:ch211-195b11.3 0,954 0,125 2,2972844007 9.99988867182683e-321 Acinar
CT027638.1 0,969 0,35 2,2531787278 9.99988867182683e-321 Acinar
CELA1 (1 of many) 0,941 0,11 2,2073210873 9.99988867182683e-321 Acinar
endou 0,941 0,082 2,0424565282 9.99988867182683e-321 Acinar
cpa2 0,936 0,057 2,0390823598 9.99988867182683e-321 Acinar
c6ast4 0,931 0,125 2,0266574803 9.99988867182683e-321 Acinar
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cpa4 0,932 0,053 2,0145444248 9.99988867182683e-321 Acinar
gamt 0,952 0,22 1,8069031817 9.99988867182683e-321 Acinar
CR753876.1 0,846 0,017 1,6779671966 9.99988867182683e-321 Acinar
CELA1 (1 of many).3 0,867 0,138 1,6256795722 9.99988867182683e-321 Acinar
dnase1 0,879 0,024 1,5986074131 9.99988867182683e-321 Acinar
bhmt 0,91 0,087 1,4992861571 9.99988867182683e-321 Acinar
aqp12 0,892 0,107 1,453926951 9.99988867182683e-321 Acinar
ahcy 0,907 0,21 1,4027495294 9.99988867182683e-321 Acinar
AL845362.1 0,636 0,011 0,7797172858 9.99988867182683e-321 Acinar
pck1 0,523 0,031 0,6224195392 9.99988867182683e-321 Acinar
cox6b1 0,589 0,057 0,5851435761 9.99988867182683e-321 Acinar
pabpc4 0,506 0,004 0,5788997295 9.99988867182683e-321 Acinar
mat1a 0,565 0,016 0,5649800221 9.99988867182683e-321 Acinar
gapdh 0,75 0,117 0,6660830228 1,8554010176391E-272 Acinar
cox5b2 0,548 0,069 0,4745801007 2,9611195595337E-253 Acinar
wu:fj16a03 0,583 0,091 0,8602536463 8,8093316733437E-226 Acinar
hdlbpa 0,799 0,257 0,8607007973 3,2579298841348E-208 Acinar
apoa1b 0,589 0,115 0,8237720966 1,1794381654546E-184 Acinar
tfa 0,548 0,096 0,7163309348 3,1950551837912E-184 Acinar
fabp10a 0,627 0,162 1,2411683247 6,567963524787E-166 Acinar
apoc1 0,598 0,144 0,9622399008 2,0913975862847E-163 Acinar
fkbp11 0,695 0,229 0,6896182262 2,2265318156437E-160 Acinar
SERP1 0,951 0,892 0,6329263308 1,4331460631943E-145 Acinar
apoa2 0,638 0,253 1,1557426059 2,94286064588827E-111 Acinar
snd1 0,625 0,227 0,4912524407 4,5174336916398E-100 Acinar
sec61a1 0,693 0,33 0,4641493134 8,91855878917427E-81 Acinar
dap 0,742 0,462 0,5320164537 2,78745805016103E-74 Acinar
idh2 0,691 0,353 0,5499041597 1,50125972046268E-68 Acinar
eef1da 0,837 0,591 0,3008538073 5,57633450961463E-51 Acinar
ndufa6 0,651 0,355 0,3350414418 1,44448331502174E-43 Acinar
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Gene Pct.Cluster Pct.Others Avg_LogFC Pval_Adjusted Cluster
CELA2A 0,963 0,118 3,69159456 9.99988867182683e-321 Acinar
CELA2B 0,78 0,025 1,8007152793 9.99988867182683e-321 Acinar
CELA3A 0,976 0,287 4,4743024454 9.99988867182683e-321 Acinar
CELA3B 0,933 0,155 4,0764600663 9.99988867182683e-321 Acinar
CLPS 0,92 0,211 4,1457941019 9.99988867182683e-321 Acinar
CPA1 0,987 0,251 4,0452616515 9.99988867182683e-321 Acinar
CPA2 0,988 0,153 3,2803373415 9.99988867182683e-321 Acinar
CTRB1 0,995 0,284 4,2425369446 9.99988867182683e-321 Acinar
CTRB2 0,999 0,366 4,0929445974 9.99988867182683e-321 Acinar
CTRC 0,983 0,125 3,2211106212 9.99988867182683e-321 Acinar
CTRL 0,809 0,03 1,3833288441 9.99988867182683e-321 Acinar
GP2 0,863 0,113 2,3914784187 9.99988867182683e-321 Acinar
KLK1 0,951 0,046 2,1774499439 9.99988867182683e-321 Acinar
MGST1 0,923 0,157 1,2610771754 9.99988867182683e-321 Acinar
PLA2G1B 0,989 0,21 3,8668824169 9.99988867182683e-321 Acinar
PNLIP 0,961 0,17 3,4338669303 9.99988867182683e-321 Acinar
PNLIPRP1 0,946 0,1 2,7976533689 9.99988867182683e-321 Acinar
PNLIPRP2 0,919 0,103 2,4152708968 9.99988867182683e-321 Acinar
PRSS1 0,999 0,331 4,2286426217 9.99988867182683e-321 Acinar
PRSS3 0,972 0,292 2,6489707268 9.99988867182683e-321 Acinar
REG1A 0,999 0,654 3,9063561889 9.99988867182683e-321 Acinar
REG1B 0,974 0,335 3,8164305772 9.99988867182683e-321 Acinar
RNASE1 0,909 0,133 1,8558209749 9.99988867182683e-321 Acinar
SYCN 0,769 0,041 2,9593649178 9.99988867182683e-321 Acinar
UGDH 0,965 0,475 1,4144538002 9.99988867182683e-321 Acinar
EEF1A1 0,999 0,997 0,5969796523 1,23255631968705E-247 Acinar
REG1P 0,634 0,01 1,2245771466 9,83349835711324E-243 Acinar
PLTP 0,683 0,049 0,9258613332 4,17621661963916E-241 Acinar
REG3G 0,701 0,08 2,3455562064 4,24287055644744E-240 Acinar
CUZD1 0,637 0,024 2,3378752451 7,67540939214768E-236 Acinar
ANPEP 0,877 0,281 1,2261890784 1,40571351787741E-225 Acinar
PRSS2 0,758 0,247 4,331155769 1,51620343471734E-223 Acinar
ALDOB 0,74 0,143 1,6654328824 1,99710858340036E-223 Acinar
PDIA2 0,575 0,021 0,7761141138 5,15551277743122E-204 Acinar
BCAT1 0,617 0,056 1,1718878504 1,01246434866152E-201 Acinar
AMY2A 0,569 0,023 1,5023079238 1,66682595152041E-201 Acinar
GSTA2 0,657 0,121 1,5887505357 2,17952958146009E-190 Acinar
RPS2 0,997 0,989 0,6346684294 1,78726913410873E-185 Acinar
CPB1 0,985 0,387 2,968904131 5,30850443709444E-173 Acinar
FAM129A 0,55 0,061 0,6023884731 1,78429564866161E-158 Acinar
RPS5 0,999 0,971 0,6032552259 3,51058965182765E-150 Acinar
GAS5 0,954 0,686 0,756148844 1,54895162130941E-149 Acinar
CXCL17 0,548 0,081 0,8128846979 2,65230694076186E-145 Acinar
RARRES2 0,552 0,091 0,8854110377 7,80410520009702E-144 Acinar
RPL10 0,999 0,979 0,8303577904 3,08576003948484E-140 Acinar
ALB 0,537 0,109 1,9153073951 2,72487074955642E-135 Acinar
EEF1B2 0,995 0,913 0,6755287445 4,81171840307148E-134 Acinar
RPL12 0,995 0,896 0,6554967974 2,78206944031423E-131 Acinar
RPS6 1 0,992 0,3398338038 4,53987068117679E-129 Acinar
IL32 0,988 0,828 0,8907888012 3,3539413000264E-123 Acinar
RPL13 1 0,996 0,3723836111 1,88556867830189E-120 Acinar
FTH1 1 0,994 0,5519495588 2,25542983954903E-119 Acinar
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SERPINB1 0,946 0,697 0,700875189 3,13277972767638E-114 Acinar
RPL35A 1 0,976 0,406020308 3,2021441766415E-111 Acinar
CEL 0,721 0,063 2,0209896629 3,38668192073684E-104 Acinar
GSTA1 0,618 0,244 1,30480373 4,10035191279992E-101 Acinar
RPLP0 1 0,983 0,5345026808 9,68763851243476E-100 Acinar
TRIB2 0,594 0,194 0,4983695287 1,98080237335674E-99 Acinar
F3 0,656 0,231 0,5517757875 7,30586683214951E-97 Acinar
SERPINA3 0,993 0,811 0,7879671359 1,02163253057658E-95 Acinar
RPL32 1 0,982 0,3650028394 4,7355973948119E-95 Acinar
RPL14 0,997 0,969 0,430689301 1,65615714429525E-94 Acinar
GNB2L1 1 0,967 0,4142959841 1,73207888553804E-94 Acinar
MT1G 0,562 0,192 1,6522486258 1,12827564007061E-93 Acinar
RPS4Y1 0,832 0,528 0,441351847 1,00458462962749E-87 Acinar
PABPC4 0,858 0,554 0,4898276532 1,9857709346736E-84 Acinar
RPS12 1 0,98 0,4332919701 4,61000684393515E-83 Acinar
GLTSCR2 0,936 0,64 0,3787967487 2,21136315607796E-82 Acinar
REG3A 0,565 0,274 3,154802064 6,51265986286449E-79 Acinar
IMPDH2 0,884 0,574 0,4736499028 8,5926959746403E-79 Acinar
RPL36A 0,924 0,884 0,4904836719 2,45137518625211E-74 Acinar
RPL36 0,999 0,96 0,40007721 2,13657275821817E-73 Acinar
AKR1C3 0,761 0,424 0,6432164974 5,66051007880874E-73 Acinar
RPL13A 0,999 0,994 0,3595134435 6,04444356060402E-73 Acinar
PTGR1 0,7 0,395 0,7943609869 2,39212528636405E-70 Acinar
RPL18A 0,996 0,952 0,4920161234 5,08715720861832E-70 Acinar
RPS9 0,999 0,98 0,4257392223 6,3349119764003E-69 Acinar
FKBP11 0,717 0,413 0,3017440615 1,89120184037145E-68 Acinar
TKT 0,961 0,782 0,4589731328 8,87802574108057E-67 Acinar
RPS8 0,999 0,994 0,2982126204 4,28671746033305E-66 Acinar
SLC25A37 0,82 0,493 0,3814176878 6,42516806571049E-65 Acinar
SNHG5 0,93 0,731 0,5081248984 7,82319001066975E-65 Acinar
GALNT2 0,811 0,497 0,3949290386 8,61971876758814E-64 Acinar
SORD 0,612 0,291 0,3568280217 4,27920058904509E-61 Acinar
EEF1D 0,969 0,852 0,3870248816 2,1543926838258E-60 Acinar
RPS18 0,983 0,967 0,3581101666 3,71595086384794E-60 Acinar
PGM1 0,72 0,403 0,2727954375 8,48601435021901E-60 Acinar
RPL35 0,997 0,954 0,4487200758 1,24451597433405E-58 Acinar
RPL8 0,998 0,991 0,3111632901 1,41289738996855E-56 Acinar
RPL9 0,972 0,865 0,3770281524 2,43700279356701E-55 Acinar
RPL29 0,974 0,892 0,4825162195 5,09237240161323E-55 Acinar
NOB1 0,695 0,357 0,2915666398 4,24775036953302E-54 Acinar
GATM 0,813 0,526 0,5431069775 3,50110445911395E-53 Acinar
CEBPD 0,862 0,579 0,4223402001 1,29638924448768E-50 Acinar
HSPA8 0,968 0,879 0,4051364509 4,06244316879597E-50 Acinar
SRM 0,72 0,4 0,2638877596 7,36120788480655E-48 Acinar
POLR1D 0,861 0,608 0,3228834079 9,68489588868074E-48 Acinar
RPS20 0,997 0,977 0,2598253566 1,40774911271311E-47 Acinar
RPSA 0,99 0,95 0,4183427794 3,55806596149529E-47 Acinar
RPS14 0,996 0,977 0,2732596707 2,84892837351813E-45 Acinar
P4HB 0,978 0,906 0,2793313369 3,96989153831383E-42 Acinar
AGTRAP 0,702 0,433 0,4323588825 1,4736769300758E-38 Acinar
ACTG1 1 0,998 0,4859390321 2,08441350970863E-37 Acinar
SOD2 0,982 0,886 0,4204082527 1,26464885704807E-35 Acinar
HNRNPA1L2 0,793 0,536 0,2781874429 5,99168035692148E-32 Acinar
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OAF 0,667 0,409 0,5179853681 5,82829788231313E-31 Acinar
C15orf48 0,61 0,415 0,480877003 1,65975914891366E-30 Acinar
CA12 0,571 0,346 0,4518125715 1,58754216043435E-29 Acinar
TC2N 0,682 0,473 0,3049931015 3,89560771205314E-29 Acinar
AKR1C2 0,516 0,303 0,6570363457 9,99065788277678E-27 Acinar
RPS26 0,904 0,835 0,2884948745 3,48973157158103E-25 Acinar
RPL13AP17 0,648 0,508 0,2709578029 5,50131092146591E-22 Acinar
GLUL 0,812 0,615 0,4032086706 1,21720539481378E-20 Acinar
CYB5A 0,792 0,67 0,272853658 8,59726925312305E-14 Acinar
VGF 0,969 0,833 0,8601649466 1,52342913952852E-215 Alpha
GLS 0,797 0,502 1,0235319312 6,49903189993781E-203 Alpha
CD99L2 0,584 0,27 0,6312123367 7,42925478984952E-194 Alpha
SPINT2 0,979 0,964 0,5067501504 1,70064637941393E-121 Alpha
SLC7A2 0,926 0,702 1,0754368618 1,57114691725894E-93 Alpha
MAFB 0,792 0,649 0,5065535368 6,27752744917625E-81 Alpha
CAMK2G 0,602 0,265 0,8732809359 3,27538518533574E-75 Alpha
PCSK2 0,965 0,92 0,8292619507 1,01928737058129E-69 Alpha
HIGD1A 0,714 0,538 0,476468529 5,90868006393044E-61 Alpha
COTL1 0,709 0,5 0,5441207854 7,27819965511867E-58 Alpha
CRYBA2 0,685 0,402 1,6007237212 2,67912717126236E-52 Alpha
ERP29 0,879 0,785 0,2854192791 8,75109305302594E-46 Alpha
GPX3 0,96 0,896 0,5203920742 1,45021877624324E-41 Alpha
FXYD5 0,622 0,322 1,0297748475 5,24313385648336E-36 Alpha
SLC7A8 0,723 0,656 0,2824751268 4,66114309458124E-26 Alpha
RGS4 0,817 0,598 0,5509317013 5,56708114302987E-24 Alpha
PDK4 0,769 0,651 0,7159825931 3,7345122924439E-14 Alpha
TTR 1 1 1,4829570483 1,49381735735136E-11 Alpha
GCG 0,998 0,769 2,4048068851 3,35686774232259E-11 Alpha
SYT5 0,514 0,384 0,3459915821 2,55059179462462E-10 Alpha
CST3 0,972 0,954 0,3367219114 2,9197475815547E-10 Alpha
ALDH1A1 0,94 0,918 0,3058801062 2,41522715846473E-06 Alpha
IRX2 0,841 0,154 1,3073102494 0,000006632 Alpha
CDKN1C 0,714 0,461 1,8745420654 2,65805894805933E-216 Beta
DLK1 0,56 0,109 2,2643672577 1,60699871633964E-180 Beta
RPL3 0,998 0,999 0,5751108556 5,83586162903751E-176 Beta
ADCYAP1 0,792 0,191 2,0893609327 7,37756694992849E-115 Beta
MEG3 0,607 0,314 0,9067306481 1,21026144487299E-106 Beta
SLC6A6 0,539 0,212 0,8606263773 2,92537220874684E-104 Beta
MAFA 0,572 0,041 1,4229506555 2,87209943975694E-76 Beta
ERO1B 0,66 0,38 1,0382310348 8,22349456444483E-74 Beta
HADH 0,883 0,724 0,5858899238 1,95912020198405E-68 Beta
ATP6V1G1 0,903 0,864 0,2961202296 2,29378925326781E-67 Beta
G6PC2 0,653 0,496 0,6268200625 1,1542867051367E-63 Beta
NPTX2 0,571 0,306 1,0415285582 2,61109802635189E-60 Beta
SURF4 0,858 0,822 0,447994563 9,12108033327513E-57 Beta
C9orf3 0,551 0,383 0,3279724129 4,30623830911651E-55 Beta
EIF4A2 0,924 0,86 0,445200542 8,09150272653895E-52 Beta
RRAGD 0,614 0,531 0,3905157769 2,91323673716647E-48 Beta
MSI2 0,524 0,358 0,7339735839 2,17687814634181E-42 Beta
TSPAN13 0,705 0,686 0,4378083583 2,83761197200997E-31 Beta
PPP1R1A 0,845 0,864 0,4260213253 4,19891031343563E-31 Beta
GAPDH 0,996 0,987 0,5180170213 1,72190833957654E-29 Beta
ZNF395 0,602 0,586 0,6222199228 1,99376518871962E-28 Beta
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YWHAQ 0,869 0,796 0,2726649564 2,16682660541859E-27 Beta
C1QL1 0,644 0,45 0,6342884224 3,73570329443374E-26 Beta
FBXO16 0,537 0,465 0,7173639099 3,71081272402035E-25 Beta
TSC22D1 0,818 0,692 0,8496934577 1,6422977492076E-23 Beta
VEGFA 0,793 0,745 0,3216421953 4,02446632061277E-20 Beta
GAD2 0,884 0,873 0,6039079339 4,00725841462798E-18 Beta
DYNLT3 0,563 0,513 0,2874510192 4,8254902235567E-15 Beta
SREBF1 0,506 0,466 0,2524269539 3,57919690641169E-13 Beta
INS 0,998 0,962 4,2879155194 1,44178898331504E-12 Beta
DNAJB9 0,666 0,554 0,3666207655 5,06218692978171E-12 Beta
DNAJC12 0,745 0,667 0,295099149 3,62289697131742E-10 Beta
PDX1 0,572 0,517 0,4481838725 7,16067538007134E-09 Beta
IAPP 0,967 0,846 3,6221970091 2,06537970235971E-08 Beta
SYT13 0,573 0,523 0,3604700692 2,32137261958594E-06 Beta
CNP 0,639 0,582 0,2501174903 0,0002347444 Beta
PLCXD3 0,624 0,508 0,260404075 0,0002746961 Beta
HSP90B1 0,866 0,854 0,4559916112 0,0005725487 Beta
SCD 0,717 0,678 0,3806323734 0,0006089205 Beta
RBP4 0,973 0,606 1,4371511168 2,78021606663511E-212 Delta
PCP4 0,828 0,601 0,4691605954 1,3937926210722E-43 Delta
RGS2 0,674 0,288 1,201825629 1,98431797016863E-41 Delta
SEC11C 0,955 0,85 0,6648399306 5,36612693132981E-36 Delta
DHRS2 0,712 0,491 0,450766932 1,38324499582327E-34 Delta
HHEX 0,529 0,327 0,5014926301 1,42340440610336E-29 Delta
SST 0,995 0,885 3,0231334376 2,63640543493176E-12 Delta
PSIP1 0,522 0,358 0,3918935667 2,50662902613556E-09 Delta
NLRP1 0,684 0,696 0,2756040318 0,0002171965 Delta
PMEPA1 0,936 0,516 2,1664103019 2,43980458184273E-295 Ductal
SERPING1 0,848 0,302 2,0441181697 2,6328826954233E-267 Ductal
MMP7 0,756 0,126 2,2650118164 5,86596636333835E-256 Ductal
S100A14 0,735 0,098 1,3914616732 6,9637819926158E-247 Ductal
ATP1A1 0,955 0,788 1,2537392904 7,27942086491743E-245 Ductal
ONECUT2 0,576 0,125 1,2529453426 5,72386147114614E-243 Ductal
ANXA2 0,989 0,913 1,3074369515 5,77950333562933E-238 Ductal
FLNA 0,832 0,277 1,6578837475 3,20057988605874E-236 Ductal
CFTR 0,684 0,104 2,0837802873 1,67429032696877E-230 Ductal
TFPI2 0,626 0,042 1,572984309 1,41027618268196E-223 Ductal
ALDH1A3 0,629 0,084 1,627508757 4,97347070083383E-210 Ductal
PPAP2C 0,693 0,148 1,1571621504 2,2915295801522E-208 Ductal
TPM4 0,874 0,598 0,881820932 8,13948108700579E-200 Ductal
KRT7 0,933 0,672 1,4151265722 6,67706529570305E-199 Ductal
IFITM2 0,824 0,454 1,3059716394 7,16175215514656E-197 Ductal
QSOX1 0,752 0,373 0,8145397581 7,19826204544392E-181 Ductal
TACSTD2 0,952 0,732 1,1467619027 1,59107654899038E-178 Ductal
TPM1 0,913 0,639 1,1077910751 9,31863073029105E-176 Ductal
COL18A1 0,731 0,088 1,3546869518 2,70239099307185E-173 Ductal
ANXA4 0,847 0,435 1,4872271453 3,66837385614964E-171 Ductal
GYPC 0,5 0,022 0,7976943522 4,06278598247728E-171 Ductal
SERPINA5 0,648 0,202 1,7298413871 1,8106146809433E-162 Ductal
DUSP1 0,834 0,543 1,0428537794 5,51587067004299E-161 Ductal
JUP 0,894 0,709 0,9907151882 7,0187546723551E-160 Ductal
ANXA3 0,615 0,151 1,0092449632 1,06488467630793E-158 Ductal
STOM 0,526 0,156 0,779686001 1,08784572301028E-158 Ductal
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SERINC2 0,877 0,591 1,2406064003 5,24175424233677E-158 Ductal
LAMC2 0,723 0,305 1,5349806536 2,46501589971136E-155 Ductal
ITGA5 0,56 0,101 0,9759217359 1,34436288007517E-152 Ductal
IER3 0,93 0,647 0,9583412062 1,14242542312951E-151 Ductal
MALL 0,589 0,115 1,1296536897 1,1354898920069E-150 Ductal
WWTR1 0,585 0,159 0,897782743 2,2149688038377E-147 Ductal
SPP1 0,63 0,254 1,4306337148 4,38789908163912E-147 Ductal
ANXA11 0,908 0,827 0,7896263536 1,64884049307359E-143 Ductal
ACTN4 0,962 0,872 0,9669487616 2,99509640066141E-142 Ductal
HSPG2 0,505 0,076 1,0109439907 5,96618885123092E-141 Ductal
CCL2 0,579 0,13 1,7667337028 4,91203143280828E-139 Ductal
ACTB 0,995 0,992 0,8663317718 4,17515470092534E-137 Ductal
TNFAIP2 0,543 0,115 1,3421466142 2,46472190109172E-136 Ductal
SLC2A1 0,554 0,197 0,7832620328 1,30950123066384E-134 Ductal
TMSB10 0,982 0,937 0,9709720055 5,35818925637628E-133 Ductal
CLDN1 0,779 0,518 1,0347263355 1,0508794016132E-132 Ductal
S100A16 0,81 0,518 1,1817936384 4,38552822464946E-129 Ductal
AHNAK 0,644 0,259 1,0369251616 4,22614891591477E-128 Ductal
CTSH 0,633 0,259 1,3328031769 4,06402907521807E-127 Ductal
SDC1 0,529 0,128 0,9045348147 1,34122984174739E-125 Ductal
CCND1 0,559 0,224 0,8640046196 3,0489856586721E-125 Ductal
ELF3 0,93 0,812 0,906350317 1,41416459342134E-120 Ductal
WDR1 0,795 0,606 0,7707634857 1,43380538150709E-120 Ductal
PFN1 0,919 0,85 0,6083836737 8,88199911889081E-118 Ductal
MYOF 0,539 0,151 0,755091394 1,21734237171213E-116 Ductal
S100A11 0,988 0,976 0,7391934456 1,80720759632237E-116 Ductal
TGFA 0,564 0,19 0,8335050703 6,49063795495022E-116 Ductal
ITGA3 0,713 0,399 0,9090411173 2,23889472300785E-114 Ductal
CAPN1 0,8 0,595 0,7997504834 3,66405663136225E-113 Ductal
ITGB5 0,605 0,304 0,5909370894 3,62118472292275E-112 Ductal
TSPAN15 0,656 0,322 0,915575774 4,84118992835638E-111 Ductal
LAD1 0,785 0,618 0,8338035189 5,8492417136323E-111 Ductal
PRDX1 0,899 0,812 0,7736279588 1,44162307309972E-110 Ductal
CITED4 0,628 0,286 0,9137259497 1,91847664891281E-108 Ductal
CNDP2 0,773 0,528 0,5882255565 1,01925730292947E-107 Ductal
DUSP5 0,633 0,303 0,8244062616 9,36815004824065E-107 Ductal
RBPMS 0,781 0,557 0,7608610116 3,27285364397504E-106 Ductal
UGCG 0,641 0,301 0,9190627387 1,59713109182636E-104 Ductal
SMAD3 0,728 0,458 0,7973177163 1,93783723191269E-104 Ductal
TNFRSF12A 0,904 0,849 0,873058682 1,5875615926745E-101 Ductal
CFL1 0,967 0,957 0,4416226634 3,07415104291112E-101 Ductal
PFKFB3 0,73 0,39 1,1452412209 6,88539558793346E-101 Ductal
PPP1R15A 0,716 0,379 0,6360290725 3,94865148232797E-100 Ductal
PDLIM3 0,533 0,174 1,1248017266 4,37202189063817E-100 Ductal
MUC20 0,577 0,22 0,9438433565 3,50923745447757E-99 Ductal
CAV2 0,626 0,294 0,8524588784 2,37108693737584E-98 Ductal
GPRC5B 0,629 0,295 0,942199941 8,03252525954192E-98 Ductal
CEBPB 0,685 0,391 0,9846165452 9,26537097170576E-98 Ductal
NCEH1 0,541 0,212 0,8037817166 2,22357944170224E-97 Ductal
NCK2 0,6 0,298 0,6868639255 3,21869896851177E-97 Ductal
B4GALT5 0,663 0,378 0,8110913375 1,41355336925099E-95 Ductal
CLDN10 0,6 0,331 1,0926759769 1,81418129198472E-93 Ductal
HSPB8 0,575 0,234 0,7726087815 1,22041423644394E-92 Ductal
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SLC44A2 0,606 0,305 0,7755375858 1,23216739714832E-92 Ductal
S100A10 0,926 0,586 1,2174160379 8,81520127258491E-92 Ductal
SLC25A23 0,564 0,286 0,493770927 2,338293716899E-91 Ductal
CNN3 0,663 0,388 0,7917884067 3,06133008423182E-89 Ductal
CAPN2 0,809 0,706 0,6545373473 5,69230966855944E-89 Ductal
MGAT4B 0,804 0,658 0,7287524237 1,37762227299486E-84 Ductal
NOTCH2 0,527 0,225 0,6448742698 1,58386248117041E-84 Ductal
CYR61 0,657 0,397 1,348093622 7,89453631758726E-84 Ductal
BTG1 0,902 0,832 0,7995133162 2,02422348276207E-83 Ductal
ARPC1B 0,842 0,684 0,4702400372 3,21217682807318E-81 Ductal
HLA.B 0,685 0,564 0,9886028485 7,20026175946113E-81 Ductal
ENO1 0,973 0,934 0,4723021414 2,70334263614886E-79 Ductal
APLP2 0,911 0,813 0,6414136388 1,24588073265633E-78 Ductal
LCN2 0,816 0,611 1,0811980986 8,51993435845139E-78 Ductal
PLAUR 0,571 0,278 1,0062327307 2,72579289586512E-77 Ductal
NDUFA4 0,828 0,799 0,6217270324 8,67340010217975E-76 Ductal
PDLIM1 0,726 0,56 0,623360514 4,71547237763415E-75 Ductal
TSPO 0,805 0,681 0,6586083737 1,09547893045406E-74 Ductal
SDHA 0,623 0,41 0,4660362206 2,10379755639266E-74 Ductal
DSG2 0,69 0,476 0,6507949302 8,9222173986896E-74 Ductal
ARL6IP1 0,792 0,602 0,5025874178 9,59544355643903E-74 Ductal
EDN1 0,56 0,247 0,9302945775 4,59717110156764E-73 Ductal
PTP4A2 0,849 0,675 0,5653434192 5,30849670548344E-72 Ductal
PRSS8 0,74 0,546 0,8302565113 9,05973827073409E-72 Ductal
PHLDA2 0,544 0,266 0,9334495782 2,78009407103779E-70 Ductal
SLC4A4 0,733 0,293 1,2570482434 1,69692580900192E-69 Ductal
GOLM1 0,717 0,531 0,7121715543 4,62254737213034E-69 Ductal
C1orf106 0,549 0,262 0,6554207102 4,65527612515423E-69 Ductal
CDC42EP1 0,849 0,792 0,677665522 4,10763642154724E-68 Ductal
LGALS3 0,773 0,613 0,6694597244 7,29868016334283E-68 Ductal
KRT18 0,952 0,957 0,6905683689 3,13660386167033E-67 Ductal
FILIP1L 0,507 0,243 0,8565375353 1,98069747696168E-66 Ductal
TNS1 0,522 0,255 0,4162921319 5,81805013255638E-66 Ductal
KRT8 0,956 0,957 0,6982358862 5,85287423844325E-66 Ductal
MYL12B 0,936 0,894 0,4491851042 2,64067192462828E-65 Ductal
SOX4 0,903 0,8 0,6747192823 4,15439961610102E-65 Ductal
BACE2 0,812 0,667 0,5578754218 4,26476467036924E-64 Ductal
KIAA1522 0,776 0,673 0,5575302777 4,13538337267479E-63 Ductal
LAMC1 0,619 0,422 0,6846297625 1,65633830183043E-62 Ductal
AGRN 0,683 0,194 1,0157986737 2,97920354923967E-62 Ductal
LBH 0,546 0,317 0,5303384556 5,78880905039959E-61 Ductal
RHOC 0,905 0,865 0,561454881 3,64842569043459E-58 Ductal
TJP2 0,635 0,415 0,4071544978 6,19855966542591E-58 Ductal
PPIC 0,609 0,426 0,5626879681 2,90321286094061E-56 Ductal
C3 0,684 0,397 0,7105506791 3,48239356363493E-56 Ductal
MYH9 0,9 0,845 0,5898171449 1,45289812330071E-55 Ductal
NAMPT 0,768 0,594 0,8154950774 2,26616953308117E-55 Ductal
ZYX 0,72 0,59 0,7262064609 1,00061132204868E-53 Ductal
TES 0,686 0,55 0,5876734542 1,01421229207319E-53 Ductal
TNIP1 0,674 0,502 0,6617437521 1,01713152231668E-53 Ductal
CAST 0,757 0,664 0,5300106467 1,07617996074763E-53 Ductal
SDCBP 0,731 0,537 0,420208184 1,1040983978991E-53 Ductal
CLDN4 0,903 0,836 0,6781067809 2,06100574930682E-53 Ductal
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CREB5 0,5 0,247 0,6408436522 2,51210161534387E-53 Ductal
SYNGR2 0,854 0,824 0,5674270028 2,74459689279213E-53 Ductal
YWHAZ 0,828 0,712 0,5417294119 2,24554023950664E-52 Ductal
TAPBP 0,87 0,757 0,3841023121 3,97007898382776E-52 Ductal
MYL12A 0,872 0,796 0,4729008533 5,25188237478071E-52 Ductal
CXADR 0,621 0,438 0,5935100117 1,71587119928223E-51 Ductal
VCL 0,602 0,416 0,6121979332 3,30240886290562E-50 Ductal
PERP 0,794 0,676 0,4521266436 1,55944586466206E-49 Ductal
CLDN3 0,595 0,412 0,5884367964 2,19101020000355E-49 Ductal
MYO1C 0,744 0,669 0,543501432 6,82552788489556E-49 Ductal
SET 0,866 0,819 0,5091233458 1,01385508131756E-48 Ductal
MYADM 0,693 0,49 0,4227070289 2,61908678215102E-48 Ductal
GNG5 0,863 0,845 0,3971389504 6,93159995384131E-48 Ductal
CTNND1 0,642 0,478 0,7312511 1,9728990741812E-47 Ductal
CTSD 0,902 0,729 1,5964008593 2,6531406933219E-47 Ductal
CBX3 0,723 0,604 0,4895871865 1,1338562521644E-46 Ductal
GIPC1 0,541 0,328 0,3433506762 6,1772192469504E-46 Ductal
MAL2 0,763 0,53 0,6240034679 1,14358027441884E-45 Ductal
EXT1 0,577 0,386 0,546229624 1,34084914261827E-45 Ductal
DYNLT1 0,734 0,628 0,3547022574 3,21724071088042E-45 Ductal
ERGIC1 0,746 0,667 0,6134456405 3,89874104786189E-45 Ductal
LMNA 0,854 0,657 0,27441642 1,08446539816344E-44 Ductal
HDGF 0,881 0,867 0,5462327564 2,39333798546649E-44 Ductal
ATP5B 0,867 0,805 0,4717089282 3,07984287456922E-44 Ductal
ANXA5 0,91 0,726 0,653339057 1,35339440670213E-43 Ductal
ZC3H12A 0,571 0,362 0,6877582731 1,49613562911361E-43 Ductal
ABCC3 0,608 0,44 0,5566994428 2,89105243491028E-43 Ductal
HIF1A 0,74 0,666 0,7082436171 2,96431593269318E-43 Ductal
PRSS22 0,553 0,377 0,6966065989 1,28064503286447E-42 Ductal
DHX15 0,566 0,386 0,3408278257 2,16131489604639E-42 Ductal
KLF6 0,866 0,775 0,574937144 2,90794397143921E-42 Ductal
SEPT9 0,76 0,366 0,5883406617 4,23409135535375E-42 Ductal
GSTP1 0,944 0,944 0,5224362306 4,34974392136407E-42 Ductal
CLDN7 0,915 0,917 0,42146044 1,05639144008496E-41 Ductal
SLC39A1 0,772 0,608 0,2994012944 1,70012553253031E-41 Ductal
TNFSF10 0,605 0,462 0,639875057 3,33316217561739E-41 Ductal
TSPAN3 0,898 0,844 0,3614595432 1,43893529289298E-40 Ductal
RAB10 0,75 0,619 0,351189004 1,50584052025976E-40 Ductal
TPGS2 0,522 0,349 0,504240713 1,155742868837E-39 Ductal
C1orf198 0,516 0,345 0,4835632718 6,85449459544614E-39 Ductal
CTNNA1 0,831 0,613 0,5833718455 7,06950092938082E-39 Ductal
ATP13A3 0,656 0,533 0,6276354557 1,76569282554634E-38 Ductal
TPI1 0,924 0,89 0,2848113004 3,52196339760808E-38 Ductal
RALA 0,526 0,353 0,3193787248 4,29115576564496E-38 Ductal
PTBP1 0,703 0,559 0,3368061101 9,55013190039407E-38 Ductal
CLINT1 0,589 0,406 0,3250693519 2,3947092933593E-37 Ductal
HN1 0,736 0,62 0,4567319401 7,66941644589307E-37 Ductal
PLSCR1 0,619 0,502 0,532829793 1,71437922963705E-36 Ductal
MAP4 0,652 0,552 0,4543551018 2,30774137797975E-36 Ductal
BCL10 0,523 0,358 0,5041991637 8,22871575185186E-36 Ductal
RAP2B 0,514 0,34 0,3642089813 9,94879775615409E-36 Ductal
WWC1 0,533 0,36 0,3367594277 1,14167230539995E-35 Ductal
STK24 0,697 0,553 0,4499697001 3,60661027986938E-35 Ductal
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DCDC2 0,516 0,167 0,6812029869 4,31105293108497E-35 Ductal
LAMB3 0,715 0,579 0,5538215684 1,01827216067042E-34 Ductal
PTPRK 0,556 0,431 0,4657889566 2,77313683590291E-34 Ductal
SH3BGRL3 0,876 0,87 0,582783011 4,5524477689416E-34 Ductal
TMEM123 0,734 0,634 0,394016746 1,191359940911E-33 Ductal
MAP1LC3B 0,736 0,703 0,4167239377 4,7759304475817E-33 Ductal
SYPL1 0,592 0,483 0,4249283078 5,76130349834149E-33 Ductal
HN1L 0,618 0,451 0,3278205898 7,68568889455006E-33 Ductal
MYH14 0,636 0,441 0,3315700489 2,68285897071425E-32 Ductal
BCL2L1 0,625 0,46 0,4384603174 2,84757731700997E-32 Ductal
ALDH3A2 0,614 0,495 0,5809693006 3,76517220464758E-32 Ductal
TAX1BP3 0,542 0,388 0,6095555251 4,53784794519289E-32 Ductal
HNRNPA0 0,726 0,569 0,2903420931 4,18404148746017E-31 Ductal
CAPNS1 0,896 0,794 0,3066658547 9,42330796663802E-31 Ductal
SEMA4B 0,619 0,41 0,3235889718 1,50967389073556E-30 Ductal
PPP1CB 0,766 0,656 0,3183669374 1,8932896256781E-30 Ductal
CDKN1A 0,792 0,627 0,3588848742 6,29454014195123E-30 Ductal
PSMA7 0,857 0,872 0,3476896521 1,69181630764049E-29 Ductal
TJP1 0,572 0,456 0,442629568 2,13653222875392E-29 Ductal
TNKS1BP1 0,516 0,387 0,4435929026 2,42503824705265E-29 Ductal
ADAM9 0,648 0,523 0,4386341242 2,61298696019212E-29 Ductal
FDFT1 0,708 0,639 0,5777152067 3,09842698455762E-29 Ductal
HADHB 0,634 0,527 0,3345673825 5,44720370944768E-29 Ductal
PGK1 0,834 0,724 0,2999876351 5,5497901168251E-29 Ductal
F11R 0,643 0,564 0,4341434832 7,2213221163562E-29 Ductal
UBE2Z 0,529 0,364 0,2785758982 1,5689248255644E-28 Ductal
STAT6 0,568 0,453 0,4287823069 3,24421042885715E-28 Ductal
MPRIP 0,517 0,371 0,4404627597 3,59349379433118E-28 Ductal
GALNT1 0,526 0,39 0,4650264207 4,2512235648679E-28 Ductal
CMPK1 0,621 0,519 0,4040015793 9,78370725852332E-28 Ductal
PSMB8 0,542 0,413 0,4261236995 1,28876382181605E-27 Ductal
IGFBP7 0,769 0,794 0,7615795846 1,29206833710666E-27 Ductal
TPM3 0,818 0,709 0,2701034144 1,6788335323103E-27 Ductal
DHCR24 0,523 0,391 0,5376608742 2,8631170950609E-27 Ductal
MSMO1 0,562 0,435 0,4507512077 8,88850622378609E-27 Ductal
PNRC1 0,799 0,757 0,4761905958 1,67021420072784E-26 Ductal
UBALD2 0,674 0,595 0,5395214026 2,15944682448416E-26 Ductal
MACF1 0,659 0,527 0,3783375131 2,92801943343806E-26 Ductal
NECAP2 0,508 0,383 0,4054134056 1,06423438764426E-25 Ductal
HMGA1 0,728 0,654 0,8909425727 2,72392302530499E-25 Ductal
TRIP6 0,522 0,413 0,4657951062 1,020579606668E-24 Ductal
RNPEP 0,549 0,455 0,4362766663 1,06294823367227E-24 Ductal
ARL6IP5 0,65 0,502 0,2798918395 1,24825501127312E-24 Ductal
PIM3 0,717 0,609 0,4976628947 2,63398198719688E-24 Ductal
IL4R 0,568 0,467 0,497062984 3,41430556736633E-24 Ductal
SDC4 0,884 0,833 0,4318823531 1,96696145861189E-23 Ductal
ATF3 0,625 0,548 0,7903605747 3,43848331240079E-23 Ductal
UBE2I 0,739 0,722 0,3678182603 1,8134304782738E-22 Ductal
SEL1L3 0,596 0,487 0,4562028483 2,21947567646481E-22 Ductal
B4GALT1 0,671 0,598 0,4191777516 1,05960412303267E-21 Ductal
FARP1 0,554 0,456 0,3719955837 1,45217343226879E-21 Ductal
PPDPF 0,884 0,816 0,3166923107 2,26678989238009E-21 Ductal
MSN 0,676 0,635 0,5010941191 7,1214227628297E-21 Ductal
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VASP 0,561 0,448 0,4595473491 7,79821953711585E-21 Ductal
HNRNPF 0,769 0,769 0,3407851711 1,02311026637009E-20 Ductal
MPZL1 0,615 0,548 0,3650132182 1,30993691942579E-20 Ductal
PFKP 0,725 0,47 0,4258211038 1,39526906919474E-20 Ductal
TUBB 0,912 0,952 0,3879155894 2,09377423899752E-20 Ductal
FOXO3 0,625 0,363 0,4369941227 3,88011444742262E-20 Ductal
COX5B 0,793 0,719 0,2728331518 2,77796700459711E-19 Ductal
EFNA1 0,636 0,548 0,4912783548 4,63193237294288E-19 Ductal
PKP3 0,5 0,385 0,4107798982 5,01185982569046E-19 Ductal
TRIM47 0,519 0,408 0,3932902502 7,75262892853933E-19 Ductal
ATP1B1 0,729 0,636 0,4440630351 1,01725373505798E-18 Ductal
CCDC6 0,538 0,44 0,3687891777 1,01742830149575E-18 Ductal
CERS2 0,732 0,71 0,2943898247 1,30478862108734E-18 Ductal
CDC37 0,69 0,662 0,4070019772 2,12441981525203E-18 Ductal
CTTN 0,614 0,551 0,3600743733 2,98937527795908E-18 Ductal
C8orf4 0,616 0,557 0,7471753432 3,15285273800103E-18 Ductal
IER2 0,834 0,567 0,3191039519 6,61765219869083E-18 Ductal
FAM129B 0,795 0,813 0,4414926436 7,84236987860752E-18 Ductal
CHP1 0,68 0,656 0,3483877176 1,34659510398657E-17 Ductal
TNFRSF10B 0,504 0,411 0,3844921618 2,07171352608555E-17 Ductal
RCC2 0,508 0,413 0,3740687471 2,98259165860871E-17 Ductal
TST 0,511 0,427 0,4032297629 3,69248814805919E-17 Ductal
DHRS3 0,657 0,653 0,6230707225 3,73697133521515E-17 Ductal
TUBB4B 0,792 0,816 0,4946405955 4,70627347738601E-17 Ductal
LAPTM4B 0,777 0,596 0,4338274556 4,86679790795414E-17 Ductal
LMO7 0,548 0,315 0,5490407828 5,05901348434231E-17 Ductal
ARSD 0,524 0,426 0,4068158971 5,08286364637866E-17 Ductal
MYO6 0,578 0,448 0,3488718436 6,91791722478379E-17 Ductal
IQGAP1 0,734 0,547 0,4343609348 1,2217292425177E-16 Ductal
BIRC3 0,569 0,44 0,438228683 2,00277266328545E-16 Ductal
AKAP13 0,598 0,534 0,3635564104 2,65756008990327E-16 Ductal
TMSB4X 0,997 0,997 0,2837039198 2,73774783167942E-16 Ductal
ZFP36L2 0,502 0,407 0,450323578 3,02860762294556E-16 Ductal
ACAA2 0,701 0,489 0,3792175745 7,65614077641924E-16 Ductal
KIFC3 0,526 0,433 0,4280722196 1,84976295864418E-15 Ductal
DDIT4 0,809 0,749 0,5353415868 2,324342054306E-15 Ductal
PXN 0,575 0,51 0,3924640021 5,16823555756214E-15 Ductal
TMEM51 0,627 0,569 0,3775114301 8,8699638011286E-15 Ductal
CLTB 0,597 0,539 0,4132810558 1,26203071142074E-14 Ductal
HPCAL1 0,505 0,417 0,4076891363 1,38526836771765E-14 Ductal
SP100 0,537 0,449 0,2937528822 2,41660583994101E-14 Ductal
CD151 0,707 0,717 0,3881265802 1,02413537972524E-13 Ductal
CTNNB1 0,619 0,441 0,4049978453 1,4008422244134E-13 Ductal
S100A13 0,571 0,497 0,3236148961 2,95048023308581E-13 Ductal
HADHA 0,711 0,741 0,2753689998 4,79478188848273E-13 Ductal
MYO5B 0,529 0,446 0,3030366215 7,39498348024722E-13 Ductal
NFKBIZ 0,645 0,582 0,4128861772 9,07080147248855E-13 Ductal
EIF6 0,65 0,64 0,354188577 9,43108758667128E-13 Ductal
RBM47 0,629 0,568 0,2980497618 9,57141830472188E-13 Ductal
CLMN 0,6 0,589 0,4108690727 2,1376186685878E-12 Ductal
TCP1 0,639 0,646 0,3196621983 2,21908041514642E-12 Ductal
TMEM50A 0,608 0,576 0,2985610998 2,97844554143012E-12 Ductal
GALNT3 0,508 0,407 0,3068875128 3,09369913790235E-12 Ductal
Markers SC Human
Page 10
DDAH2 0,608 0,44 0,2624431328 3,67502970181794E-12 Ductal
CSNK1E 0,68 0,475 0,3800365638 4,40273431229699E-12 Ductal
VAMP8 0,839 0,873 0,2539323288 7,3945581124507E-12 Ductal
BHLHE40 0,697 0,653 0,3809683691 1,03998335935122E-11 Ductal
EIF4G1 0,773 0,786 0,3351949152 1,32136084554446E-11 Ductal
NCOA7 0,629 0,487 0,4380408284 2,0872280396262E-11 Ductal
TMBIM1 0,897 0,916 0,2551285464 2,50626441613097E-11 Ductal
STAU1 0,687 0,694 0,2816491523 3,1442868621887E-11 Ductal
GNG12 0,68 0,492 0,2779124253 4,27428551192057E-11 Ductal
XRCC5 0,724 0,628 0,2701459664 5,94252664583236E-11 Ductal
CTBP2 0,552 0,482 0,291295567 6,04789331501011E-11 Ductal
HMGB1 0,869 0,789 0,3020703265 1,38883412772009E-10 Ductal
FLII 0,572 0,54 0,3255515452 2,10837957792595E-10 Ductal
TGIF1 0,543 0,479 0,3308602593 6,01011411866391E-10 Ductal
TMEM87A 0,569 0,512 0,293023822 8,48329527102085E-10 Ductal
DERL1 0,501 0,456 0,3026750922 1,41076164684789E-09 Ductal
ENAH 0,621 0,592 0,36477059 1,60236670415585E-09 Ductal
SUN2 0,572 0,354 0,2831826869 2,35282657016288E-09 Ductal
PPP1R14B 0,728 0,722 0,3819426387 2,63179645357196E-09 Ductal
KRT19 0,953 0,462 2,1585819391 3,64424564925321E-09 Ductal
BRI3 0,854 0,885 0,2725362762 1,10753042627981E-08 Ductal
EIF4G2 0,911 0,823 0,2656868309 1,76392147923269E-08 Ductal
LYPLA2 0,6 0,58 0,3727970873 1,77868645208789E-08 Ductal
JUN 0,867 0,69 0,3342689695 5,57247477556677E-08 Ductal
ADM 0,51 0,414 0,429772353 0,000000066 Ductal
PGD 0,508 0,457 0,3229928877 6,86826438819731E-08 Ductal
NFKBIA 0,775 0,767 0,5383822386 8,03894829565906E-08 Ductal
TFPI 0,515 0,441 0,2889369863 1,7129160067843E-07 Ductal
RELA 0,521 0,493 0,3052408575 1,75389956822097E-07 Ductal
CHMP2B 0,523 0,493 0,2693555261 1,9722138114054E-07 Ductal
HNRNPAB 0,665 0,67 0,293694959 2,23760755415264E-07 Ductal
VDAC2 0,795 0,83 0,2695874506 2,46451246528917E-07 Ductal
PICALM 0,518 0,349 0,2931112229 2,57445519571737E-07 Ductal
LASP1 0,634 0,628 0,2650517495 0,000000278 Ductal
APH1A 0,605 0,609 0,3198259798 3,89715077731062E-07 Ductal
ZFP36L1 0,927 0,932 0,326203611 0,000000542 Ductal
SYNCRIP 0,609 0,585 0,2705976425 5,46721989096314E-07 Ductal
SRSF3 0,723 0,78 0,2890721599 8,05845980736884E-07 Ductal
TINAGL1 0,796 0,038 1,6117658476 8,52873078323075E-07 Ductal
ARHGDIA 0,749 0,789 0,3009962372 9,24574570340368E-07 Ductal
ITGA2 0,588 0,543 0,4233471861 1,11070970174428E-06 Ductal
EIF1AX 0,731 0,761 0,2981089063 1,6758208392043E-06 Ductal
NFE2L2 0,613 0,625 0,2576421997 0,000004921 Ductal
GDE1 0,559 0,568 0,2934452785 4,95877075592781E-06 Ductal
MPST 0,553 0,534 0,3198777132 6,98208770281105E-06 Ductal
ELOVL1 0,629 0,641 0,2963601791 7,59585897170304E-06 Ductal
NFIB 0,573 0,526 0,2605413495 3,25546414639515E-05 Ductal
LITAF 0,872 0,462 1,1030052813 4,70375989093281E-05 Ductal
LAMP2 0,641 0,612 0,2594478851 0,000049262 Ductal
PDLIM5 0,592 0,553 0,2562451342 0,00005558 Ductal
PNPLA2 0,605 0,475 0,2584950065 8,68605719994701E-05 Ductal
BZW1 0,716 0,726 0,2704897055 0,0001870071 Ductal
HEBP1 0,505 0,488 0,2635561605 0,0008399864 Ductal
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TM4SF5 0,615 0,032 1,3693346722 3,75712617669899E-54 Epsilon
GHRL 1 0,063 6,540181084 3,99927890161298E-48 Epsilon
ACSL1 1 0,511 2,3696143168 3,7199000616629E-13 Epsilon
SPTSSB 0,962 0,428 1,7635717697 7,76812821368196E-13 Epsilon
NNMT 0,692 0,164 1,8565259231 3,07100461527844E-11 Epsilon
VTN 0,615 0,17 1,5470174046 0,000000067 Epsilon
CDKN2A 0,731 0,211 0,8246919239 5,46083371244829E-06 Epsilon
FRZB 0,731 0,294 1,4454990486 3,35028348011587E-05 Epsilon
PLAC8 0,808 0,318 0,7487469044 7,65374462727078E-05 Epsilon
HEPACAM2 0,808 0,478 1,7692727031 0,0006289325 Epsilon
ACOT7 0,538 0,16 0,8438494236 0,0008850845 Epsilon
SERTM1 0,506 0,087 0,9154259156 8,27520249248414E-135 Gamma
STMN2 0,85 0,63 0,8559542009 5,17330880650638E-59 Gamma
PAX6 0,954 0,835 0,6911687694 1,71777811645179E-51 Gamma
SLC6A4 0,518 0,244 0,7909528048 1,72756456353615E-44 Gamma
ETV1 0,673 0,421 0,693020194 3,48195757560133E-26 Gamma
SCG2 0,973 0,935 0,4596019124 9,94065170371895E-25 Gamma
CARD11 0,53 0,272 0,5274642499 4,51454976285447E-18 Gamma
ID2 0,835 0,693 0,5605926407 3,97816166434255E-17 Gamma
SCGB2A1 0,661 0,499 0,4227061326 2,23261284766201E-16 Gamma
PPY 0,995 0,577 6,1621226941 4,69402205059878E-13 Gamma
AQP3 0,818 0,759 1,1388036203 7,53453354879978E-13 Gamma
C16orf45 0,63 0,498 0,4366386787 2,72840432662841E-12 Gamma
DDR1 0,908 0,842 0,3514192831 9,18256980250636E-12 Gamma
INPP5F 0,571 0,384 0,3575533459 4,19332497138101E-11 Gamma
PTP4A3 0,709 0,577 0,5087284288 1,8234668024323E-10 Gamma
ID4 0,632 0,503 0,5108819437 2,34537968818928E-10 Gamma
MALAT1 0,976 0,97 0,469634952 5,72085783042863E-06 Gamma
FXYD2 0,811 0,72 0,3588950844 0,0004297099 Gamma
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Set of genes regulated in pax6b-/- mutant in PECs and EECs which also present a close




Gene Pax6.GRN Gene Pax6.GRN Gene Pax6.GRN
abcc9 Both hapln1a Both pou3f3a Both
acmsd Both her4.1 Both PPP1R3G Both
adcyap1b Both hmx4 Both ptn Both
aes Both hsd17b12a Both rnd1b Both
alcamb Both large2 Both rnd2 Both
arid5b Both lenep Both rnf19a Both
atf2 Both lipg Both rorab Both
atp1a3a Both lmo4a Both rtn4rl2b Both
bambib Both map2k6 Both scrt1a Both
BX284638.1 Both mdkb Both si:ch211-255p10.3 Both
BX530077.1 Both meis1b Both si:dkey-280e21.3 Both
cbfa2t2 Both nat8l Both slc7a7 Both
cd9b Both neurod1 Both sox4a Both
cdkn1ca Both nid2a Both sp8a Both
copz2 Both nlgn4a Both sprn2 Both
ctnnd2b Both nog1 Both st5 Both
dcxr Both nrp2b Both syt6a Both
dll4 Both odc1 Both tle3a Both
eif4ebp3l Both olfml3a Both trdn Both
elp4 Both pard3bb Both yjefn3 Both
etv5b Both pdgfbb Both
fam49al Both pfkfb3 Both
flna Both plch1 Both
fstl1a Both plcxd3 Both
gadd45ga Both plod2 Both
ackr3a PECs hoxa3a PECs robo2 PECs
ackr3b PECs hoxc5a PECs roraa PECs
acot11a PECs hoxc6a PECs rorcb PECs
adgrv1 PECs hs3st3b1b PECs rps12 PECs
adora2aa PECs id1 PECs rps13 PECs
afdna PECs igsf9b PECs rps19 PECs
aff4 PECs il17rd PECs rps28 PECs
afg1lb PECs il4r.1 PECs runx1t1 PECs
ak3 PECs im:7152348 PECs sall1a PECs
AMOTL1 PECs INAVA PECs sat1a.2 PECs
ANKFN1 PECs insm1b PECs scarb2a PECs
apln PECs iqgap2 PECs scrt2 PECs
arl3l1 PECs irx3b PECs sema3gb PECs
arl4aa PECs jarid2a PECs sema4ba PECs
arpp21 PECs kcnd3 PECs sema5a PECs
asb15a PECs kctd12b PECs sept12 PECs
ascl1a PECs kdm7ab PECs sept9a PECs
ascl1b PECs kirrel3l PECs serf2 PECs
asf1ba PECs klf12b PECs serpinh1b PECs
atp10a PECs kmt2a PECs shisa9b PECs
atp1b4 PECs larp1 PECs shroom3 PECs
azin1b PECs lbx1b PECs si:ch1073-209e23. PECs
baz1b PECs ldb1b PECs si:ch1073-345a8.1 PECs
bcas3 PECs ldha PECs si:ch211-149l1.2 PECs
bmp1a PECs lfng PECs si:ch211-161c3.5 PECs
bnip3lb PECs lhfpl6 PECs si:ch211-172l8.4 PECs
bod1l1 PECs lima1a PECs si:ch211-197l9.5 PECs
Pax6 bound
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btbd3a PECs llgl1 PECs si:ch211-204c21.1 PECs
BX927244.1 PECs LO016987.2 PECs si:ch211-216b21.2 PECs
c1qtnf12 PECs lrp2a PECs si:ch211-219a15.3 PECs
CABZ01073963.1 PECs lypd6 PECs si:ch211-242b18.1 PECs
CABZ01079241.1 PECs lypd6b PECs si:ch211-243j20.2 PECs
cd82a PECs mafa PECs si:ch211-246i5.5 PECs
cdkn1cb PECs mafb PECs si:ch211-282k23.2 PECs
celf2 PECs map3k10 PECs si:ch73-63e15.2 PECs
cep83 PECs mapk15 PECs si:dkey-195m11.8 PECs
cers2a PECs mapkbp1 PECs si:dkey-209n16.2 PECs
chrnb1 PECs marcksl1b PECs si:dkey-21c1.8 PECs
chrnb3a PECs mid1ip1l PECs si:dkey-225f23.5 PECs
cited2 PECs mknk2b PECs si:dkey-256e7.5 PECs
cldn5a PECs mtus1b PECs si:dkey-261m9.12 PECs
cntfr PECs myb PECs si:dkey-49n23.1 PECs
coq2 PECs mych PECs si:dkey-7j22.1 PECs
cplx2 PECs mydgf PECs si:dkey-91m11.5 PECs
CR855996.2 PECs myo10l1 PECs si:dkeyp-117b11.3 PECs
crabp2a PECs myo15b PECs si:dkeyp-41f9.4 PECs
crabp2b PECs myt1b PECs si:rp71-17i16.6 PECs
CRACR2A PECs nanos1 PECs si:rp71-62i8.1 PECs
crb2a PECs nap1l1 PECs six3a PECs
CT573817.1 PECs nbn PECs si:zfos-223e1.2 PECs
cxcl12b PECs ncoa1 PECs slc22a23 PECs
cyp1c2 PECs nelfa PECs slc25a24 PECs
cyth1b PECs nfat5a PECs slc30a2 PECs
dapk3 PECs nfatc3a PECs slc39a13 PECs
ddhd1a PECs nhlh2 PECs slc3a2a PECs
dennd2da PECs nkd1 PECs slc46a2 PECs
dgkzb PECs nlrc3l1 PECs slc6a22.1 PECs
dlc PECs notch1a PECs slc6a9 PECs
dpydb PECs nova2 PECs slc9a6a PECs
E2F2 PECs npb PECs smad1 PECs
ebf3a PECs npr1a PECs sncb PECs
ednrab PECs nr0b2a PECs sncgb PECs
eef2k PECs nr5a2 PECs snx18a PECs
efnb2a PECs nrip1b PECs sobpb PECs
egf PECs nrxn3b PECs sort1a PECs
egr3 PECs oct2 PECs sox13 PECs
elovl4b PECs otpa PECs sox1a PECs
eml1 PECs otud7b PECs sptlc2b PECs
emx2 PECs p4ha2 PECs ssbp2 PECs
enah PECs palm1b PECs st8sia1 PECs
enc2 PECs papss2b PECs stac3 PECs
epas1b PECs pax3a PECs stat3 PECs
epha3 PECs pax6a PECs stim1a PECs
etaa1 PECs pcdh18b PECs ston2 PECs
eva1a PECs pcgf1 PECs stox1 PECs
eya2 PECs pdgfab PECs syne2b PECs
fabp11a PECs PHF21B PECs tagln3a PECs
fam212b PECs phf23b PECs tanc2a PECs
fam214b PECs pik3c2b PECs tbc1d9 PECs
fam228a PECs plce1 PECs tbx2b PECs
Pax6 bound
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fam69c PECs pleca PECs tcf12 PECs
farp1 PECs pltp PECs tenm3 PECs
fbxo4 PECs plxnb1a PECs theg PECs
fgfr1b PECs polr2a PECs tiparp PECs
fgfr2 PECs pou2f2a PECs tmem151a PECs
fgfr4 PECs pou3f1 PECs tmem256 PECs
flrt3 PECs pou4f1 PECs tmem47 PECs
foxa PECs ppardb PECs tnrc18 PECs
foxb1b PECs ppox PECs trmt9b PECs
foxg1b PECs ppp1r14ba PECs trpc3 PECs
foxo3b PECs ppp2r2ba PECs trpm1b PECs
FQ311908.1 PECs prdm14 PECs tshz3a PECs
fsta PECs prdx5 PECs ttc26 PECs
fstl1b PECs prickle1b PECs tuba1c PECs
gabrb1 PECs prkcbp1l PECs tulp1a PECs
gabrb2 PECs prmt6 PECs ucn3l PECs
gadd45gb.1 PECs prrg2 PECs ush1c PECs
gapdhs PECs prtga PECs usp45 PECs
gas1a PECs ptch2 PECs usp8 PECs
gas2b PECs pth1rb PECs ust PECs
glceb PECs ptmaa PECs vax1 PECs
gna11a PECs ptmab PECs vezf1a PECs
gnai1 PECs ptpn11b PECs vezf1b PECs
gpam PECs ptprt PECs vim PECs
gpm6aa PECs qsox2 PECs vstm2l PECs
gpr158a PECs rab1ab PECs wdr19 PECs
grapa PECs rad1 PECs wnt7aa PECs
gria1a PECs ralbp1 PECs ypel3 PECs
gria3a PECs rarab PECs zeb1a PECs
gsx1 PECs rasgrp3 PECs zeb1b PECs
hbegfa PECs rassf7a PECs zeb2a PECs
hepacama PECs rbpjb PECs zgc:100920 PECs
her12 PECs rcn3 PECs zgc:110045 PECs
her15.1 PECs rdh10a PECs zgc:153372 PECs
her15.2 PECs rergla PECs zgc:162939 PECs
her2 PECs rgma PECs zic2a PECs
her3 PECs rhbdl3 PECs zic5 PECs
her4.2 PECs rhoua PECs znf703 PECs
hif1an PECs rln1 PECs znrf1 PECs
hmx2 PECs rnf24 PECs
homeza PECs rnf38 PECs
abcc5 EECs fzd9b EECs rimkla EECs
abhd3 EECs galn EECs rlbp1a EECs
acana EECs gas8 EECs robo2 EECs
acsl5 EECs gata2a EECs rx3 EECs
adamts18 EECs gclm EECs scarb2c EECs
angpt2b EECs gjd1a EECs schip1 EECs
angptl4 EECs gnpat EECs sema3fa EECs
ankrd6b EECs gpr78a EECs sfxn1 EECs
ANPEP EECs hdac4 EECs si:ch211-137a8.4 EECs
atp1b3a EECs hey1 EECs si:ch211-148f13.1 EECs
atp6v0a2a EECs hic2 EECs si:ch211-195b13.1 EECs
auts2a EECs hmga1b EECs si:ch211-251b21.1 EECs
Pax6 bound
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avpr2ab EECs hoxb6a EECs si:ch211-95j8.3 EECs
CABZ01075125.1 EECs hoxb9a EECs si:ch73-386h18.1 EECs
CABZ01087623.1 EECs insm1a EECs si:dkey-30h22.11 EECs
CABZ01117603.1 EECs ism1 EECs si:dkey-85n7.6 EECs
cadps2 EECs itpkca EECs slc1a5 EECs
cbx4 EECs junbb EECs slc38a2 EECs
ccdc85ca EECs kirrel1a EECs slc38a3a EECs
ccnb1 EECs kynu EECs sncga EECs
ccne2 EECs lhfpl5a EECs sox1b EECs
cdc14b EECs LO017965.1 EECs spen EECs
cers2b EECs lrrc38b EECs spry2 EECs
chl1b EECs magi1a EECs tbrg4 EECs
col12a1a EECs mki67 EECs tbx3a EECs
col9a1b EECs mlip EECs timm10 EECs
cspg5a EECs mllt11 EECs tmem132e EECs
csrnp1b EECs mplkip EECs tmem35 EECs
cthl EECs mycn EECs tmlhe EECs
CU694264.1 EECs nmt2 EECs tnpo1 EECs
CU929160.1 EECs npy2rl EECs traf4a EECs
dhx32b EECs nr1d1 EECs trim3b EECs
dse EECs nt5dc2 EECs ttll6 EECs
efna2b EECs nyap2b EECs ttyh3b EECs
entpd2a.1 EECs oc90 EECs txnipa EECs
EPB41L2 EECs pacsin1b EECs tyms EECs
epb41l4a EECs pax2a EECs urahb EECs
epha4a EECs pax6b EECs wbp1la EECs
fam13a EECs pik3ip1 EECs wdr76 EECs
fech EECs pld2 EECs ywhaqa EECs
fgfr3 EECs plpp1a EECs zgc:101699 EECs
flvcr2b EECs pqlc2 EECs zgc:158689 EECs
FP236812.1 EECs prkd1 EECs zgc:165555 EECs
fzd10 EECs proca1 EECs zmp:0000000760 EECs
fzd7a EECs ptprt EECs
fzd9a EECs rgcc EECs
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Gene Pax6.GRN Gene Pax6.GRN Gene Pax6.GRN
meis1b Both tcf12 PECs prdm14 PECs
rorab Both egr3 PECs scrt2 PECs
scrt1a Both zeb1a PECs mych PECs
arid5b Both ascl1a PECs sox1a PECs
pou3f3a Both her2 PECs tulp1a PECs
sox4a Both hmx2 PECs jarid2a PECs
atf2 Both nfat5a PECs sall1a PECs
etv5b Both nr5a2 PECs mafb PECs
hmx4 Both vezf1a PECs insm1b PECs
sp8a Both CABZ01079241.1 PECs lbx1b PECs
neurod1 Both ascl1b PECs nhlh2 PECs
pou2f2a PECs foxb1b PECs id1 PECs
ppardb PECs vezf1b PECs rarab PECs
hoxc6a PECs zeb2a PECs sox13 PECs
E2F2 PECs nr0b2a PECs epas1b PECs
nfatc3a PECs six3a PECs rx3 EECs
myt1b PECs emx2 PECs hoxb9a EECs
vax1 PECs foxa PECs insm1a EECs
irx3b PECs ebf3a PECs junbb EECs
zic5 PECs homeza PECs nr1d1 EECs
foxo3b PECs aff4 PECs pax2a EECs
foxg1b PECs gsx1 PECs sox1b EECs
myb PECs hoxa3a PECs csrnp1b EECs
zeb1b PECs pou3f1 PECs tbx3a EECs
hoxc5a PECs tbx2b PECs gata2a EECs
pax3a PECs her12 PECs mycn EECs
smad1 PECs roraa PECs hey1 EECs
otpa PECs mafa PECs hic2 EECs
rorcb PECs stat3 PECs hoxb6a EECs
pou4f1 PECs zic2a PECs pax6b EECs
pax6a PECs her3 PECs hmga1b EECs
rbpjb PECs klf12b PECs
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